1	The	DT	O	the	det	3	SENT_1	[p1l1104t87r1148b109],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_1	[p1l1157t87r1386b116],
3	Journal	NNP	O	Journal	nsubj	18	SENT_1	[p1l1394t87r1479b115],
4	(	JJ	O	(	amod	18	SENT_1	[p1l1489t87r1565b116],
5	2004	CD	DATE	2004	dep	4	SENT_1	[p1l1489t87r1565b116],
6	)	CD	NUMBER	)	number	7	SENT_1	[p1l1489t87r1565b116],
7	4	CD	NUMBER	4	dep	5	SENT_1	[p1l1574t88r1594b114],
8	,	,	O	,	_	0	SENT_1	[p1l1574t88r1594b114],
9	49-53	CD	NUMBER	49-53	num	13	SENT_1	[p1l1604t88r1671b109],
10	©	CD	NUMBER	©	num	13	SENT_1	[p1l1105t120r1121b139],
11	2004	CD	DATE	2004	num	13	SENT_1	[p1l1129t119r1175b139],
12	Nature	NNP	O	Nature	nn	13	SENT_1	[p1l1185t120r1247b139],
13	Publishing	NNP	O	Publishing	appos	5	SENT_1	[p1l1256t119r1350b145],
14	Group	NNP	O	Group	nn	16	SENT_1	[p1l1359t119r1417b145],
15	All	NNP	O	All	nn	16	SENT_1	[p1l1425t119r1446b139],
16	rights	NNS	O	rights	nsubj	17	SENT_1	[p1l1456t119r1507b145],
17	reserved	VBD	O	reserve	rcmod	13	SENT_1	[p1l1516t119r1591b139],
18	1470-269X	NN	O	1470-269x	_	0	SENT_1	[p1l1601t119r1736b141],
19	/	:	O	/	punct	23	SENT_1	[p1l1601t119r1736b141],
20	04	CD	NUMBER	04	dep	23	SENT_1	[p1l1601t119r1736b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l1745t119r1809b140],
22	25.00	CD	MONEY	25.00	num	21	SENT_1	[p1l1745t119r1809b140],
23	www.nature.com/tp]	NN	O	www.nature.com/tp]	parataxis	18	SENT_1	[p1l1104t165r1300b190],

1	NEW	NNP	O	NEW	_	0	SENT_2	[p1l2089t81r2151b142],

1	ORIGINAL	JJ	O	original	amod	2	SENT_3	[p1l1665t229r1919b268],
2	ARTICLE	NN	O	article	_	0	SENT_3	[p1l1939t229r2149b268],

1	A	DT	O	a	det	2	SENT_4	[p1l8t365r70b436],
2	Gilbert	NNP	PERSON	Gilbert	poss	5	SENT_4	[p1l107t362r466b437],
3	's	POS	O	's	_	0	SENT_4	[p1l107t362r466b437],
4	syndrome	NN	O	syndrome	nn	5	SENT_4	[p1l505t362r935b461],
5	UGTlAl	NN	O	ugtlal	nsubj	7	SENT_4	[p1l983t364r1321b437],
6	variant	JJ	O	variant	amod	5	SENT_4	[p1l1368t364r1666b437],
7	confers	VBZ	O	confer	_	0	SENT_4	[p1l1703t362r2012b437],
8	susceptibility	NN	O	susceptibility	dobj	7	SENT_4	[p1l11t487r571b586],
9	to	TO	O	to	aux	10	SENT_4	[p1l608t496r693b562],
10	trani	VB	O	trani	xcomp	7	SENT_4	[p1l733t487r1459b562],
11	|	NN	O	|	dobj	10	SENT_4	[p1l733t487r1459b562],
12	ast	IN	O	ast	mark	14	SENT_4	[p1l733t487r1459b562],
13	—	NN	O	—	nsubj	14	SENT_4	[p1l733t487r1459b562],
14	induced	VBD	O	induce	advcl	10	SENT_4	[p1l733t487r1459b562],
15	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	14	SENT_4	[p1l15t612r832b711],

1	TM	NNP	O	TM	nn	10	SENT_5	[p1l8t799r75b833],
2	Danoff	NNP	PERSON	Danoff	nn	10	SENT_5	[p1l99t793r250b833],
3	‘	NNP	O	‘	nn	10	SENT_5	[p1l99t793r250b833],
4	DA	NNP	O	DA	nn	10	SENT_5	[p1l12t857r73b891],
5	Campbellz	NNP	O	Campbellz	nn	10	SENT_5	[p1l91t851r311b903],
6	LC	NN	O	lc	nn	10	SENT_5	[p1l12t915r62b950],
7	McCarthy3	NN	O	mccarthy3	nn	10	SENT_5	[p1l84t909r307b961],
8	KF	NN	O	kf	nn	10	SENT_5	[p1l12t973r57b1007],
9	Lewis3	NN	O	lewis3	nn	10	SENT_5	[p1l79t967r208b1008],
10	MH	NN	O	mh	nsubj	13	SENT_5	[p1l12t1031r82b1065],
11	Repasch	JJ	O	repasch	amod	12	SENT_5	[p1l106t1025r287b1077],
12	‘	NN	O	‘	dep	10	SENT_5	[p1l106t1025r287b1077],
13	AM	VBP	O	be	_	0	SENT_5	[p1l8t1090r78b1124],
14	Saunders4	JJ	O	saunders4	amod	16	SENT_5	[p1l100t1084r308b1124],
15	NK	NN	O	nk	nn	16	SENT_5	[p1l12t1148r73b1182],
16	Spurr	NN	O	spurr	nsubj	17	SENT_5	[p1l92t1142r222b1194],
17	“	CD	NUMBER	“	xcomp	13	SENT_5	[p1l92t1142r222b1194],
18	I	PRP	O	I	nsubj	19	SENT_5	[p1l12t1206r30b1249],
19	]	VBP	O	]	rcmod	17	SENT_5	[p1l12t1206r30b1249],
20	Purvis3	NN	O	purvis3	nn	21	SENT_5	[p1l53t1200r191b1240],
21	AD	NN	O	ad	dobj	19	SENT_5	[p1l8t1264r71b1298],
22	Roses4	NN	O	roses4	nn	24	SENT_5	[p1l93t1258r223b1299],
23	C-F	NN	O	c-f	nn	24	SENT_5	[p1l10t1322r78b1357],
24	Xu3	NN	O	xu3	dep	21	SENT_5	[p1l97t1316r172b1357],

1	‘	NN	O	‘	nn	3	SENT_6	[p1l10t1475r126b1504],
2	Clinical	JJ	O	clinical	amod	3	SENT_6	[p1l10t1475r126b1504],
3	Pharmacology	NN	O	pharmacology	_	0	SENT_6	[p1l137t1478r336b1511],
4	and	CC	O	and	_	0	SENT_6	[p1l347t1478r401b1504],
5	Discovery	NNP	O	Discovery	nn	45	SENT_6	[p1l412t1479r544b1511],
6	Medicine	NNP	O	Medicine	nn	45	SENT_6	[p1l554t1478r684b1509],
7	,	,	O	,	_	0	SENT_6	[p1l554t1478r684b1509],
8	Glaxo	NNP	ORGANIZATION	Glaxo	dep	45	SENT_6	[p1l11t1516r244b1546],
9	$	$	MONEY	$	amod	8	SENT_6	[p1l11t1516r244b1546],
10	mithKline	JJ	MONEY	mithkline	dep	9	SENT_6	[p1l11t1516r244b1546],
11	,	,	O	,	_	0	SENT_6	[p1l11t1516r244b1546],
12	Philadelphia	NNP	LOCATION	Philadelphia	appos	8	SENT_6	[p1l260t1516r435b1549],
13	,	,	O	,	_	0	SENT_6	[p1l260t1516r435b1549],
14	PA	NN	ORGANIZATION	pa	appos	12	SENT_6	[p1l451t1517r492b1546],
15	,	,	O	,	_	0	SENT_6	[p1l451t1517r492b1546],
16	USA	NNP	LOCATION	USA	appos	12	SENT_6	[p1l509t1516r572b1546],
17	;	:	O	;	_	0	SENT_6	[p1l509t1516r572b1546],
18	2EtioIogics	NNPS	ORGANIZATION	2EtioIogics	nn	19	SENT_6	[p1l9t1550r152b1586],
19	Ltd.	NNP	ORGANIZATION	Ltd.	dep	12	SENT_6	[p1l164t1553r222b1584],
20	,	,	O	,	_	0	SENT_6	[p1l164t1553r222b1584],
21	Medical	NNP	ORGANIZATION	Medical	nn	29	SENT_6	[p1l237t1553r347b1578],
22	Research	NNP	ORGANIZATION	Research	nn	29	SENT_6	[p1l358t1553r479b1578],
23	Council	NNP	ORGANIZATION	Council	nn	29	SENT_6	[p1l492t1553r599b1584],
24	,	,	O	,	_	0	SENT_6	[p1l492t1553r599b1584],
25	Harwell	NNP	PERSON	Harwell	appos	29	SENT_6	[p1l11t1591r120b1621],
26	,	,	O	,	_	0	SENT_6	[p1l11t1591r120b1621],
27	Oxfordshire	NNP	LOCATION	Oxfordshire	appos	29	SENT_6	[p1l137t1591r301b1621],
28	,	,	O	,	_	0	SENT_6	[p1l137t1591r301b1621],
29	UK	NNP	LOCATION	UK	appos	19	SENT_6	[p1l318t1592r363b1621],
30	;	:	O	;	_	0	SENT_6	[p1l318t1592r363b1621],
31	3Discovery	NNP	O	3Discovery	nn	32	SENT_6	[p1l377t1587r523b1623],
32	Genetics	NNP	O	Genetics	dep	12	SENT_6	[p1l534t1591r656b1621],
33	,	,	O	,	_	0	SENT_6	[p1l534t1591r656b1621],
34	GIaxoSmithKIine	NNP	ORGANIZATION	GIaxoSmithKIine	nn	37	SENT_6	[p1l11t1628r238b1653],
35	Medicines	NNP	ORGANIZATION	Medicines	nn	37	SENT_6	[p1l250t1628r386b1653],
36	Research	NNP	ORGANIZATION	Research	nn	37	SENT_6	[p1l399t1628r519b1653],
37	Centre	NNP	ORGANIZATION	Centre	appos	32	SENT_6	[p1l533t1629r628b1658],
38	,	,	O	,	_	0	SENT_6	[p1l533t1629r628b1658],
39	Gunnels	NNP	LOCATION	Gunnels	nn	41	SENT_6	[p1l11t1665r122b1690],
40	Wood	NNP	LOCATION	Wood	nn	41	SENT_6	[p1l137t1665r216b1690],
41	Road	NNP	LOCATION	Road	appos	8	SENT_6	[p1l228t1665r303b1696],
42	,	,	O	,	_	0	SENT_6	[p1l228t1665r303b1696],
43	Stevenage	NNP	LOCATION	Stevenage	appos	41	SENT_6	[p1l319t1666r466b1698],
44	,	,	O	,	_	0	SENT_6	[p1l319t1666r466b1698],
45	UK	NNP	LOCATION	UK	conj_and	3	SENT_6	[p1l483t1666r529b1696],
46	;	:	O	;	_	0	SENT_6	[p1l483t1666r529b1696],
47	4Genetics	NNP	O	4Genetics	nn	48	SENT_6	[p1l541t1662r673b1690],
48	Research	NNP	O	Research	dep	3	SENT_6	[p1l11t1703r138b1733],
49	,	,	O	,	_	0	SENT_6	[p1l11t1703r138b1733],
50	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	appos	48	SENT_6	[p1l154t1703r386b1733],
51	,	,	O	,	_	0	SENT_6	[p1l154t1703r386b1733],
52	Research	NNP	O	Research	nn	54	SENT_6	[p1l403t1703r523b1728],
53	Triangle	NNP	O	Triangle	nn	54	SENT_6	[p1l538t1703r649b1736],
54	Park	NNP	O	Park	appos	48	SENT_6	[p1l11t1740r76b1770],
55	,	,	O	,	_	0	SENT_6	[p1l11t1740r76b1770],
56	NC	NNP	O	NC	appos	48	SENT_6	[p1l92t1741r142b1770],
57	,	,	O	,	_	0	SENT_6	[p1l92t1741r142b1770],
58	USA	NNP	LOCATION	USA	appos	48	SENT_6	[p1l159t1741r213b1765],

1	Correspondence	NN	O	correspondence	_	0	SENT_7	[p1l10t1823r271b1856],
2	:	:	O	:	_	0	SENT_7	[p1l10t1823r271b1856],
3	C-F	NN	O	c-f	nn	4	SENT_7	[p1l10t1872r57b1896],
4	Xu	NN	O	xu	dep	1	SENT_7	[p1l67t1872r116b1902],
5	,	,	O	,	_	0	SENT_7	[p1l67t1872r116b1902],
6	Discovery	NNP	O	Discovery	nn	11	SENT_7	[p1l129t1871r276b1905],
7	Genetics	NNP	O	Genetics	nn	11	SENT_7	[p1l285t1871r425b1902],
8	,	,	O	,	_	0	SENT_7	[p1l285t1871r425b1902],
9	G	NNP	O	G	appos	11	SENT_7	[p1l436t1871r692b1896],
10	|	CD	NUMBER	|	num	11	SENT_7	[p1l436t1871r692b1896],
11	axoSmithK	NNP	O	axoSmithK	appos	1	SENT_7	[p1l436t1871r692b1896],
12	|	CD	NUMBER	|	num	13	SENT_7	[p1l436t1871r692b1896],
13	ine	NN	O	ine	dep	11	SENT_7	[p1l436t1871r692b1896],
14	Medicines	NNP	ORGANIZATION	Medicines	nn	16	SENT_7	[p1l11t1909r165b1934],
15	Research	NNP	ORGANIZATION	Research	nn	16	SENT_7	[p1l179t1909r313b1934],
16	Centre	NNP	ORGANIZATION	Centre	dep	1	SENT_7	[p1l327t1910r438b1939],
17	,	,	O	,	_	0	SENT_7	[p1l327t1910r438b1939],
18	Gunnels	NNP	LOCATION	Gunnels	nn	20	SENT_7	[p1l453t1909r578b1934],
19	Wood	NNP	LOCATION	Wood	nn	20	SENT_7	[p1l590t1909r682b1934],
20	Road	NNP	LOCATION	Road	appos	16	SENT_7	[p1l11t1947r95b1978],
21	,	,	O	,	_	0	SENT_7	[p1l11t1947r95b1978],
22	Stevenage	NNP	LOCATION	Stevenage	nn	24	SENT_7	[p1l110t1948r269b1980],
23	SG1	NN	O	sg1	nn	24	SENT_7	[p1l283t1948r338b1972],
24	2NY	NN	O	2ny	appos	1	SENT_7	[p1l356t1948r427b1978],
25	,	,	O	,	_	0	SENT_7	[p1l356t1948r427b1978],
26	UK	NNP	LOCATION	UK	appos	1	SENT_7	[p1l443t1948r494b1972],
27	.	.	O	.	_	0	SENT_7	[p1l443t1948r494b1972],

1	Tel	NNP	O	Tel	_	0	SENT_8	[p1l8t1985r63b2010],
2	:	:	O	:	_	0	SENT_8	[p1l8t1985r63b2010],
3	+44	CD	NUMBER	+44	number	4	SENT_8	[p1l83t1986r151b2013],
4	1438	CD	DATE	1438	num	6	SENT_8	[p1l164t1985r237b2010],
5	76	CD	DATE	76	number	6	SENT_8	[p1l251t1985r286b2010],
6	8392	CD	NUMBER	8392	dep	1	SENT_8	[p1l298t1985r373b2010],
7	Fax	NNP	O	Fax	dep	6	SENT_8	[p1l11t2035r68b2059],
8	:	:	O	:	_	0	SENT_8	[p1l11t2035r68b2059],
9	+44	CD	NUMBER	+44	number	10	SENT_8	[p1l89t2035r156b2061],
10	1438	CD	DATE	1438	dep	6	SENT_8	[p1l170t2034r243b2059],
11	76	CD	DATE	76	num	13	SENT_8	[p1l256t2034r291b2059],
12	4231	CD	DATE	4231	num	13	SENT_8	[p1l303t2034r373b2059],
13	E-mail	NN	O	e-mail	dep	10	SENT_8	[p1l11t2071r111b2097],
14	:	:	O	:	_	0	SENT_8	[p1l11t2071r111b2097],
15	cfx74267@gsk.com	NN	O	cfx74267@gsk.com	dep	1	SENT_8	[p1l125t2071r418b2105],

1	Received	VBN	O	receive	_	0	SENT_9	[p1l11t2653r154b2678],
2	:	:	O	:	_	0	SENT_9	[p1l11t2653r154b2678],
3	31	CD	DATE	31	num	4	SENT_9	[p1l169t2653r199b2678],
4	July	NNP	DATE	July	dobj	1	SENT_9	[p1l216t2653r272b2686],
5	2003	CD	DATE	2003	num	4	SENT_9	[p1l284t2653r357b2678],
6	Revised	VBN	O	revise	partmod	4	SENT_9	[p1l11t2690r134b2715],
7	:	:	O	:	_	0	SENT_9	[p1l11t2690r134b2715],
8	26	CD	DATE	26	num	9	SENT_9	[p1l148t2691r184b2715],
9	September	NNP	DATE	September	dep	4	SENT_9	[p1l198t2690r367b2723],
10	2003	CD	DATE	2003	num	9	SENT_9	[p1l379t2691r452b2715],
11	Accepted	JJ	O	accepted	dep	9	SENT_9	[p1l8t2728r161b2761],
12	:	:	O	:	_	0	SENT_9	[p1l8t2728r161b2761],
13	02	CD	DATE	02	num	14	SENT_9	[p1l174t2728r211b2753],
14	October	NNP	DATE	October	dep	4	SENT_9	[p1l224t2728r350b2753],
15	2003	CD	DATE	2003	num	14	SENT_9	[p1l362t2728r435b2753],
16	Published	VBN	O	publish	partmod	14	SENT_9	[p1l11t2765r158b2790],
17	online	NN	O	online	prep	16	SENT_9	[p1l172t2765r267b2790],
18	2	CD	DATE	2	dep	17	SENT_9	[p1l280t2766r297b2790],
19	December	NNP	DATE	December	tmod	16	SENT_9	[p1l311t2765r469b2790],
20	2003	CD	DATE	2003	num	19	SENT_9	[p1l481t2766r554b2790],

1	ABSTRACT	NN	O	abstract	nn	2	SENT_10	[p1l748t792r945b819],
2	Tranilast	NN	O	tranilast	_	0	SENT_10	[p1l747t834r901b866],
3	(	CD	NUMBER	(	num	4	SENT_10	[p1l921t834r1695b876],
4	N	NN	O	n	rcmod	2	SENT_10	[p1l921t834r1695b876],
5	-	:	O	-	_	0	SENT_10	[p1l921t834r1695b876],
6	(	NN	O	(	dep	4	SENT_10	[p1l921t834r1695b876],
7	3	CD	NUMBER	3	num	8	SENT_10	[p1l921t834r1695b876],
8	’	NN	O	’	rcmod	6	SENT_10	[p1l921t834r1695b876],
9	4	CD	NUMBER	4	dep	8	SENT_10	[p1l921t834r1695b876],
10	’	SYM	O	’	dep	8	SENT_10	[p1l921t834r1695b876],
11	-	:	O	-	_	0	SENT_10	[p1l921t834r1695b876],
12	demethoxycinnamoyl	NN	O	demethoxycinnamoyl	dep	6	SENT_10	[p1l921t834r1695b876],
13	)	SYM	O	)	dep	4	SENT_10	[p1l921t834r1695b876],
14	-	:	O	-	_	0	SENT_10	[p1l921t834r1695b876],
15	anthranilic	JJ	O	anthranilic	amod	18	SENT_10	[p1l921t834r1695b876],
16	acid	NN	O	acid	nn	18	SENT_10	[p1l1715t834r1787b866],
17	(	NN	O	(	nn	18	SENT_10	[p1l1809t835r1918b874],
18	N-5	NN	O	n-5	dep	2	SENT_10	[p1l1809t835r1918b874],
19	)	CD	NUMBER	)	num	20	SENT_10	[p1l1809t835r1918b874],
20	)	NN	O	)	nsubj	24	SENT_10	[p1l1809t835r1918b874],
21	is	VBZ	O	be	cop	24	SENT_10	[p1l1940t835r1963b866],
22	an	DT	O	a	det	24	SENT_10	[p1l1983t844r2024b866],
23	investigational	JJ	O	investigational	amod	24	SENT_10	[p1l2047t835r2149b866, p1l748t881r917b922],
24	drug	NN	O	drug	rcmod	18	SENT_10	[p1l947t881r1030b922],
25	for	IN	O	for	_	0	SENT_10	[p1l1058t881r1109b912],
26	the	DT	O	the	det	27	SENT_10	[p1l1135t881r1192b912],
27	prevention	NN	O	prevention	prep_for	24	SENT_10	[p1l1222t882r1414b922],
28	of	IN	O	of	_	0	SENT_10	[p1l1444t881r1479b912],
29	restenosis	NN	O	restenosis	prep_of	27	SENT_10	[p1l1506t882r1679b912],
30	following	VBG	O	follow	_	0	SENT_10	[p1l1706t881r1874b922],
31	percutaneous	JJ	O	percutaneous	amod	34	SENT_10	[p1l1905t885r2150b922],
32	transluminal	JJ	O	transluminal	amod	34	SENT_10	[p1l748t928r970b959],
33	coronary	JJ	O	coronary	amod	34	SENT_10	[p1l993t937r1153b969],
34	revascularization	NN	O	revascularization	prep_following	29	SENT_10	[p1l1175t928r1484b959],
35	.	.	O	.	_	0	SENT_10	[p1l1175t928r1484b959],

1	An	DT	O	a	det	2	SENT_11	[p1l1506t929r1553b959],
2	increase	NN	O	increase	nsubjpass	7	SENT_11	[p1l1577t929r1721b959],
3	in	IN	O	in	_	0	SENT_11	[p1l1743t929r1772b959],
4	bilirubin	NN	O	bilirubin	nn	5	SENT_11	[p1l1797t928r1942b959],
5	levels	NNS	O	level	prep_in	2	SENT_11	[p1l1967t928r2061b959],
6	was	VBD	O	be	auxpass	7	SENT_11	[p1l2081t937r2149b959],
7	observed	VBN	O	observe	_	0	SENT_11	[p1l749t974r911b1006],
8	in	IN	O	in	_	0	SENT_11	[p1l933t975r962b1005],
9	12	CD	PERCENT	12	num	10	SENT_11	[p1l985t975r1066b1006],
10	%	NN	PERCENT	%	prep_in	7	SENT_11	[p1l985t975r1066b1006],
11	of	IN	O	of	_	0	SENT_11	[p1l1085t975r1120b1006],
12	patients	NNS	O	patient	prep_of	10	SENT_11	[p1l1139t975r1281b1016],
13	upon	IN	O	upon	_	0	SENT_11	[p1l1301t984r1392b1016],
14	administration	NN	O	administration	prep_upon	7	SENT_11	[p1l1413t974r1673b1006],
15	of	IN	O	of	_	0	SENT_11	[p1l1694t974r1729b1006],
16	tranilast	NN	O	tranilast	prep_of	14	SENT_11	[p1l1746t974r1890b1006],
17	in	IN	O	in	_	0	SENT_11	[p1l1909t975r1938b1005],
18	a	DT	O	a	det	19	SENT_11	[p1l1959t984r1976b1006],
19	phase	NN	O	phase	prep_in	7	SENT_11	[p1l1997t974r2100b1016],
20	III	CD	NUMBER	iii	num	22	SENT_11	[p1l2122t976r2148b1005],
21	clinical	JJ	O	clinical	amod	22	SENT_11	[p1l749t1021r869b1053],
22	trial	NN	O	trial	dep	19	SENT_11	[p1l883t1021r960b1052],
23	.	.	O	.	_	0	SENT_11	[p1l883t1021r960b1052],

1	To	TO	O	to	aux	2	SENT_12	[p1l974t1023r1019b1052],
2	identify	VB	O	identify	purpcl	16	SENT_12	[p1l1034t1021r1168b1062],
3	the	DT	O	the	det	6	SENT_12	[p1l1180t1021r1237b1053],
4	potential	JJ	O	potential	amod	6	SENT_12	[p1l1252t1021r1409b1062],
5	genetic	JJ	O	genetic	amod	6	SENT_12	[p1l1424t1022r1557b1062],
6	factors	NNS	O	factor	dobj	2	SENT_12	[p1l1568t1021r1689b1053],
7	that	WDT	O	that	nsubj	9	SENT_12	[p1l1701t1021r1774b1053],
8	may	MD	O	may	aux	9	SENT_12	[p1l1787t1030r1862b1062],
9	account	VB	O	account	rcmod	6	SENT_12	[p1l1875t1025r2020b1053],
10	for	IN	O	for	_	0	SENT_12	[p1l2030t1021r2081b1052],
11	the	DT	O	the	det	13	SENT_12	[p1l2092t1021r2149b1053],
12	drug-induced	JJ	O	drug-induced	amod	13	SENT_12	[p1l749t1068r994b1109],
13	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_for	9	SENT_12	[p1l1031t1068r1382b1109],
14	,	,	O	,	_	0	SENT_12	[p1l1031t1068r1382b1109],
15	we	PRP	O	we	nsubj	16	SENT_12	[p1l1417t1077r1469b1099],
16	examined	VBD	O	examine	_	0	SENT_12	[p1l1503t1068r1679b1099],
17	polymorphisms	NNS	O	polymorphism	dobj	16	SENT_12	[p1l1715t1068r1994b1109],
18	in	IN	O	in	_	0	SENT_12	[p1l2028t1069r2058b1099],
19	the	DT	O	the	det	27	SENT_12	[p1l2092t1068r2149b1099],
20	uridine	NN	O	uridine	nn	27	SENT_12	[p1l750t1115r868b1146],
21	diphosphate	NN	O	diphosphate	nn	27	SENT_12	[p1l892t1115r1107b1156],
22	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	27	SENT_12	[p1l1128t1115r1540b1156],
23	7A1	NN	O	7a1	nn	27	SENT_12	[p1l1569t1116r1627b1146],
24	(	CD	NUMBER	(	num	27	SENT_12	[p1l1657t1115r1834b1154],
25	UGT7Al	NN	O	ugt7al	nn	27	SENT_12	[p1l1657t1115r1834b1154],
26	)	NN	O	)	nn	27	SENT_12	[p1l1657t1115r1834b1154],
27	gene	NN	O	gene	prep_in	16	SENT_12	[p1l1859t1124r1948b1156],
28	in	IN	O	in	prep	27	SENT_12	[p1l1974t1115r2003b1146],
29	over	IN	O	over	pcomp	28	SENT_12	[p1l2029t1124r2108b1146],
30	a	DT	O	a	det	32	SENT_12	[p1l2131t1124r2148b1146],
31	thousand	CD	NUMBER	thousand	num	32	SENT_12	[p1l748t1161r917b1193],
32	patients	NNS	O	patient	pobj	29	SENT_12	[p1l932t1162r1084b1203],
33	.	.	O	.	_	0	SENT_12	[p1l932t1162r1084b1203],

1	Our	PRP$	O	we	poss	2	SENT_13	[p1l1099t1162r1169b1193],
2	results	NNS	O	result	nsubj	3	SENT_13	[p1l1181t1161r1293b1193],
3	suggested	VBD	O	suggest	_	0	SENT_13	[p1l1305t1161r1488b1203],
4	that	IN	O	that	complm	21	SENT_13	[p1l1502t1161r1574b1193],
5	the	DT	O	the	det	8	SENT_13	[p1l1585t1161r1643b1193],
6	TA	NNP	O	TA	nn	8	SENT_13	[p1l1654t1163r1703b1192],
7	repeat	NN	O	repeat	nn	8	SENT_13	[p1l1716t1165r1829b1203],
8	polymorphism	NN	O	polymorphism	nsubj	21	SENT_13	[p1l1842t1161r2103b1203],
9	in	IN	O	in	_	0	SENT_13	[p1l2119t1162r2148b1192],
10	UGTiAl	NNP	O	UGTiAl	prep_in	8	SENT_13	[p1l752t1209r907b1246],
11	,	,	O	,	_	0	SENT_13	[p1l752t1209r907b1246],
12	which	WDT	O	which	nsubj	13	SENT_13	[p1l945t1208r1053b1240],
13	predisposes	VBZ	O	predispose	rcmod	8	SENT_13	[p1l1092t1208r1301b1250],
14	some	DT	O	some	det	15	SENT_13	[p1l1337t1218r1433b1240],
15	individuals	NNS	O	individual	dobj	13	SENT_13	[p1l1471t1208r1662b1240],
16	to	TO	O	to	_	0	SENT_13	[p1l1698t1212r1734b1240],
17	Gilbert	NNP	PERSON	Gilbert	poss	19	SENT_13	[p1l1771t1208r1921b1240],
18	's	POS	O	's	_	0	SENT_13	[p1l1771t1208r1921b1240],
19	syndrome	NN	O	syndrome	prep_to	13	SENT_13	[p1l1957t1208r2147b1250],
20	,	,	O	,	_	0	SENT_13	[p1l1957t1208r2147b1250],
21	predicted	VBD	O	predict	ccomp	3	SENT_13	[p1l750t1255r919b1296],
22	the	DT	O	the	det	23	SENT_13	[p1l950t1255r1007b1287],
23	susceptibility	NN	O	susceptibility	dobj	21	SENT_13	[p1l1037t1255r1271b1296],
24	to	TO	O	to	_	0	SENT_13	[p1l1299t1259r1335b1287],
25	tranilast-induced	JJ	O	tranilast-induced	amod	26	SENT_13	[p1l1364t1255r1668b1287],
26	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	21	SENT_13	[p1l1700t1255r2052b1296],
27	.	.	O	.	_	0	SENT_13	[p1l1700t1255r2052b1296],

1	The	DT	O	the	det	3	SENT_14	[p1l2082t1255r2149b1287],
2	(	CD	NUMBER	(	num	3	SENT_14	[p1l749t1302r954b1341],
3	TA	NNP	O	TA	dep	13	SENT_14	[p1l749t1302r954b1341],
4	)	NN	O	)	dep	3	SENT_14	[p1l749t1302r954b1341],
5	;	:	O	;	_	0	SENT_14	[p1l749t1302r954b1341],
6	/	:	O	/	punct	9	SENT_14	[p1l749t1302r954b1341],
7	(	CD	NUMBER	(	num	9	SENT_14	[p1l749t1302r954b1341],
8	TA	NNP	O	TA	nn	9	SENT_14	[p1l749t1302r954b1341],
9	)	NN	O	)	nsubj	13	SENT_14	[p1l749t1302r954b1341],
10	;	:	O	;	_	0	SENT_14	[p1l749t1302r954b1341],
11	genotype	NN	O	genotype	dep	9	SENT_14	[p1l977t1306r1149b1343],
12	was	VBD	O	be	cop	13	SENT_14	[p1l1171t1311r1239b1333],
13	present	JJ	DATE	present	dep	29	SENT_14	[p1l1263t1306r1396b1343],
14	in	IN	O	in	_	0	SENT_14	[p1l1419t1303r1448b1333],
15	39	CD	PERCENT	39	num	16	SENT_14	[p1l1474t1303r1555b1333],
16	%	NN	PERCENT	%	prep_in	13	SENT_14	[p1l1474t1303r1555b1333],
17	of	IN	O	of	_	0	SENT_14	[p1l1579t1302r1614b1333],
18	the	DT	O	the	det	21	SENT_14	[p1l1634t1302r1692b1333],
19	127	CD	NUMBER	127	num	21	SENT_14	[p1l1717t1303r1783b1333],
20	hyperbilirubinemic	JJ	O	hyperbilirubinemic	amod	21	SENT_14	[p1l1808t1302r2150b1343],
21	patients	NNS	O	patient	prep_of	16	SENT_14	[p1l750t1349r892b1390],
22	vs	CC	O	vs	_	0	SENT_14	[p1l914t1358r947b1380],
23	7	CD	PERCENT	7	num	24	SENT_14	[p1l968t1349r1025b1380],
24	%	NN	PERCENT	%	prep_of	16	SENT_14	[p1l968t1349r1025b1380],
25	of	IN	O	of	_	0	SENT_14	[p1l1046t1349r1081b1380],
26	the	DT	O	the	det	28	SENT_14	[p1l1100t1348r1158b1380],
27	909	CD	NUMBER	909	num	28	SENT_14	[p1l1179t1349r1246b1380],
28	controls	NNS	O	control	prep_of	24	SENT_14	[p1l1268t1348r1412b1380],
29	(	VBP	O	(	_	0	SENT_14	[p1l1433t1349r1535b1388],
30	P	NN	O	p	npadvmod	33	SENT_14	[p1l1433t1349r1535b1388],
31	=	JJ	O	=	amod	30	SENT_14	[p1l1433t1349r1535b1388],
32	2	CD	NUMBER	2	tmod	31	SENT_14	[p1l1433t1349r1535b1388],
33	>	JJR	O	>	acomp	29	SENT_14	[p1l1550t1345r1714b1388],
34	<	JJR	O	<	dep	33	SENT_14	[p1l1550t1345r1714b1388],
35	1O	CD	NUMBER	1o	num	36	SENT_14	[p1l1550t1345r1714b1388],
36	’	NN	O	’	nsubj	29	SENT_14	[p1l1550t1345r1714b1388],
37	22	CD	NUMBER	22	num	38	SENT_14	[p1l1550t1345r1714b1388],
38	)	NN	O	)	dep	36	SENT_14	[p1l1550t1345r1714b1388],
39	.	.	O	.	_	0	SENT_14	[p1l1550t1345r1714b1388],

1	Rapid	JJ	O	rapid	amod	2	SENT_15	[p1l1739t1348r1836b1390],
2	identification	NN	O	identification	nsubj	20	SENT_15	[p1l1859t1348r2094b1380],
3	of	IN	O	of	_	0	SENT_15	[p1l2116t1348r2151b1380],
4	genetic	JJ	O	genetic	amod	5	SENT_15	[p1l749t1460r882b1501],
5	factors	NNS	O	factor	prep_of	2	SENT_15	[p1l895t1459r1016b1491],
6	accounting	VBG	O	account	partmod	5	SENT_15	[p1l1031t1460r1232b1501],
7	for	IN	O	for	_	0	SENT_15	[p1l1247t1459r1298b1491],
8	the	DT	O	the	det	11	SENT_15	[p1l1311t1459r1368b1491],
9	observed	VBN	O	observe	amod	11	SENT_15	[p1l1383t1459r1546b1491],
10	adverse	JJ	O	adverse	amod	11	SENT_15	[p1l1562t1459r1698b1491],
11	effect	NN	O	effect	prep_for	6	SENT_15	[p1l1713t1459r1813b1491],
12	during	IN	O	during	_	0	SENT_15	[p1l1827t1459r1944b1501],
13	the	DT	O	the	det	14	SENT_15	[p1l1960t1459r2018b1491],
14	course	NN	O	course	prep_during	11	SENT_15	[p1l2033t1469r2149b1491],
15	of	IN	O	of	_	0	SENT_15	[p1l749t1506r784b1537],
16	a	DT	O	a	det	19	SENT_15	[p1l807t1515r824b1537],
17	double-blind	JJ	O	double-blind	amod	19	SENT_15	[p1l850t1506r1081b1537],
18	clinical	JJ	O	clinical	amod	19	SENT_15	[p1l1107t1506r1228b1537],
19	trial	NN	O	trial	prep_of	14	SENT_15	[p1l1253t1506r1319b1537],
20	demonstrated	VBD	O	demonstrate	_	0	SENT_15	[p1l1345t1506r1598b1537],
21	the	DT	O	the	det	23	SENT_15	[p1l1623t1506r1681b1537],
22	potential	JJ	O	potential	amod	23	SENT_15	[p1l1707t1506r1864b1547],
23	application	NN	O	application	dobj	20	SENT_15	[p1l1891t1506r2090b1547],
24	of	IN	O	of	_	0	SENT_15	[p1l2116t1506r2151b1537],
25	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	23	SENT_15	[p1l750t1553r1084b1594],
26	in	IN	O	in	_	0	SENT_15	[p1l1122t1553r1151b1584],
27	the	DT	O	the	det	29	SENT_15	[p1l1189t1553r1246b1584],
28	clinical	JJ	O	clinical	amod	29	SENT_15	[p1l1284t1553r1404b1584],
29	development	NN	O	development	prep_in	20	SENT_15	[p1l1443t1553r1685b1594],
30	of	IN	O	of	_	0	SENT_15	[p1l1720t1553r1755b1584],
31	safe	JJ	O	safe	amod	34	SENT_15	[p1l1790t1553r1858b1584],
32	and	CC	O	and	_	0	SENT_15	[p1l1895t1553r1961b1584],
33	effective	JJ	O	effective	amod	34	SENT_15	[p1l1999t1553r2149b1584],
34	medicines	NNS	O	medicine	prep_of	29	SENT_15	[p1l750t1599r941b1631],
35	.	.	O	.	_	0	SENT_15	[p1l750t1599r941b1631],

1	The	DT	O	the	det	3	SENT_16	[p1l753t1646r812b1677],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_16	[p1l827t1646r1159b1687],
3	journal	NN	O	journal	_	0	SENT_16	[p1l1171t1646r1296b1685],
4	(	CD	NUMBER	(	dep	3	SENT_16	[p1l1323t1646r1441b1685],
5	2004	CD	DATE	2004	num	6	SENT_16	[p1l1323t1646r1441b1685],
6	)	NN	O	)	dep	4	SENT_16	[p1l1323t1646r1441b1685],
7	4	CD	NUMBER	4	dep	3	SENT_16	[p1l1457t1648r1489b1684],
8	,	,	O	,	_	0	SENT_16	[p1l1457t1648r1489b1684],
9	49-53	CD	NUMBER	49-53	appos	7	SENT_16	[p1l1506t1647r1629b1677],
10	.	.	O	.	_	0	SENT_16	[p1l1506t1647r1629b1677],

1	doi	FW	O	doi	_	0	SENT_17	[p1l1646t1646r2132b1687],
2	:10.1038	CD	NUMBER	:10.1038	dep	1	SENT_17	[p1l1646t1646r2132b1687],
3	/	:	O	/	punct	4	SENT_17	[p1l1646t1646r2132b1687],
4	sj	NN	O	sj	dep	2	SENT_17	[p1l1646t1646r2132b1687],
5	.	.	O	.	_	0	SENT_17	[p1l1646t1646r2132b1687],

1	tpj	NN	O	tpj	nsubj	3	SENT_18	[p1l1646t1646r2132b1687],
2	.6500221	CD	NUMBER	.6500221	num	1	SENT_18	[p1l1646t1646r2132b1687],
3	Published	VBN	O	publish	_	0	SENT_18	[p1l751t1693r919b1724],
4	online	NN	O	online	prep	3	SENT_18	[p1l936t1693r1044b1724],
5	2	CD	DATE	2	dep	4	SENT_18	[p1l1061t1694r1081b1724],
6	December	NNP	DATE	December	tmod	3	SENT_18	[p1l1099t1693r1284b1724],
7	2003	CD	DATE	2003	num	6	SENT_18	[p1l1299t1694r1389b1724],

1	Keywords	NNPS	O	Keywords	_	0	SENT_19	[p1l749t1789r920b1822],
2	:	:	O	:	_	0	SENT_19	[p1l749t1789r920b1822],
3	Gilbert	NNP	PERSON	Gilbert	poss	5	SENT_19	[p1l939t1789r1081b1814],
4	's	POS	O	's	_	0	SENT_19	[p1l939t1789r1081b1814],
5	syndrome	NN	O	syndrome	dep	1	SENT_19	[p1l1097t1789r1271b1822],
6	;	:	O	;	_	0	SENT_19	[p1l1097t1789r1271b1822],
7	pharmacogenetics	NNS	O	pharmacogenetic	dep	5	SENT_19	[p1l1289t1789r1606b1822],
8	;	:	O	;	_	0	SENT_19	[p1l1289t1789r1606b1822],
9	tranilast	NN	O	tranilast	dep	7	SENT_19	[p1l1623t1789r1775b1819],
10	;	:	O	;	_	0	SENT_19	[p1l1623t1789r1775b1819],
11	UGT1A1	NN	O	ugt1a1	dep	5	SENT_19	[p1l1793t1790r1936b1819],
12	;	:	O	;	_	0	SENT_19	[p1l1793t1790r1936b1819],
13	hyperbilirubinemia	NN	O	hyperbilirubinemia	dep	11	SENT_19	[p1l1953t1789r2149b1822, p1l749t1826r884b1852],

1	INTRODUCTION	NN	O	introduction	nn	5	SENT_20	[p1l749t2105r1036b2133],
2	Percutaneous	JJ	O	percutaneous	amod	5	SENT_20	[p1l748t2153r978b2180],
3	transluminal	JJ	O	transluminal	amod	5	SENT_20	[p1l993t2151r1215b2180],
4	coronary	JJ	O	coronary	amod	5	SENT_20	[p1l1231t2160r1386b2189],
5	revascularization	NN	O	revascularization	nsubjpass	11	SENT_20	[p1l1399t2151r1692b2180],
6	(	CD	NUMBER	(	num	8	SENT_20	[p1l1709t2152r1826b2187],
7	PTCR	NN	O	ptcr	nn	8	SENT_20	[p1l1709t2152r1826b2187],
8	)	NN	O	)	dep	5	SENT_20	[p1l1709t2152r1826b2187],
9	is	VBZ	O	be	auxpass	11	SENT_20	[p1l1842t2153r1867b2180],
10	widely	RB	O	widely	advmod	11	SENT_20	[p1l1881t2151r1996b2189],
11	used	VBN	O	use	_	0	SENT_20	[p1l2009t2151r2088b2180],
12	for	IN	O	for	_	0	SENT_20	[p1l2102t2151r2150b2180],
13	the	DT	O	the	det	14	SENT_20	[p1l748t2198r803b2226],
14	treatment	NN	O	treatment	prep_for	11	SENT_20	[p1l824t2202r995b2226],
15	of	IN	O	of	_	0	SENT_20	[p1l1015t2198r1050b2226],
16	ischemic	JJ	O	ischemic	amod	18	SENT_20	[p1l1068t2198r1220b2226],
17	heart	NN	O	heart	nn	18	SENT_20	[p1l1241t2198r1330b2226],
18	disease	NN	O	disease	prep_of	14	SENT_20	[p1l1350t2198r1478b2232],
19	;	:	O	;	_	0	SENT_20	[p1l1350t2198r1478b2232],
20	however	RB	O	however	advmod	27	SENT_20	[p1l1500t2198r1654b2232],
21	,	,	O	,	_	0	SENT_20	[p1l1500t2198r1654b2232],
22	restenosis	NN	O	restenosis	nsubj	27	SENT_20	[p1l1677t2200r1844b2226],
23	requiring	VBG	O	require	partmod	22	SENT_20	[p1l1865t2200r2025b2235],
24	repeat	NN	O	repeat	nn	25	SENT_20	[p1l2044t2202r2150b2235],
25	procedures	NNS	O	procedure	dobj	23	SENT_20	[p1l748t2245r936b2282],
26	remains	VBZ	O	remain	cop	27	SENT_20	[p1l956t2246r1092b2273],
27	problematic	JJ	O	problematic	parataxis	11	SENT_20	[p1l1112t2245r1329b2282],
28	.	.	O	.	_	0	SENT_20	[p1l1112t2245r1329b2282],

1	In	IN	O	in	_	0	SENT_21	[p1l1350t2246r1386b2273],
2	the	DT	DURATION	the	det	4	SENT_21	[p1l1405t2245r1460b2273],
3	6	CD	DURATION	6	num	4	SENT_21	[p1l1481t2246r1499b2273],
4	months	NNS	NUMBER	month	prep_in	11	SENT_21	[p1l1519t2245r1653b2273],
5	following	VBG	O	follow	_	0	SENT_21	[p1l1672t2245r1837b2282],
6	successful	JJ	O	successful	amod	7	SENT_21	[p1l1857t2245r2025b2273],
7	PTCR	NN	O	ptcr	prep_following	4	SENT_21	[p1l2045t2246r2147b2279],
8	,	,	O	,	_	0	SENT_21	[p1l2045t2246r2147b2279],
9	restenosis	NN	O	restenosis	nsubj	11	SENT_21	[p1l748t2294r916b2321],
10	may	MD	O	may	aux	11	SENT_21	[p1l936t2300r1011b2330],
11	occur	VB	O	occur	_	0	SENT_21	[p1l1030t2300r1125b2321],
12	in	IN	O	in	_	0	SENT_21	[p1l1145t2294r1179b2320],
13	up	RB	O	up	quantmod	15	SENT_21	[p1l1199t2300r1243b2330],
14	to	TO	O	to	dep	15	SENT_21	[p1l1263t2296r1297b2321],
15	50	CD	PERCENT	50	num	16	SENT_21	[p1l1319t2293r1393b2321],
16	%	NN	PERCENT	%	prep_in	11	SENT_21	[p1l1319t2293r1393b2321],
17	of	IN	O	of	_	0	SENT_21	[p1l1413t2292r1448b2321],
18	patients	NNS	O	patient	prep_of	16	SENT_21	[p1l1466t2289r1630b2330],
19	}	CD	NUMBER	}	num	22	SENT_21	[p1l1466t2289r1630b2330],
20	Tranilast	NN	O	tranilast	nn	22	SENT_21	[p1l1651t2292r1801b2321],
21	(	NN	O	(	nn	22	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
22	N	NN	O	n	dobj	11	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
23	(	CD	NUMBER	(	number	24	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
24	3	CD	NUMBER	3	num	25	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
25	’	NN	O	’	nsubj	27	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
26	4	CD	NUMBER	4	amod	25	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
27	’d	MD	O	’d	rcmod	22	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
28	emethoxycinnamoyl	VB	O	emethoxycinnamoyl	dep	27	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
29	)	SYM	O	)	dep	28	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
30	-	:	O	-	_	0	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
31	anthranilic	JJ	O	anthranilic	amod	34	SENT_21	[p1l1822t2291r2149b2328, p1l747t2339r1174b2377],
32	acid	NN	O	acid	nn	34	SENT_21	[p1l1201t2339r1271b2368],
33	(	NN	O	(	nn	34	SENT_21	[p1l1300t2340r1396b2375],
34	N	NN	O	n	dep	22	SENT_21	[p1l1300t2340r1396b2375],
35	—	CD	NUMBER	—	number	36	SENT_21	[p1l1300t2340r1396b2375],
36	5	CD	NUMBER	5	num	38	SENT_21	[p1l1300t2340r1396b2375],
37	)	NN	O	)	nn	38	SENT_21	[p1l1300t2340r1396b2375],
38	)	NN	O	)	nsubj	42	SENT_21	[p1l1300t2340r1396b2375],
39	is	VBZ	O	be	cop	42	SENT_21	[p1l1425t2341r1449b2368],
40	an	DT	O	a	det	42	SENT_21	[p1l1477t2348r1519b2368],
41	antiallergic	JJ	O	antiallergic	amod	42	SENT_21	[p1l1546t2339r1739b2377],
42	compound	NN	O	compound	rcmod	34	SENT_21	[p1l1766t2339r1963b2377],
43	,	,	O	,	_	0	SENT_21	[p1l1766t2339r1963b2377],
44	clinically	RB	O	clinically	advmod	45	SENT_21	[p1l1993t2339r2151b2377],
45	effective	JJ	O	effective	amod	22	SENT_21	[p1l749t2386r892b2415],
46	in	IN	O	in	_	0	SENT_21	[p1l911t2388r945b2415],
47	the	DT	O	the	det	48	SENT_21	[p1l963t2387r1018b2415],
48	control	NN	O	control	prep_in	45	SENT_21	[p1l1036t2387r1161b2415],
49	of	IN	O	of	_	0	SENT_21	[p1l1180t2386r1215b2415],
50	autoimmune	JJ	O	autoimmune	amod	51	SENT_21	[p1l1231t2388r1455b2415],
51	disease	NN	O	disease	prep_of	48	SENT_21	[p1l1474t2387r1592b2415],
52	such	JJ	O	such	_	0	SENT_21	[p1l1611t2387r1690b2415],
53	as	IN	O	as	_	0	SENT_21	[p1l1708t2395r1740b2415],
54	bronchial	JJ	O	bronchial	amod	55	SENT_21	[p1l1757t2387r1924b2415],
55	asthma	NN	O	asthma	prep_such_as	51	SENT_21	[p1l1943t2387r2068b2415],
56	and	CC	O	and	_	0	SENT_21	[p1l2086t2387r2150b2415],
57	atoptic	JJ	O	atoptic	amod	58	SENT_21	[p1l749t2435r868b2471],
58	dermatitis	NN	O	dermatitis	prep_such_as	51	SENT_21	[p1l884t2434r1067b2462],
59	.	.	O	.	_	0	SENT_21	[p1l884t2434r1067b2462],

1	Based	VBN	O	base	_	0	SENT_22	[p1l1085t2434r1181b2462],
2	on	IN	O	on	pcomp	1	SENT_22	[p1l1197t2442r1241b2462],
3	previous	JJ	O	previous	amod	5	SENT_22	[p1l1256t2435r1402b2471],
4	clinical	JJ	O	clinical	amod	5	SENT_22	[p1l1418t2434r1543b2462],
5	trials	NNS	O	trial	pobj	2	SENT_22	[p1l1558t2430r1670b2468],
6	?	.	O	?	_	0	SENT_22	[p1l1558t2430r1670b2468],

1	tranilast	NN	O	tranilast	nsubjpass	3	SENT_23	[p1l1685t2434r1827b2462],
2	was	VBD	O	be	auxpass	3	SENT_23	[p1l1841t2442r1903b2462],
3	hypothesized	VBN	O	hypothesize	_	0	SENT_23	[p1l1919t2434r2150b2471],
4	to	TO	O	to	aux	6	SENT_23	[p1l748t2484r782b2509],
5	be	VB	O	be	cop	6	SENT_23	[p1l813t2481r852b2509],
6	effective	JJ	O	effective	xcomp	3	SENT_23	[p1l885t2480r1028b2509],
7	in	IN	O	in	_	0	SENT_23	[p1l1060t2482r1095b2509],
8	reducing	VBG	O	reduce	prepc_in	6	SENT_23	[p1l1127t2481r1279b2518],
9	the	DT	O	the	det	10	SENT_23	[p1l1310t2481r1365b2509],
10	frequency	NN	O	frequency	dobj	8	SENT_23	[p1l1397t2480r1569b2518],
11	of	IN	O	of	_	0	SENT_23	[p1l1600t2480r1635b2509],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_23	[p1l1665t2481r1913b2509],
13	events	NNS	O	event	prep_of	10	SENT_23	[p1l1944t2484r2053b2509],
14	and	CC	O	and	_	0	SENT_23	[p1l2086t2480r2150b2509],
15	angiographic	JJ	O	angiographic	amod	16	SENT_23	[p1l749t2528r975b2565],
16	restenosis	NN	O	restenosis	prep_of	10	SENT_23	[p1l991t2529r1158b2556],
17	in	IN	O	in	_	0	SENT_23	[p1l1174t2529r1209b2556],
18	patients	NNS	O	patient	prep_in	8	SENT_23	[p1l1224t2529r1362b2565],
19	undergoing	VBG	O	undergo	partmod	18	SENT_23	[p1l1378t2528r1579b2565],
20	PTCR	NN	O	ptcr	dobj	19	SENT_23	[p1l1595t2528r1697b2556],
21	.	.	O	.	_	0	SENT_23	[p1l1595t2528r1697b2556],

1	The	DT	O	the	det	4	SENT_24	[p1l1714t2528r1779b2556],
2	PRESTO	NNP	O	PRESTO	nn	4	SENT_24	[p1l1796t2528r1931b2556],
3	(	CD	NUMBER	(	num	4	SENT_24	[p1l1949t2528r2150b2563],
4	Prevention	NNP	O	Prevention	nsubj	12	SENT_24	[p1l1949t2528r2150b2563],
5	of	IN	O	of	_	0	SENT_24	[p1l749t2575r784b2603],
6	REStenosis	NN	O	restenosis	prep_of	4	SENT_24	[p1l795t2576r978b2603],
7	with	IN	O	with	_	0	SENT_24	[p1l991t2575r1070b2603],
8	Tranilast	NN	O	tranilast	prep_with	6	SENT_24	[p1l1082t2575r1232b2603],
9	and	CC	O	and	_	0	SENT_24	[p1l1246t2575r1310b2603],
10	its	PRP$	O	its	poss	11	SENT_24	[p1l1323t2576r1362b2603],
11	Outcomes	NNS	O	outcome	conj_and	8	SENT_24	[p1l1376t2575r1562b2610],
12	)	VBP	O	)	_	0	SENT_24	[p1l1376t2575r1562b2610],
13	study	NN	O	study	nsubjpass	15	SENT_24	[p1l1578t2575r1672b2612],
14	was	VBD	O	be	auxpass	15	SENT_24	[p1l1683t2583r1746b2603],
15	designed	VBN	O	design	ccomp	12	SENT_24	[p1l1760t2575r1912b2612],
16	to	TO	O	to	aux	17	SENT_24	[p1l1925t2578r1959b2603],
17	determine	VB	O	determine	xcomp	15	SENT_24	[p1l1973t2575r2149b2603],
18	the	DT	O	the	det	19	SENT_24	[p1l748t2621r803b2650],
19	safety	NN	O	safety	dobj	17	SENT_24	[p1l819t2621r918b2659],
20	and	CC	O	and	_	0	SENT_24	[p1l932t2621r996b2650],
21	efficacy	NN	O	efficacy	conj_and	19	SENT_24	[p1l1011t2621r1142b2659],
22	of	IN	O	of	_	0	SENT_24	[p1l1156t2621r1191b2650],
23	tranilast	NN	O	tranilast	prep_of	19	SENT_24	[p1l1204t2621r1346b2650],
24	in	IN	O	in	_	0	SENT_24	[p1l1360t2623r1395b2649],
25	the	DT	O	the	det	26	SENT_24	[p1l1409t2621r1464b2650],
26	prevention	NN	O	prevention	prep_in	17	SENT_24	[p1l1479t2623r1670b2659],
27	of	IN	O	of	_	0	SENT_24	[p1l1685t2621r1720b2650],
28	restenosis	NN	O	restenosis	prep_of	26	SENT_24	[p1l1732t2623r1900b2650],
29	after	IN	O	after	_	0	SENT_24	[p1l1915t2621r1992b2650],
30	PTCR	NN	ORGANIZATION	ptcr	prep_after	17	SENT_24	[p1l2007t2622r2101b2650],
31	in	IN	O	in	_	0	SENT_24	[p1l2115t2623r2150b2649],
32	Western	JJ	MISC	western	amod	34	SENT_24	[p1l748t2670r888b2697],
33	populati0ns	NNS	O	populati0n	nn	34	SENT_24	[p1l908t2665r1141b2706],
34	.3	NN	NUMBER	.3	prep_in	30	SENT_24	[p1l908t2665r1141b2706],
35	During	IN	O	during	_	0	SENT_24	[p1l1161t2670r1283b2706],
36	this	DT	O	this	det	40	SENT_24	[p1l1301t2668r1365b2697],
37	phase	NN	O	phase	nn	40	SENT_24	[p1l1384t2669r1482b2706],
38	III	CD	NUMBER	iii	num	40	SENT_24	[p1l1502t2670r1539b2696],
39	clinical	JJ	O	clinical	amod	40	SENT_24	[p1l1559t2668r1684b2697],
40	trial	NN	O	trial	prep_during	17	SENT_24	[p1l1704t2668r1781b2703],
41	,	,	O	,	_	0	SENT_24	[p1l1704t2668r1781b2703],
42	hyperbilirubinemia	NN	O	hyperbilirubinemia	appos	40	SENT_24	[p1l1803t2668r2147b2706],
43	,	,	O	,	_	0	SENT_24	[p1l1803t2668r2147b2706],
44	characterized	VBN	O	characterize	dep	17	SENT_24	[p1l749t2715r978b2743],
45	by	IN	O	by	_	0	SENT_24	[p1l997t2715r1040b2752],
46	raised	VBN	O	raise	amod	50	SENT_24	[p1l1059t2715r1159b2743],
47	unconjugated	JJ	O	unconjugated	amod	50	SENT_24	[p1l1178t2715r1418b2752],
48	serum	NN	O	serum	nn	50	SENT_24	[p1l1439t2723r1543b2743],
49	bilirubin	NN	O	bilirubin	nn	50	SENT_24	[p1l1563t2715r1714b2743],
50	levels	NNS	O	level	prep_by	44	SENT_24	[p1l1735t2715r1838b2750],
51	,	,	O	,	_	0	SENT_24	[p1l1735t2715r1838b2750],
52	was	VBD	O	be	auxpass	53	SENT_24	[p1l1859t2723r1922b2743],
53	observed	VBN	O	observe	rcmod	50	SENT_24	[p1l1943t2715r2095b2743],
54	in	IN	O	in	_	0	SENT_24	[p1l2115t2717r2150b2743],
55	approximately	RB	O	approximately	quantmod	56	SENT_24	[p1l749t2762r1001b2799],
56	12	CD	PERCENT	12	num	57	SENT_24	[p1l1022t2763r1094b2790],
57	%	NN	PERCENT	%	prep_in	53	SENT_24	[p1l1022t2763r1094b2790],
58	of	IN	O	of	_	0	SENT_24	[p1l1114t2762r1149b2790],
59	patients	NNS	O	patient	prep_of	57	SENT_24	[p1l1166t2763r1313b2799],
60	.	.	O	.	_	0	SENT_24	[p1l1166t2763r1313b2799],

1	The	DT	O	the	det	2	SENT_25	[p1l1334t2762r1399b2790],
2	etiology	NN	O	etiology	_	0	SENT_25	[p1l1419t2762r1559b2799],
3	of	IN	O	of	_	0	SENT_25	[p1l1578t2762r1613b2790],
4	this	DT	O	this	det	6	SENT_25	[p1l1630t2762r1693b2790],
5	mild	JJ	O	mild	amod	6	SENT_25	[p1l1713t2762r1793b2790],
6	elevation	NN	O	elevation	prep_of	2	SENT_25	[p1l1813t2762r1971b2790],
7	in	IN	O	in	_	0	SENT_25	[p1l1991t2763r2025b2790],
8	serum	NN	O	serum	prep_in	2	SENT_25	[p1l2046t2770r2150b2790],

1	Genetic	JJ	O	genetic	amod	2	SENT_26	[p1l646t2965r828b3010],
2	susceptibility	NN	O	susceptibility	nsubj	16	SENT_26	[p1l847t2964r1166b3024],
3	to	TO	O	to	_	0	SENT_26	[p1l1183t2970r1234b3010],
4	tranilast-induced	JJ	O	tranilast-induced	amod	7	SENT_26	[p1l1252t2965r1665b3010],
5	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	7	SENT_26	[p1l1686t2965r2148b3024],
6	TM	NNP	O	TM	nn	7	SENT_26	[p1l1821t3038r1887b3077],
7	Danoff	NNP	PERSON	Danoff	prep_to	2	SENT_26	[p1l1910t3036r2047b3078],
8	et	FW	O	et	nn	11	SENT_26	[p1l2065t3041r2101b3078],
9	al	FW	O	al	nn	11	SENT_26	[p1l2117t3036r2153b3078],
10	bilirubin	NN	O	bilirubin	nn	11	SENT_26	[p2l7t84r317b142],
11	level	NN	O	level	dep	7	SENT_26	[p2l370t84r532b142],
12	was	VBD	O	be	cop	13	SENT_26	[p2l584t101r712b142],
13	unknown	JJ	O	unknown	_	0	SENT_26	[p2l765t84r1126b154],
14	,	,	O	,	_	0	SENT_26	[p2l765t84r1126b154],
15	but	CC	O	but	_	0	SENT_26	[p2l1183t84r1302b142],
16	raised	VBD	O	raise	conj_but	13	SENT_26	[p2l1355t84r1560b142],
17	risks	NNS	O	risk	dobj	16	SENT_26	[p2l1613t84r1767b142],
18	of	IN	O	of	_	0	SENT_26	[p2l1821t84r1893b142],
19	major	JJ	O	major	amod	21	SENT_26	[p2l1942t87r2149b160],
20	hepatic	JJ	O	hepatic	amod	21	SENT_26	[p2l9t179r269b255],
21	complications	NNS	O	complication	prep_of	17	SENT_26	[p2l299t179r799b255],
22	associated	VBN	O	associate	partmod	21	SENT_26	[p2l830t179r1186b237],
23	with	IN	O	with	_	0	SENT_26	[p2l1213t179r1375b237],
24	tranilast	NN	O	tranilast	prep_with	22	SENT_26	[p2l1404t179r1712b237],
25	.	.	O	.	_	0	SENT_26	[p2l1404t179r1712b237],

1	Serum	NN	O	serum	nn	2	SENT_27	[p2l86t275r306b331],
2	bilirubin	NN	O	bilirubin	nsubjpass	11	SENT_27	[p2l338t273r648b331],
3	is	VBZ	O	be	auxpass	4	SENT_27	[p2l681t276r732b331],
4	derived	VBN	O	derive	_	0	SENT_27	[p2l766t273r1027b331],
5	primarily	RB	O	primarily	advmod	4	SENT_27	[p2l1059t273r1389b349],
6	from	IN	O	from	_	0	SENT_27	[p2l1420t273r1590b331],
7	degradation	NN	O	degradation	prep_from	4	SENT_27	[p2l1624t273r2048b349],
8	of	IN	O	of	_	0	SENT_27	[p2l2081t273r2153b331],
9	hemoglobin	NN	O	hemoglobin	prep_of	7	SENT_27	[p2l9t368r441b444],
10	and	CC	O	and	_	0	SENT_27	[p2l492t368r623b426],
11	transported	VBN	O	transport	conj_and	4	SENT_27	[p2l672t368r1082b444],
12	to	TO	O	to	_	0	SENT_27	[p2l1131t376r1201b426],
13	the	DT	O	the	det	14	SENT_27	[p2l1251t368r1364b426],
14	liver	NN	O	liver	prep_to	11	SENT_27	[p2l1415t368r1570b426],
15	by	IN	O	by	_	0	SENT_27	[p2l1617t369r1704b444],
16	binding	VBG	O	bind	agent	4	SENT_27	[p2l1749t368r2030b444],
17	to	TO	O	to	_	0	SENT_27	[p2l2078t376r2148b426],
18	albumin	NN	O	albumin	prep_to	16	SENT_27	[p2l9t464r324b522],
19	.	.	O	.	_	0	SENT_27	[p2l9t464r324b522],

1	Within	IN	O	within	_	0	SENT_28	[p2l397t464r651b522],
2	the	DT	O	the	det	3	SENT_28	[p2l721t464r834b522],
3	heptocytes	NNS	O	heptocyte	prep_within	15	SENT_28	[p2l905t464r1306b540],
4	,	,	O	,	_	0	SENT_28	[p2l905t464r1306b540],
5	uridine	NN	O	uridine	nn	7	SENT_28	[p2l1379t464r1635b522],
6	diphosphate	NN	O	diphosphate	nn	7	SENT_28	[p2l1707t464r2147b540],
7	glucuronosyltransferase	NN	O	glucuronosyltransferase	nsubj	15	SENT_28	[p2l9t558r849b634],
8	1A1	NN	O	1a1	nn	11	SENT_28	[p2l891t560r1017b616],
9	(	CD	NUMBER	(	num	11	SENT_28	[p2l1060t559r1410b631],
10	UGT1A1	NN	O	ugt1a1	nn	11	SENT_28	[p2l1060t559r1410b631],
11	)	NN	O	)	dep	7	SENT_28	[p2l1060t559r1410b631],
12	is	VBZ	O	be	cop	15	SENT_28	[p2l1449t562r1499b616],
13	the	DT	O	the	det	15	SENT_28	[p2l1535t559r1647b616],
14	only	JJ	O	only	amod	15	SENT_28	[p2l1683t559r1843b634],
15	enzyme	NN	O	enzyme	_	0	SENT_28	[p2l1876t575r2148b634],
16	that	WDT	O	that	nsubj	17	SENT_28	[p2l8t652r152b710],
17	contributes	VBZ	O	contribute	rcmod	15	SENT_28	[p2l192t652r591b710],
18	to	TO	O	to	_	0	SENT_28	[p2l633t659r702b710],
19	bilirubin	NN	O	bilirubin	nn	20	SENT_28	[p2l741t652r1050b710],
20	glucuronidation	NN	O	glucuronidation	prep_to	17	SENT_28	[p2l1091t645r1722b728],
21	.4	CD	NUMBER	.4	num	22	SENT_28	[p2l1091t645r1722b728],
22	Glucuronidation	NN	O	glucuronidation	nsubj	24	SENT_28	[p2l1763t652r2147b710, p2l9t748r239b806],
23	is	VBZ	O	be	cop	24	SENT_28	[p2l277t751r327b806],
24	essential	JJ	O	essential	rcmod	20	SENT_28	[p2l367t748r667b806],
25	for	IN	O	for	_	0	SENT_28	[p2l706t748r804b806],
26	the	DT	O	the	det	28	SENT_28	[p2l842t748r954b806],
27	biliary	JJ	O	biliary	amod	28	SENT_28	[p2l992t748r1221b824],
28	elimination	NN	O	elimination	prep_for	24	SENT_28	[p2l1257t748r1673b806],
29	of	IN	O	of	_	0	SENT_28	[p2l1712t748r1784b806],
30	bilirubin	NN	O	bilirubin	prep_of	28	SENT_28	[p2l1816t748r2144b818],
31	,	,	O	,	_	0	SENT_28	[p2l1816t748r2144b818],
32	and	CC	O	and	_	0	SENT_28	[p2l9t843r141b900],
33	deficiencies	NNS	O	deficiency	conj_and	15	SENT_28	[p2l171t842r581b900],
34	in	IN	O	in	_	0	SENT_28	[p2l613t846r683b900],
35	the	DT	O	the	det	38	SENT_28	[p2l712t843r825b900],
36	UGT1A1	NN	O	ugt1a1	nn	38	SENT_28	[p2l862t844r1145b900],
37	gene	NN	O	gene	nn	38	SENT_28	[p2l1183t859r1346b918],
38	result	NN	O	result	prep_in	33	SENT_28	[p2l1377t843r1572b900],
39	in	IN	O	in	_	0	SENT_28	[p2l1602t846r1672b900],
40	the	DT	O	the	det	41	SENT_28	[p2l1703t843r1815b900],
41	accumulation	NN	O	accumulation	prep_in	38	SENT_28	[p2l1847t859r2148b900, p2l9t938r216b996],
42	of	IN	O	of	_	0	SENT_28	[p2l250t938r321b996],
43	unconjugated	JJ	O	unconjugated	amod	44	SENT_28	[p2l348t938r841b1014],
44	bilirubin	NN	O	bilirubin	prep_of	41	SENT_28	[p2l872t938r1182b996],
45	in	IN	O	in	_	0	SENT_28	[p2l1214t941r1285b995],
46	the	DT	O	the	det	47	SENT_28	[p2l1318t938r1430b996],
47	serum	NN	O	serum	prep_in	44	SENT_28	[p2l1466t955r1696b996],
48	.	.	O	.	_	0	SENT_28	[p2l1466t955r1696b996],

1	In	IN	O	in	_	0	SENT_29	[p2l1735t941r1807b995],
2	humans	NNS	O	human	prep_in	5	SENT_29	[p2l1840t938r2143b1008],
3	,	,	O	,	_	0	SENT_29	[p2l1840t938r2143b1008],
4	there	EX	O	there	expl	5	SENT_29	[p2l8t1032r189b1090],
5	are	VBP	O	be	_	0	SENT_29	[p2l218t1049r319b1090],
6	at	IN	O	at	quantmod	8	SENT_29	[p2l348t1040r412b1090],
7	least	JJS	O	least	mwe	6	SENT_29	[p2l439t1032r597b1090],
8	three	CD	NUMBER	three	num	9	SENT_29	[p2l623t1032r804b1090],
9	forms	NNS	O	form	nsubj	5	SENT_29	[p2l832t1032r1032b1090],
10	of	IN	O	of	_	0	SENT_29	[p2l1061t1032r1133b1090],
11	inheritable	JJ	O	inheritable	amod	12	SENT_29	[p2l1156t1032r1542b1090],
12	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	9	SENT_29	[p2l1571t1032r2148b1108, p2l9t1131r140b1186],
13	caused	VBN	O	cause	partmod	12	SENT_29	[p2l207t1128r442b1186],
14	by	IN	O	by	_	0	SENT_29	[p2l506t1128r594b1204],
15	deficiencies	NNS	O	deficiency	agent	13	SENT_29	[p2l659t1128r1069b1186],
16	of	IN	O	of	_	0	SENT_29	[p2l1136t1128r1208b1186],
17	UGT1A1	NN	O	ugt1a1	prep_of	15	SENT_29	[p2l1275t1129r1584b1186],
18	.	.	O	.	_	0	SENT_29	[p2l1275t1129r1584b1186],

1	Crigler	NNP	PERSON	Crigler	_	0	SENT_30	[p2l1656t1128r2149b1204],
2	.	.	O	.	_	0	SENT_30	[p2l1656t1128r2149b1204],

1	—	NN	O	—	_	0	SENT_31	[p2l1656t1128r2149b1204],
2	.	.	O	.	_	0	SENT_31	[p2l1656t1128r2149b1204],

1	Najjar	NNP	PERSON	Najjar	nn	2	SENT_32	[p2l1656t1128r2149b1204],
2	syndrome	NN	O	syndrome	nsubjpass	13	SENT_32	[p2l10t1222r359b1298],
3	type	NN	O	type	amod	2	SENT_32	[p2l390t1230r541b1298],
4	1	CD	NUMBER	1	number	3	SENT_32	[p2l579t1224r608b1279],
5	is	VBZ	O	be	auxpass	6	SENT_32	[p2l644t1225r694b1280],
6	characterized	VBN	O	characterize	_	0	SENT_32	[p2l726t1222r1195b1280],
7	by	IN	O	by	_	0	SENT_32	[p2l1224t1222r1311b1298],
8	lethal	JJ	O	lethal	amod	10	SENT_32	[p2l1339t1222r1539b1280],
9	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	10	SENT_32	[p2l1571t1222r2148b1298, p2l9t1309r193b1386],
10	,5	NN	O	,5	agent	6	SENT_32	[p2l1571t1222r2148b1298, p2l9t1309r193b1386],
11	and	CC	O	and	_	0	SENT_32	[p2l230t1316r361b1373],
12	is	VBZ	O	be	auxpass	13	SENT_32	[p2l394t1318r444b1373],
13	caused	VBN	O	cause	conj_and	6	SENT_32	[p2l479t1316r714b1373],
14	by	IN	O	by	_	0	SENT_32	[p2l746t1315r833b1391],
15	complete	JJ	O	complete	amod	16	SENT_32	[p2l866t1316r1191b1391],
16	lack	NN	O	lack	agent	13	SENT_32	[p2l1225t1315r1366b1373],
17	of	IN	O	of	_	0	SENT_32	[p2l1398t1315r1470b1373],
18	UGT1A1	NN	O	ugt1a1	nn	19	SENT_32	[p2l1499t1317r1797b1373],
19	actiVity	NN	O	activity	prep_of	16	SENT_32	[p2l1838t1309r2149b1391],
20	.6	CD	NUMBER	.6	num	19	SENT_32	[p2l1838t1309r2149b1391],
21	Left	VBN	O	leave	partmod	16	SENT_32	[p2l9t1412r142b1470],
22	untreated	JJ	O	untreated	acomp	21	SENT_32	[p2l184t1412r545b1482],
23	,	,	O	,	_	0	SENT_32	[p2l184t1412r545b1482],
24	Crigler	NNP	PERSON	Crigler	dep	21	SENT_32	[p2l596t1412r1089b1488],
25	.	.	O	.	_	0	SENT_32	[p2l596t1412r1089b1488],

1	—	NN	O	—	_	0	SENT_33	[p2l596t1412r1089b1488],
2	.	.	O	.	_	0	SENT_33	[p2l596t1412r1089b1488],

1	Na	NN	MISC	na	dep	10	SENT_34	[p2l596t1412r1089b1488],
2	]	NN	O	]	nn	4	SENT_34	[p2l596t1412r1089b1488],
3	'	''	O	'	_	0	SENT_34	[p2l596t1412r1089b1488],
4	]	NN	O	]	dep	1	SENT_34	[p2l596t1412r1089b1488],
5	'	''	O	'	_	0	SENT_34	[p2l596t1412r1089b1488],
6	ar	NN	O	ar	nn	7	SENT_34	[p2l596t1412r1089b1488],
7	syndrome	NN	O	syndrome	nsubj	10	SENT_34	[p2l1134t1412r1483b1488],
8	type	NN	O	type	nsubj	10	SENT_34	[p2l1528t1419r1679b1488],
9	1	CD	NUMBER	1	num	8	SENT_34	[p2l1730t1414r1759b1469],
10	results	VBZ	O	result	_	0	SENT_34	[p2l1808t1412r2033b1470],
11	in	IN	O	in	_	0	SENT_34	[p2l2078t1415r2149b1469],
12	death	NN	O	death	prep_in	10	SENT_34	[p2l9t1507r207b1564],
13	from	IN	O	from	_	0	SENT_34	[p2l254t1506r423b1564],
14	bilirubin	NN	O	bilirubin	nn	15	SENT_34	[p2l469t1507r779b1564],
15	encephalopathy	NN	O	encephalopathy	prep_from	10	SENT_34	[p2l827t1507r1411b1582],
16	.	.	O	.	_	0	SENT_34	[p2l827t1507r1411b1582],

1	Crigler	NNP	PERSON	Crigler	_	0	SENT_35	[p2l1464t1507r1957b1582],
2	.	.	O	.	_	0	SENT_35	[p2l1464t1507r1957b1582],

1	—	NN	O	—	_	0	SENT_36	[p2l1464t1507r1957b1582],
2	.	.	O	.	_	0	SENT_36	[p2l1464t1507r1957b1582],

1	Najjar	NNP	PERSON	Najjar	nn	2	SENT_37	[p2l1464t1507r1957b1582],
2	syndrome	NN	O	syndrome	nsubjpass	6	SENT_37	[p2l2005t1523r2148b1582, p2l9t1602r236b1660],
3	type	NN	O	type	amod	2	SENT_37	[p2l267t1609r418b1678],
4	2	CD	NUMBER	2	number	3	SENT_37	[p2l451t1604r490b1659],
5	is	VBZ	O	be	auxpass	6	SENT_37	[p2l520t1605r571b1660],
6	differentiated	VBN	O	differentiate	_	0	SENT_37	[p2l603t1602r1083b1660],
7	by	IN	O	by	_	0	SENT_37	[p2l1112t1602r1199b1678],
8	the	DT	O	the	det	10	SENT_37	[p2l1227t1602r1340b1660],
9	intermediate	JJ	O	intermediate	amod	10	SENT_37	[p2l1372t1602r1824b1660],
10	levels	NNS	O	level	agent	6	SENT_37	[p2l1856t1602r2049b1660],
11	of	IN	O	of	_	0	SENT_37	[p2l2081t1602r2153b1660],
12	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	10	SENT_37	[p2l9t1697r714b1773],
13	,	,	O	,	_	0	SENT_37	[p2l9t1697r714b1773],
14	and	CC	O	and	_	0	SENT_37	[p2l742t1697r873b1755],
15	is	VBZ	O	be	cop	17	SENT_37	[p2l894t1700r945b1755],
16	the	DT	O	the	det	17	SENT_37	[p2l968t1697r1080b1755],
17	result	NN	O	result	conj_and	6	SENT_37	[p2l1103t1697r1298b1755],
18	of	IN	O	of	_	0	SENT_37	[p2l1320t1697r1392b1755],
19	severe	JJ	O	severe	amod	20	SENT_37	[p2l1411t1714r1622b1755],
20	deficiencies	NNS	O	deficiency	prep_of	17	SENT_37	[p2l1646t1697r2056b1755],
21	in	IN	O	in	_	0	SENT_37	[p2l2078t1700r2149b1754],
22	UGT1A1	NN	O	ugt1a1	nn	23	SENT_37	[p2l8t1793r307b1850],
23	activity	NN	O	activity	prep_in	20	SENT_37	[p2l396t1795r660b1868],
24	(	CD	NUMBER	(	num	25	SENT_37	[p2l744t1792r829b1864],
25	~	NN	O	~	nsubj	31	SENT_37	[p2l744t1792r829b1864],
26	10	CD	PERCENT	10	number	27	SENT_37	[p2l850t1793r997b1850],
27	%	NN	PERCENT	%	amod	25	SENT_37	[p2l850t1793r997b1850],
28	of	IN	O	of	_	0	SENT_37	[p2l1081t1792r1153b1850],
29	normal	JJ	O	normal	amod	30	SENT_37	[p2l1231t1792r1488b1850],
30	activities	NNS	O	activity	prep_of	25	SENT_37	[p2l1572t1792r1930b1864],
31	)	VBP	O	)	rcmod	17	SENT_37	[p2l1572t1792r1930b1864],
32	.	.	O	.	_	0	SENT_37	[p2l1572t1792r1930b1864],

1	The	DT	O	the	det	2	SENT_38	[p2l2015t1792r2148b1850],
2	incidences	NNS	O	incidence	nsubj	11	SENT_38	[p2l9t1885r381b1943],
3	of	IN	O	of	_	0	SENT_38	[p2l412t1885r483b1943],
4	both	DT	O	both	det	5	SENT_38	[p2l506t1885r673b1943],
5	syndromes	NNS	O	syndrome	prep_of	2	SENT_38	[p2l705t1885r1085b1961],
6	are	VBP	O	be	aux	11	SENT_38	[p2l1116t1902r1217b1943],
7	very	RB	O	very	advmod	11	SENT_38	[p2l1245t1902r1400b1961],
8	rare	JJ	O	rare	amod	9	SENT_38	[p2l1426t1878r1663b1943],
9	.7	NN	NUMBER	.7	pobj	7	SENT_38	[p2l1426t1878r1663b1943],
10	'	''	O	'	_	0	SENT_38	[p2l1426t1878r1663b1943],
11	8	CD	NUMBER	8	_	0	SENT_38	[p2l1426t1878r1663b1943],

1	A	DT	O	a	det	3	SENT_39	[p2l84t1981r135b2036],
2	third	JJ	ORDINAL	third	amod	3	SENT_39	[p2l157t1979r332b2037],
3	condition	NN	O	condition	nsubjpass	10	SENT_39	[p2l356t1979r721b2050],
4	,	,	O	,	_	0	SENT_39	[p2l356t1979r721b2050],
5	Gilbert	NNP	PERSON	Gilbert	poss	7	SENT_39	[p2l751t1979r1043b2037],
6	’s	POS	O	’s	_	0	SENT_39	[p2l751t1979r1043b2037],
7	syndrome	NN	O	syndrome	appos	3	SENT_39	[p2l1069t1972r1473b2055],
8	,9	CD	NUMBER	,9	dep	7	SENT_39	[p2l1069t1972r1473b2055],
9	is	VBZ	O	be	auxpass	10	SENT_39	[p2l1497t1982r1548b2037],
10	characterized	VBN	O	characterize	_	0	SENT_39	[p2l1573t1979r2043b2037],
11	by	IN	O	by	_	0	SENT_39	[p2l2064t1979r2151b2055],
12	mild	JJ	O	mild	amod	13	SENT_39	[p2l9t2075r172b2133],
13	hyperbilirubinemia	NN	O	hyperbilirubinemia	agent	10	SENT_39	[p2l206t2075r911b2151],
14	,	,	O	,	_	0	SENT_39	[p2l206t2075r911b2151],
15	and	CC	O	and	_	0	SENT_39	[p2l952t2075r1083b2133],
16	is	VBZ	O	be	cop	19	SENT_39	[p2l1118t2078r1168b2133],
17	a	DT	O	a	det	19	SENT_39	[p2l1204t2092r1239b2133],
18	benign	JJ	O	benign	amod	19	SENT_39	[p2l1271t2075r1518b2151],
19	form	NN	O	form	conj_and	10	SENT_39	[p2l1552t2075r1722b2133],
20	of	IN	O	of	_	0	SENT_39	[p2l1758t2075r1829b2133],
21	episodic	JJ	O	episodic	amod	22	SENT_39	[p2l1861t2075r2149b2151],
22	jaundice	NN	O	jaundice	prep_of	19	SENT_39	[p2l10t2170r310b2246],
23	that	WDT	O	that	nsubj	24	SENT_39	[p2l377t2170r521b2228],
24	occurs	VBZ	O	occur	rcmod	19	SENT_39	[p2l588t2187r811b2228],
25	in	IN	O	in	_	0	SENT_39	[p2l879t2173r949b2227],
26	approximately	RB	O	approximately	quantmod	27	SENT_39	[p2l1016t2170r1533b2246],
27	3	CD	PERCENT	3	num	28	SENT_39	[p2l1599t2171r1833b2228],
28	—	NN	PERCENT	—	prep_in	24	SENT_39	[p2l1599t2171r1833b2228],
29	10	CD	PERCENT	10	num	30	SENT_39	[p2l1599t2171r1833b2228],
30	%	NN	PERCENT	%	dobj	24	SENT_39	[p2l1599t2171r1833b2228],
31	of	IN	O	of	_	0	SENT_39	[p2l1901t2170r1973b2228],
32	the	DT	O	the	det	35	SENT_39	[p2l2035t2170r2148b2228],
33	population	NN	O	population	nn	35	SENT_39	[p2l8t2255r568b2338],
34	.1	CD	NUMBER	.1	num	35	SENT_39	[p2l8t2255r568b2338],
35	°	NN	O	°	prep_of	30	SENT_39	[p2l8t2255r568b2338],
36	'	''	O	'	_	0	SENT_39	[p2l8t2255r568b2338],
37	“	CD	NUMBER	“	dep	35	SENT_39	[p2l8t2255r568b2338],
38	Gilbert	NNP	PERSON	Gilbert	poss	40	SENT_39	[p2l605t2262r898b2320],
39	’s	POS	O	’s	_	0	SENT_39	[p2l605t2262r898b2320],
40	syndrome	NN	O	syndrome	nsubjpass	42	SENT_39	[p2l933t2263r1282b2338],
41	is	VBZ	O	be	auxpass	42	SENT_39	[p2l1316t2265r1366b2320],
42	thought	VBN	O	think	rcmod	30	SENT_39	[p2l1400t2262r1688b2338],
43	to	TO	O	to	aux	45	SENT_39	[p2l1720t2270r1790b2320],
44	be	VB	O	be	cop	45	SENT_39	[p2l1822t2263r1902b2320],
45	harmless	JJ	O	harmless	xcomp	42	SENT_39	[p2l1936t2262r2148b2320, p2l9t2358r128b2416],
46	and	CC	O	and	_	0	SENT_39	[p2l164t2358r296b2416],
47	often	RB	O	often	advmod	48	SENT_39	[p2l330t2358r514b2416],
48	goes	VBZ	O	go	conj_and	24	SENT_39	[p2l549t2375r701b2434],
49	undetected	JJ	O	undetected	acomp	48	SENT_39	[p2l734t2358r1149b2416],
50	.	.	O	.	_	0	SENT_39	[p2l734t2358r1149b2416],

1	Baseline	NN	O	baseline	nn	3	SENT_40	[p2l1189t2358r1475b2416],
2	bilirubin	NN	O	bilirubin	nn	3	SENT_40	[p2l1508t2358r1818b2416],
3	levels	NNS	O	level	nsubj	9	SENT_40	[p2l1852t2358r2045b2416],
4	of	IN	O	of	_	0	SENT_40	[p2l2081t2358r2153b2416],
5	Gilbert	NNP	PERSON	Gilbert	poss	8	SENT_40	[p2l10t2454r302b2512],
6	’s	POS	O	’s	_	0	SENT_40	[p2l10t2454r302b2512],
7	syndrome	NN	O	syndrome	nn	8	SENT_40	[p2l353t2454r703b2530],
8	patients	NNS	O	patient	prep_of	3	SENT_40	[p2l752t2457r1034b2530],
9	are	VBP	O	be	_	0	SENT_40	[p2l1085t2471r1186b2512],
10	generally	RB	O	generally	advmod	9	SENT_40	[p2l1237t2454r1562b2530],
11	within	IN	O	within	_	0	SENT_40	[p2l1607t2454r1843b2512],
12	normal	JJ	O	normal	amod	13	SENT_40	[p2l1891t2454r2148b2512],
13	limits	NNS	O	limit	prep_within	9	SENT_40	[p2l9t2548r227b2606],
14	.	.	O	.	_	0	SENT_40	[p2l9t2548r227b2606],

1	Episodes	NNS	O	episode	nsubjpass	6	SENT_41	[p2l257t2549r558b2624],
2	of	IN	O	of	_	0	SENT_41	[p2l584t2548r656b2606],
3	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	1	SENT_41	[p2l676t2548r1364b2624],
4	can	MD	O	can	aux	6	SENT_41	[p2l1390t2565r1512b2606],
5	be	VB	O	be	auxpass	6	SENT_41	[p2l1535t2548r1615b2606],
6	brought	VBN	O	bring	_	0	SENT_41	[p2l1638t2548r1924b2624],
7	on	RP	O	on	prep	6	SENT_41	[p2l1950t2565r2041b2606],
8	by	IN	O	by	_	0	SENT_41	[p2l2064t2548r2151b2624],
9	a	DT	O	a	det	10	SENT_41	[p2l9t2660r44b2701],
10	number	NN	O	number	prep_by	7	SENT_41	[p2l73t2644r352b2701],
11	of	IN	O	of	_	0	SENT_41	[p2l382t2643r453b2701],
12	triggers	NNS	O	trigger	prep_of	10	SENT_41	[p2l478t2647r738b2719],
13	such	JJ	O	such	_	0	SENT_41	[p2l769t2644r929b2701],
14	as	IN	O	as	_	0	SENT_41	[p2l960t2660r1025b2701],
15	psychological	JJ	O	psychological	amod	23	SENT_41	[p2l1054t2644r1538b2719],
16	stress	NN	O	stress	nn	20	SENT_41	[p2l1570t2651r1772b2714],
17	,	,	O	,	_	0	SENT_41	[p2l1570t2651r1772b2714],
18	infection	NN	O	infection	nn	23	SENT_41	[p2l1806t2643r2144b2714],
19	,	,	O	,	_	0	SENT_41	[p2l1806t2643r2144b2714],
20	fasting	NN	O	fasting	nn	23	SENT_41	[p2l9t2737r247b2813],
21	and	CC	O	and	_	0	SENT_41	[p2l273t2737r404b2795],
22	physical	JJ	O	physical	nn	23	SENT_41	[p2l430t2737r720b2813],
23	activities	NNS	O	activity	prep_such_as	12	SENT_41	[p2l748t2730r1227b2795],
24	.1	CD	NUMBER	.1	num	25	SENT_41	[p2l748t2730r1227b2795],
25	°	NN	O	°	dobj	6	SENT_41	[p2l748t2730r1227b2795],
26	'	''	O	'	_	0	SENT_41	[p2l748t2730r1227b2795],
27	“	CD	NUMBER	“	num	30	SENT_41	[p2l748t2730r1227b2795],
28	Hepatic	JJ	O	hepatic	amod	30	SENT_41	[p2l1258t2740r1529b2813],
29	UGT1A1	NN	O	ugt1a1	nn	30	SENT_41	[p2l1555t2739r1854b2795],
30	activity	NN	O	activity	nsubj	40	SENT_41	[p2l1887t2740r2151b2813],
31	in	IN	O	in	_	0	SENT_41	[p2l9t2836r79b2890],
32	individuals	NNS	O	individual	prep_in	30	SENT_41	[p2l129t2833r522b2890],
33	with	IN	O	with	_	0	SENT_41	[p2l572t2833r734b2890],
34	Gilbert	NNP	PERSON	Gilbert	poss	36	SENT_41	[p2l786t2833r1078b2890],
35	’s	POS	O	’s	_	0	SENT_41	[p2l786t2833r1078b2890],
36	syndrome	NN	O	syndrome	prep_with	32	SENT_41	[p2l1131t2833r1480b2908],
37	is	VBZ	O	be	cop	40	SENT_41	[p2l1532t2836r1582b2890],
38	approximately	RB	O	approximately	quantmod	39	SENT_41	[p2l1634t2833r2151b2908],
39	30	CD	PERCENT	30	num	40	SENT_41	[p2l10t2928r162b2984],
40	%	NN	PERCENT	%	rcmod	25	SENT_41	[p2l10t2928r162b2984],
41	that	IN	O	that	complm	42	SENT_41	[p2l202t2926r345b2984],
42	of	IN	O	of	dep	40	SENT_41	[p2l385t2926r456b2984],
43	normal	JJ	O	normal	amod	45	SENT_41	[p2l492t2926r749b2984],
44	healthy	JJ	O	healthy	amod	45	SENT_41	[p2l790t2926r1061b3002],
45	individuals	NNS	O	individual	pobj	42	SENT_41	[p2l1098t2919r1581b2984],
46	.	.	O	.	_	0	SENT_41	[p2l1098t2919r1581b2984],

1	”	NN	O	”	nn	3	SENT_42	[p2l1098t2919r1581b2984],
2	Several	JJ	O	several	amod	3	SENT_42	[p2l1621t2926r1866b2984],
3	studies	NNS	O	study	nsubj	5	SENT_42	[p2l1908t2926r2148b2984],
4	have	VBP	O	have	aux	5	SENT_42	[p2l9t3022r173b3080],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_42	[p2l241t3022r732b3080],
6	that	IN	O	that	complm	15	SENT_42	[p2l797t3022r940b3080],
7	the	DT	O	the	det	9	SENT_42	[p2l1006t3022r1118b3080],
8	genetic	JJ	O	genetic	amod	9	SENT_42	[p2l1185t3025r1440b3098],
9	predisposition	NN	O	predisposition	nsubjpass	15	SENT_42	[p2l1505t3022r2012b3098],
10	to	TO	O	to	_	0	SENT_42	[p2l2078t3029r2148b3080],
11	Gilbert	NNP	PERSON	Gilbert	poss	13	SENT_42	[p2l10t3117r302b3175],
12	’s	POS	O	’s	_	0	SENT_42	[p2l10t3117r302b3175],
13	syndrome	NN	O	syndrome	prep_to	9	SENT_42	[p2l332t3117r681b3193],
14	is	VBZ	O	be	auxpass	15	SENT_42	[p2l709t3120r760b3175],
15	associated	VBN	O	associate	ccomp	5	SENT_42	[p2l789t3117r1144b3175],
16	with	IN	O	with	_	0	SENT_42	[p2l1170t3117r1331b3175],
17	a	DT	O	a	det	20	SENT_42	[p2l1360t3134r1394b3175],
18	TA	NNP	O	TA	nn	20	SENT_42	[p2l1419t3118r1514b3174],
19	repeat	NN	O	repeat	nn	20	SENT_42	[p2l1540t3124r1757b3193],
20	expansion	NN	O	expansion	prep_with	15	SENT_42	[p2l1785t3120r2148b3193],
21	in	IN	O	in	_	0	SENT_42	[p2l9t3212r79b3266],
22	the	DT	O	the	det	24	SENT_42	[p2l125t3209r237b3267],
23	TATAA	NN	O	tataa	nn	24	SENT_42	[p2l282t3211r523b3266],
24	box	NN	O	box	prep_in	15	SENT_42	[p2l566t3209r699b3267],
25	of	IN	O	of	_	0	SENT_42	[p2l744t3209r816b3267],
26	the	DT	O	the	det	28	SENT_42	[p2l857t3210r970b3267],
27	UGT1A1	NN	O	ugt1a1	nn	28	SENT_42	[p2l1022t3211r1305b3267],
28	gene	NN	O	gene	prep_of	24	SENT_42	[p2l1359t3202r1703b3285],
29	.13	CD	NUMBER	.13	number	30	SENT_42	[p2l1359t3202r1703b3285],
30	‘	CD	NUMBER	‘	dep	33	SENT_42	[p2l1359t3202r1703b3285],
31	15	CD	NUMBER	15	num	32	SENT_42	[p2l1359t3202r1703b3285],
32	Individuals	NNS	O	individual	npadvmod	33	SENT_42	[p2l1752t3209r2148b3267],
33	homozygous	JJ	O	homozygous	amod	28	SENT_42	[p2l9t3306r460b3381],
34	for	IN	O	for	_	0	SENT_42	[p2l486t3305r584b3363],
35	the	DT	O	the	det	38	SENT_42	[p2l608t3306r720b3363],
36	(	CD	NUMBER	(	num	38	SENT_42	[p2l749t3306r924b3377],
37	TA	NNP	O	TA	nn	38	SENT_42	[p2l749t3306r924b3377],
38	)	NN	O	)	prep_for	28	SENT_42	[p2l749t3306r924b3377],
39	7	CD	NUMBER	7	num	40	SENT_42	[p2l749t3306r924b3377],
40	allele	NN	O	allele	nsubj	41	SENT_42	[p2l950t3305r1131b3363],
41	have	VBP	O	have	rcmod	28	SENT_42	[p2l1157t3305r1322b3363],
42	higher	JJR	O	higher	amod	45	SENT_42	[p2l1347t3305r1578b3381],
43	serum	NN	O	serum	nn	45	SENT_42	[p2l1603t3322r1816b3363],
44	bilirubin	NN	O	bilirubin	nn	45	SENT_42	[p2l1838t3305r2148b3363],
45	levels	NNS	O	level	dobj	41	SENT_42	[p2l9t3401r202b3459],
46	when	WRB	O	when	advmod	86	SENT_42	[p2l225t3401r423b3459],
47	compared	VBN	O	compare	_	0	SENT_42	[p2l449t3401r799b3477],
48	to	TO	O	to	prepc_compared_to	86	SENT_42	[p2l824t3408r893b3459],
49	individuals	NNS	O	individual	pobj	86	SENT_42	[p2l919t3401r1313b3459],
50	who	WP	O	who	nsubj	51	SENT_42	[p2l1336t3401r1490b3459],
51	carry	VBP	O	carry	rcmod	49	SENT_42	[p2l1516t3418r1692b3477],
52	one	CD	NUMBER	one	num	55	SENT_42	[p2l1716t3418r1844b3459],
53	or	CC	O	or	_	0	SENT_42	[p2l1871t3418r1943b3459],
54	more	JJR	O	more	num	55	SENT_42	[p2l1966t3418r2147b3459],
55	copy	NN	O	copy	npadvmod	56	SENT_42	[p2l9t3510r179b3569],
56	of	IN	O	of	advmod	51	SENT_42	[p2l213t3493r285b3551],
57	the	DT	O	the	det	63	SENT_42	[p2l317t3494r429b3551],
58	(	CD	NUMBER	(	num	63	SENT_42	[p2l470t3494r646b3566],
59	TA	NNP	O	TA	nn	63	SENT_42	[p2l470t3494r646b3566],
60	)	CD	NUMBER	)	num	63	SENT_42	[p2l470t3494r646b3566],
61	6	CD	NUMBER	6	num	63	SENT_42	[p2l470t3494r646b3566],
62	allele	NN	O	allele	nn	63	SENT_42	[p2l683t3486r1129b3551],
63	.13	NN	NUMBER	.13	dobj	51	SENT_42	[p2l683t3486r1129b3551],
64	'	''	DATE	'	_	0	SENT_42	[p2l683t3486r1129b3551],
65	15	CD	DATE	15	number	66	SENT_42	[p2l683t3486r1129b3551],
66	‘	CD	NUMBER	‘	nsubj	86	SENT_42	[p2l683t3486r1129b3551],
67	17	CD	NUMBER	17	num	70	SENT_42	[p2l683t3486r1129b3551],
68	Reporter	NN	O	reporter	nn	70	SENT_42	[p2l1168t3496r1469b3569],
69	construct	NN	O	construct	nn	70	SENT_42	[p2l1504t3501r1835b3551],
70	analysis	NN	O	analysis	dep	66	SENT_42	[p2l1872t3494r2148b3569],
71	showed	VBD	O	show	partmod	66	SENT_42	[p2l10t3590r277b3647],
72	that	IN	O	that	complm	82	SENT_42	[p2l318t3590r461b3647],
73	the	DT	O	the	det	74	SENT_42	[p2l502t3590r615b3647],
74	activity	NN	O	activity	nsubj	82	SENT_42	[p2l658t3593r922b3665],
75	of	IN	O	of	_	0	SENT_42	[p2l962t3589r1034b3647],
76	the	DT	O	the	det	77	SENT_42	[p2l1071t3590r1183b3647],
77	A	NN	O	a	prep_of	74	SENT_42	[p2l1225t3590r1607b3662],
78	(	CD	NUMBER	(	num	77	SENT_42	[p2l1225t3590r1607b3662],
79	TA	NNP	O	TA	dep	82	SENT_42	[p2l1225t3590r1607b3662],
80	)	CD	NUMBER	)	num	82	SENT_42	[p2l1225t3590r1607b3662],
81	7TAA	NN	O	7taa	nn	82	SENT_42	[p2l1225t3590r1607b3662],
82	promoter	NN	O	promoter	ccomp	71	SENT_42	[p2l1647t3597r1980b3665],
83	was	VBD	O	be	cop	86	SENT_42	[p2l2020t3606r2148b3647],
84	approximately	RB	O	approximately	quantmod	85	SENT_42	[p2l9t3683r526b3759],
85	18-33	CD	PERCENT	18-33	num	86	SENT_42	[p2l575t3685r848b3741],
86	%	NN	PERCENT	%	dep	45	SENT_42	[p2l575t3685r848b3741],
87	that	IN	O	that	complm	88	SENT_42	[p2l892t3683r1036b3741],
88	of	IN	O	of	dep	86	SENT_42	[p2l1081t3683r1153b3741],
89	the	DT	O	the	det	91	SENT_42	[p2l1194t3683r1306b3741],
90	wild-type	JJ	O	wild-type	amod	91	SENT_42	[p2l1350t3683r1683b3759],
91	construct	NN	O	construct	pobj	88	SENT_42	[p2l1730t3676r2147b3741],
92	.	.	O	.	_	0	SENT_42	[p2l1730t3676r2147b3741],

1	”	NN	O	”	_	0	SENT_43	[p2l1730t3676r2147b3741],

1	Furthermore	RB	O	furthermore	dep	5	SENT_44	[p3l9t17r471b87],
2	,	,	O	,	_	0	SENT_44	[p3l9t17r471b87],
3	in	FW	O	in	dep	1	SENT_44	[p3l527t17r587b74],
4	vivo	FW	O	vivo	pobj	3	SENT_44	[p3l637t17r767b74],
5	experiments	NNS	O	experiment	nsubj	6	SENT_44	[p3l817t20r1253b92],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_44	[p3l1304t17r1794b74],
7	that	IN	O	that	complm	14	SENT_44	[p3l1843t17r1986b74],
8	the	DT	O	the	det	12	SENT_44	[p3l2035t17r2148b74],
9	hepatic	JJ	O	hepatic	amod	12	SENT_44	[p3l9t112r269b188],
10	bilirubin	NN	O	bilirubin	nn	12	SENT_44	[p3l337t112r647b170],
11	UGT	NN	O	ugt	nn	12	SENT_44	[p3l718t113r883b170],
12	activity	NN	O	activity	nsubjpass	14	SENT_44	[p3l948t115r1212b188],
13	was	VBD	O	be	auxpass	14	SENT_44	[p3l1279t129r1407b170],
14	reduced	VBN	O	reduce	ccomp	6	SENT_44	[p3l1479t112r1758b170],
15	in	IN	O	in	_	0	SENT_44	[p3l1829t115r1899b169],
16	(	CD	NUMBER	(	num	18	SENT_44	[p3l1973t112r2148b184],
17	TA	NNP	O	TA	nn	18	SENT_44	[p3l1973t112r2148b184],
18	)	NN	O	)	prep_in	14	SENT_44	[p3l1973t112r2148b184],
19	7	CD	NUMBER	7	num	20	SENT_44	[p3l1973t112r2148b184],
20	homozygotes	NNS	O	homozygote	dep	18	SENT_44	[p3l9t198r569b281],
21	.	.	O	.	_	0	SENT_44	[p3l9t198r569b281],

1	”	NN	O	”	_	0	SENT_45	[p3l9t198r569b281],

1	The	DT	O	the	det	2	SENT_46	[p3l83t301r216b359],
2	frequency	NN	O	frequency	_	0	SENT_46	[p3l260t301r615b377],
3	of	IN	O	of	_	0	SENT_46	[p3l657t301r729b359],
4	the	DT	O	the	det	7	SENT_46	[p3l767t301r880b359],
5	(	CD	NUMBER	(	num	7	SENT_46	[p3l929t301r1104b373],
6	TA	NNP	O	TA	nn	7	SENT_46	[p3l929t301r1104b373],
7	)	NN	O	)	prep_of	12	SENT_46	[p3l929t301r1104b373],
8	7	CD	NUMBER	7	num	9	SENT_46	[p3l929t301r1104b373],
9	allele	NN	O	allele	nsubj	12	SENT_46	[p3l1149t301r1330b359],
10	is	VBZ	O	be	cop	12	SENT_46	[p3l1375t304r1426b359],
11	30-40	CD	PERCENT	30-40	num	12	SENT_46	[p3l1472t302r1749b359],
12	%	NN	PERCENT	%	ccomp	2	SENT_46	[p3l1472t302r1749b359],
13	in	IN	O	in	_	0	SENT_46	[p3l1794t304r1864b358],
14	Caucasians	NNPS	MISC	Caucasians	prep_in	12	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
15	,13	CD	NUMBER	,13	dep	14	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
16	'	''	DATE	'	_	0	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
17	15	CD	DATE	15	amod	12	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
18	'	''	DATE	'	_	0	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
19	17	CD	DATE	17	dep	2	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
20	'19	CD	DATE	'19	dep	25	SENT_46	[p3l1909t302r2147b359, p3l10t386r513b464],
21	while	IN	O	while	dep	25	SENT_46	[p3l567t393r761b451],
22	it	PRP	O	it	nsubj	25	SENT_46	[p3l816t397r865b451],
23	is	VBZ	O	be	cop	25	SENT_46	[p3l918t396r969b451],
24	less	RBR	O	less	advmod	25	SENT_46	[p3l1023t393r1143b451],
25	frequent	JJ	O	frequent	dep	19	SENT_46	[p3l1197t393r1498b469],
26	in	IN	O	in	_	0	SENT_46	[p3l1552t396r1622b450],
27	the	DT	O	the	det	29	SENT_46	[p3l1676t394r1788b451],
28	Japanese	JJ	MISC	japanese	amod	29	SENT_46	[p3l1835t396r2148b469],
29	population	NN	O	population	prep_in	25	SENT_46	[p3l14t511r423b587],
30	,	,	O	,	_	0	SENT_46	[p3l14t511r423b587],
31	with	IN	O	with	_	0	SENT_46	[p3l504t511r665b569],
32	the	DT	O	the	det	33	SENT_46	[p3l743t511r855b569],
33	frequency	NN	O	frequency	prep_with	25	SENT_46	[p3l934t511r1287b587],
34	being	VBG	O	be	cop	38	SENT_46	[p3l1360t511r1558b587],
35	approximately	RB	O	approximately	quantmod	36	SENT_46	[p3l1636t511r2151b587],
36	16	CD	PERCENT	16	dep	37	SENT_46	[p3l20t597r334b662],
37	%	NN	PERCENT	%	dep	38	SENT_46	[p3l20t597r334b662],
38	.2	NN	NUMBER	.2	partmod	33	SENT_46	[p3l20t597r334b662],
39	°	CD	NUMBER	°	number	40	SENT_46	[p3l20t597r334b662],
40	'21	CD	NUMBER	'21	num	38	SENT_46	[p3l20t597r334b662],
41	It	PRP	O	it	nsubjpass	43	SENT_46	[p3l360t606r412b662],
42	was	VBD	O	be	auxpass	43	SENT_46	[p3l433t621r560b662],
43	suggested	VBN	O	suggest	rcmod	38	SENT_46	[p3l585t604r923b680],
44	that	IN	O	that	complm	49	SENT_46	[p3l945t604r1088b662],
45	the	DT	O	the	det	47	SENT_46	[p3l1110t604r1222b662],
46	GLY71Arg	NN	O	gly71arg	nn	47	SENT_46	[p3l1247t605r1603b680],
47	polymorphism	NN	O	polymorphism	nsubj	49	SENT_46	[p3l1624t604r2148b680],
48	may	MD	O	may	aux	49	SENT_46	[p3l14t716r167b775],
49	contribute	VB	O	contribute	ccomp	43	SENT_46	[p3l232t699r599b757],
50	to	TO	O	to	_	0	SENT_46	[p3l667t707r736b757],
51	Gilbert	NNP	PERSON	Gilbert	poss	53	SENT_46	[p3l806t699r1098b757],
52	's	POS	O	's	_	0	SENT_46	[p3l806t699r1098b757],
53	syndrome	NN	O	syndrome	prep_to	49	SENT_46	[p3l1167t699r1534b775],
54	,	,	O	,	_	0	SENT_46	[p3l1167t699r1534b775],
55	particularly	RB	O	particularly	advmod	38	SENT_46	[p3l1605t699r2013b775],
56	in	IN	O	in	_	0	SENT_46	[p3l2078t702r2148b756],
57	Japanese	JJ	MISC	japanese	amod	60	SENT_46	[p3l6t795r318b868],
58	and	CC	O	and	_	0	SENT_46	[p3l349t792r480b850],
59	Asian	JJ	LOCATION	asian	amod	60	SENT_46	[p3l508t794r701b850],
60	patients	NNS	O	patient	prep_in	55	SENT_46	[p3l730t785r1263b868],
61	.14	CD	NUMBER	.14	tmod	55	SENT_46	[p3l730t785r1263b868],
62	'	''	DATE	'	_	0	SENT_46	[p3l730t785r1263b868],
63	22	CD	DATE	22	num	64	SENT_46	[p3l730t785r1263b868],
64	'23	CD	DATE	'23	attr	38	SENT_46	[p3l730t785r1263b868],

1	Given	VBN	O	give	prep	6	SENT_47	[p3l92t891r302b947],
2	these	DT	O	these	det	3	SENT_47	[p3l340t889r521b947],
3	data	NNS	O	datum	dep	1	SENT_47	[p3l561t889r726b959],
4	,	,	O	,	_	0	SENT_47	[p3l561t889r726b959],
5	we	PRP	O	we	nsubj	6	SENT_47	[p3l767t906r863b947],
6	set	VBD	O	set	_	0	SENT_47	[p3l904t896r996b947],
7	out	RP	O	out	prt	6	SENT_47	[p3l1035t896r1152b947],
8	to	TO	O	to	aux	9	SENT_47	[p3l1189t896r1259b947],
9	investigate	VB	O	investigate	xcomp	6	SENT_47	[p3l1298t892r1678b965],
10	the	DT	O	the	det	12	SENT_47	[p3l1717t889r1829b947],
11	possible	JJ	O	possible	amod	12	SENT_47	[p3l1868t889r2147b965],
12	association	NN	O	association	dobj	9	SENT_47	[p3l15t987r405b1042],
13	of	IN	O	of	_	0	SENT_47	[p3l467t984r538b1042],
14	both	CC	O	both	preconj	17	SENT_47	[p3l593t984r760b1042],
15	the	DT	O	the	det	17	SENT_47	[p3l821t984r934b1042],
16	TA	NNP	O	TA	nn	17	SENT_47	[p3l994t986r1088b1041],
17	repeat	NN	O	repeat	prep_of	12	SENT_47	[p3l1149t991r1365b1060],
18	and	CC	O	and	_	0	SENT_47	[p3l1426t984r1557b1042],
19	the	DT	O	the	det	21	SENT_47	[p3l1618t984r1731b1042],
20	GLY71Arg	NN	O	gly71arg	nn	21	SENT_47	[p3l1794t986r2150b1060],
21	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_47	[p3l14t1079r568b1154],
22	within	IN	O	within	_	0	SENT_47	[p3l614t1079r848b1136],
23	UGT1/l1	NN	O	ugt1/l1	prep_within	9	SENT_47	[p3l900t1080r1207b1149],
24	,	,	O	,	_	0	SENT_47	[p3l900t1080r1207b1149],
25	with	IN	O	with	_	0	SENT_47	[p3l1255t1079r1416b1136],
26	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	9	SENT_47	[p3l1462t1079r2149b1154],
27	observed	VBN	O	observe	partmod	26	SENT_47	[p3l15t1174r327b1232],
28	during	IN	O	during	_	0	SENT_47	[p3l355t1174r590b1250],
29	repeat	NN	O	repeat	nn	30	SENT_47	[p3l617t1181r833b1250],
30	dosing	NN	O	dosing	prep_during	27	SENT_47	[p3l862t1174r1096b1250],
31	with	IN	O	with	_	0	SENT_47	[p3l1121t1174r1283b1232],
32	tranilast	NN	O	tranilast	prep_with	27	SENT_47	[p3l1311t1174r1601b1232],
33	in	IN	O	in	_	0	SENT_47	[p3l1629t1177r1699b1231],
34	the	DT	O	the	det	36	SENT_47	[p3l1728t1174r1840b1232],
35	PRESTO	NNP	O	PRESTO	nn	36	SENT_47	[p3l1870t1176r2147b1232],
36	cohort	NN	O	cohort	prep_in	32	SENT_47	[p3l15t1269r265b1327],
37	.	.	O	.	_	0	SENT_47	[p3l15t1269r265b1327],

1	Our	PRP$	O	we	poss	2	SENT_48	[p3l309t1271r444b1327],
2	results	NNS	O	result	nsubj	3	SENT_48	[p3l482t1269r706b1327],
3	supported	VBD	O	support	_	0	SENT_48	[p3l748t1269r1100b1345],
4	the	DT	O	the	det	5	SENT_48	[p3l1139t1269r1251b1327],
5	hypothesis	NN	O	hypothesis	dobj	3	SENT_48	[p3l1291t1269r1673b1345],
6	that	IN	O	that	complm	13	SENT_48	[p3l1713t1269r1856b1327],
7	genetic	JJ	O	genetic	amod	8	SENT_48	[p3l1895t1272r2149b1345],
8	predisposition	NN	O	predisposition	nsubj	13	SENT_48	[p3l14t1364r519b1440],
9	to	TO	O	to	_	0	SENT_48	[p3l543t1371r612b1422],
10	Gilbert	NNP	PERSON	Gilbert	poss	12	SENT_48	[p3l638t1364r930b1422],
11	's	POS	O	's	_	0	SENT_48	[p3l638t1364r930b1422],
12	syndrome	NN	O	syndrome	prep_to	8	SENT_48	[p3l955t1364r1304b1440],
13	predicted	VBD	O	predict	ccomp	3	SENT_48	[p3l1328t1364r1659b1440],
14	susceptibility	NN	O	susceptibility	dobj	13	SENT_48	[p3l1684t1364r2151b1440],
15	to	TO	O	to	_	0	SENT_48	[p3l14t1466r84b1517],
16	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	18	SENT_48	[p3l111t1459r798b1535],
17	following	VBG	O	follow	amod	18	SENT_48	[p3l824t1459r1162b1535],
18	administration	NN	O	administration	prep_to	13	SENT_48	[p3l1189t1459r1715b1517],
19	of	IN	O	of	_	0	SENT_48	[p3l1743t1459r1814b1517],
20	tranilast	NN	O	tranilast	prep_of	18	SENT_48	[p3l1836t1459r2144b1517],
21	.	.	O	.	_	0	SENT_48	[p3l1836t1459r2144b1517],

1	RESULTS	NNS	O	result	_	0	SENT_49	[p3l17t1680r333b1736],

1	Genotype	NN	O	genotype	nsubj	2	SENT_50	[p3l16t1776r359b1850],
2	results	VBZ	O	result	_	0	SENT_50	[p3l424t1774r649b1832],
3	for	IN	O	for	mark	11	SENT_50	[p3l714t1774r812b1832],
4	the	DT	O	the	det	7	SENT_50	[p3l876t1774r989b1832],
5	TA	NNP	O	TA	nn	7	SENT_50	[p3l1053t1776r1147b1831],
6	repeat	NN	O	repeat	nn	7	SENT_50	[p3l1211t1781r1427b1850],
7	polymorphism	NN	O	polymorphism	nsubjpass	11	SENT_50	[p3l1491t1774r2015b1850],
8	of	IN	O	of	_	0	SENT_50	[p3l2081t1774r2152b1832],
9	UGT1/l1	NN	O	ugt1/l1	prep_of	7	SENT_50	[p3l20t1870r302b1926],
10	were	VBD	O	be	auxpass	11	SENT_50	[p3l371t1885r534b1926],
11	generated	VBN	O	generate	advcl	2	SENT_50	[p3l599t1868r944b1944],
12	for	IN	O	for	_	0	SENT_50	[p3l1008t1868r1106b1926],
13	1042	CD	DATE	1042	num	14	SENT_50	[p3l1174t1870r1339b1926],
14	patients	NNS	O	patient	prep_for	11	SENT_50	[p3l1402t1871r1702b1944],
15	.	.	O	.	_	0	SENT_50	[p3l1402t1871r1702b1944],

1	The	DT	O	the	det	3	SENT_51	[p3l1769t1868r1901b1926],
2	allele	NN	O	allele	nn	3	SENT_51	[p3l1966t1868r2147b1926],
3	frequencies	NNS	O	frequency	nsubj	25	SENT_51	[p3l14t1964r415b2040],
4	for	IN	O	for	_	0	SENT_51	[p3l462t1964r560b2022],
5	(	CD	NUMBER	(	num	6	SENT_51	[p3l608t1964r801b2036],
6	TA	NNP	O	TA	prep_for	3	SENT_51	[p3l608t1964r801b2036],
7	)	CD	NUMBER	)	number	8	SENT_51	[p3l608t1964r801b2036],
8	5	CD	NUMBER	5	dep	6	SENT_51	[p3l608t1964r801b2036],
9	,	,	O	,	_	0	SENT_51	[p3l608t1964r801b2036],
10	(	CD	NUMBER	(	num	11	SENT_51	[p3l855t1964r1048b2036],
11	TA	NNP	O	TA	prep_for	3	SENT_51	[p3l855t1964r1048b2036],
12	)	CD	NUMBER	)	number	13	SENT_51	[p3l855t1964r1048b2036],
13	6	CD	NUMBER	6	dep	11	SENT_51	[p3l855t1964r1048b2036],
14	,	,	O	,	_	0	SENT_51	[p3l855t1964r1048b2036],
15	(	CD	NUMBER	(	num	17	SENT_51	[p3l1102t1964r1276b2036],
16	TA	NNP	O	TA	nn	17	SENT_51	[p3l1102t1964r1276b2036],
17	)	NN	O	)	conj_and	6	SENT_51	[p3l1102t1964r1276b2036],
18	7	CD	NUMBER	7	dep	17	SENT_51	[p3l1102t1964r1276b2036],
19	and	CC	O	and	_	0	SENT_51	[p3l1323t1964r1454b2022],
20	(	CD	NUMBER	(	num	21	SENT_51	[p3l1503t1964r1678b2036],
21	TA	NNP	O	TA	conj_and	6	SENT_51	[p3l1503t1964r1678b2036],
22	)	CD	NUMBER	)	number	23	SENT_51	[p3l1503t1964r1678b2036],
23	8	CD	NUMBER	8	dep	21	SENT_51	[p3l1503t1964r1678b2036],
24	were	VBD	O	be	cop	25	SENT_51	[p3l1723t1981r1886b2022],
25	0.001	CD	NUMBER	0.001	_	0	SENT_51	[p3l1933t1966r2143b2034],
26	,	,	O	,	_	0	SENT_51	[p3l1933t1966r2143b2034],
27	0.67	CD	NUMBER	0.67	conj_and	25	SENT_51	[p3l15t2060r181b2129],
28	,	,	O	,	_	0	SENT_51	[p3l15t2060r181b2129],
29	0.33	CD	NUMBER	0.33	conj_and	25	SENT_51	[p3l209t2060r356b2116],
30	and	CC	O	and	_	0	SENT_51	[p3l383t2058r514b2116],
31	0.001	CD	NUMBER	0.001	conj_and	25	SENT_51	[p3l536t2060r746b2129],
32	,	,	O	,	_	0	SENT_51	[p3l536t2060r746b2129],
33	respectively	RB	O	respectively	advmod	25	SENT_51	[p3l774t2059r1202b2134],
34	.	.	O	.	_	0	SENT_51	[p3l774t2059r1202b2134],

1	The	DT	O	the	det	3	SENT_52	[p3l1227t2058r1359b2116],
2	(	CD	NUMBER	(	num	3	SENT_52	[p3l1386t2058r1525b2131],
3	TA	NNP	O	TA	nsubj	7	SENT_52	[p3l1386t2058r1525b2131],
4	)	CD	NUMBER	)	num	6	SENT_52	[p3l1386t2058r1525b2131],
5	5	CD	NUMBER	5	num	6	SENT_52	[p3l1534t2092r1559b2129],
6	allele	NN	O	allele	dep	3	SENT_52	[p3l1586t2058r1767b2116],
7	appears	VBZ	O	appear	_	0	SENT_52	[p3l1791t2075r2055b2134],
8	to	TO	O	to	aux	9	SENT_52	[p3l2078t2066r2148b2116],
9	function	VB	O	function	xcomp	7	SENT_52	[p3l14t2154r319b2212],
10	normally	RB	O	normally	advmod	9	SENT_52	[p3l341t2154r675b2230],
11	,	,	O	,	_	0	SENT_52	[p3l341t2154r675b2230],
12	while	IN	O	while	mark	30	SENT_52	[p3l701t2154r894b2212],
13	the	DT	O	the	det	15	SENT_52	[p3l917t2154r1029b2212],
14	(	CD	NUMBER	(	num	15	SENT_52	[p3l1056t2154r1230b2226],
15	TA	NNP	O	TA	nsubjpass	30	SENT_52	[p3l1056t2154r1230b2226],
16	)	CD	NUMBER	)	number	17	SENT_52	[p3l1056t2154r1230b2226],
17	8	CD	NUMBER	8	num	18	SENT_52	[p3l1056t2154r1230b2226],
18	allele	NN	O	allele	dep	15	SENT_52	[p3l1254t2154r1453b2224],
19	,	,	O	,	_	0	SENT_52	[p3l1254t2154r1453b2224],
20	similar	JJ	O	similar	amod	27	SENT_52	[p3l1482t2154r1721b2212],
21	to	TO	O	to	_	0	SENT_52	[p3l1742t2161r1812b2212],
22	the	DT	O	the	det	25	SENT_52	[p3l1834t2154r1947b2212],
23	(	CD	NUMBER	(	num	25	SENT_52	[p3l1974t2154r2147b2226],
24	TA	NNP	O	TA	nn	25	SENT_52	[p3l1974t2154r2147b2226],
25	)	NN	O	)	prep_to	20	SENT_52	[p3l1974t2154r2147b2226],
26	7	CD	NUMBER	7	num	25	SENT_52	[p3l1974t2154r2147b2226],
27	allele	NN	O	allele	appos	15	SENT_52	[p3l15t2247r215b2317],
28	,	,	O	,	_	0	SENT_52	[p3l15t2247r215b2317],
29	is	VBZ	O	be	auxpass	30	SENT_52	[p3l262t2250r312b2305],
30	associated	VBN	O	associate	advcl	7	SENT_52	[p3l356t2247r711b2305],
31	with	IN	O	with	_	0	SENT_52	[p3l752t2247r913b2305],
32	Gilbert	NNP	PERSON	Gilbert	poss	34	SENT_52	[p3l957t2247r1248b2305],
33	's	POS	O	's	_	0	SENT_52	[p3l957t2247r1248b2305],
34	syndrome	NN	O	syndrome	prep_with	30	SENT_52	[p3l1293t2240r1729b2323],
35	.	.	O	.	_	0	SENT_52	[p3l1293t2240r1729b2323],

1	”	NN	O	”	nsubjpass	20	SENT_53	[p3l1293t2240r1729b2323],
2	Six	CD	NUMBER	six	num	3	SENT_53	[p3l1774t2249r1876b2305],
3	individuals	NNS	O	individual	dep	1	SENT_53	[p3l1917t2247r2148b2305, p3l15t2342r197b2399],
4	who	WP	O	who	nsubj	5	SENT_53	[p3l242t2342r395b2399],
5	had	VBD	O	have	rcmod	1	SENT_53	[p3l442t2342r574b2399],
6	either	CC	O	either	preconj	9	SENT_53	[p3l621t2342r826b2399],
7	the	DT	O	the	det	9	SENT_53	[p3l871t2342r983b2399],
8	(	CD	NUMBER	(	num	9	SENT_53	[p3l1034t2342r1206b2414],
9	TA	NNP	O	TA	dobj	5	SENT_53	[p3l1034t2342r1206b2414],
10	)	CD	NUMBER	)	number	11	SENT_53	[p3l1034t2342r1206b2414],
11	5	CD	NUMBER	5	dep	9	SENT_53	[p3l1034t2342r1206b2414],
12	or	CC	O	or	_	0	SENT_53	[p3l1256t2358r1327b2399],
13	the	DT	O	the	det	15	SENT_53	[p3l1372t2342r1485b2399],
14	(	CD	NUMBER	(	num	15	SENT_53	[p3l1535t2342r1710b2414],
15	TA	NNP	O	TA	conj_or	9	SENT_53	[p3l1535t2342r1710b2414],
16	)	CD	NUMBER	)	number	17	SENT_53	[p3l1535t2342r1710b2414],
17	8	CD	NUMBER	8	num	18	SENT_53	[p3l1535t2342r1710b2414],
18	allele	NN	O	allele	dep	15	SENT_53	[p3l1757t2342r1939b2399],
19	were	VBD	O	be	auxpass	20	SENT_53	[p3l1984t2358r2147b2399],
20	excluded	VBN	O	exclude	_	0	SENT_53	[p3l15t2438r331b2496],
21	due	JJ	O	due	acomp	20	SENT_53	[p3l354t2438r480b2496],
22	to	TO	O	to	_	0	SENT_53	[p3l503t2445r573b2496],
23	their	PRP$	O	they	poss	25	SENT_53	[p3l596t2438r764b2496],
24	low	JJ	O	low	amod	25	SENT_53	[p3l785t2438r913b2496],
25	frequencies	NNS	O	frequency	prep_to	20	SENT_53	[p3l934t2438r1353b2514],
26	,	,	O	,	_	0	SENT_53	[p3l934t2438r1353b2514],
27	with	IN	O	with	_	0	SENT_53	[p3l1378t2438r1539b2496],
28	1036	CD	NUMBER	1036	num	29	SENT_53	[p3l1567t2440r1732b2496],
29	individuals	NNS	O	individual	prep_with	20	SENT_53	[p3l1755t2438r2147b2496],
30	remaining	VBG	O	remain	partmod	29	SENT_53	[p3l14t2537r380b2610],
31	in	IN	O	in	_	0	SENT_53	[p3l408t2537r478b2591],
32	subsequent	JJ	O	subsequent	amod	33	SENT_53	[p3l509t2534r905b2610],
33	analysis	NN	O	analysis	prep_in	30	SENT_53	[p3l936t2534r1228b2610],
34	.	.	O	.	_	0	SENT_53	[p3l936t2534r1228b2610],

1	Significant	JJ	O	significant	amod	2	SENT_54	[p3l92t2621r469b2697],
2	differences	NNS	O	difference	nsubjpass	7	SENT_54	[p3l583t2621r963b2679],
3	in	IN	O	in	_	0	SENT_54	[p3l1077t2624r1147b2678],
4	genotype	NN	O	genotype	nn	5	SENT_54	[p3l1260t2628r1585b2697],
5	distributions	NNS	O	distribution	prep_in	2	SENT_54	[p3l1699t2621r2147b2679],
6	were	VBD	O	be	auxpass	7	SENT_54	[p3l13t2733r176b2774],
7	found	VBN	O	find	_	0	SENT_54	[p3l224t2716r435b2774],
8	between	IN	O	between	_	0	SENT_54	[p3l481t2716r778b2774],
9	cases	NNS	O	case	prep_between	7	SENT_54	[p3l826t2733r997b2774],
10	(	CD	NUMBER	(	num	12	SENT_54	[p3l1050t2716r1380b2788],
11	bilirubin	NN	O	bilirubin	nn	12	SENT_54	[p3l1050t2716r1380b2788],
12	levels	NNS	O	level	dep	13	SENT_54	[p3l1428t2716r1621b2774],
13	>	JJR	O	>	dep	9	SENT_54	[p3l1682t2716r2145b2792],
14	2.00	CD	NUMBER	2.00	num	16	SENT_54	[p3l1682t2716r2145b2792],
15	mg/dl	NN	O	mg/dl	nn	16	SENT_54	[p3l1682t2716r2145b2792],
16	)	NN	O	)	dep	13	SENT_54	[p3l1682t2716r2145b2792],
17	and	CC	O	and	_	0	SENT_54	[p3l15t2810r146b2868],
18	controls	VBZ	O	control	conj_and	7	SENT_54	[p3l228t2810r514b2868],
19	(	CD	NUMBER	(	num	21	SENT_54	[p3l600t2810r930b2883],
20	bilirubin	NN	O	bilirubin	nn	21	SENT_54	[p3l600t2810r930b2883],
21	levels	NNS	O	level	dobj	18	SENT_54	[p3l1012t2810r1205b2868],
22	<	JJR	O	<	dep	18	SENT_54	[p3l1298t2812r1511b2875],
23	2.00	CD	NUMBER	2.00	num	24	SENT_54	[p3l1298t2812r1511b2875],
24	mg/dl	NN	O	mg/dl	dobj	7	SENT_54	[p3l1528t2810r1761b2886],
25	)	CD	NUMBER	)	number	26	SENT_54	[p3l1528t2810r1761b2886],
26	(	CD	NUMBER	(	dep	24	SENT_54	[p3l1849t2810r2056b2883],
27	Table	NNP	O	Table	dep	26	SENT_54	[p3l1849t2810r2056b2883],
28	1	CD	NUMBER	1	num	27	SENT_54	[p3l2092t2812r2143b2881],
29	,	,	O	,	_	0	SENT_54	[p3l2092t2812r2143b2881],
30	P	NN	O	p	nsubj	37	SENT_54	[p3l11t2905r245b2961],
31	=	JJ	O	=	quantmod	32	SENT_54	[p3l11t2905r245b2961],
32	2	CD	NUMBER	2	num	33	SENT_54	[p3l11t2905r245b2961],
33	>	JJR	O	>	npadvmod	34	SENT_54	[p3l11t2905r245b2961],
34	<	JJR	O	<	amod	30	SENT_54	[p3l11t2905r245b2961],
35	10	CD	NUMBER	10	num	37	SENT_54	[p3l276t2896r508b2976],
36	””	NN	O	””	nn	37	SENT_54	[p3l276t2896r508b2976],
37	)	NN	O	)	conj_and	7	SENT_54	[p3l276t2896r508b2976],
38	.	.	O	.	_	0	SENT_54	[p3l276t2896r508b2976],

1	In	IN	O	in	_	0	SENT_55	[p3l566t2907r639b2961],
2	all	DT	O	all	prep_in	10	SENT_55	[p3l692t2904r791b2974],
3	,	,	O	,	_	0	SENT_55	[p3l692t2904r791b2974],
4	39	CD	PERCENT	39	num	5	SENT_55	[p3l850t2906r1001b2962],
5	%	NN	PERCENT	%	nsubj	10	SENT_55	[p3l850t2906r1001b2962],
6	of	IN	O	of	_	0	SENT_55	[p3l1054t2904r1125b2962],
7	the	DT	O	the	det	9	SENT_55	[p3l1173t2904r1286b2962],
8	127	CD	NUMBER	127	num	9	SENT_55	[p3l1345t2906r1464b2961],
9	cases	NNS	O	case	prep_of	5	SENT_55	[p3l1519t2921r1691b2962],
10	carried	VBD	O	carry	_	0	SENT_55	[p3l1744t2904r1983b2962],
11	the	DT	O	the	det	14	SENT_55	[p3l2035t2904r2147b2962],
12	(	CD	NUMBER	(	num	14	SENT_55	[p3l18t3000r404b3072],
13	TA	NNP	O	TA	nn	14	SENT_55	[p3l18t3000r404b3072],
14	)	NN	O	)	dobj	10	SENT_55	[p3l18t3000r404b3072],
15	7	CD	NUMBER	7	num	14	SENT_55	[p3l18t3000r404b3072],
16	/	:	O	/	punct	19	SENT_55	[p3l18t3000r404b3072],
17	(	CD	NUMBER	(	num	19	SENT_55	[p3l18t3000r404b3072],
18	TA	NNP	O	TA	nn	19	SENT_55	[p3l18t3000r404b3072],
19	)	NN	O	)	dep	10	SENT_55	[p3l18t3000r404b3072],
20	7	CD	NUMBER	7	num	21	SENT_55	[p3l18t3000r404b3072],
21	genotype	NN	O	genotype	dep	19	SENT_55	[p3l443t3007r786b3076],
22	,	,	O	,	_	0	SENT_55	[p3l443t3007r786b3076],
23	in	IN	O	in	_	0	SENT_55	[p3l829t3003r899b3057],
24	comparison	NN	O	comparison	prep_in	19	SENT_55	[p3l937t3003r1352b3076],
25	with	IN	O	with	_	0	SENT_55	[p3l1388t3000r1549b3058],
26	only	JJ	O	only	quantmod	27	SENT_55	[p3l1589t3000r1748b3076],
27	7	CD	PERCENT	7	num	28	SENT_55	[p3l1788t3002r1892b3057],
28	%	NN	PERCENT	%	prep_with	24	SENT_55	[p3l1788t3002r1892b3057],
29	of	IN	O	of	_	0	SENT_55	[p3l1931t3000r2002b3058],
30	the	DT	O	the	det	32	SENT_55	[p3l2035t3000r2147b3058],
31	909	CD	NUMBER	909	num	32	SENT_55	[p3l15t3096r139b3152],
32	controls	NNS	O	control	prep_of	28	SENT_55	[p3l176t3095r480b3152],
33	.	.	O	.	_	0	SENT_55	[p3l176t3095r480b3152],

1	These	DT	O	these	det	2	SENT_56	[p3l516t3095r717b3152],
2	data	NNS	O	datum	nsubj	3	SENT_56	[p3l753t3095r901b3152],
3	predicted	VBD	O	predict	_	0	SENT_56	[p3l934t3095r1265b3170],
4	an	DT	O	a	det	6	SENT_56	[p3l1299t3111r1383b3152],
5	odds	NNS	O	odds	nn	6	SENT_56	[p3l1418t3095r1581b3152],
6	ratio	NN	O	ratio	dobj	3	SENT_56	[p3l1615t3098r1776b3152],
7	of	IN	O	of	_	0	SENT_56	[p3l1811t3094r1883b3152],
8	8.2	CD	NUMBER	8.2	prep_of	6	SENT_56	[p3l1913t3096r2017b3152],
9	for	IN	O	for	_	0	SENT_56	[p3l2052t3094r2149b3152],
10	cases	NNS	O	case	prep_for	3	SENT_56	[p3l15t3207r186b3248],
11	vs	CC	O	vs	_	0	SENT_56	[p3l224t3207r287b3248],
12	controls	NNS	O	control	conj_vs	10	SENT_56	[p3l326t3190r629b3260],
13	,	,	O	,	_	0	SENT_56	[p3l326t3190r629b3260],
14	in	IN	O	in	_	0	SENT_56	[p3l671t3193r741b3247],
15	relation	NN	O	relation	prep_in	3	SENT_56	[p3l778t3190r1053b3248],
16	to	TO	O	to	_	0	SENT_56	[p3l1089t3197r1159b3248],
17	(	CD	NUMBER	(	num	21	SENT_56	[p3l1200t3190r1374b3262],
18	TA	NNP	O	TA	nn	21	SENT_56	[p3l1200t3190r1374b3262],
19	)	NN	O	)	nn	21	SENT_56	[p3l1200t3190r1374b3262],
20	7	CD	NUMBER	7	num	21	SENT_56	[p3l1200t3190r1374b3262],
21	homozygotes	NNS	O	homozygote	prep_to	3	SENT_56	[p3l1412t3190r1883b3266],
22	vs	CC	O	vs	_	0	SENT_56	[p3l1921t3207r1984b3248],
23	any	DT	O	any	det	26	SENT_56	[p3l2022t3207r2151b3266],
24	other	JJ	O	other	amod	26	SENT_56	[p3l15t3285r203b3343],
25	TA	NNP	O	TA	nn	26	SENT_56	[p3l230t3287r325b3342],
26	genotypes	NNS	O	genotype	prep_to	3	SENT_56	[p3l354t3292r729b3361],
27	.	.	O	.	_	0	SENT_56	[p3l354t3292r729b3361],

1	Genotype	NN	O	genotype	nn	2	SENT_57	[p3l765t3287r1107b3361],
2	frequencies	NNS	O	frequency	nsubj	17	SENT_57	[p3l1139t3285r1540b3361],
3	of	IN	O	of	_	0	SENT_57	[p3l1571t3285r1642b3343],
4	the	DT	O	the	det	7	SENT_57	[p3l1668t3285r1780b3343],
5	TA	NNP	O	TA	nn	7	SENT_57	[p3l1809t3287r1904b3342],
6	repeat	NN	O	repeat	nn	7	SENT_57	[p3l1933t3292r2149b3361],
7	polymorphism	NN	O	polymorphism	prep_of	2	SENT_57	[p3l14t3380r538b3455],
8	between	IN	O	between	_	0	SENT_57	[p3l570t3380r867b3437],
9	the	DT	O	the	det	12	SENT_57	[p3l900t3380r1012b3437],
10	same	JJ	O	same	amod	12	SENT_57	[p3l1048t3396r1221b3437],
11	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	12	SENT_57	[p3l1256t3380r1943b3455],
12	cases	NNS	O	case	prep_between	7	SENT_57	[p3l1977t3396r2148b3437],
13	and	CC	O	and	_	0	SENT_57	[p3l15t3475r146b3533],
14	the	DT	O	the	det	16	SENT_57	[p3l181t3475r293b3533],
15	super	JJ	O	super	amod	16	SENT_57	[p3l331t3492r518b3551],
16	controls	NNS	O	control	conj_and	12	SENT_57	[p3l553t3475r838b3533],
17	(	VBP	O	(	_	0	SENT_57	[p3l878t3475r1209b3547],
18	bilirubin	NN	O	bilirubin	nn	19	SENT_57	[p3l878t3475r1209b3547],
19	levels	NNS	O	level	nsubjpass	26	SENT_57	[p3l1244t3475r1437b3533],
20	<	JJR	O	<	dep	26	SENT_57	[p3l1484t3485r1533b3540],
21	1.00	CD	NUMBER	1.00	num	23	SENT_57	[p3l1554t3477r1697b3533],
22	mg/dl	NN	O	mg/dl	nn	23	SENT_57	[p3l1714t3475r1947b3551],
23	)	NN	O	)	nsubjpass	26	SENT_57	[p3l1714t3475r1947b3551],
24	were	VBD	O	be	auxpass	26	SENT_57	[p3l1984t3492r2147b3533],
25	also	RB	O	also	advmod	26	SENT_57	[p3l15t3568r149b3626],
26	compared	VBN	O	compare	xcomp	17	SENT_57	[p3l182t3568r532b3644],
27	(	RB	O	(	advmod	26	SENT_57	[p3l567t3568r773b3640],
28	Table	NNP	O	Table	dobj	26	SENT_57	[p3l567t3568r773b3640],
29	1	CD	NUMBER	1	num	28	SENT_57	[p3l811t3570r863b3639],
30	,	,	O	,	_	0	SENT_57	[p3l811t3570r863b3639],
31	P	NN	O	p	appos	28	SENT_57	[p3l896t3570r1066b3626],
32	=	JJ	O	=	amod	31	SENT_57	[p3l896t3570r1066b3626],
33	8	CD	NUMBER	8	tmod	32	SENT_57	[p3l896t3570r1066b3626],
34	x	CC	O	x	_	0	SENT_57	[p3l1093t3587r1130b3624],
35	10	CD	NUMBER	10	number	36	SENT_57	[p3l1162t3561r1394b3640],
36	‘	CD	NUMBER	‘	conj_x	28	SENT_57	[p3l1162t3561r1394b3640],
37	33	CD	NUMBER	33	num	38	SENT_57	[p3l1162t3561r1394b3640],
38	)	NN	O	)	dep	36	SENT_57	[p3l1162t3561r1394b3640],
39	.	.	O	.	_	0	SENT_57	[p3l1162t3561r1394b3640],

1	Only	RB	O	only	quantmod	2	SENT_58	[p3l1431t3568r1607b3644],
2	3	CD	PERCENT	3	num	3	SENT_58	[p3l1638t3570r1745b3626],
3	%	NN	PERCENT	%	nsubj	9	SENT_58	[p3l1638t3570r1745b3626],
4	of	IN	O	of	_	0	SENT_58	[p3l1778t3568r1849b3626],
5	the	DT	O	the	det	8	SENT_58	[p3l1876t3568r1989b3626],
6	541	CD	NUMBER	541	num	8	SENT_58	[p3l2023t3570r2143b3626],
7	super	JJ	O	super	amod	8	SENT_58	[p3l16t3681r203b3740],
8	controls	NNS	O	control	prep_of	3	SENT_58	[p3l249t3664r534b3722],
9	had	VBD	O	have	_	0	SENT_58	[p3l582t3664r714b3722],
10	the	DT	O	the	det	13	SENT_58	[p3l760t3664r872b3722],
11	(	CD	NUMBER	(	num	13	SENT_58	[p3l924t3664r1309b3736],
12	TA	NNP	O	TA	nn	13	SENT_58	[p3l924t3664r1309b3736],
13	)	NN	O	)	dobj	9	SENT_58	[p3l924t3664r1309b3736],
14	7	CD	NUMBER	7	amod	13	SENT_58	[p3l924t3664r1309b3736],
15	/	:	O	/	punct	18	SENT_58	[p3l924t3664r1309b3736],
16	(	CD	NUMBER	(	num	18	SENT_58	[p3l924t3664r1309b3736],
17	TA	NNP	O	TA	nn	18	SENT_58	[p3l924t3664r1309b3736],
18	)	NN	O	)	dep	13	SENT_58	[p3l924t3664r1309b3736],
19	7	CD	NUMBER	7	num	20	SENT_58	[p3l924t3664r1309b3736],
20	genotype	NN	O	genotype	dep	18	SENT_58	[p3l1357t3671r1701b3740],
21	.	.	O	.	_	0	SENT_58	[p3l1357t3671r1701b3740],

1	These	DT	O	these	det	2	SENT_59	[p3l1750t3664r1952b3722],
2	data	NNS	O	datum	nsubj	3	SENT_59	[p3l2000t3664r2149b3722],
3	predicted	VBD	O	predict	_	0	SENT_59	[p4l14t16r345b92],
4	an	DT	O	a	det	6	SENT_59	[p4l384t33r468b74],
5	odds	NNS	O	odds	nn	6	SENT_59	[p4l508t16r671b74],
6	ratio	NN	O	ratio	dobj	3	SENT_59	[p4l711t19r873b74],
7	of	IN	O	of	_	0	SENT_59	[p4l912t16r984b74],
8	22.8	CD	NUMBER	22.8	prep_of	6	SENT_59	[p4l1020t18r1167b74],
9	for	IN	O	for	_	0	SENT_59	[p4l1207t16r1305b74],
10	the	DT	O	the	det	11	SENT_59	[p4l1343t17r1455b74],
11	cases	NNS	O	case	prep_for	3	SENT_59	[p4l1495t33r1667b74],
12	vs	CC	O	vs	_	0	SENT_59	[p4l1706t33r1769b74],
13	the	DT	O	the	det	15	SENT_59	[p4l1809t17r1921b74],
14	super	JJ	O	super	amod	15	SENT_59	[p4l1962t33r2149b92],
15	controls	NNS	O	control	conj_vs	11	SENT_59	[p4l15t112r319b182],
16	,	,	O	,	_	0	SENT_59	[p4l15t112r319b182],
17	in	IN	O	in	_	0	SENT_59	[p4l356t114r426b168],
18	relation	NN	O	relation	prep_in	3	SENT_59	[p4l458t111r732b169],
19	to	TO	O	to	_	0	SENT_59	[p4l764t119r834b169],
20	(	CD	NUMBER	(	num	24	SENT_59	[p4l870t111r1045b184],
21	TA	NNP	O	TA	nn	24	SENT_59	[p4l870t111r1045b184],
22	)	NN	O	)	nn	24	SENT_59	[p4l870t111r1045b184],
23	7	CD	NUMBER	7	num	24	SENT_59	[p4l870t111r1045b184],
24	homozygotes	NNS	O	homozygote	prep_to	3	SENT_59	[p4l1078t111r1548b187],
25	vs	CC	O	vs	_	0	SENT_59	[p4l1581t128r1645b169],
26	any	DT	O	any	det	29	SENT_59	[p4l1678t128r1808b187],
27	other	JJ	O	other	amod	29	SENT_59	[p4l1838t111r2026b169],
28	TA	NNP	O	TA	nn	29	SENT_59	[p4l2055t113r2149b168],
29	genotypes	NNS	O	genotype	prep_to	3	SENT_59	[p4l15t214r389b283],
30	.	.	O	.	_	0	SENT_59	[p4l15t214r389b283],

1	It	PRP	O	it	nsubj	3	SENT_60	[p4l456t209r508b265],
2	is	VBZ	O	be	cop	3	SENT_60	[p4l570t210r620b265],
3	interesting	JJ	O	interesting	_	0	SENT_60	[p4l682t210r1063b283],
4	to	TO	O	to	aux	5	SENT_60	[p4l1124t214r1194b265],
5	note	VB	O	note	xcomp	3	SENT_60	[p4l1256t214r1413b265],
6	that	IN	O	that	complm	51	SENT_60	[p4l1477t207r1620b265],
7	the	DT	O	the	det	8	SENT_60	[p4l1681t207r1793b265],
8	level	NN	O	level	nsubj	51	SENT_60	[p4l1856t207r2018b265],
9	of	IN	O	of	_	0	SENT_60	[p4l2081t207r2152b265],
10	significance	NN	O	significance	prep_of	8	SENT_60	[p4l16t299r431b375],
11	increased	VBN	O	increase	partmod	10	SENT_60	[p4l478t300r807b357],
12	from	IN	O	from	_	0	SENT_60	[p4l852t299r1021b357],
13	1O	NN	O	1o	prep_from	11	SENT_60	[p4l1072t292r1260b357],
14	‘	CD	NUMBER	‘	number	19	SENT_60	[p4l1072t292r1260b357],
15	22	CD	NUMBER	22	number	19	SENT_60	[p4l1072t292r1260b357],
16	to	TO	O	to	dep	19	SENT_60	[p4l1305t307r1374b357],
17	10	CD	NUMBER	10	number	19	SENT_60	[p4l1426t292r1630b370],
18	‘	CD	NUMBER	‘	number	19	SENT_60	[p4l1426t292r1630b370],
19	33	CD	NUMBER	33	num	13	SENT_60	[p4l1426t292r1630b370],
20	,	,	O	,	_	0	SENT_60	[p4l1426t292r1630b370],
21	even	RB	O	even	advmod	45	SENT_60	[p4l1681t317r1845b357],
22	though	IN	O	though	dep	45	SENT_60	[p4l1890t300r2148b375],
23	the	DT	O	the	det	24	SENT_60	[p4l14t396r127b454],
24	number	NN	O	number	nsubj	45	SENT_60	[p4l150t396r428b454],
25	of	IN	O	of	_	0	SENT_60	[p4l450t396r521b454],
26	controls	NNS	O	control	prep_of	24	SENT_60	[p4l540t396r826b454],
27	reduced	VBN	O	reduce	partmod	26	SENT_60	[p4l849t396r1128b454],
28	from	IN	O	from	_	0	SENT_60	[p4l1150t396r1319b454],
29	909	CD	NUMBER	909	number	31	SENT_60	[p4l1342t398r1466b454],
30	to	TO	NUMBER	to	dep	31	SENT_60	[p4l1491t403r1560b454],
31	541	CD	NUMBER	541	prep_from	27	SENT_60	[p4l1585t398r1706b454],
32	in	IN	O	in	_	0	SENT_60	[p4l1733t399r1803b453],
33	the	DT	O	the	det	36	SENT_60	[p4l1825t396r1937b454],
34	super	JJ	O	super	amod	36	SENT_60	[p4l1962t413r2149b472],
35	control	NN	O	control	nn	36	SENT_60	[p4l15t491r270b549],
36	subset	NN	O	subset	prep_in	27	SENT_60	[p4l303t491r535b562],
37	,	,	O	,	_	0	SENT_60	[p4l303t491r535b562],
38	illustrating	VBG	O	illustrate	xcomp	27	SENT_60	[p4l570t491r958b567],
39	the	DT	O	the	det	40	SENT_60	[p4l987t491r1099b549],
40	impact	NN	O	impact	dobj	38	SENT_60	[p4l1131t494r1374b567],
41	of	IN	O	of	_	0	SENT_60	[p4l1405t491r1476b549],
42	using	VBG	O	use	prepc_of	40	SENT_60	[p4l1501t494r1693b567],
43	‘	NN	O	‘	dobj	42	SENT_60	[p4l1724t491r2146b567],
44	stringently	RB	O	stringently	advmod	42	SENT_60	[p4l1724t491r2146b567],
45	’	VBD	O	’	ccomp	11	SENT_60	[p4l1724t491r2146b567],
46	instead	RB	O	instead	_	0	SENT_60	[p4l14t586r268b643],
47	of	IN	O	of	_	0	SENT_60	[p4l299t585r370b643],
48	‘	CD	NUMBER	‘	npadvmod	49	SENT_60	[p4l399t586r684b661],
49	loosely	RB	O	loosely	prepc_instead_of	45	SENT_60	[p4l399t586r684b661],
50	’	RB	O	’	advmod	51	SENT_60	[p4l399t586r684b661],
51	defined	VBN	O	define	ccomp	5	SENT_60	[p4l718t585r982b643],
52	control	NN	O	control	nn	53	SENT_60	[p4l1013t586r1268b643],
53	groups	NNS	O	group	dobj	51	SENT_60	[p4l1300t602r1535b661],
54	on	IN	O	on	_	0	SENT_60	[p4l1568t602r1659b643],
55	the	DT	O	the	det	56	SENT_60	[p4l1690t586r1802b643],
56	power	NN	O	power	prep_on	51	SENT_60	[p4l1833t602r2051b661],
57	of	IN	O	of	_	0	SENT_60	[p4l2081t585r2153b643],
58	association	NN	O	association	nn	59	SENT_60	[p4l15t684r405b739],
59	studies	NNS	O	study	prep_of	56	SENT_60	[p4l435t681r693b739],
60	.	.	O	.	_	0	SENT_60	[p4l435t681r693b739],

1	These	DT	O	these	det	2	SENT_61	[p4l723t681r925b739],
2	findings	NNS	O	finding	nsubj	3	SENT_61	[p4l954t681r1242b757],
3	agreed	VBD	O	agree	_	0	SENT_61	[p4l1272t681r1500b757],
4	with	IN	O	with	_	0	SENT_61	[p4l1526t681r1687b739],
5	the	DT	O	the	det	6	SENT_61	[p4l1715t681r1827b739],
6	observations	NNS	O	observation	prep_with	3	SENT_61	[p4l1857t681r2148b739, p4l14t777r189b832],
7	discussed	VBN	O	discuss	partmod	6	SENT_61	[p4l254t774r581b832],
8	by	IN	O	by	_	0	SENT_61	[p4l643t774r731b850],
9	Schork	NNP	PERSON	Schork	agent	7	SENT_61	[p4l793t774r1033b832],
10	et	FW	O	et	nn	11	SENT_61	[p4l1095t780r1156b832],
11	611,24	FW	O	611,24	dobj	3	SENT_61	[p4l1213t767r1360b845],
12	who	WP	O	who	nsubj	13	SENT_61	[p4l1423t774r1576b832],
13	described	VBD	O	describe	rcmod	11	SENT_61	[p4l1641t774r1971b832],
14	the	DT	O	the	det	15	SENT_61	[p4l2035t775r2147b832],
15	importance	NN	O	importance	dobj	13	SENT_61	[p4l14t873r420b946],
16	of	IN	O	of	_	0	SENT_61	[p4l462t870r533b928],
17	the	DT	O	the	det	18	SENT_61	[p4l570t870r682b928],
18	definition	NN	O	definition	prep_of	15	SENT_61	[p4l725t870r1076b928],
19	of	IN	O	of	_	0	SENT_61	[p4l1118t870r1189b928],
20	the	DT	O	the	det	22	SENT_61	[p4l1226t870r1338b928],
21	control	JJ	O	control	amod	22	SENT_61	[p4l1380t870r1635b928],
22	subjects	NNS	O	subject	prep_of	18	SENT_61	[p4l1678t870r1971b946],
23	,	,	O	,	_	0	SENT_61	[p4l1678t870r1971b946],
24	and	CC	O	and	advmod	13	SENT_61	[p4l2018t870r2148b928],

1	Table	NNP	O	Table	dep	10	SENT_62	[p4l9t1043r101b1070],
2	1	CD	NUMBER	1	num	4	SENT_62	[p4l118t1044r129b1070],
3	Genotype	NN	O	genotype	nn	4	SENT_62	[p4l173t1044r333b1079],
4	distribution	NN	O	distribution	dep	1	SENT_62	[p4l348t1044r537b1070],
5	at	IN	O	at	_	0	SENT_62	[p4l553t1047r584b1070],
6	the	DT	O	the	det	7	SENT_62	[p4l596t1044r649b1070],
7	UGT1A1	NN	O	ugt1a1	prep_at	4	SENT_62	[p4l666t1044r789b1070],
8	TA	NNP	O	TA	dep	10	SENT_62	[p4l804t1045r849b1070],
9	repeat	NN	O	repeat	nn	10	SENT_62	[p4l863t1047r968b1079],
10	polymorphism	NN	O	polymorphism	_	0	SENT_62	[p4l982t1044r1217b1079],
11	in	IN	O	in	_	0	SENT_62	[p4l1233t1044r1260b1070],
12	patients	NNS	O	patient	prep_in	10	SENT_62	[p4l1276t1044r1407b1079],
13	from	IN	O	from	_	0	SENT_62	[p4l1420t1044r1498b1070],
14	a	DT	O	a	det	18	SENT_62	[p4l1513t1051r1530b1070],
15	phase	NN	O	phase	nn	18	SENT_62	[p4l1545t1044r1639b1079],
16	III	CD	NUMBER	iii	num	18	SENT_62	[p4l1655t1045r1682b1070],
17	clinical	JJ	O	clinical	amod	18	SENT_62	[p4l1697t1044r1806b1070],
18	trial	NN	O	trial	prep_from	12	SENT_62	[p4l1821t1044r1884b1070],
19	of	IN	O	of	_	0	SENT_62	[p4l1899t1044r1932b1070],
20	tranilast	NN	O	tranilast	prep_of	18	SENT_62	[p4l1944t1044r2079b1070],

1	Hyperbilirubinemia	NN	O	hyperbilirubinemia	_	0	SENT_63	[p4l11t1128r290b1163],
2	status	NN	O	status	nn	4	SENT_63	[p4l303t1131r391b1155],
3	(	CD	NUMBER	(	num	4	SENT_63	[p4l595t1128r765b1161],
4	TA	NNP	O	TA	dep	1	SENT_63	[p4l595t1128r765b1161],
5	)	CD	NUMBER	)	number	6	SENT_63	[p4l595t1128r765b1161],
6	6	CD	NUMBER	6	dep	4	SENT_63	[p4l595t1128r765b1161],
7	/	:	O	/	punct	9	SENT_63	[p4l595t1128r765b1161],
8	(	CD	NUMBER	(	num	9	SENT_63	[p4l595t1128r765b1161],
9	TA	NNP	O	TA	dep	6	SENT_63	[p4l595t1128r765b1161],
10	)	CD	NUMBER	)	num	9	SENT_63	[p4l595t1128r765b1161],
11	5	CD	NUMBER	5	number	12	SENT_63	[p4l595t1128r765b1161],
12	(	CD	NUMBER	(	num	23	SENT_63	[p4l970t1128r983b1161],
13	TA	NNP	O	TA	nn	23	SENT_63	[p4l985t1128r1076b1161],
14	)	CD	NUMBER	)	number	15	SENT_63	[p4l985t1128r1076b1161],
15	5	CD	NUMBER	5	amod	23	SENT_63	[p4l985t1128r1076b1161],
16	/	:	O	/	punct	19	SENT_63	[p4l985t1128r1076b1161],
17	(	CD	NUMBER	(	num	19	SENT_63	[p4l985t1128r1076b1161],
18	TA	NNP	O	TA	nn	19	SENT_63	[p4l1078t1128r1124b1161],
19	)	NN	O	)	dep	15	SENT_63	[p4l1078t1128r1124b1161],
20	7	CD	NUMBER	7	number	21	SENT_63	[p4l1128t1143r1141b1160],
21	(	CD	NUMBER	(	dep	19	SENT_63	[p4l1345t1128r1358b1161],
22	TA	NNP	O	TA	dep	21	SENT_63	[p4l1360t1128r1406b1161],
23	)	NN	O	)	dep	9	SENT_63	[p4l1360t1128r1406b1161],
24	7	CD	NUMBER	7	dep	23	SENT_63	[p4l1410t1128r1451b1161],
25	/	:	O	/	punct	9	SENT_63	[p4l1410t1128r1451b1161],
26	(	CD	NUMBER	(	num	28	SENT_63	[p4l1410t1128r1451b1161],
27	TA	NNP	O	TA	nn	28	SENT_63	[p4l1453t1128r1499b1161],
28	)	NN	O	)	dep	4	SENT_63	[p4l1453t1128r1499b1161],
29	7	CD	NUMBER	7	num	32	SENT_63	[p4l1503t1143r1516b1160],
30	Total	JJ	O	total	amod	32	SENT_63	[p4l1724t1128r1798b1155],
31	P-value	JJ	O	p-value	amod	32	SENT_63	[p4l2017t1128r2135b1155],
32	”	NN	O	”	dep	1	SENT_63	[p4l2017t1128r2135b1155],

1	Cases	NNS	O	case	dep	111	SENT_64	[p4l10t1217r95b1243],
2	22	CD	PERCENT	22	dep	111	SENT_64	[p4l615t1217r652b1243],
3	(	CD	PERCENT	(	dep	111	SENT_64	[p4l668t1217r762b1250],
4	17	CD	PERCENT	17	dep	111	SENT_64	[p4l668t1217r762b1250],
5	%	NN	PERCENT	%	dep	111	SENT_64	[p4l668t1217r762b1250],
6	)	CD	NUMBER	)	dep	111	SENT_64	[p4l668t1217r762b1250],
7	55	CD	NUMBER	55	dep	111	SENT_64	[p4l990t1218r1027b1243],
8	(	NN	O	(	dep	111	SENT_64	[p4l1042t1217r1137b1250],
9	43	CD	PERCENT	43	dep	111	SENT_64	[p4l1042t1217r1137b1250],
10	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1042t1217r1137b1250],
11	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1042t1217r1137b1250],
12	so	RB	O	so	dep	111	SENT_64	[p4l1365t1217r1403b1243],
13	(	JJ	O	(	dep	111	SENT_64	[p4l1418t1217r1512b1250],
14	39	CD	PERCENT	39	dep	111	SENT_64	[p4l1418t1217r1512b1250],
15	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1418t1217r1512b1250],
16	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1418t1217r1512b1250],
17	127	CD	NUMBER	127	dep	111	SENT_64	[p4l1741t1217r1797b1243],
18	Controls	NNP	O	Controls	dep	111	SENT_64	[p4l10t1258r139b1285],
19	444	CD	PERCENT	444	dep	111	SENT_64	[p4l594t1259r653b1285],
20	(	CD	PERCENT	(	dep	111	SENT_64	[p4l668t1258r762b1292],
21	49	CD	PERCENT	49	dep	111	SENT_64	[p4l668t1258r762b1292],
22	%	NN	PERCENT	%	dep	111	SENT_64	[p4l668t1258r762b1292],
23	)	CD	NUMBER	)	dep	111	SENT_64	[p4l668t1258r762b1292],
24	398	CD	NUMBER	398	dep	111	SENT_64	[p4l971t1259r1028b1285],
25	(	NN	O	(	dep	111	SENT_64	[p4l1042t1258r1137b1292],
26	44	CD	PERCENT	44	dep	111	SENT_64	[p4l1042t1258r1137b1292],
27	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1042t1258r1137b1292],
28	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1042t1258r1137b1292],
29	67	CD	NUMBER	67	dep	111	SENT_64	[p4l1366t1259r1403b1285],
30	(	NN	O	(	dep	111	SENT_64	[p4l1418t1258r1492b1292],
31	7	CD	PERCENT	7	dep	111	SENT_64	[p4l1418t1258r1492b1292],
32	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1418t1258r1492b1292],
33	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1418t1258r1492b1292],
34	909	CD	NUMBER	909	dep	111	SENT_64	[p4l1739t1259r1797b1285],
35	2	CD	NUMBER	2	dep	111	SENT_64	[p4l2002t1259r2019b1285],
36	X	NN	O	x	dep	111	SENT_64	[p4l2032t1267r2049b1285],
37	10-22	CD	NUMBER	10-22	dep	111	SENT_64	[p4l2063t1255r2149b1285],
38	Super	NNP	O	Super	dep	111	SENT_64	[p4l11t1302r99b1336],
39	control	NN	O	control	dep	111	SENT_64	[p4l111t1297r236b1327],
40	“	CD	NUMBER	“	dep	111	SENT_64	[p4l111t1297r236b1327],
41	318	CD	NUMBER	318	dep	111	SENT_64	[p4l597t1302r653b1327],
42	(	NN	O	(	dep	111	SENT_64	[p4l668t1301r762b1334],
43	59	CD	PERCENT	59	dep	111	SENT_64	[p4l668t1301r762b1334],
44	%	NN	PERCENT	%	dep	111	SENT_64	[p4l668t1301r762b1334],
45	)	CD	NUMBER	)	dep	111	SENT_64	[p4l668t1301r762b1334],
46	208	CD	NUMBER	208	dep	111	SENT_64	[p4l970t1302r1028b1327],
47	(	NN	O	(	dep	111	SENT_64	[p4l1042t1301r1137b1334],
48	38	CD	PERCENT	38	dep	111	SENT_64	[p4l1042t1301r1137b1334],
49	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1042t1301r1137b1334],
50	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1042t1301r1137b1334],
51	15	CD	NUMBER	15	dep	111	SENT_64	[p4l1367t1302r1402b1327],
52	(	NN	O	(	dep	111	SENT_64	[p4l1418t1301r1492b1334],
53	3	CD	PERCENT	3	dep	111	SENT_64	[p4l1418t1301r1492b1334],
54	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1418t1301r1492b1334],
55	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1418t1301r1492b1334],
56	541	CD	NUMBER	541	dep	111	SENT_64	[p4l1739t1302r1790b1327],
57	8	CD	NUMBER	8	dep	111	SENT_64	[p4l2002t1302r2019b1327],
58	>	JJR	O	>	dep	111	SENT_64	[p4l2032t1309r2049b1327],
59	<	JJR	O	<	dep	111	SENT_64	[p4l2032t1309r2049b1327],
60	10	CD	NUMBER	10	dep	111	SENT_64	[p4l2063t1297r2149b1327],
61	*	NN	O	*	dep	111	SENT_64	[p4l2063t1297r2149b1327],
62	”	CD	NUMBER	”	dep	111	SENT_64	[p4l2063t1297r2149b1327],
63	Total	JJ	O	total	dep	111	SENT_64	[p4l9t1343r99b1369],
64	‘	NN	O	‘	dep	111	SENT_64	[p4l9t1343r99b1369],
65	466	CD	NUMBER	466	dep	111	SENT_64	[p4l594t1344r653b1369],
66	(	NN	O	(	dep	111	SENT_64	[p4l668t1343r762b1376],
67	45	CD	PERCENT	45	dep	111	SENT_64	[p4l668t1343r762b1376],
68	%	NN	PERCENT	%	dep	111	SENT_64	[p4l668t1343r762b1376],
69	)	CD	NUMBER	)	dep	111	SENT_64	[p4l668t1343r762b1376],
70	453	CD	NUMBER	453	dep	111	SENT_64	[p4l969t1344r1027b1369],
71	(	NN	O	(	dep	111	SENT_64	[p4l1042t1343r1137b1376],
72	44	CD	PERCENT	44	dep	111	SENT_64	[p4l1042t1343r1137b1376],
73	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1042t1343r1137b1376],
74	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1042t1343r1137b1376],
75	117	CD	NUMBER	117	dep	111	SENT_64	[p4l1346t1344r1403b1369],
76	(	NN	O	(	dep	111	SENT_64	[p4l1418t1343r1512b1376],
77	11	CD	PERCENT	11	dep	111	SENT_64	[p4l1418t1343r1512b1376],
78	%	NN	PERCENT	%	dep	111	SENT_64	[p4l1418t1343r1512b1376],
79	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1418t1343r1512b1376],
80	1036	CD	DATE	1036	dep	111	SENT_64	[p4l1720t1344r1797b1369],
81	acenotype	JJ	O	acenotype	dep	111	SENT_64	[p4l10t1416r149b1450],
82	distribution	NN	O	distribution	dep	111	SENT_64	[p4l168t1421r312b1443],
83	comparison	NN	O	comparison	dep	111	SENT_64	[p4l332t1422r479b1450],
84	between	IN	O	between	dep	111	SENT_64	[p4l500t1421r608b1443],
85	cases	NNS	O	case	dep	111	SENT_64	[p4l628t1428r692b1443],
86	(	CD	NUMBER	(	dep	111	SENT_64	[p4l711t1421r824b1449],
87	bilirubin	NN	O	bilirubin	dep	111	SENT_64	[p4l711t1421r824b1449],
88	level	NN	O	level	dep	111	SENT_64	[p4l845t1421r899b1443],
89	>	JJR	O	>	dep	111	SENT_64	[p4l924t1422r1005b1443],
90	2.00	CD	NUMBER	2.00	dep	111	SENT_64	[p4l924t1422r1005b1443],
91	mg/dl	NN	O	mg/dl	dep	111	SENT_64	[p4l1013t1421r1098b1450],
92	)	NN	O	)	dep	111	SENT_64	[p4l1013t1421r1098b1450],
93	and	CC	O	and	dep	111	SENT_64	[p4l1118t1421r1164b1443],
94	controls	VBZ	O	control	dep	111	SENT_64	[p4l1184t1421r1284b1443],
95	(	CD	NUMBER	(	dep	111	SENT_64	[p4l1304t1421r1417b1449],
96	bilirubin	NN	O	bilirubin	dep	111	SENT_64	[p4l1304t1421r1417b1449],
97	level	NN	O	level	dep	111	SENT_64	[p4l1438t1421r1492b1443],
98	£	CD	MONEY	£	dep	111	SENT_64	[p4l1516t1422r1597b1446],
99	2.00	CD	MONEY	2.00	dep	111	SENT_64	[p4l1516t1422r1597b1446],
100	mg/dl	NN	O	mg/dl	dep	111	SENT_64	[p4l1605t1421r1691b1450],
101	)	CD	NUMBER	)	dep	111	SENT_64	[p4l1605t1421r1691b1450],
102	or	CC	O	or	dep	111	SENT_64	[p4l1710t1428r1736b1443],
103	super	JJ	O	super	dep	111	SENT_64	[p4l1753t1428r1823b1450],
104	controls	NNS	O	control	dep	111	SENT_64	[p4l1841t1421r1941b1443],
105	(	VBP	O	(	dep	111	SENT_64	[p4l1961t1421r2074b1449],
106	bilirubin	NN	O	bilirubin	dep	111	SENT_64	[p4l1961t1421r2074b1449],
107	level	NN	O	level	dep	111	SENT_64	[p4l2095t1421r2149b1443],
108	$	$	MONEY	$	dep	111	SENT_64	[p4l14t1459r94b1483],
109	1.00	CD	MONEY	1.00	dep	111	SENT_64	[p4l14t1459r94b1483],
110	mg/dl	NN	O	mg/dl	dep	111	SENT_64	[p4l103t1458r196b1487],
111	)	NN	O	)	_	0	SENT_64	[p4l103t1458r196b1487],
112	.	.	O	.	_	0	SENT_64	[p4l103t1458r196b1487],

1	“	NN	O	“	nsubj	6	SENT_65	[p4l10t1492r96b1524],
2	Super	NNP	O	Super	nn	3	SENT_65	[p4l10t1492r96b1524],
3	control	NN	O	control	dep	1	SENT_65	[p4l106t1495r195b1517],
4	is	VBZ	O	be	cop	6	SENT_65	[p4l208t1495r224b1517],
5	a	DT	O	a	det	6	SENT_65	[p4l235t1501r247b1517],
6	subset	NN	O	subset	_	0	SENT_65	[p4l259t1495r340b1517],
7	of	IN	O	of	_	0	SENT_65	[p4l350t1495r375b1517],
8	the	DT	O	the	det	9	SENT_65	[p4l385t1495r425b1517],
9	control	NN	O	control	prep_of	6	SENT_65	[p4l437t1495r525b1517],
10	set	VBN	O	set	partmod	9	SENT_65	[p4l537t1497r579b1517],
11	.	.	O	.	_	0	SENT_65	[p4l537t1497r579b1517],

1	‘	NNP	O	‘	nn	2	SENT_66	[p4l9t1533r78b1554],
2	Data	NNP	O	Data	nsubjpass	11	SENT_66	[p4l9t1533r78b1554],
3	from	IN	O	from	_	0	SENT_66	[p4l89t1532r148b1554],
4	six	CD	NUMBER	six	prep_from	2	SENT_66	[p4l161t1532r193b1554],
5	of	IN	O	of	_	0	SENT_66	[p4l204t1532r229b1554],
6	the	DT	O	the	det	8	SENT_66	[p4l239t1532r279b1554],
7	1042	CD	DATE	1042	num	8	SENT_66	[p4l292t1532r355b1554],
8	patients	NNS	O	patient	prep_of	4	SENT_66	[p4l368t1532r467b1561],
9	are	VBP	O	be	auxpass	11	SENT_66	[p4l479t1538r516b1554],
10	not	RB	O	not	neg	11	SENT_66	[p4l529t1534r570b1554],
11	shown	VBN	O	show	_	0	SENT_66	[p4l581t1532r671b1559],
12	,	,	O	,	_	0	SENT_66	[p4l581t1532r671b1559],
13	who	WP	O	who	nsubj	14	SENT_66	[p4l683t1532r738b1554],
14	had	VBD	O	have	ccomp	11	SENT_66	[p4l751t1532r796b1554],
15	either	CC	O	either	preconj	18	SENT_66	[p4l808t1532r881b1554],
16	the	DT	O	the	det	18	SENT_66	[p4l891t1532r932b1554],
17	(	CD	NUMBER	(	num	18	SENT_66	[p4l944t1532r1008b1560],
18	TA	NNP	O	TA	dobj	14	SENT_66	[p4l944t1532r1008b1560],
19	)	CD	NUMBER	)	number	20	SENT_66	[p4l944t1532r1008b1560],
20	5	CD	NUMBER	5	dep	18	SENT_66	[p4l944t1532r1008b1560],
21	or	CC	O	or	_	0	SENT_66	[p4l1020t1538r1046b1554],
22	the	DT	O	the	det	24	SENT_66	[p4l1056t1532r1096b1554],
23	(	CD	NUMBER	(	num	24	SENT_66	[p4l1108t1532r1173b1560],
24	TA	NNP	O	TA	dobj	14	SENT_66	[p4l1108t1532r1173b1560],
25	)	CD	NUMBER	)	num	27	SENT_66	[p4l1108t1532r1173b1560],
26	g	NN	O	g	nn	27	SENT_66	[p4l1108t1532r1173b1560],
27	allele	NN	O	allele	dep	24	SENT_66	[p4l1185t1532r1255b1554],
28	.	.	O	.	_	0	SENT_66	[p4l1185t1532r1255b1554],

1	The	DT	O	the	det	3	SENT_67	[p4l9t1661r56b1683],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_67	[p4l68t1661r318b1690],
3	journal	NN	O	journal	_	0	SENT_67	[p4l329t1661r416b1688],

1	%	NN	O	%	nsubj	6	SENT_68	[p4l90t2349r140b2403],
2	of	IN	O	of	_	0	SENT_68	[p4l90t2263r140b2325],
3	cases	NNS	O	case	nn	5	SENT_68	[p4l106t2103r140b2251],
4	hilimhin	NN	O	hilimhin	nn	5	SENT_68	[p4l887t2887r1139b2936],
5	levels	NNS	O	level	prep_of	1	SENT_68	[p4l1163t2890r1315b2936],
6	{	VBP	O	{	_	0	SENT_68	[p4l1336t2887r1545b2948],
7	mg	NN	O	mg	dobj	6	SENT_68	[p4l1336t2887r1545b2948],
8	}	SYM	O	}	dep	10	SENT_68	[p4l1336t2887r1545b2948],
9	-	:	O	-	_	0	SENT_68	[p4l1336t2887r1545b2948],
10	till	IN	O	till	rcmod	7	SENT_68	[p4l1336t2887r1545b2948],

1	P	NN	O	p	_	0	SENT_69	[p4l534t2994r743b3023],
2	pm-tranilast	JJ	O	pm-tranilast	amod	3	SENT_69	[p4l764t2985r1089b3048],
3	Ell	NN	PERSON	ell	dep	1	SENT_69	[p4l1422t2985r1841b3048],
4	.	.	O	.	_	0	SENT_69	[p4l1422t2985r1841b3048],

1	Il	NN	O	il	nn	4	SENT_70	[p4l1422t2985r1841b3048],
2	‘	CD	NUMBER	‘	num	4	SENT_70	[p4l1422t2985r1841b3048],
3	ll	NN	O	ll	nn	4	SENT_70	[p4l1422t2985r1841b3048],
4	‘	NN	O	‘	_	0	SENT_70	[p4l1422t2985r1841b3048],
5	l	NN	O	l	nn	6	SENT_70	[p4l1422t2985r1841b3048],
6	_	NN	O	_	dep	4	SENT_70	[p4l1422t2985r1841b3048],
7	.	.	O	.	_	0	SENT_70	[p4l1422t2985r1841b3048],

1	_	NN	O	_	_	0	SENT_71	[p4l1422t2985r1841b3048],
2	'	''	O	'	_	0	SENT_71	[p4l1422t2985r1841b3048],
3	«	NN	O	«	dep	1	SENT_71	[p4l1422t2985r1841b3048],
4	'	''	O	'	_	0	SENT_71	[p4l1422t2985r1841b3048],
5	£	CD	MONEY	£	number	6	SENT_71	[p4l1422t2985r1841b3048],
6	_	CD	MONEY	_	dep	3	SENT_71	[p4l1422t2985r1841b3048],
7	--	:	O	--	_	0	SENT_71	[p4l1422t2985r1841b3048],
8	[	CD	NUMBER	[	dep	3	SENT_71	[p4l1422t2985r1841b3048],
9	l.	NN	O	l.	dep	8	SENT_71	[p4l1422t2985r1841b3048],
10	'	''	O	'	_	0	SENT_71	[p4l1422t2985r1841b3048],
11	t	NN	O	t	dep	8	SENT_71	[p4l1422t2985r1841b3048],
12	'	''	O	'	_	0	SENT_71	[p4l1422t2985r1841b3048],
13	lI1	NN	O	li1	prep	1	SENT_71	[p4l1422t2985r1841b3048],
14	‘	CD	NUMBER	‘	num	15	SENT_71	[p4l1422t2985r1841b3048],
15	llElt	NN	O	llelt	dep	13	SENT_71	[p4l1422t2985r1841b3048],
16	?	.	O	?	_	0	SENT_71	[p4l1422t2985r1841b3048],
17	'	''	O	'	_	0	SENT_71	[p4l1422t2985r1841b3048],

1	[	NN	O	[	_	0	SENT_72	[p4l1422t2985r1841b3048],

1	U	NNP	O	U	nn	2	SENT_73	[p5l94t48r140b114],
2	‘	NNP	O	‘	_	0	SENT_73	[p5l94t48r140b114],
3	‘	CD	NUMBER	‘	num	4	SENT_73	[p5l94t599r144b652],
4	fa	NN	O	fa	dep	2	SENT_73	[p5l94t599r144b652],
5	of	IN	O	of	_	0	SENT_73	[p5l94t512r144b570],
6	an	DT	O	a	det	7	SENT_73	[p5l111t438r144b496],
7	ntruls	NNS	O	ntrul	prep_of	4	SENT_73	[p5l98t266r144b430],

1	Pl	NN	O	pl	_	0	SENT_74	[p5l1075t2151r1195b2204],
2	.	.	O	.	_	0	SENT_74	[p5l1075t2151r1195b2204],

1	«	NN	O	«	_	0	SENT_75	[p5l1985t2147r2079b2216],
2	qt	NN	O	qt	dep	1	SENT_75	[p5l1985t2147r2079b2216],
3	«	CD	NUMBER	«	number	4	SENT_75	[p5l2009t2224r2059b2253],
4	.5	CD	NUMBER	.5	num	5	SENT_75	[p5l2009t2224r2059b2253],
5	A	DT	O	a	dep	2	SENT_75	[p5l2021t2257r2058b2294],

1	1	CD	NUMBER	1	num	2	SENT_76	[p5l1261t2331r1303b2356],
2	ﬁr-Tl	NN	O	ﬁr-tl	_	0	SENT_76	[p5l1261t2224r1307b2311],
3	H	NN	O	h	num	2	SENT_76	[p5l1262t2171r1307b2200],
4	4	CD	NUMBER	4	number	3	SENT_76	[p5l1409t2331r1459b2364],
5	2-4	CD	NUMBER	2-4	number	3	SENT_76	[p5l1409t2224r1459b2311],
6	44	CD	NUMBER	44	number	3	SENT_76	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
7	.	.	O	.	_	0	SENT_76	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],

1	.	.	O	.	_	0	SENT_77	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],

1	l	NN	O	l	_	0	SENT_78	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
2	-	:	O	-	_	0	SENT_78	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
3	!	.	O	!	_	0	SENT_78	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],

1	l	NN	O	l	_	0	SENT_79	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
2	-	:	O	-	_	0	SENT_79	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
3	»	NN	O	»	dep	1	SENT_79	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
4	5	CD	NUMBER	5	num	3	SENT_79	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
5	.	.	O	.	_	0	SENT_79	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],

1	ll	NN	O	ll	_	0	SENT_80	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
2	.	.	O	.	_	0	SENT_80	[p5l1409t2171r1459b2204, p5l1562t2152r1615b2364],
3	"	''	O	"	punct	1	SENT_80	[p5l1709t2335r1751b2360],

1	1	CD	NUMBER	1	number	2	SENT_81	[p5l1709t2335r1751b2360],
2	5-5	CD	NUMBER	5-5	_	0	SENT_81	[p5l1709t2224r1751b2310],
3	fi	NN	O	fus	nn	6	SENT_81	[p5l1709t2171r1755b2204],
4	E1	NN	O	e1	nn	6	SENT_81	[p5l1865t2331r1911b2364],
5	U	NNP	O	U	nn	6	SENT_81	[p5l1865t2282r1911b2311],
6	E	NNP	O	E	dep	2	SENT_81	[p5l1865t2224r1911b2253],
7	:	:	O	:	_	0	SENT_81	[p5l1865t2224r1911b2253],
8	E	NN	O	e	nn	9	SENT_81	[p5l1865t2175r1911b2204],
9	n	NN	O	n	dep	2	SENT_81	[p5l1114t2192r1163b2278],
10	+	CC	O	+	_	0	SENT_81	[p5l1114t2192r1163b2278],
11	«	CD	NUMBER	«	number	12	SENT_81	[p5l1114t2282r1163b2327],
12	:2	CD	NUMBER	:2	conj_+	9	SENT_81	[p5l1114t2282r1163b2327],
13	F9	NN	O	f9	dep	12	SENT_81	[p5l1114t2335r1163b2364],
14	"	''	O	"	punct	13	SENT_81	[p5l1114t2335r1163b2364],
15	.	.	O	.	_	0	SENT_81	[p5l1114t2335r1163b2364],

1	bilirubin	NN	O	bilirubin	nn	2	SENT_82	[p5l883t2413r1138b2463],
2	IE	NN	O	ie	_	0	SENT_82	[p5l1159t2413r1541b2475],
3	!	.	O	!	_	0	SENT_82	[p5l1159t2413r1541b2475],

1	-	:	O	-	_	0	SENT_83	[p5l1159t2413r1541b2475],
2	'	''	O	'	_	0	SENT_83	[p5l1159t2413r1541b2475],
3	.	.	O	.	_	0	SENT_83	[p5l1159t2413r1541b2475],

1	—	NN	O	—	_	0	SENT_84	[p5l1159t2413r1541b2475],
2	.	.	O	.	_	0	SENT_84	[p5l1159t2413r1541b2475],

1	i	LS	O	i	_	0	SENT_85	[p5l1159t2413r1541b2475],
2	:	:	O	:	_	0	SENT_85	[p5l1159t2413r1541b2475],
3	Lﬁi	NN	O	lﬁi	nn	4	SENT_85	[p5l1159t2413r1541b2475],
4	~	NN	O	~	dep	1	SENT_85	[p5l1159t2413r1541b2475],
5	[	CD	NUMBER	[	num	6	SENT_85	[p5l1159t2413r1541b2475],
6	irl1g	NN	O	irl1g	dep	4	SENT_85	[p5l1159t2413r1541b2475],
7	.	.	O	.	_	0	SENT_85	[p5l1159t2413r1541b2475],

1	I	PRP	O	I	_	0	SENT_86	[p5l1159t2413r1541b2475],
2	"	``	O	"	punct	3	SENT_86	[p5l1159t2413r1541b2475],
3	tIl	NN	O	til	dep	1	SENT_86	[p5l1159t2413r1541b2475],
4	)	NN	O	)	dep	1	SENT_86	[p5l1159t2413r1541b2475],

1	.	.	O	.	_	0	SENT_87	[p5l534t2548r744b2578],

1	—	NN	O	—	_	0	SENT_88	[p5l534t2548r744b2578],
2	.	.	O	.	_	0	SENT_88	[p5l534t2548r744b2578],

1	-	:	O	-	_	0	SENT_89	[p5l534t2548r744b2578],
2	p	NN	O	p	nsubj	5	SENT_89	[p5l764t2540r1089b2603],
3	-	:	O	-	_	0	SENT_89	[p5l764t2540r1089b2603],
4	'	''	O	'	_	0	SENT_89	[p5l764t2540r1089b2603],
5	r	NN	O	r	_	0	SENT_89	[p5l764t2540r1089b2603],
6	:	:	O	:	_	0	SENT_89	[p5l764t2540r1089b2603],
7	:	:	O	:	_	0	SENT_89	[p5l764t2540r1089b2603],
8	.	.	O	.	_	0	SENT_89	[p5l764t2540r1089b2603],

1	—	NN	O	—	_	0	SENT_90	[p5l764t2540r1089b2603],
2	.	.	O	.	_	0	SENT_90	[p5l764t2540r1089b2603],

1	tr	NN	O	tr	_	0	SENT_91	[p5l764t2540r1089b2603],
2	:1	CD	NUMBER	:1	rcmod	1	SENT_91	[p5l764t2540r1089b2603],
3	niia	NN	O	nium	dep	2	SENT_91	[p5l764t2540r1089b2603],
4	:	:	O	:	_	0	SENT_91	[p5l764t2540r1089b2603],
5	:	:	O	:	_	0	SENT_91	[p5l764t2540r1089b2603],
6	i	FW	O	i	dep	1	SENT_91	[p5l764t2540r1089b2603],
7	--	:	O	--	_	0	SENT_91	[p5l1184t2549r1397b2578],
8	cluring	NN	O	cluring	dep	6	SENT_91	[p5l1422t2540r1841b2603],
9	.	.	O	.	_	0	SENT_91	[p5l1422t2540r1841b2603],

1	—	NN	O	—	_	0	SENT_92	[p5l1422t2540r1841b2603],
2	.	.	O	.	_	0	SENT_92	[p5l1422t2540r1841b2603],

1	Irani1	NN	O	irani1	_	0	SENT_93	[p5l1422t2540r1841b2603],
2	,	,	O	,	_	0	SENT_93	[p5l1422t2540r1841b2603],
3	as	IN	O	as	dep	1	SENT_93	[p5l1422t2540r1841b2603],
4	:1	NN	O	:1	pobj	3	SENT_93	[p5l1422t2540r1841b2603],

1	Figure	NNP	O	Figure	nsubj	65	SENT_94	[p5l11t2727r203b2794],
2	1	CD	NUMBER	1	num	1	SENT_94	[p5l239t2728r261b2777],
3	Pre	SYM	O	pre	dep	14	SENT_94	[p5l343t2729r462b2778],
4	-	:	O	-	_	0	SENT_94	[p5l343t2729r462b2778],
5	and	CC	O	and	cc	11	SENT_94	[p5l494t2726r609b2778],
6	during	IN	O	during	_	0	SENT_94	[p5l642t2726r848b2794],
7	tranilast	NN	O	tranilast	nn	8	SENT_94	[p5l882t2726r1141b2778],
8	administration	NN	O	administration	prep_during	11	SENT_94	[p5l1171t2726r1631b2778],
9	serum	NN	O	serum	nn	11	SENT_94	[p5l1665t2741r1854b2778],
10	bilirubin	NN	O	bilirubin	nn	11	SENT_94	[p5l1890t2726r2150b2778],
11	levels	NNS	O	level	dep	14	SENT_94	[p5l10t2810r180b2861],
12	in	IN	O	in	_	0	SENT_94	[p5l219t2810r272b2861],
13	1036	CD	DATE	1036	prep_in	11	SENT_94	[p5l316t2811r464b2861],
14	patients	NNS	O	patient	dep	20	SENT_94	[p5l503t2810r755b2877],
15	from	IN	O	from	_	0	SENT_94	[p5l791t2810r942b2861],
16	the	DT	O	the	det	19	SENT_94	[p5l980t2810r1082b2861],
17	PRESTO	NNP	O	PRESTO	nn	19	SENT_94	[p5l1123t2811r1366b2861],
18	clinical	JJ	O	clinical	amod	19	SENT_94	[p5l1404t2810r1615b2861],
19	trial	NN	O	trial	prep_from	14	SENT_94	[p5l1655t2804r1827b2861],
20	.3	NN	NUMBER	.3	dep	25	SENT_94	[p5l1655t2804r1827b2861],
21	(	CD	NUMBER	(	num	20	SENT_94	[p5l1868t2810r1951b2875],
22	a	DT	O	a	det	24	SENT_94	[p5l1868t2810r1951b2875],
23	)	NN	O	)	nn	24	SENT_94	[p5l1868t2810r1951b2875],
24	cases	NNS	O	case	nsubj	25	SENT_94	[p5l1991t2825r2152b2861],
25	(	VBP	O	(	dep	40	SENT_94	[p5l10t2896r133b2961],
26	n	NN	O	n	dobj	25	SENT_94	[p5l10t2896r133b2961],
27	=	JJ	O	=	amod	26	SENT_94	[p5l10t2896r133b2961],
28	127	CD	NUMBER	127	tmod	27	SENT_94	[p5l154t2897r278b2958],
29	,	,	O	,	_	0	SENT_94	[p5l154t2897r278b2958],
30	bilirubin	NN	O	bilirubin	nn	31	SENT_94	[p5l344t2896r603b2948],
31	levels	NNS	O	level	nsubj	40	SENT_94	[p5l667t2896r837b2948],
32	>	JJR	O	>	dep	31	SENT_94	[p5l906t2897r1097b2948],
33	2.00	CD	NUMBER	2.00	num	35	SENT_94	[p5l906t2897r1097b2948],
34	mg/dl	NN	O	mg/dl	nn	35	SENT_94	[p5l1115t2896r1349b2963],
35	)	NN	O	)	dep	31	SENT_94	[p5l1115t2896r1349b2963],
36	;	:	O	;	_	0	SENT_94	[p5l1115t2896r1349b2963],
37	(	CD	NUMBER	(	num	39	SENT_94	[p5l1414t2896r1503b2961],
38	b	NN	O	b	nn	39	SENT_94	[p5l1414t2896r1503b2961],
39	)	NN	O	)	nsubj	40	SENT_94	[p5l1414t2896r1503b2961],
40	controls	VBZ	O	control	rcmod	1	SENT_94	[p5l1565t2896r1818b2948],
41	(	CD	NUMBER	(	num	42	SENT_94	[p5l1880t2896r2148b2961],
42	n	NN	O	n	dobj	40	SENT_94	[p5l1880t2896r2148b2961],
43	=	JJ	O	=	quantmod	44	SENT_94	[p5l1880t2896r2148b2961],
44	909	CD	NUMBER	909	dep	42	SENT_94	[p5l1880t2896r2148b2961],
45	,	,	O	,	_	0	SENT_94	[p5l1880t2896r2148b2961],
46	bilirubin	NN	O	bilirubin	nn	47	SENT_94	[p5l10t2981r269b3033],
47	levels	NNS	O	level	dep	48	SENT_94	[p5l302t2981r472b3033],
48	<	JJR	O	<	appos	42	SENT_94	[p5l511t2982r701b3039],
49	2.00	CD	NUMBER	2.00	num	51	SENT_94	[p5l511t2982r701b3039],
50	mg/dl	NN	O	mg/dl	nn	51	SENT_94	[p5l718t2981r954b3048],
51	)	NN	O	)	dep	48	SENT_94	[p5l718t2981r954b3048],
52	;	:	O	;	_	0	SENT_94	[p5l718t2981r954b3048],
53	(	CD	NUMBER	(	num	54	SENT_94	[p5l988t2981r1067b3046],
54	c	NN	O	c	dep	42	SENT_94	[p5l988t2981r1067b3046],
55	)	CD	NUMBER	)	num	57	SENT_94	[p5l988t2981r1067b3046],
56	super	JJ	O	super	amod	57	SENT_94	[p5l1099t2996r1274b3048],
57	controls	NNS	O	control	dep	54	SENT_94	[p5l1301t2981r1570b3043],
58	,	,	O	,	_	0	SENT_94	[p5l1301t2981r1570b3043],
59	which	WDT	O	which	nsubj	62	SENT_94	[p5l1600t2981r1786b3033],
60	is	VBZ	O	be	cop	62	SENT_94	[p5l1818t2981r1860b3033],
61	a	DT	O	a	det	62	SENT_94	[p5l1890t2996r1921b3033],
62	subset	NN	O	subset	rcmod	42	SENT_94	[p5l1951t2981r2154b3033],
63	of	IN	O	of	_	0	SENT_94	[p5l8t3066r72b3117],
64	controls	NNS	O	control	prep_of	62	SENT_94	[p5l96t3066r349b3117],
65	(	VBP	O	(	_	0	SENT_94	[p5l378t3066r646b3131],
66	n	NN	O	n	npadvmod	72	SENT_94	[p5l378t3066r646b3131],
67	=	JJ	O	=	amod	66	SENT_94	[p5l378t3066r646b3131],
68	541	CD	NUMBER	541	tmod	67	SENT_94	[p5l378t3066r646b3131],
69	,	,	O	,	_	0	SENT_94	[p5l378t3066r646b3131],
70	bilirubin	NN	O	bilirubin	nn	71	SENT_94	[p5l679t3066r938b3117],
71	levels	NNS	O	level	appos	68	SENT_94	[p5l969t3066r1139b3117],
72	<	JJR	O	<	acomp	65	SENT_94	[p5l1175t3067r1366b3124],
73	1.00	CD	NUMBER	1.00	num	75	SENT_94	[p5l1175t3067r1366b3124],
74	mg/dl	NN	O	mg/dl	nn	75	SENT_94	[p5l1383t3066r1618b3133],
75	)	NN	O	)	dep	65	SENT_94	[p5l1383t3066r1618b3133],
76	.	.	O	.	_	0	SENT_94	[p5l1383t3066r1618b3133],

1	how	WRB	O	how	advmod	3	SENT_95	[p6l8t84r162b142],
2	power	NN	O	power	nsubj	3	SENT_95	[p6l187t101r405b160],
3	decreases	VBZ	O	decrease	csubjpass	11	SENT_95	[p6l433t84r757b142],
4	as	IN	O	as	_	0	SENT_95	[p6l786t101r851b142],
5	less	JJR	O	less	amod	9	SENT_95	[p6l880t84r999b142],
6	extreme	JJ	O	extreme	amod	9	SENT_95	[p6l1028t91r1312b142],
7	control	NN	O	control	nn	9	SENT_95	[p6l1342t84r1598b142],
8	sample	NN	O	sample	nn	9	SENT_95	[p6l1628t84r1873b160],
9	thresholds	NNS	O	threshold	prep_as	3	SENT_95	[p6l1901t84r2150b142, p6l8t179r150b237],
10	are	VBP	O	be	auxpass	11	SENT_95	[p6l189t196r290b237],
11	used	VBN	O	use	_	0	SENT_95	[p6l326t179r505b237],
12	.	.	O	.	_	0	SENT_95	[p6l326t179r505b237],

1	Thus	RB	O	thus	advmod	13	SENT_96	[p6l544t179r717b237],
2	the	DT	O	the	det	3	SENT_96	[p6l754t179r867b237],
3	analysis	NN	O	analysis	nsubj	13	SENT_96	[p6l906t179r1182b255],
4	of	IN	O	of	_	0	SENT_96	[p6l1220t179r1292b237],
5	the	DT	O	the	det	6	SENT_96	[p6l1324t179r1437b237],
6	extremes	NNS	O	extreme	prep_of	3	SENT_96	[p6l1476t186r1792b237],
7	(	RB	O	(	advmod	8	SENT_96	[p6l1832t179r1985b251],
8	low	JJ	O	low	amod	6	SENT_96	[p6l1832t179r1985b251],
9	and	CC	O	and	_	0	SENT_96	[p6l2020t179r2152b237],
10	high	JJ	O	high	amod	11	SENT_96	[p6l8t274r193b349],
11	)	NN	O	)	prep_of	3	SENT_96	[p6l8t274r193b349],
12	may	MD	O	may	aux	13	SENT_96	[p6l219t290r372b349],
13	increase	VB	O	increase	_	0	SENT_96	[p6l392t277r675b331],
14	the	DT	O	the	det	15	SENT_96	[p6l699t273r811b331],
15	ability	NN	O	ability	dobj	13	SENT_96	[p6l835t273r1060b349],
16	to	TO	O	to	aux	17	SENT_96	[p6l1080t281r1150b331],
17	detect	VB	O	detect	infmod	15	SENT_96	[p6l1173t274r1387b331],
18	sensitive	JJ	O	sensitive	amod	21	SENT_96	[p6l1411t277r1713b331],
19	and	CC	O	and	_	0	SENT_96	[p6l1737t274r1868b331],
20	specific	JJ	O	specific	conj_and	18	SENT_96	[p6l1892t273r2152b349],
21	variants	NNS	O	variant	dobj	17	SENT_96	[p6l6t372r287b427],
22	in	IN	O	in	_	0	SENT_96	[p6l318t372r388b426],
23	smaller	JJR	O	smaller	amod	24	SENT_96	[p6l419t369r674b427],
24	phase	NN	O	phase	prep_in	17	SENT_96	[p6l701t369r902b445],
25	II	CD	NUMBER	ii	num	27	SENT_96	[p6l933t372r982b426],
26	clinical	JJ	O	clinical	amod	27	SENT_96	[p6l1013t369r1269b427],
27	trials	NNS	O	trial	dep	24	SENT_96	[p6l1298t369r1489b427],
28	.	.	O	.	_	0	SENT_96	[p6l1298t369r1489b427],

1	The	DT	O	the	det	5	SENT_97	[p6l83t464r215b521],
2	mean	JJ	O	mean	amod	5	SENT_97	[p6l249t480r445b521],
3	serum	NN	O	serum	nn	5	SENT_97	[p6l479t480r692b521],
4	bilirubin	NN	O	bilirubin	nn	5	SENT_97	[p6l723t464r1034b521],
5	level	NN	O	level	nsubj	20	SENT_97	[p6l1066t463r1229b521],
6	of	IN	O	of	_	0	SENT_97	[p6l1263t463r1334b521],
7	the	DT	O	the	det	9	SENT_97	[p6l1362t464r1475b521],
8	1036	CD	DATE	1036	num	9	SENT_97	[p6l1514t465r1679b521],
9	subjects	NNS	O	subject	prep_of	5	SENT_97	[p6l1715t464r1991b539],
10	was	VBD	O	be	cop	12	SENT_97	[p6l2022t480r2151b521],
11	0.57	CD	NUMBER	0.57	num	12	SENT_97	[p6l8t560r381b625],
12	i0	NN	O	i0	_	0	SENT_97	[p6l8t560r381b625],
13	.01	CD	NUMBER	.01	num	14	SENT_97	[p6l8t560r381b625],
14	mg/dl	NN	O	mg/dl	dep	12	SENT_97	[p6l404t559r614b634],
15	before	IN	O	before	_	0	SENT_97	[p6l661t558r881b616],
16	tranilast	NN	O	tranilast	nn	17	SENT_97	[p6l932t559r1223b616],
17	administration	NN	O	administration	prep_before	12	SENT_97	[p6l1274t559r1819b629],
18	,	,	O	,	_	0	SENT_97	[p6l1274t559r1819b629],
19	and	CC	O	and	_	0	SENT_97	[p6l1875t559r2006b616],
20	increased	VBD	O	increase	conj_and	12	SENT_97	[p6l2055t562r2150b616, p6l8t654r265b712],
21	to	TO	O	to	_	0	SENT_97	[p6l321t661r390b712],
22	1	CD	NUMBER	1	prep_to	20	SENT_97	[p6l455t656r825b720],
23	.	.	O	.	_	0	SENT_97	[p6l455t656r825b720],

1	Z8i0	NN	O	z8i0	_	0	SENT_98	[p6l455t656r825b720],
2	.03	CD	NUMBER	.03	num	3	SENT_98	[p6l455t656r825b720],
3	mg/dl	NN	O	mg/dl	dep	1	SENT_98	[p6l845t654r1055b730],
4	after	IN	O	after	_	0	SENT_98	[p6l1113t654r1271b712],
5	tranilast	NN	O	tranilast	prep_after	3	SENT_98	[p6l1327t654r1637b712],
6	.	.	O	.	_	0	SENT_98	[p6l1327t654r1637b712],

1	The	DT	O	the	det	4	SENT_99	[p6l1696t654r1829b712],
2	average	JJ	O	average	amod	4	SENT_99	[p6l1888t671r2150b730],
3	bilirubin	NN	O	bilirubin	nn	4	SENT_99	[p6l6t749r316b806],
4	level	NN	O	level	_	0	SENT_99	[p6l343t749r505b806],
5	increased	VBN	O	increase	conj_and	5	SENT_99	[p6l533t749r864b806],
6	from	IN	O	from	_	0	SENT_99	[p6l891t748r1060b806],
7	0.53	CD	NUMBER	0.53	prep_from	5	SENT_99	[p6l1087t750r1234b806],
8	to	TO	NUMBER	to	_	0	SENT_99	[p6l1265t756r1334b806],
9	1.00	CD	NUMBER	1.00	num	10	SENT_99	[p6l1368t750r1512b806],
10	mg/dl	NN	O	mg/dl	prep_to	5	SENT_99	[p6l1529t749r1738b824],
11	in	IN	O	in	_	0	SENT_99	[p6l1766t752r1836b806],
12	controls	NNS	O	control	prep_in	10	SENT_99	[p6l1864t749r2151b806],
13	and	CC	O	and	_	0	SENT_99	[p6l9t844r140b901],
14	from	IN	O	from	_	0	SENT_99	[p6l163t843r333b901],
15	0.46	CD	NUMBER	0.46	number	17	SENT_99	[p6l357t845r506b901],
16	to	TO	NUMBER	to	dep	17	SENT_99	[p6l530t851r600b901],
17	0.74	CD	NUMBER	0.74	num	18	SENT_99	[p6l625t845r773b901],
18	mg/dl	NN	O	mg/dl	prep_from	5	SENT_99	[p6l792t844r1001b919],
19	in	IN	O	in	_	0	SENT_99	[p6l1025t847r1096b901],
20	super	JJ	O	super	amod	21	SENT_99	[p6l1121t860r1309b919],
21	controls	NNS	O	control	prep_in	18	SENT_99	[p6l1331t844r1637b914],
22	,	,	O	,	_	0	SENT_99	[p6l1331t844r1637b914],
23	and	CC	O	and	_	0	SENT_99	[p6l1666t844r1797b901],
24	increased	VBN	O	increase	conj_and	5	SENT_99	[p6l1821t844r2152b901],
25	from	IN	O	from	_	0	SENT_99	[p6l8t939r178b997],
26	0.91	CD	NUMBER	0.91	number	28	SENT_99	[p6l222t941r368b997],
27	to	TO	NUMBER	to	dep	28	SENT_99	[p6l418t946r487b997],
28	3.24	CD	NUMBER	3.24	prep_from	24	SENT_99	[p6l534t941r681b997],
29	mg/dl	NN	O	mg/dl	dep	33	SENT_99	[p6l700t939r909b1015],
30	in	IN	O	in	_	0	SENT_99	[p6l954t942r1025b996],
31	cases	NNS	O	case	prep_in	29	SENT_99	[p6l1070t956r1242b997],
32	(	CD	NUMBER	(	num	33	SENT_99	[p6l1291t939r1530b1015],
33	Figure	NN	O	figure	dep	4	SENT_99	[p6l1291t939r1530b1015],
34	1	CD	NUMBER	1	num	35	SENT_99	[p6l1582t939r1661b1011],
35	)	NN	O	)	dep	33	SENT_99	[p6l1582t939r1661b1011],
36	.	.	O	.	_	0	SENT_99	[p6l1582t939r1661b1011],

1	The	DT	O	the	det	2	SENT_100	[p6l1708t939r1841b997],
2	average	NN	O	average	_	0	SENT_100	[p6l1888t956r2151b1015],

1	Genetic	JJ	O	genetic	amod	2	SENT_101	[p6l9t1180r190b1225],
2	susceptibility	NN	O	susceptibility	_	0	SENT_101	[p6l209t1180r529b1239],
3	to	TO	O	to	_	0	SENT_101	[p6l546t1185r596b1225],
4	tranilast-induced	JJ	O	tranilast-induced	amod	5	SENT_101	[p6l614t1180r1027b1225],
5	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	2	SENT_101	[p6l1049t1180r1511b1239],
6	@	IN	O	@	_	0	SENT_101	[p6l2026t1168r2152b1293],
7	TM	NNP	O	TM	nn	8	SENT_101	[p6l7t1253r73b1292],
8	Danoff	NNP	PERSON	Danoff	prep_@	5	SENT_101	[p6l96t1251r233b1293],
9	et	FW	O	et	nn	10	SENT_101	[p6l251t1256r287b1293],
10	al	FW	O	al	dep	2	SENT_101	[p6l304t1251r339b1293],

1	‘	NN	O	‘	_	0	SENT_102	[p6l298t1955r341b2005],
2	.	.	O	.	_	0	SENT_102	[p6l298t1955r341b2005],

1	o	NN	O	o	_	0	SENT_103	[p6l298t1955r341b2005],
2	5	CD	NUMBER	5	num	3	SENT_103	[p6l304t1541r343b1804],
3	?!	NN	O	?!	dep	1	SENT_103	[p6l304t1541r343b1804],

1	“	RB	O	“	dep	2	SENT_104	[p6l304t1541r343b1804],
2	OOI	NNP	O	OOI	_	0	SENT_104	[p6l347t1539r380b2005],
3	—	SYM	O	—	dep	5	SENT_104	[p6l347t1539r380b2005],
4	-	:	O	-	_	0	SENT_104	[p6l347t1539r380b2005],
5	IN	IN	O	in	dep	2	SENT_104	[p6l347t1539r380b2005],
6	)	SYM	O	)	dep	8	SENT_104	[p6l347t1539r380b2005],
7	-	:	O	-	_	0	SENT_104	[p6l347t1539r380b2005],
8	I3-OW	NN	O	i3-ow	dep	5	SENT_104	[p6l347t1539r380b2005],
9	.	.	O	.	_	0	SENT_104	[p6l347t1539r380b2005],

1	(	NN	O	(	nn	2	SENT_105	[p6l187t1871r249b2080],
2	mg/dl	NN	O	mg/dl	_	0	SENT_105	[p6l187t1871r249b2080],
3	)	CD	NUMBER	)	dep	2	SENT_105	[p6l187t1871r249b2080],

1	E3	NN	O	e3	_	0	SENT_106	[p6l296t2268r339b2317],
2	93	CD	NUMBER	93	num	1	SENT_106	[p6l294t2165r339b2213],
3	S3	NN	O	s3	dep	1	SENT_106	[p6l298t2057r341b2108],
4	l	NN	O	l	prep	3	SENT_106	[p6l347t2270r376b2315],
5	\	NN	O	\	dep	4	SENT_106	[p6l347t2270r376b2315],
6	.	.	O	.	_	0	SENT_106	[p6l347t2270r376b2315],
7	)	SYM	O	)	dep	1	SENT_106	[p6l347t2270r376b2315],

1	43	CD	NUMBER	43	_	0	SENT_107	[p6l345t2165r376b2213],
2	ex	FW	O	ex	dep	1	SENT_107	[p6l349t2057r378b2108],

1	Increase	NN	O	increase	_	0	SENT_108	[p6l107t2081r153b2319],
2	in	IN	O	in	_	0	SENT_108	[p6l105t2006r153b2060],
3	bilirubin	NN	O	bilirubin	nn	4	SENT_108	[p6l105t1731r153b1986],
4	levels	NNS	O	level	prep_in	1	SENT_108	[p6l105t1555r153b1711],

1	(	NN	O	(	_	0	SENT_109	[p6l509t2454r852b2514],
2	TA	NNP	O	TA	dep	1	SENT_109	[p6l509t2454r852b2514],
3	)	CD	NUMBER	)	number	4	SENT_109	[p6l509t2454r852b2514],
4	6	CD	NUMBER	6	amod	2	SENT_109	[p6l509t2454r852b2514],
5	/	:	O	/	punct	26	SENT_109	[p6l509t2454r852b2514],
6	(	CD	NUMBER	(	num	7	SENT_109	[p6l509t2454r852b2514],
7	TA	NNP	O	TA	dep	26	SENT_109	[p6l509t2454r852b2514],
8	)	CD	NUMBER	)	num	7	SENT_109	[p6l509t2454r852b2514],
9	6	CD	NUMBER	6	num	10	SENT_109	[p6l509t2454r852b2514],
10	(	NN	O	(	dep	7	SENT_109	[p6l1057t2458r1398b2516],
11	TA	NNP	O	TA	dep	7	SENT_109	[p6l1057t2458r1398b2516],
12	)	CD	NUMBER	)	number	13	SENT_109	[p6l1057t2458r1398b2516],
13	6	CD	NUMBER	6	dep	11	SENT_109	[p6l1057t2458r1398b2516],
14	/	:	O	/	punct	17	SENT_109	[p6l1057t2458r1398b2516],
15	(	CD	NUMBER	(	num	17	SENT_109	[p6l1057t2458r1398b2516],
16	TA	NNP	O	TA	nn	17	SENT_109	[p6l1057t2458r1398b2516],
17	)	NN	O	)	dep	13	SENT_109	[p6l1057t2458r1398b2516],
18	7	CD	NUMBER	7	number	19	SENT_109	[p6l1057t2458r1398b2516],
19	(	CD	NUMBER	(	dep	17	SENT_109	[p6l1607t2460r1947b2518],
20	TA	NNP	O	TA	nn	21	SENT_109	[p6l1607t2460r1947b2518],
21	)	NN	O	)	dep	19	SENT_109	[p6l1607t2460r1947b2518],
22	7	CD	NUMBER	7	num	21	SENT_109	[p6l1607t2460r1947b2518],
23	/	:	O	/	punct	17	SENT_109	[p6l1607t2460r1947b2518],
24	(	CD	NUMBER	(	num	26	SENT_109	[p6l1607t2460r1947b2518],
25	TA	NNP	O	TA	nn	26	SENT_109	[p6l1607t2460r1947b2518],
26	)	NN	O	)	dep	4	SENT_109	[p6l1607t2460r1947b2518],
27	7	CD	NUMBER	7	dep	1	SENT_109	[p6l1607t2460r1947b2518],

1	TA	NNP	O	TA	_	0	SENT_110	[p6l937t2563r1022b2610],
2	repeat	NN	O	repeat	nn	3	SENT_110	[p6l1045t2567r1228b2624],
3	genotypes	NNS	O	genotype	dep	1	SENT_110	[p6l1246t2567r1531b2624],

1	C7	NN	O	c7	_	0	SENT_111	[p6l345t2372r376b2420],

1	Figure	NN	O	figure	nn	3	SENT_112	[p6l13t2702r205b2769],
2	2	CD	NUMBER	2	num	3	SENT_112	[p6l243t2703r278b2752],
3	Association	NNP	O	Association	nsubjpass	31	SENT_112	[p6l344t2702r700b2753],
4	between	IN	O	between	_	0	SENT_112	[p6l741t2701r1011b2753],
5	tranilast-induced	JJ	O	tranilast-induced	amod	6	SENT_112	[p6l1048t2701r1581b2753],
6	increase	NN	O	increase	prep_between	3	SENT_112	[p6l1622t2702r1876b2753],
7	in	IN	O	in	_	0	SENT_112	[p6l1915t2702r1967b2752],
8	bilirubin	NN	O	bilirubin	nn	9	SENT_112	[p6l2009t2701r2149b2753, p6l11t2786r147b2838],
9	levels	NNS	O	level	prep_in	6	SENT_112	[p6l186t2786r356b2838],
10	and	CC	O	and	_	0	SENT_112	[p6l391t2786r505b2838],
11	the	DT	O	the	det	14	SENT_112	[p6l543t2786r644b2838],
12	TA	NNP	O	TA	nn	14	SENT_112	[p6l678t2789r764b2837],
13	repeat	NN	O	repeat	nn	14	SENT_112	[p6l799t2792r1002b2854],
14	polymorphism	NN	O	polymorphism	conj_and	6	SENT_112	[p6l1038t2786r1490b2854],
15	of	IN	O	of	_	0	SENT_112	[p6l1529t2786r1592b2838],
16	UGT1A1	NN	O	ugt1a1	prep_of	14	SENT_112	[p6l1630t2788r1868b2838],
17	in	IN	O	in	_	0	SENT_112	[p6l1908t2787r1961b2837],
18	1036	CD	DATE	1036	num	19	SENT_112	[p6l2002t2788r2150b2838],
19	individuals	NNS	O	individual	prep_in	16	SENT_112	[p6l11t2868r346b2919],
20	from	IN	O	from	_	0	SENT_112	[p6l366t2869r516b2919],
21	the	DT	O	the	det	26	SENT_112	[p6l540t2868r641b2919],
22	PRESTO	NNP	O	PRESTO	nn	26	SENT_112	[p6l666t2870r908b2919],
23	clinical	JJ	O	clinical	amod	26	SENT_112	[p6l930t2868r1141b2919],
24	trial	NN	O	trial	nn	26	SENT_112	[p6l1164t2862r1335b2919],
25	.3	NN	NUMBER	.3	nn	26	SENT_112	[p6l1164t2862r1335b2919],
26	Mean	NN	O	mean	prep_from	19	SENT_112	[p6l1361t2871r1533b2919],
27	and	CC	O	and	_	0	SENT_112	[p6l1557t2868r1671b2919],
28	standard	JJ	O	standard	amod	29	SENT_112	[p6l1695t2868r1971b2919],
29	error	NN	O	error	prep_from	19	SENT_112	[p6l1995t2883r2152b2919],
30	are	VBP	O	be	auxpass	31	SENT_112	[p6l10t2968r106b3004],
31	shown	VBN	O	show	_	0	SENT_112	[p6l134t2953r355b3004],
32	.	.	O	.	_	0	SENT_112	[p6l134t2953r355b3004],

1	bilirubin	NN	O	bilirubin	nn	2	SENT_113	[p7l7t66r317b124],
2	level	NN	O	level	nsubj	3	SENT_113	[p7l379t66r542b124],
3	varied	VBD	O	vary	_	0	SENT_113	[p7l601t66r820b124],
4	as	IN	O	as	_	0	SENT_113	[p7l882t83r947b124],
5	a	DT	O	a	det	6	SENT_113	[p7l1010t83r1045b124],
6	function	NN	O	function	prep_as	3	SENT_113	[p7l1107t66r1412b124],
7	of	IN	O	of	_	0	SENT_113	[p7l1475t66r1547b124],
8	the	DT	O	the	det	11	SENT_113	[p7l1604t66r1717b124],
9	TA	NNP	O	TA	nn	11	SENT_113	[p7l1778t68r1872b123],
10	repeat	NN	O	repeat	nn	11	SENT_113	[p7l1933t74r2150b142],
11	genotypes	NNS	O	genotype	prep_of	6	SENT_113	[p7l10t168r385b236],
12	,	,	O	,	_	0	SENT_113	[p7l10t168r385b236],
13	with	IN	O	with	_	0	SENT_113	[p7l411t161r572b218],
14	the	DT	O	the	det	17	SENT_113	[p7l595t161r707b218],
15	(	CD	NUMBER	(	num	17	SENT_113	[p7l735t161r909b233],
16	TA	NNP	O	TA	nn	17	SENT_113	[p7l735t161r909b233],
17	)	NN	O	)	prep_with	6	SENT_113	[p7l735t161r909b233],
18	7	CD	NUMBER	7	num	19	SENT_113	[p7l735t161r909b233],
19	allele	NN	O	allele	dobj	3	SENT_113	[p7l934t161r1116b219],
20	being	VBG	O	be	auxpass	21	SENT_113	[p7l1137t161r1336b236],
21	associated	VBN	O	associate	partmod	19	SENT_113	[p7l1359t161r1714b219],
22	with	IN	O	with	_	0	SENT_113	[p7l1736t161r1897b219],
23	higher	JJR	O	higher	amod	24	SENT_113	[p7l1920t161r2150b236],
24	levels	NNS	O	level	prep_with	21	SENT_113	[p7l10t256r203b314],
25	of	IN	O	of	_	0	SENT_113	[p7l235t256r307b314],
26	bilirubin	NN	O	bilirubin	nn	27	SENT_113	[p7l333t256r643b314],
27	level	NN	O	level	prep_of	24	SENT_113	[p7l674t256r836b314],
28	both	CC	O	both	prep	27	SENT_113	[p7l867t256r1034b314],
29	pre	JJ	O	pre	amod	33	SENT_113	[p7l1065t273r1200b332],
30	-	:	O	-	_	0	SENT_113	[p7l1065t273r1200b332],
31	and	CC	O	and	_	0	SENT_113	[p7l1234t256r1365b314],
32	post-tranilast	JJ	O	post-tranilast	amod	33	SENT_113	[p7l1395t256r1864b332],
33	administration	NN	O	administration	dep	28	SENT_113	[p7l1897t256r2148b314, p7l10t354r324b408],
34	.	.	O	.	_	0	SENT_113	[p7l1897t256r2148b314, p7l10t354r324b408],

1	The	DT	O	the	det	4	SENT_114	[p7l355t351r488b408],
2	average	JJ	O	average	amod	4	SENT_114	[p7l519t367r782b426],
3	bilirubin	NN	O	bilirubin	nn	4	SENT_114	[p7l810t351r1120b408],
4	level	NN	O	level	nsubj	5	SENT_114	[p7l1149t351r1311b408],
5	increased	VBN	O	increase	_	0	SENT_114	[p7l1341t351r1672b408],
6	from	IN	O	from	_	0	SENT_114	[p7l1701t350r1870b408],
7	0.93	CD	NUMBER	0.93	number	9	SENT_114	[p7l1900t352r2047b408],
8	to	TO	NUMBER	to	dep	9	SENT_114	[p7l2079t358r2148b408],
9	2.22	CD	NUMBER	2.22	num	10	SENT_114	[p7l11t448r159b503],
10	mg/dl	NN	O	mg/dl	prep_from	5	SENT_114	[p7l176t446r385b521],
11	in	IN	O	in	_	0	SENT_114	[p7l425t449r495b503],
12	(	CD	NUMBER	(	num	16	SENT_114	[p7l539t446r713b518],
13	TA	NNP	O	TA	nn	16	SENT_114	[p7l539t446r713b518],
14	)	NN	O	)	nn	16	SENT_114	[p7l539t446r713b518],
15	7	CD	NUMBER	7	num	16	SENT_114	[p7l539t446r713b518],
16	homozygotes	NNS	O	homozygote	prep_in	5	SENT_114	[p7l754t446r1244b522],
17	,	,	O	,	_	0	SENT_114	[p7l754t446r1244b522],
18	while	IN	O	while	mark	20	SENT_114	[p7l1287t446r1480b504],
19	it	PRP	O	it	nsubj	20	SENT_114	[p7l1521t449r1570b504],
20	increased	VBD	O	increase	dep	16	SENT_114	[p7l1610t446r1940b504],
21	from	IN	O	from	_	0	SENT_114	[p7l1980t446r2149b504],
22	0.48	CD	NUMBER	0.48	number	24	SENT_114	[p7l10t542r158b598],
23	to	TO	NUMBER	to	dep	24	SENT_114	[p7l218t548r287b598],
24	1.01	CD	NUMBER	1.01	num	25	SENT_114	[p7l353t542r491b598],
25	mg/dl	NN	O	mg/dl	prep_from	20	SENT_114	[p7l513t540r723b616],
26	in	IN	O	in	_	0	SENT_114	[p7l782t544r852b597],
27	(	CD	NUMBER	(	num	31	SENT_114	[p7l915t541r1089b612],
28	TA	NNP	O	TA	nn	31	SENT_114	[p7l915t541r1089b612],
29	)	CD	NUMBER	)	num	31	SENT_114	[p7l915t541r1089b612],
30	6	CD	NUMBER	6	num	31	SENT_114	[p7l915t541r1089b612],
31	homozygotes	NNS	O	homozygote	prep_in	20	SENT_114	[p7l1148t540r1620b616],
32	and	CC	O	and	_	0	SENT_114	[p7l1681t541r1812b598],
33	0.58	CD	NUMBER	0.58	number	35	SENT_114	[p7l1871t542r2019b598],
34	to	TO	O	to	dep	35	SENT_114	[p7l2079t548r2148b598],
35	1.31	CD	NUMBER	1.31	num	36	SENT_114	[p7l15t637r154b693],
36	mg/dl	NN	O	mg/dl	prep_in	20	SENT_114	[p7l176t635r385b711],
37	in	IN	O	in	_	0	SENT_114	[p7l419t638r489b692],
38	heterozygotes	NNS	O	heterozygote	prep_in	36	SENT_114	[p7l521t636r1029b711],
39	.	.	O	.	_	0	SENT_114	[p7l521t636r1029b711],

1	Figure	NN	O	figure	nsubj	3	SENT_115	[p7l1067t638r1281b711],
2	2	CD	NUMBER	2	num	1	SENT_115	[p7l1316t637r1355b692],
3	showed	VBD	O	show	_	0	SENT_115	[p7l1389t636r1656b693],
4	the	DT	O	the	det	5	SENT_115	[p7l1689t636r1801b693],
5	increases	NNS	O	increase	dobj	3	SENT_115	[p7l1834t639r2148b693],
6	in	IN	O	in	_	0	SENT_115	[p7l10t734r80b788],
7	bilirubin	NN	O	bilirubin	nn	8	SENT_115	[p7l111t731r421b789],
8	levels	NNS	O	level	prep_in	3	SENT_115	[p7l455t731r648b789],
9	according	VBG	O	accord	_	0	SENT_115	[p7l683t731r1030b807],
10	to	TO	O	to	prepc_according_to	3	SENT_115	[p7l1063t738r1132b789],
11	genotypes	NNS	O	genotype	pobj	3	SENT_115	[p7l1168t738r1525b807],
12	of	IN	O	of	_	0	SENT_115	[p7l1560t731r1631b789],
13	the	DT	O	the	det	16	SENT_115	[p7l1661t731r1773b789],
14	TA	NNP	O	TA	nn	16	SENT_115	[p7l1805t733r1900b788],
15	repeat	NN	O	repeat	nn	16	SENT_115	[p7l1933t738r2150b807],
16	polymorphism	NN	O	polymorphism	prep_of	11	SENT_115	[p7l9t826r552b901],
17	.	.	O	.	_	0	SENT_115	[p7l9t826r552b901],

1	Four	CD	NUMBER	four	num	2	SENT_116	[p7l87t923r245b978],
2	individuals	NNS	O	individual	nsubjpass	4	SENT_116	[p7l282t921r675b978],
3	were	VBD	O	be	auxpass	4	SENT_116	[p7l713t937r876b978],
4	found	VBN	O	find	_	0	SENT_116	[p7l916t921r1127b978],
5	to	TO	O	to	aux	7	SENT_116	[p7l1166t928r1235b978],
6	be	VB	O	be	cop	7	SENT_116	[p7l1272t921r1353b978],
7	heterozygous	JJ	O	heterozygous	xcomp	4	SENT_116	[p7l1392t921r1861b996],
8	for	IN	O	for	_	0	SENT_116	[p7l1901t920r1999b978],
9	the	DT	O	the	det	11	SENT_116	[p7l2036t921r2148b978],
10	G/A	NN	O	g/a	nn	11	SENT_116	[p7l11t1016r149b1081],
11	substitution	NN	O	substitution	prep_for	7	SENT_116	[p7l176t1016r618b1086],
12	,	,	O	,	_	0	SENT_116	[p7l176t1016r618b1086],
13	giving	VBG	O	give	xcomp	7	SENT_116	[p7l649t1019r869b1092],
14	rise	NN	O	rise	dobj	13	SENT_116	[p7l894t1019r1012b1074],
15	to	TO	O	to	_	0	SENT_116	[p7l1039t1024r1109b1074],
16	a	DT	O	a	det	17	SENT_116	[p7l1136t1033r1170b1074],
17	frequency	NN	O	frequency	prep_to	13	SENT_116	[p7l1196t1016r1550b1092],
18	of	IN	O	of	_	0	SENT_116	[p7l1575t1016r1646b1074],
19	0.16	CD	PERCENT	0.16	num	20	SENT_116	[p7l1668t1018r1887b1074],
20	%	NN	PERCENT	%	prep_of	17	SENT_116	[p7l1668t1018r1887b1074],
21	for	IN	O	for	_	0	SENT_116	[p7l1913t1016r2011b1074],
22	the	DT	O	the	det	24	SENT_116	[p7l2036t1016r2148b1074],
23	GLY71Arg	JJ	O	gly71arg	amod	24	SENT_116	[p7l11t1112r367b1186],
24	change	NN	O	change	prep_for	20	SENT_116	[p7l413t1111r663b1186],
25	in	IN	O	in	_	0	SENT_116	[p7l711t1114r781b1168],
26	this	DT	O	this	det	27	SENT_116	[p7l827t1111r956b1169],
27	sample	NN	O	sample	prep_in	24	SENT_116	[p7l1005t1111r1268b1187],
28	.	.	O	.	_	0	SENT_116	[p7l1005t1111r1268b1187],

1	These	DT	O	these	det	3	SENT_117	[p7l1316t1111r1518b1169],
2	four	CD	NUMBER	four	num	3	SENT_117	[p7l1565t1111r1710b1169],
3	individuals	NNS	O	individual	nsubj	5	SENT_117	[p7l1755t1111r2148b1169],
4	were	VBD	O	be	cop	5	SENT_117	[p7l8t1223r171b1264],
5	homozygous	JJ	O	homozygous	_	0	SENT_117	[p7l220t1206r672b1282],
6	for	IN	O	for	_	0	SENT_117	[p7l721t1206r820b1264],
7	the	DT	O	the	det	9	SENT_117	[p7l867t1206r979b1264],
8	(	CD	NUMBER	(	num	9	SENT_117	[p7l1032t1206r1207b1278],
9	TA	NNP	O	TA	prep_for	5	SENT_117	[p7l1032t1206r1207b1278],
10	)	CD	NUMBER	)	number	11	SENT_117	[p7l1032t1206r1207b1278],
11	6	CD	NUMBER	6	num	12	SENT_117	[p7l1032t1206r1207b1278],
12	allele	NN	O	allele	dep	9	SENT_117	[p7l1256t1206r1438b1264],
13	for	IN	O	for	_	0	SENT_117	[p7l1487t1206r1584b1264],
14	the	DT	O	the	det	17	SENT_117	[p7l1632t1206r1744b1264],
15	TA	NNP	O	TA	nn	17	SENT_117	[p7l1791t1208r1886b1263],
16	repeat	NN	O	repeat	nn	17	SENT_117	[p7l1933t1214r2150b1282],
17	polymorphism	NN	O	polymorphism	prep_for	12	SENT_117	[p7l9t1300r552b1376],
18	.	.	O	.	_	0	SENT_117	[p7l9t1300r552b1376],

1	All	DT	O	all	det	3	SENT_118	[p7l606t1301r704b1357],
2	four	CD	NUMBER	four	num	3	SENT_118	[p7l755t1300r900b1358],
3	individuals	NNS	O	individual	nsubj	4	SENT_118	[p7l950t1301r1343b1358],
4	were	VBD	O	be	_	0	SENT_118	[p7l1392t1317r1556b1358],
5	in	IN	O	in	_	0	SENT_118	[p7l1608t1304r1678b1357],
6	the	DT	O	the	det	8	SENT_118	[p7l1728t1301r1841b1358],
7	control	NN	O	control	nn	8	SENT_118	[p7l1893t1301r2149b1358],
8	group	NN	O	group	prep_in	4	SENT_118	[p7l10t1414r233b1473],
9	,	,	O	,	_	0	SENT_118	[p7l10t1414r233b1473],
10	suggesting	VBG	O	suggest	xcomp	4	SENT_118	[p7l261t1400r631b1472],
11	that	IN	O	that	complm	17	SENT_118	[p7l652t1397r796b1455],
12	the	DT	O	the	det	14	SENT_118	[p7l817t1397r930b1455],
13	GLY71Arg	NN	O	gly71arg	nn	14	SENT_118	[p7l955t1398r1311b1472],
14	polymorphism	NN	O	polymorphism	nsubjpass	17	SENT_118	[p7l1332t1397r1857b1473],
15	was	VBD	O	be	auxpass	17	SENT_118	[p7l1878t1414r2006b1455],
16	not	RB	O	not	neg	17	SENT_118	[p7l2029t1404r2149b1455],
17	associated	VBN	O	associate	ccomp	10	SENT_118	[p7l10t1492r366b1549],
18	with	IN	O	with	_	0	SENT_118	[p7l434t1492r596b1549],
19	the	DT	O	the	det	21	SENT_118	[p7l666t1491r778b1549],
20	observed	VBN	O	observe	amod	21	SENT_118	[p7l850t1491r1163b1549],
21	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	17	SENT_118	[p7l1233t1491r1921b1567],
22	after	IN	O	after	_	0	SENT_118	[p7l1992t1491r2150b1549],
23	tranilast	NN	O	tranilast	nn	24	SENT_118	[p7l9t1587r300b1644],
24	administration	NN	O	administration	prep_after	21	SENT_118	[p7l330t1587r857b1644],
25	in	IN	O	in	_	0	SENT_118	[p7l887t1590r957b1643],
26	this	DT	O	this	det	28	SENT_118	[p7l987t1587r1116b1644],
27	Caucasian	JJ	MISC	caucasian	amod	28	SENT_118	[p7l1148t1588r1506b1644],
28	sample	NN	O	sample	prep_in	24	SENT_118	[p7l1538t1586r1801b1662],
29	.	.	O	.	_	0	SENT_118	[p7l1538t1586r1801b1662],

1	DISCUSSION	NN	O	discussion	_	0	SENT_119	[p7l12t1816r462b1872],

1	Acute	JJ	O	acute	amod	2	SENT_120	[p7l8t1912r208b1968],
2	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubj	8	SENT_120	[p7l231t1910r920b1986],
3	is	VBZ	O	be	cop	8	SENT_120	[p7l942t1913r992b1968],
4	a	DT	O	a	det	8	SENT_120	[p7l1016t1927r1051b1968],
5	commonly	RB	O	commonly	advmod	6	SENT_120	[p7l1073t1910r1460b1986],
6	reported	VBN	O	report	amod	8	SENT_120	[p7l1480t1910r1779b1986],
7	side	JJ	O	side	amod	8	SENT_120	[p7l1802t1910r1935b1968],
8	effect	NN	O	effect	_	0	SENT_120	[p7l1959t1910r2150b1968],
9	of	IN	O	of	_	0	SENT_120	[p7l10t2003r81b2061],
10	a	DT	O	a	det	11	SENT_120	[p7l122t2020r157b2061],
11	number	NN	O	number	prep_of	8	SENT_120	[p7l200t2003r480b2061],
12	of	IN	O	of	_	0	SENT_120	[p7l523t2003r594b2061],
13	medicines	NNS	O	medicine	prep_of	11	SENT_120	[p7l634t1996r1173b2061],
14	.25	CD	NUMBER	.25	num	13	SENT_120	[p7l634t1996r1173b2061],
15	‘	CD	NUMBER	‘	number	16	SENT_120	[p7l634t1996r1173b2061],
16	27	CD	NUMBER	27	num	18	SENT_120	[p7l634t1996r1173b2061],
17	The	DT	O	the	det	18	SENT_120	[p7l1216t2003r1349b2061],
18	presence	NN	O	presence	nsubj	23	SENT_120	[p7l1393t2020r1698b2079],
19	of	IN	O	of	_	0	SENT_120	[p7l1744t2003r1816b2061],
20	Gilbert	NNP	PERSON	Gilbert	poss	22	SENT_120	[p7l1857t2003r2149b2061],
21	's	POS	O	's	_	0	SENT_120	[p7l1857t2003r2149b2061],
22	mutation	NN	O	mutation	prep_of	18	SENT_120	[p7l10t2102r341b2157],
23	predisposes	VBZ	O	predispose	rcmod	13	SENT_120	[p7l391t2099r794b2175],
24	HIV-infected	JJ	MISC	hiv-infected	amod	25	SENT_120	[p7l846t2099r1295b2157],
25	patients	NNS	O	patient	dobj	23	SENT_120	[p7l1345t2102r1627b2175],
26	to	TO	O	to	_	0	SENT_120	[p7l1678t2107r1747b2157],
27	indinavirinduced	JJ	O	indinavirinduced	amod	28	SENT_120	[p7l1798t2099r2148b2157, p7l10t2192r295b2249],
28	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	23	SENT_120	[p7l319t2185r1093b2267],
29	.	.	O	.	_	0	SENT_120	[p7l319t2185r1093b2267],

1	”	NNP	O	”	nn	3	SENT_121	[p7l319t2185r1093b2267],
2	Genetic	NNP	O	Genetic	nn	3	SENT_121	[p7l1122t2193r1394b2249],
3	variation	NN	O	variation	nsubjpass	9	SENT_121	[p7l1416t2195r1736b2249],
4	of	IN	O	of	_	0	SENT_121	[p7l1762t2191r1833b2249],
5	UGT1/11	NN	O	ugt1/11	prep_of	3	SENT_121	[p7l1859t2193r2142b2249],
6	has	VBZ	O	have	aux	9	SENT_121	[p7l9t2287r125b2344],
7	also	RB	O	also	advmod	9	SENT_121	[p7l156t2287r290b2344],
8	been	VBN	O	be	auxpass	9	SENT_121	[p7l319t2287r489b2344],
9	shown	VBN	O	show	_	0	SENT_121	[p7l520t2287r752b2344],
10	to	TO	O	to	aux	12	SENT_121	[p7l782t2294r851b2344],
11	be	VB	O	be	auxpass	12	SENT_121	[p7l880t2287r959b2344],
12	associated	VBN	O	associate	xcomp	9	SENT_121	[p7l992t2287r1348b2344],
13	with	IN	O	with	_	0	SENT_121	[p7l1375t2287r1536b2344],
14	both	DT	O	both	det	15	SENT_121	[p7l1564t2287r1731b2344],
15	irinotecaninduced	JJ	O	irinotecaninduced	prep_with	12	SENT_121	[p7l1761t2290r2148b2344, p7l10t2382r295b2439],

1	hyperbilirubinemia	NN	O	hyperbilirubinemia	_	0	SENT_122	[p7l431t2382r1119b2457],
2	and	CC	O	and	_	0	SENT_122	[p7l1256t2382r1387b2439],
3	increased	VBN	O	increase	amod	5	SENT_122	[p7l1523t2382r1853b2439],
4	drug	NN	O	drug	nn	5	SENT_122	[p7l1990t2382r2150b2457],
5	toxicity	NN	O	toxicity	conj_and	1	SENT_122	[p7l9t2468r443b2550],
6	.26	CD	NUMBER	.26	number	7	SENT_122	[p7l9t2468r443b2550],
7	'27	CD	NUMBER	'27	dep	1	SENT_122	[p7l9t2468r443b2550],
8	During	IN	O	during	_	0	SENT_122	[p7l475t2477r724b2550],
9	our	PRP$	O	we	poss	12	SENT_122	[p7l754t2491r872b2532],
10	phase	NN	O	phase	nn	12	SENT_122	[p7l900t2475r1101b2550],
11	III	CD	NUMBER	iii	num	12	SENT_122	[p7l1133t2477r1208b2532],
12	trial	NN	O	trial	prep_during	18	SENT_122	[p7l1240t2475r1381b2532],
13	of	IN	O	of	_	0	SENT_122	[p7l1413t2475r1484b2532],
14	tranilast	NN	O	tranilast	prep_of	12	SENT_122	[p7l1509t2475r1817b2545],
15	,	,	O	,	_	0	SENT_122	[p7l1509t2475r1817b2545],
16	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubjpass	18	SENT_122	[p7l1852t2475r2148b2550, p7l10t2569r422b2627],
17	was	VBD	O	be	auxpass	18	SENT_122	[p7l448t2586r576b2627],
18	observed	VBN	O	observe	rcmod	7	SENT_122	[p7l605t2569r917b2627],
19	in	IN	O	in	_	0	SENT_122	[p7l945t2572r1015b2626],
20	up	RB	O	up	quantmod	22	SENT_122	[p7l1041t2586r1131b2645],
21	to	TO	O	to	dep	22	SENT_122	[p7l1159t2576r1229b2627],
22	12	CD	PERCENT	12	num	23	SENT_122	[p7l1263t2571r1410b2626],
23	%	NN	PERCENT	%	prep_in	18	SENT_122	[p7l1263t2571r1410b2626],
24	of	IN	O	of	_	0	SENT_122	[p7l1439t2569r1510b2627],
25	patients	NNS	O	patient	prep_of	23	SENT_122	[p7l1533t2562r1903b2645],
26	.	.	O	.	_	0	SENT_122	[p7l1533t2562r1903b2645],

1	”	NN	O	”	npadvmod	16	SENT_123	[p7l1533t2562r1903b2645],
2	At	IN	O	at	_	0	SENT_123	[p7l1929t2571r2009b2627],
3	the	DT	O	the	det	4	SENT_123	[p7l2036t2569r2148b2627],
4	time	NN	O	time	prep_at	16	SENT_123	[p7l9t2668r186b2735],
5	,	,	O	,	_	0	SENT_123	[p7l9t2668r186b2735],
6	the	DT	O	the	det	7	SENT_123	[p7l222t2665r334b2722],
7	etiology	NN	O	etiology	nsubj	16	SENT_123	[p7l368t2665r655b2740],
8	of	IN	O	of	_	0	SENT_123	[p7l684t2664r755b2722],
9	this	DT	O	this	det	10	SENT_123	[p7l782t2665r911b2722],
10	elevation	NN	O	elevation	prep_of	7	SENT_123	[p7l944t2665r1269b2722],
11	in	IN	O	in	_	0	SENT_123	[p7l1300t2668r1371b2722],
12	serum	NN	O	serum	nn	14	SENT_123	[p7l1404t2681r1616b2722],
13	bilirubin	NN	O	bilirubin	nn	14	SENT_123	[p7l1645t2665r1955b2722],
14	level	NN	O	level	prep_in	10	SENT_123	[p7l1987t2665r2149b2722],
15	was	VBD	O	be	cop	16	SENT_123	[p7l8t2776r135b2817],
16	unknown	JJ	O	unknown	_	0	SENT_123	[p7l166t2760r527b2817],
17	.	.	O	.	_	0	SENT_123	[p7l166t2760r527b2817],

1	The	DT	O	the	det	3	SENT_124	[p7l560t2760r692b2817],
2	affected	VBN	O	affect	amod	3	SENT_124	[p7l725t2759r1001b2817],
3	individuals	NNS	O	individual	nsubj	4	SENT_124	[p7l1032t2760r1425b2817],
4	showed	VBD	O	show	_	0	SENT_124	[p7l1458t2760r1724b2817],
5	no	DT	O	no	det	6	SENT_124	[p7l1755t2776r1846b2817],
6	signs	NNS	O	sign	dobj	4	SENT_124	[p7l1879t2763r2050b2835],
7	of	IN	O	of	_	0	SENT_124	[p7l2082t2759r2153b2817],
8	liver	NN	O	liver	nn	9	SENT_124	[p7l9t2855r164b2913],
9	damage	NN	O	damage	prep_of	6	SENT_124	[p7l213t2855r484b2931],
10	or	CC	O	or	_	0	SENT_124	[p7l534t2872r605b2913],
11	overt	JJ	O	overt	amod	12	SENT_124	[p7l653t2863r833b2913],
12	hemolysis	NN	O	hemolysis	prep_of	6	SENT_124	[p7l881t2855r1254b2931],
13	;	:	O	;	_	0	SENT_124	[p7l881t2855r1254b2931],
14	however	RB	O	however	advmod	22	SENT_124	[p7l1307t2855r1621b2925],
15	,	,	O	,	_	0	SENT_124	[p7l1307t2855r1621b2925],
16	the	DT	O	the	det	18	SENT_124	[p7l1674t2855r1787b2913],
17	observed	VBN	O	observe	amod	18	SENT_124	[p7l1837t2855r2149b2913],
18	reaction	NN	O	reaction	nsubj	22	SENT_124	[p7l10t2953r298b3008],
19	may	MD	O	may	aux	22	SENT_124	[p7l321t2967r473b3026],
20	have	VB	O	have	aux	22	SENT_124	[p7l495t2950r659b3008],
21	been	VBN	O	be	cop	22	SENT_124	[p7l681t2950r851b3008],
22	indicative	JJ	O	indicative	parataxis	4	SENT_124	[p7l875t2950r1224b3008],
23	of	IN	O	of	_	0	SENT_124	[p7l1249t2950r1320b3008],
24	severe	JJ	O	severe	amod	26	SENT_124	[p7l1341t2967r1552b3008],
25	adverse	JJ	O	adverse	amod	26	SENT_124	[p7l1578t2950r1837b3008],
26	reaction	NN	O	reaction	prep_of	22	SENT_124	[p7l1861t2953r2149b3008],
27	to	TO	O	to	_	0	SENT_124	[p7l9t3052r79b3103],
28	tranilast	NN	O	tranilast	prep_to	22	SENT_124	[p7l110t3045r418b3103],
29	.	.	O	.	_	0	SENT_124	[p7l110t3045r418b3103],

1	As	IN	O	as	_	0	SENT_125	[p7l452t3047r532b3103],
2	part	NN	O	part	prep_as	11	SENT_125	[p7l562t3053r703b3121],
3	of	IN	O	of	_	0	SENT_125	[p7l733t3045r805b3103],
4	candidate	NN	O	candidate	nn	5	SENT_125	[p7l832t3045r1175b3103],
5	gene	NN	O	gene	prep_of	2	SENT_125	[p7l1207t3062r1370b3121],
6	variant	JJ	O	variant	amod	8	SENT_125	[p7l1399t3048r1650b3103],
7	experimental	JJ	O	experimental	amod	8	SENT_125	[p7l1681t3045r2149b3121],
8	design	NN	O	design	dep	5	SENT_125	[p7l10t3139r254b3215],
9	,	,	O	,	_	0	SENT_125	[p7l10t3139r254b3215],
10	we	PRP	O	we	nsubj	11	SENT_125	[p7l298t3156r394b3197],
11	studied	VBD	O	study	_	0	SENT_125	[p7l438t3140r695b3197],
12	genetic	JJ	O	genetic	amod	13	SENT_125	[p7l736t3143r991b3215],
13	polymorphisms	NNS	O	polymorphism	dobj	11	SENT_125	[p7l1031t3140r1588b3215],
14	in	IN	O	in	_	0	SENT_125	[p7l1630t3143r1700b3196],
15	UGT1/11	NN	O	ugt1/11	prep_in	11	SENT_125	[p7l1747t3141r2030b3197],
16	in	IN	O	in	_	0	SENT_125	[p7l2079t3143r2149b3196],
17	these	DT	O	these	det	18	SENT_125	[p7l9t3235r191b3293],
18	patients	NNS	O	patient	prep_in	11	SENT_125	[p7l250t3238r551b3311],
19	.	.	O	.	_	0	SENT_125	[p7l250t3238r551b3311],

1	Our	PRP$	O	we	poss	2	SENT_126	[p7l616t3237r750b3293],
2	data	NNS	O	datum	nsubj	3	SENT_126	[p7l808t3235r957b3293],
3	suggested	VBD	O	suggest	_	0	SENT_126	[p7l1017t3235r1356b3311],
4	that	IN	O	that	_	0	SENT_126	[p7l1414t3235r1557b3293],
5	an	DT	O	a	det	8	SENT_126	[p7l1617t3252r1701b3293],
6	underlying	JJ	O	underlying	amod	8	SENT_126	[p7l1758t3235r2150b3311],
7	genetic	JJ	O	genetic	amod	8	SENT_126	[p7l10t3332r264b3405],
8	predisposition	NN	O	predisposition	prep_that	3	SENT_126	[p7l294t3330r801b3405],
9	to	TO	O	to	_	0	SENT_126	[p7l832t3337r902b3387],
10	Gilbert	NNP	PERSON	Gilbert	poss	13	SENT_126	[p7l935t3330r1227b3387],
11	's	POS	O	's	_	0	SENT_126	[p7l935t3330r1227b3387],
12	syndrome	NN	O	syndrome	nn	13	SENT_126	[p7l1261t3330r1610b3405],
13	accounts	NNS	O	account	prep_to	8	SENT_126	[p7l1643t3337r1953b3387],
14	for	IN	O	for	_	0	SENT_126	[p7l1986t3329r2084b3387],
15	a	DT	O	a	det	17	SENT_126	[p7l2115t3346r2150b3387],
16	major	JJ	O	major	amod	17	SENT_126	[p7l10t3428r217b3500],
17	proportion	NN	O	proportion	prep_for	3	SENT_126	[p7l277t3428r664b3500],
18	of	IN	O	of	_	0	SENT_126	[p7l727t3424r798b3482],
19	genetic	JJ	O	genetic	amod	20	SENT_126	[p7l856t3428r1111b3500],
20	susceptibility	NN	O	susceptibility	prep_of	17	SENT_126	[p7l1174t3425r1642b3500],
21	to	TO	O	to	_	0	SENT_126	[p7l1701t3432r1771b3482],
22	tranilastinduced	JJ	O	tranilastinduced	amod	23	SENT_126	[p7l1833t3425r2148b3482, p7l10t3520r295b3578],
23	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	3	SENT_126	[p7l324t3520r1030b3596],
24	.	.	O	.	_	0	SENT_126	[p7l324t3520r1030b3596],

1	Variability	NN	O	variability	nsubjpass	13	SENT_127	[p7l85t3615r439b3690],
2	in	IN	O	in	_	0	SENT_127	[p7l456t3618r525b3672],
3	phenotype	NN	O	phenotype	nn	4	SENT_127	[p7l544t3615r913b3690],
4	expression	NN	O	expression	prep_in	1	SENT_127	[p7l935t3618r1294b3690],
5	in	IN	O	in	_	0	SENT_127	[p7l1314t3618r1382b3672],
6	patients	NNS	O	patient	prep_in	4	SENT_127	[p7l1402t3618r1673b3690],
7	with	IN	O	with	_	0	SENT_127	[p7l1692t3615r1848b3672],
8	Gilbert	NNP	PERSON	Gilbert	poss	10	SENT_127	[p7l1870t3615r2149b3672],
9	's	POS	O	's	_	0	SENT_127	[p7l1870t3615r2149b3672],
10	mutation	NN	O	mutation	prep_with	6	SENT_127	[p7l10t3713r330b3767],
11	is	VBZ	O	be	auxpass	13	SENT_127	[p7l402t3713r451b3767],
12	well	RB	O	well	advmod	13	SENT_127	[p7l523t3710r662b3767],
13	documented	VBN	O	document	_	0	SENT_127	[p7l736t3710r1184b3780],
14	,	,	O	,	_	0	SENT_127	[p7l736t3710r1184b3780],
15	with	IN	O	with	_	0	SENT_127	[p7l1259t3710r1416b3767],
16	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	13	SENT_127	[p7l1489t3710r2150b3785],
17	developing	VBG	O	develop	partmod	16	SENT_127	[p8l10t17r403b93],
18	in	IN	O	in	_	0	SENT_127	[p8l449t20r519b74],
19	patients	NNS	O	patient	prep_in	17	SENT_127	[p8l565t20r848b93],
20	with	IN	O	with	_	0	SENT_127	[p8l893t17r1055b75],
21	the	DT	O	the	det	23	SENT_127	[p8l1102t17r1214b75],
22	lowest	JJS	O	lowest	amod	23	SENT_127	[p8l1262t17r1487b75],
23	levels	NNS	O	level	prep_with	19	SENT_127	[p8l1534t17r1727b75],
24	of	IN	O	of	_	0	SENT_127	[p8l1775t17r1847b75],
25	hepatic	JJ	O	hepatic	amod	26	SENT_127	[p8l1889t17r2150b93],
26	www.nature.com/tpj	NN	O	www.nature.com/tpj	prep_of	23	SENT_127	[p8l1597t285r2148b343],

1	@	IN	O	@	_	0	SENT_128	[p8l9t446r136b571],
2	Genetic	JJ	O	genetic	amod	3	SENT_128	[p8l647t458r828b503],
3	susceptibility	NN	O	susceptibility	pobj	1	SENT_128	[p8l847t458r1166b517],
4	to	TO	O	to	_	0	SENT_128	[p8l1183t463r1233b503],
5	tranilast-induced	JJ	O	tranilast-induced	amod	8	SENT_128	[p8l1251t458r1664b503],
6	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	8	SENT_128	[p8l1685t458r2146b517],
7	TM	NNP	O	TM	nn	8	SENT_128	[p8l1819t531r1885b570],
8	Danoff	NNP	PERSON	Danoff	prep_to	3	SENT_128	[p8l1908t529r2045b571],
9	et	FW	O	et	nn	10	SENT_128	[p8l2063t534r2099b571],
10	al	FW	O	al	dep	8	SENT_128	[p8l2115t529r2151b571],

1	UGT	NN	O	ugt	_	0	SENT_129	[p8l9t826r175b882],
2	activity	NN	O	activity	dep	1	SENT_129	[p8l206t817r549b900],
3	.	.	O	.	_	0	SENT_129	[p8l206t817r549b900],

1	”	RB	O	”	advmod	4	SENT_130	[p8l206t817r549b900],
2	It	PRP	O	it	nsubjpass	4	SENT_130	[p8l588t827r639b882],
3	is	VBZ	O	be	auxpass	4	SENT_130	[p8l676t827r726b882],
4	known	VBN	O	know	ccomp	21	SENT_130	[p8l764t824r1008b882],
5	that	IN	O	that	complm	11	SENT_130	[p8l1046t824r1189b882],
6	individuals	NNS	O	individual	nsubj	11	SENT_130	[p8l1226t824r1618b882],
7	with	IN	O	with	_	0	SENT_130	[p8l1654t824r1816b882],
8	Gilbert	NNP	PERSON	Gilbert	poss	10	SENT_130	[p8l1854t824r2146b882],
9	's	POS	O	's	_	0	SENT_130	[p8l1854t824r2146b882],
10	mutation	NN	O	mutation	prep_with	6	SENT_130	[p8l10t921r341b976],
11	have	VBP	O	have	ccomp	4	SENT_130	[p8l363t918r528b976],
12	low	JJ	O	low	amod	13	SENT_130	[p8l552t918r681b976],
13	levels	NNS	O	level	dobj	11	SENT_130	[p8l702t918r894b976],
14	of	IN	O	of	_	0	SENT_130	[p8l918t918r990b976],
15	UGT1A1	NN	O	ugt1a1	nn	16	SENT_130	[p8l1009t919r1307b976],
16	activity	NN	O	activity	prep_of	13	SENT_130	[p8l1336t911r1679b994],
17	,	,	O	,	_	0	SENT_130	[p8l1336t911r1679b994],
18	”	NN	O	”	nsubj	21	SENT_130	[p8l1336t911r1679b994],
19	and	CC	O	and	_	0	SENT_130	[p8l1703t918r1834b976],
20	tranilast	NN	O	tranilast	conj_and	18	SENT_130	[p8l1856t918r2147b976],
21	inhibit	VBP	O	inhibit	_	0	SENT_130	[p8l10t1013r251b1071],
22	UGT	NNP	O	UGT	nn	24	SENT_130	[p8l290t1015r455b1071],
23	1A1	NN	O	1a1	nn	24	SENT_130	[p8l463t1015r588b1070],
24	activity	NN	O	activity	dobj	21	SENT_130	[p8l634t1016r898b1089],
25	(	CD	NUMBER	(	num	26	SENT_130	[p8l938t1014r1111b1086],
26	data	NNS	O	datum	npadvmod	27	SENT_130	[p8l938t1014r1111b1086],
27	not	RB	O	not	neg	28	SENT_130	[p8l1150t1021r1270b1071],
28	shown	VBN	O	show	partmod	24	SENT_130	[p8l1312t1013r1588b1086],
29	)	NN	O	)	dobj	28	SENT_130	[p8l1312t1013r1588b1086],
30	.	.	O	.	_	0	SENT_130	[p8l1312t1013r1588b1086],

1	Thus	RB	O	thus	advmod	11	SENT_131	[p8l1630t1013r1820b1084],
2	,	,	O	,	_	0	SENT_131	[p8l1630t1013r1820b1084],
3	patients	NNS	O	patient	nsubj	11	SENT_131	[p8l1864t1016r2146b1089],
4	who	WP	O	who	nsubj	10	SENT_131	[p8l8t1108r161b1166],
5	are	VBP	O	be	cop	10	SENT_131	[p8l196t1125r297b1166],
6	(	CD	NUMBER	(	num	10	SENT_131	[p8l334t1108r508b1181],
7	TA	NNP	O	TA	nn	10	SENT_131	[p8l334t1108r508b1181],
8	)	NN	O	)	nn	10	SENT_131	[p8l334t1108r508b1181],
9	7	CD	NUMBER	7	num	10	SENT_131	[p8l334t1108r508b1181],
10	homozygotes	NNS	O	homozygote	rcmod	3	SENT_131	[p8l542t1109r1013b1184],
11	manifest	VBP	O	manifest	_	0	SENT_131	[p8l1048t1108r1354b1166],
12	increased	VBN	O	increase	amod	13	SENT_131	[p8l1386t1108r1717b1166],
13	susceptibility	NN	O	susceptibility	dobj	11	SENT_131	[p8l1751t1108r2146b1184, p8l10t1207r103b1280],
14	to	TO	O	to	_	0	SENT_131	[p8l150t1211r220b1262],
15	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	11	SENT_131	[p8l270t1204r957b1280],
16	as	IN	O	as	_	0	SENT_131	[p8l1008t1221r1072b1262],
17	a	DT	O	a	det	18	SENT_131	[p8l1124t1221r1158b1262],
18	consequence	NN	O	consequence	prep_as	11	SENT_131	[p8l1209t1221r1662b1280],
19	of	IN	O	of	_	0	SENT_131	[p8l1714t1204r1785b1262],
20	tranilastinduced	JJ	O	tranilastinduced	amod	21	SENT_131	[p8l1831t1204r2146b1262, p8l10t1299r295b1356],
21	inhibition	NN	O	inhibition	prep_of	18	SENT_131	[p8l324t1299r685b1356],
22	of	IN	O	of	_	0	SENT_131	[p8l715t1298r786b1356],
23	UGT	NNP	O	UGT	nn	25	SENT_131	[p8l811t1300r976b1356],
24	1A1	NN	O	1a1	nn	25	SENT_131	[p8l984t1300r1109b1356],
25	activity	NN	O	activity	prep_of	21	SENT_131	[p8l1145t1302r1418b1374],
26	.	.	O	.	_	0	SENT_131	[p8l1145t1302r1418b1374],

1	Variation	NN	O	variation	nsubj	8	SENT_132	[p8l85t1396r404b1452],
2	in	IN	O	in	_	0	SENT_132	[p8l440t1397r510b1451],
3	allele	NN	O	allele	nn	4	SENT_132	[p8l546t1394r722b1452],
4	frequencies	NNS	O	frequency	prep_in	1	SENT_132	[p8l759t1394r1149b1470],
5	between	IN	O	between	_	0	SENT_132	[p8l1184t1394r1474b1452],
6	ethnic	JJ	O	ethnic	amod	7	SENT_132	[p8l1511t1394r1729b1452],
7	groups	NNS	O	group	prep_between	4	SENT_132	[p8l1765t1411r1996b1470],
8	has	VBZ	O	have	_	0	SENT_132	[p8l2032t1394r2147b1452],
9	implications	NNS	O	implication	dobj	8	SENT_132	[p8l10t1489r439b1565],
10	for	IN	O	for	_	0	SENT_132	[p8l471t1489r568b1547],
11	worldwide	JJ	O	worldwide	amod	12	SENT_132	[p8l596t1489r959b1547],
12	development	NN	O	development	prep_for	9	SENT_132	[p8l992t1489r1446b1565],
13	and	CC	O	and	_	0	SENT_132	[p8l1478t1489r1608b1547],
14	surveillance	NN	O	surveillance	prep_for	9	SENT_132	[p8l1641t1489r2047b1547],
15	of	IN	O	of	_	0	SENT_132	[p8l2080t1489r2152b1547],
16	medicines	NNS	O	medicine	prep_of	9	SENT_132	[p8l10t1584r374b1654],
17	,	,	O	,	_	0	SENT_132	[p8l10t1584r374b1654],
18	and	CC	O	and	_	0	SENT_132	[p8l430t1584r560b1641],
19	is	VBZ	O	be	cop	22	SENT_132	[p8l610t1587r658b1641],
20	an	DT	O	a	det	22	SENT_132	[p8l711t1600r794b1641],
21	important	JJ	O	important	amod	22	SENT_132	[p8l845t1587r1196b1659],
22	factor	NN	O	factor	conj_and	8	SENT_132	[p8l1246t1583r1444b1641],
23	to	TO	O	to	aux	24	SENT_132	[p8l1494t1591r1562b1641],
24	consider	VB	O	consider	xcomp	22	SENT_132	[p8l1614t1584r1904b1641],
25	when	WRB	O	when	advmod	26	SENT_132	[p8l1952t1584r2146b1641],
26	interpreting	VBG	O	interpret	advcl	24	SENT_132	[p8l10t1683r423b1756],
27	pharmacogenetic	JJ	O	pharmacogenetic	amod	28	SENT_132	[p8l442t1680r1040b1756],
28	information	NN	O	information	dobj	26	SENT_132	[p8l1061t1680r1498b1738],
29	.	.	O	.	_	0	SENT_132	[p8l1061t1680r1498b1738],

1	Frequencies	NNS	O	frequency	dep	21	SENT_133	[p8l1523t1683r1926b1756],
2	of	IN	O	of	_	0	SENT_133	[p8l1948t1680r2020b1738],
3	the	DT	O	the	det	5	SENT_133	[p8l2036t1680r2146b1738],
4	(	CD	NUMBER	(	num	5	SENT_133	[p8l13t1774r405b1846],
5	TA	NNP	O	TA	prep_of	1	SENT_133	[p8l13t1774r405b1846],
6	)	CD	NUMBER	)	number	7	SENT_133	[p8l13t1774r405b1846],
7	6	CD	NUMBER	6	amod	5	SENT_133	[p8l13t1774r405b1846],
8	/	:	O	/	punct	12	SENT_133	[p8l13t1774r405b1846],
9	(	CD	NUMBER	(	num	10	SENT_133	[p8l13t1774r405b1846],
10	TA	NNP	O	TA	dep	12	SENT_133	[p8l13t1774r405b1846],
11	)	CD	NUMBER	)	num	12	SENT_133	[p8l13t1774r405b1846],
12	6	CD	NUMBER	6	dep	7	SENT_133	[p8l13t1774r405b1846],
13	,	,	O	,	_	0	SENT_133	[p8l13t1774r405b1846],
14	(	CD	NUMBER	(	num	15	SENT_133	[p8l440t1774r814b1847],
15	TA	NNP	O	TA	appos	12	SENT_133	[p8l440t1774r814b1847],
16	)	CD	NUMBER	)	number	17	SENT_133	[p8l440t1774r814b1847],
17	6	CD	NUMBER	6	dep	15	SENT_133	[p8l440t1774r814b1847],
18	/	:	O	/	punct	12	SENT_133	[p8l440t1774r814b1847],
19	(	CD	NUMBER	(	dep	21	SENT_133	[p8l440t1774r814b1847],
20	TA	NNP	O	TA	nn	21	SENT_133	[p8l440t1774r814b1847],
21	)	NN	O	)	dep	26	SENT_133	[p8l440t1774r814b1847],
22	7	CD	NUMBER	7	num	21	SENT_133	[p8l440t1774r814b1847],
23	and	CC	O	and	_	0	SENT_133	[p8l842t1774r970b1832],
24	TA	NNP	O	TA	conj_and	21	SENT_133	[p8l994t1774r1349b1847],
25	)	CD	NUMBER	)	num	24	SENT_133	[p8l994t1774r1349b1847],
26	7	CD	NUMBER	7	dep	30	SENT_133	[p8l994t1774r1349b1847],
27	/	:	O	/	punct	30	SENT_133	[p8l994t1774r1349b1847],
28	(	CD	NUMBER	(	num	30	SENT_133	[p8l994t1774r1349b1847],
29	TA	NNP	O	TA	nn	30	SENT_133	[p8l994t1774r1349b1847],
30	)	NN	O	)	_	0	SENT_133	[p8l994t1774r1349b1847],
31	7	CD	NUMBER	7	num	32	SENT_133	[p8l994t1774r1349b1847],
32	genotypes	NNS	O	genotype	nsubj	34	SENT_133	[p8l1376t1782r1723b1850],
33	were	VBD	O	be	cop	34	SENT_133	[p8l1748t1791r1909b1832],
34	45	CD	NUMBER	45	rcmod	30	SENT_133	[p8l1935t1777r2033b1845],
35	,	,	O	,	_	0	SENT_133	[p8l1935t1777r2033b1845],
36	44	CD	NUMBER	44	num	39	SENT_133	[p8l2065t1777r2145b1831],
37	and	CC	O	and	_	0	SENT_133	[p8l10t1870r139b1928],
38	11	CD	PERCENT	11	num	39	SENT_133	[p8l197t1871r358b1940],
39	%	NN	PERCENT	%	rcmod	34	SENT_133	[p8l197t1871r358b1940],
40	,	,	O	,	_	0	SENT_133	[p8l197t1871r358b1940],
41	respectively	RB	O	respectively	advmod	39	SENT_133	[p8l415t1870r829b1946],
42	,	,	O	,	_	0	SENT_133	[p8l415t1870r829b1946],
43	in	IN	O	in	_	0	SENT_133	[p8l886t1873r955b1927],
44	this	DT	O	this	det	46	SENT_133	[p8l1007t1870r1133b1928],
45	Caucasian	JJ	MISC	caucasian	amod	46	SENT_133	[p8l1187t1871r1536b1928],
46	sample	NN	O	sample	prep_in	34	SENT_133	[p8l1590t1870r1846b1946],
47	,	,	O	,	_	0	SENT_133	[p8l1590t1870r1846b1946],
48	with	IN	O	with	_	0	SENT_133	[p8l1901t1870r2059b1928],
49	a	DT	O	a	det	52	SENT_133	[p8l2112t1887r2146b1928],
50	calculated	VBN	O	calculate	amod	52	SENT_133	[p8l10t1964r356b2022],
51	allele	NN	O	allele	nn	52	SENT_133	[p8l398t1964r574b2022],
52	frequency	NN	O	frequency	prep_with	34	SENT_133	[p8l617t1964r961b2040],
53	for	IN	O	for	_	0	SENT_133	[p8l1000t1964r1096b2022],
54	(	CD	NUMBER	(	num	56	SENT_133	[p8l1141t1965r1311b2037],
55	TA	NNP	O	TA	nn	56	SENT_133	[p8l1141t1965r1311b2037],
56	)	NN	O	)	nsubj	60	SENT_133	[p8l1141t1965r1311b2037],
57	7	CD	NUMBER	7	dep	56	SENT_133	[p8l1141t1965r1311b2037],
58	being	VBG	O	be	cop	60	SENT_133	[p8l1352t1964r1545b2040],
59	33	CD	PERCENT	33	num	60	SENT_133	[p8l1587t1966r1753b2022],
60	%	NN	PERCENT	%	prepc_for	52	SENT_133	[p8l1587t1966r1753b2022],
61	.	.	O	.	_	0	SENT_133	[p8l1587t1966r1753b2022],

1	This	DT	O	this	nsubj	2	SENT_134	[p8l1798t1964r1943b2022],
2	is	VBZ	O	be	_	0	SENT_134	[p8l1986t1967r2036b2022],
3	in	IN	O	in	_	0	SENT_134	[p8l2078t1967r2147b2021],
4	agreement	NN	O	agreement	prep_in	2	SENT_134	[p8l10t2067r374b2135],
5	with	IN	O	with	_	0	SENT_134	[p8l446t2059r604b2117],
6	other	JJ	O	other	amod	8	SENT_134	[p8l679t2059r863b2117],
7	reported	VBN	O	report	amod	8	SENT_134	[p8l937t2060r1227b2135],
8	frequencies	NNS	O	frequency	prep_with	4	SENT_134	[p8l1302t2059r1692b2135],
9	in	IN	O	in	_	0	SENT_134	[p8l1767t2062r1836b2116],
10	Caucasians	NNPS	MISC	Caucasians	prep_in	8	SENT_134	[p8l1913t2061r2146b2117, p8l11t2146r417b2211],
11	.15	CD	NUMBER	.15	tmod	8	SENT_134	[p8l1913t2061r2146b2117, p8l11t2146r417b2211],
12	'	''	DATE	'	_	0	SENT_134	[p8l1913t2061r2146b2117, p8l11t2146r417b2211],
13	17	CD	DATE	17	number	14	SENT_134	[p8l1913t2061r2146b2117, p8l11t2146r417b2211],
14	'19	CD	DATE	'19	num	16	SENT_134	[p8l1913t2061r2146b2117, p8l11t2146r417b2211],
15	The	DT	O	the	det	16	SENT_134	[p8l460t2153r591b2211],
16	frequency	NN	O	frequency	dep	4	SENT_134	[p8l634t2153r978b2229],
17	of	IN	O	of	_	0	SENT_134	[p8l1020t2153r1090b2211],
18	the	DT	O	the	det	21	SENT_134	[p8l1129t2153r1238b2211],
19	(	CD	NUMBER	(	num	21	SENT_134	[p8l1287t2153r1456b2225],
20	TA	NNP	O	TA	nn	21	SENT_134	[p8l1287t2153r1456b2225],
21	)	NN	O	)	prep_of	16	SENT_134	[p8l1287t2153r1456b2225],
22	7	CD	NUMBER	7	num	23	SENT_134	[p8l1287t2153r1456b2225],
23	allele	NN	O	allele	nsubj	36	SENT_134	[p8l1501t2153r1694b2223],
24	,	,	O	,	_	0	SENT_134	[p8l1501t2153r1694b2223],
25	however	RB	O	however	advmod	36	SENT_134	[p8l1742t2153r2048b2223],
26	,	,	O	,	_	0	SENT_134	[p8l1742t2153r2048b2223],
27	is	VBZ	O	be	cop	36	SENT_134	[p8l2097t2156r2146b2211],
28	much	RB	O	much	advmod	29	SENT_134	[p8l10t2249r209b2306],
29	lower	JJR	O	lower	acomp	36	SENT_134	[p8l230t2249r420b2306],
30	in	IN	O	in	_	0	SENT_134	[p8l440t2252r509b2306],
31	Japanese	JJ	MISC	japanese	amod	34	SENT_134	[p8l521t2251r825b2324],
32	and	CC	O	and	_	0	SENT_134	[p8l847t2249r976b2306],
33	Asian	JJ	LOCATION	asian	amod	34	SENT_134	[p8l995t2250r1185b2306],
34	populations	NNS	O	population	prep_in	36	SENT_134	[p8l1204t2249r1633b2324],
35	,	,	O	,	_	0	SENT_134	[p8l1204t2249r1633b2324],
36	resulting	VBG	O	result	rcmod	21	SENT_134	[p8l1659t2249r1960b2324],
37	in	IN	O	in	_	0	SENT_134	[p8l1980t2252r2049b2306],
38	23	CD	PERCENT	23	number	39	SENT_134	[p8l2070t2250r2149b2306, p8l11t2344r118b2400],
39	%	NN	PERCENT	%	amod	40	SENT_134	[p8l2070t2250r2149b2306, p8l11t2344r118b2400],
40	frequency	NN	O	frequency	prep_in	36	SENT_134	[p8l146t2342r490b2418],
41	of	IN	O	of	_	0	SENT_134	[p8l518t2342r588b2400],
42	(	CD	NUMBER	(	num	44	SENT_134	[p8l615t2342r785b2414],
43	TA	NNP	O	TA	nn	44	SENT_134	[p8l615t2342r785b2414],
44	)	NN	O	)	prep_of	40	SENT_134	[p8l615t2342r785b2414],
45	7	CD	NUMBER	7	num	46	SENT_134	[p8l615t2342r785b2414],
46	homozygotes	NNS	O	homozygote	dep	44	SENT_134	[p8l814t2335r1359b2418],
47	.	.	O	.	_	0	SENT_134	[p8l814t2335r1359b2418],

1	”	NN	O	”	nsubj	3	SENT_135	[p8l814t2335r1359b2418],
2	This	DT	O	this	dep	1	SENT_135	[p8l1386t2342r1532b2400],
3	suggests	VBZ	O	suggest	_	0	SENT_135	[p8l1563t2349r1838b2418],
4	that	IN	O	that	complm	17	SENT_135	[p8l1867t2342r2007b2400],
5	the	DT	O	the	det	6	SENT_135	[p8l2035t2342r2146b2400],
6	proportion	NN	O	proportion	nsubj	17	SENT_135	[p8l9t2441r387b2514],
7	of	IN	O	of	_	0	SENT_135	[p8l424t2438r495b2496],
8	patients	NNS	O	patient	prep_of	6	SENT_135	[p8l528t2441r802b2514],
9	manifesting	VBG	O	manifest	partmod	8	SENT_135	[p8l840t2438r1252b2514],
10	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	9	SENT_135	[p8l1288t2438r1956b2514],
11	after	IN	O	after	_	0	SENT_135	[p8l1994t2438r2148b2496],
12	tranilast	NN	O	tranilast	nn	13	SENT_135	[p8l9t2533r291b2591],
13	treatment	NN	O	treatment	prep_after	9	SENT_135	[p8l318t2540r659b2591],
14	may	MD	O	may	aux	17	SENT_135	[p8l687t2550r837b2609],
15	be	VB	O	be	cop	17	SENT_135	[p8l861t2533r940b2591],
16	correspondingly	RB	O	correspondingly	advmod	17	SENT_135	[p8l969t2533r1532b2609],
17	lower	JJR	O	lower	ccomp	3	SENT_135	[p8l1558t2533r1748b2591],
18	in	IN	O	in	_	0	SENT_135	[p8l1775t2536r1845b2590],
19	Asians	NNPS	MISC	Asians	prep_in	17	SENT_135	[p8l1871t2534r2108b2591],
20	.	.	O	.	_	0	SENT_135	[p8l1871t2534r2108b2591],

1	Attrition	NN	O	attrition	nsubj	11	SENT_136	[p8l85t2630r393b2686],
2	of	IN	O	of	_	0	SENT_136	[p8l450t2628r522b2686],
3	drugs	NNS	O	drug	prep_of	1	SENT_136	[p8l575t2628r764b2704],
4	during	IN	O	during	_	0	SENT_136	[p8l822t2628r1057b2704],
5	development	NN	O	development	prep_during	3	SENT_136	[p8l1113t2628r1578b2704],
6	due	JJ	O	due	_	0	SENT_136	[p8l1635t2628r1761b2686],
7	to	TO	O	to	_	0	SENT_136	[p8l1818t2635r1888b2686],
8	safety	NN	O	safety	nn	9	SENT_136	[p8l1947t2628r2149b2704],
9	concerns	NNS	O	concern	prep_due_to	5	SENT_136	[p8l10t2739r324b2780],
10	is	VBZ	O	be	cop	11	SENT_136	[p8l350t2725r400b2780],
11	one	CD	NUMBER	one	_	0	SENT_136	[p8l425t2739r554b2780],
12	of	IN	O	of	_	0	SENT_136	[p8l580t2722r651b2780],
13	the	DT	O	the	det	15	SENT_136	[p8l671t2722r783b2780],
14	main	JJ	O	main	amod	15	SENT_136	[p8l809t2725r991b2780],
15	problems	NNS	O	problem	prep_of	11	SENT_136	[p8l1014t2722r1341b2798],
16	in	IN	O	in	_	0	SENT_136	[p8l1367t2725r1437b2779],
17	the	DT	O	the	det	19	SENT_136	[p8l1461t2722r1573b2780],
18	pharmaceutical	JJ	O	pharmaceutical	amod	19	SENT_136	[p8l1598t2722r2146b2798],
19	pipeline	NN	O	pipeline	prep_in	15	SENT_136	[p8l9t2818r314b2894],
20	.	.	O	.	_	0	SENT_136	[p8l9t2818r314b2894],

1	This	DT	O	this	det	2	SENT_137	[p8l346t2818r495b2876],
2	study	NN	O	study	nsubj	3	SENT_137	[p8l528t2818r720b2894],
3	showed	VBD	O	show	_	0	SENT_137	[p8l749t2818r1015b2876],
4	that	IN	O	that	complm	7	SENT_137	[p8l1044t2818r1187b2876],
5	tranilast	NN	O	tranilast	nn	6	SENT_137	[p8l1216t2818r1821b2876],
6	—	NN	O	—	nsubj	7	SENT_137	[p8l1216t2818r1821b2876],
7	induced	VBD	O	induce	ccomp	3	SENT_137	[p8l1216t2818r1821b2876],
8	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	9	SENT_137	[p8l1850t2818r2146b2894, p8l10t2912r422b2970],
9	susceptibility	NN	O	susceptibility	nsubj	12	SENT_137	[p8l453t2912r921b2988],
10	was	VBD	O	be	cop	12	SENT_137	[p8l946t2929r1074b2970],
11	partly	RB	O	partly	advmod	12	SENT_137	[p8l1103t2913r1312b2988],
12	due	JJ	O	due	ccomp	7	SENT_137	[p8l1339t2912r1464b2970],
13	to	TO	O	to	_	0	SENT_137	[p8l1495t2920r1565b2970],
14	the	DT	O	the	det	15	SENT_137	[p8l1595t2912r1707b2970],
15	recipient	JJ	O	recipient	prep_to	12	SENT_137	[p8l1737t2915r2050b2988],
16	of	IN	O	of	_	0	SENT_137	[p8l2079t2912r2151b2970],
17	medicine	NN	O	medicine	prep_of	15	SENT_137	[p8l10t3007r335b3065],
18	carrying	VBG	O	carry	xcomp	12	SENT_137	[p8l365t3010r656b3083],
19	an	DT	O	a	det	20	SENT_137	[p8l683t3024r768b3065],
20	allele	NN	O	allele	dobj	18	SENT_137	[p8l797t3007r978b3065],
21	known	VBN	O	know	partmod	20	SENT_137	[p8l1008t3007r1252b3065],
22	to	TO	O	to	aux	24	SENT_137	[p8l1280t3015r1350b3065],
23	be	VB	O	be	auxpass	24	SENT_137	[p8l1377t3007r1457b3065],
24	related	VBN	O	relate	xcomp	21	SENT_137	[p8l1486t3007r1726b3065],
25	to	TO	O	to	_	0	SENT_137	[p8l1754t3015r1824b3065],
26	Gilbert	NNP	PERSON	Gilbert	poss	28	SENT_137	[p8l1854t3007r2146b3065],
27	's	POS	O	's	_	0	SENT_137	[p8l1854t3007r2146b3065],
28	syndrome	NN	O	syndrome	prep_to	24	SENT_137	[p8l11t3103r379b3179],
29	.	.	O	.	_	0	SENT_137	[p8l11t3103r379b3179],

1	It	PRP	O	it	nsubj	4	SENT_138	[p8l439t3105r491b3161],
2	was	VBD	O	be	cop	4	SENT_138	[p8l544t3120r672b3161],
3	therefore	RB	O	therefore	advmod	4	SENT_138	[p8l728t3103r1048b3161],
4	possible	JJ	O	possible	_	0	SENT_138	[p8l1104t3103r1384b3179],
5	to	TO	O	to	aux	6	SENT_138	[p8l1440t3110r1510b3161],
6	define	VB	O	define	xcomp	4	SENT_138	[p8l1567t3103r1784b3161],
7	a	DT	O	a	det	9	SENT_138	[p8l1842t3120r1876b3161],
8	benign	JJ	O	benign	amod	9	SENT_138	[p8l1932t3103r2146b3177],
9	condition	NN	O	condition	dobj	6	SENT_138	[p8l10t3198r357b3255],
10	associated	VBN	O	associate	partmod	9	SENT_138	[p8l403t3198r758b3255],
11	with	IN	O	with	_	0	SENT_138	[p8l801t3198r962b3255],
12	tranilast	NN	O	tranilast	nn	13	SENT_138	[p8l1008t3198r1613b3255],
13	—	NN	O	—	prep_with	10	SENT_138	[p8l1008t3198r1613b3255],
14	induced	VBD	O	induce	partmod	13	SENT_138	[p8l1008t3198r1613b3255],
15	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	14	SENT_138	[p8l1657t3198r2145b3273, p8l10t3296r247b3363],
16	,	,	O	,	_	0	SENT_138	[p8l1657t3198r2145b3273, p8l10t3296r247b3363],
17	rather	RB	O	rather	_	0	SENT_138	[p8l284t3293r496b3350],
18	than	IN	O	than	_	0	SENT_138	[p8l528t3293r692b3350],
19	to	TO	O	to	aux	20	SENT_138	[p8l724t3300r794b3350],
20	suspect	VB	O	suspect	conj_negcc	13	SENT_138	[p8l829t3300r1084b3368],
21	patients	NNS	O	patient	dobj	20	SENT_138	[p8l1115t3296r1397b3368],
22	being	VBG	O	be	cop	23	SENT_138	[p8l1428t3293r1626b3368],
23	susceptible	JJ	O	susceptible	xcomp	20	SENT_138	[p8l1659t3293r2043b3368],
24	to	TO	O	to	_	0	SENT_138	[p8l2076t3300r2146b3350],
25	some	DT	O	some	det	32	SENT_138	[p9l11t34r192b75],
26	unknown	JJ	O	unknown	amod	32	SENT_138	[p9l225t17r585b88],
27	,	,	O	,	_	0	SENT_138	[p9l225t17r585b88],
28	potentially	RB	O	potentially	advmod	30	SENT_138	[p9l623t17r1012b93],
29	more	RBR	O	more	advmod	30	SENT_138	[p9l1044t34r1224b75],
30	severe	JJ	O	severe	amod	32	SENT_138	[p9l1261t34r1471b75],
31	hepatic	JJ	O	hepatic	amod	32	SENT_138	[p9l1506t17r1766b93],
32	complications	NNS	O	complication	prep_to	23	SENT_138	[p9l1800t17r2146b93, p9l9t115r203b170],
33	.	.	O	.	_	0	SENT_138	[p9l1800t17r2146b93, p9l9t115r203b170],

1	Rapid	JJ	O	rapid	amod	2	SENT_139	[p9l235t112r435b188],
2	identification	NN	O	identification	nsubj	20	SENT_139	[p9l462t112r944b170],
3	of	IN	O	of	_	0	SENT_139	[p9l971t112r1043b170],
4	an	DT	O	a	det	5	SENT_139	[p9l1067t129r1151b170],
5	etiology	NN	O	etiology	prep_of	2	SENT_139	[p9l1179t112r1466b188],
6	associated	VBN	O	associate	partmod	5	SENT_139	[p9l1492t112r1847b170],
7	with	IN	O	with	_	0	SENT_139	[p9l1873t112r2034b170],
8	an	DT	O	a	det	10	SENT_139	[p9l2062t129r2147b170],
9	adverse	JJ	O	adverse	amod	10	SENT_139	[p9l10t207r269b265],
10	effect	NN	O	effect	prep_with	6	SENT_139	[p9l305t207r495b265],
11	during	IN	O	during	_	0	SENT_139	[p9l530t207r764b283],
12	the	DT	O	the	det	13	SENT_139	[p9l797t207r909b265],
13	course	NN	O	course	prep_during	6	SENT_139	[p9l944t224r1167b265],
14	of	IN	O	of	_	0	SENT_139	[p9l1203t207r1274b265],
15	a	DT	O	a	det	16	SENT_139	[p9l1305t224r1340b265],
16	Phase	NN	O	phase	prep_of	13	SENT_139	[p9l1373t207r1570b265],
17	III	CD	NUMBER	iii	num	19	SENT_139	[p9l1606t210r1681b264],
18	clinical	JJ	O	clinical	amod	19	SENT_139	[p9l1716t207r1971b265],
19	trial	NN	O	trial	dep	16	SENT_139	[p9l2005t207r2146b265],
20	demonstrated	VBD	O	demonstrate	_	0	SENT_139	[p9l10t301r500b359],
21	the	DT	O	the	det	25	SENT_139	[p9l532t301r644b359],
22	power	NN	O	power	nn	25	SENT_139	[p9l676t318r894b377],
23	and	CC	O	and	_	0	SENT_139	[p9l926t301r1057b359],
24	potential	JJ	O	potential	nn	25	SENT_139	[p9l1089t301r1409b377],
25	use	NN	O	use	dobj	20	SENT_139	[p9l1440t318r1553b359],
26	of	IN	O	of	_	0	SENT_139	[p9l1587t301r1658b359],
27	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	25	SENT_139	[p9l1685t301r2146b377, p9l10t400r215b455],
28	in	IN	O	in	_	0	SENT_139	[p9l242t400r312b454],
29	clinical	JJ	O	clinical	amod	30	SENT_139	[p9l339t397r594b455],
30	studies	NNS	O	study	prep_in	20	SENT_139	[p9l623t397r881b467],
31	,	,	O	,	_	0	SENT_139	[p9l623t397r881b467],
32	especially	RB	O	especially	advmod	38	SENT_139	[p9l914t397r1255b473],
33	since	IN	O	since	dep	38	SENT_139	[p9l1281t400r1455b455],
34	the	DT	O	the	det	36	SENT_139	[p9l1484t397r1596b455],
35	study	NN	O	study	nn	36	SENT_139	[p9l1625t397r1817b473],
36	design	NN	O	design	nsubj	38	SENT_139	[p9l1842t397r2068b473],
37	is	VBZ	O	be	cop	38	SENT_139	[p9l2095t400r2146b455],
38	prospective	JJ	O	prospective	dep	20	SENT_139	[p9l9t494r411b567],
39	and	CC	O	and	_	0	SENT_139	[p9l439t492r569b549],
40	double	JJ	O	double	amod	41	SENT_139	[p9l594t491r834b549],
41	blind	JJ	O	blind	dep	20	SENT_139	[p9l858t491r1063b549],
42	.	.	O	.	_	0	SENT_139	[p9l858t491r1063b549],

1	Such	JJ	O	such	amod	2	SENT_140	[p9l1093t491r1261b549],
2	information	NN	O	information	nsubj	4	SENT_140	[p9l1285t491r1716b549],
3	is	VBZ	O	be	cop	4	SENT_140	[p9l1741t494r1792b549],
4	crucial	JJ	O	crucial	_	0	SENT_140	[p9l1818t491r2051b549],
5	in	IN	O	in	_	0	SENT_140	[p9l2076t494r2147b548],
6	inﬂuencing	VBG	O	inﬂuencing	prepc_in	4	SENT_140	[p9l10t586r419b662],
7	the	DT	O	the	det	9	SENT_140	[p9l482t586r594b644],
8	regulatory	JJ	O	regulatory	amod	9	SENT_140	[p9l658t586r1022b662],
9	environment	NN	O	environment	dobj	6	SENT_140	[p9l1083t589r1548b644],
10	surrounding	VBG	O	surround	xcomp	6	SENT_140	[p9l1613t586r2049b662],
11	a	DT	O	a	det	12	SENT_140	[p9l2112t603r2147b644],
12	medicine	NN	O	medicine	poss	14	SENT_140	[p9l10t682r370b740],
13	's	POS	O	's	_	0	SENT_140	[p9l10t682r370b740],
14	progress	NN	O	progress	dobj	10	SENT_140	[p9l409t699r686b758],
15	to	TO	O	to	_	0	SENT_140	[p9l724t689r792b740],
16	commercialization	NN	O	commercialization	prep_to	10	SENT_140	[p9l832t682r1486b740],
17	.	.	O	.	_	0	SENT_140	[p9l832t682r1486b740],

1	Unfortunately	RB	O	unfortunately	advmod	11	SENT_141	[p9l1528t682r2017b758],
2	for	IN	O	for	_	0	SENT_141	[p9l2052t682r2147b740],
3	the	DT	O	the	det	4	SENT_141	[p9l9t777r119b834],
4	company	NN	O	company	prep_for	11	SENT_141	[p9l140t793r470b852],
5	,	,	O	,	_	0	SENT_141	[p9l140t793r470b852],
6	the	DT	O	the	det	7	SENT_141	[p9l495t777r604b834],
7	development	NN	O	development	nsubjpass	11	SENT_141	[p9l626t777r1077b852],
8	of	IN	O	of	_	0	SENT_141	[p9l1098t776r1167b834],
9	tranilast	NN	O	tranilast	prep_of	7	SENT_141	[p9l1183t777r1461b834],
10	was	VBD	O	be	auxpass	11	SENT_141	[p9l1479t793r1604b834],
11	terminated	VBN	O	terminate	_	0	SENT_141	[p9l1625t777r2003b834],
12	due	JJ	O	due	acomp	11	SENT_141	[p9l2023t777r2146b834],
13	to	TO	O	to	_	0	SENT_141	[p9l9t879r78b929],
14	the	DT	O	the	det	15	SENT_141	[p9l118t872r227b929],
15	lack	NN	O	lack	prep_to	12	SENT_141	[p9l269t872r405b929],
16	of	IN	O	of	_	0	SENT_141	[p9l444t871r514b929],
17	efficacy	NN	O	efficacy	prep_of	15	SENT_141	[p9l550t871r808b947],
18	in	IN	O	in	_	0	SENT_141	[p9l845t875r914b929],
19	preventing	VBG	O	prevent	prepc_in	11	SENT_141	[p9l953t875r1326b947],
20	restenosis	NN	O	restenosis	dobj	19	SENT_141	[p9l1365t875r1694b929],
21	of	IN	O	of	_	0	SENT_141	[p9l1736t871r1806b929],
22	coronary	JJ	O	coronary	amod	23	SENT_141	[p9l1843t888r2150b947],
23	vessels	NNS	O	vessel	prep_of	20	SENT_141	[p9l7t958r315b1023],
24	.	.	O	.	_	0	SENT_141	[p9l7t958r315b1023],

1	”	NN	O	”	dep	5	SENT_142	[p9l7t958r315b1023],
2	If	IN	O	if	dep	5	SENT_142	[p9l365t965r417b1022],
3	this	DT	O	this	det	4	SENT_142	[p9l462t965r587b1023],
4	drug	NN	O	drug	nsubj	9	SENT_142	[p9l638t965r794b1041],
5	had	VBD	O	have	advcl	16	SENT_142	[p9l842t965r971b1023],
6	good	JJ	O	good	amod	7	SENT_142	[p9l1019t965r1189b1041],
7	efficacy	NN	O	efficacy	dobj	5	SENT_142	[p9l1239t965r1497b1041],
8	and	CC	O	and	_	0	SENT_142	[p9l1545t965r1672b1023],
9	reached	VBD	O	reach	conj_and	5	SENT_142	[p9l1722t965r1988b1023],
10	the	DT	O	the	det	11	SENT_142	[p9l2036t965r2146b1023],
11	marketplace	NN	O	marketplace	dobj	9	SENT_142	[p9l10t1061r441b1137],
12	,	,	O	,	_	0	SENT_142	[p9l10t1061r441b1137],
13	one	CD	NUMBER	one	nsubj	16	SENT_142	[p9l505t1078r630b1119],
14	would	MD	O	would	aux	16	SENT_142	[p9l687t1061r902b1119],
15	be	VB	O	be	cop	16	SENT_142	[p9l958t1061r1037b1119],
16	able	JJ	O	able	_	0	SENT_142	[p9l1097t1061r1232b1119],
17	to	TO	O	to	aux	18	SENT_142	[p9l1291t1068r1359b1119],
18	identify	VB	O	identify	xcomp	16	SENT_142	[p9l1418t1061r1685b1137],
19	the	DT	O	the	det	22	SENT_142	[p9l1741t1061r1850b1119],
20	benign	JJ	O	benign	amod	22	SENT_142	[p9l1907t1061r2147b1137],
21	hyperbilirubinemic	JJ	O	hyperbilirubinemic	amod	22	SENT_142	[p9l10t1156r670b1232],
22	condition	NN	O	condition	dobj	18	SENT_142	[p9l707t1156r1042b1214],
23	by	IN	O	by	_	0	SENT_142	[p9l1077t1156r1163b1232],
24	monitoring	VBG	O	monitor	prepc_by	18	SENT_142	[p9l1198t1159r1592b1232],
25	bilirubin	NN	O	bilirubin	nn	26	SENT_142	[p9l1626t1156r1923b1214],
26	levels	NNS	O	level	dobj	24	SENT_142	[p9l1960t1156r2146b1214],
27	both	CC	O	both	preconj	28	SENT_142	[p9l8t1250r170b1308],
28	before	IN	O	before	prep	24	SENT_142	[p9l202t1250r413b1308],
29	and	CC	O	and	_	0	SENT_142	[p9l449t1250r577b1308],
30	during	IN	O	during	conj_and	28	SENT_142	[p9l612t1250r839b1326],
31	the	DT	O	the	det	32	SENT_142	[p9l871t1251r981b1308],
32	course	NN	O	course	pobj	30	SENT_142	[p9l1017t1267r1232b1308],
33	of	IN	O	of	_	0	SENT_142	[p9l1268t1250r1338b1308],
34	the	DT	O	the	det	35	SENT_142	[p9l1367t1250r1477b1308],
35	medicine	NN	O	medicine	prep_of	32	SENT_142	[p9l1512t1250r1845b1308],
36	.	.	O	.	_	0	SENT_142	[p9l1512t1250r1845b1308],

1	Genetic	JJ	O	genetic	amod	2	SENT_143	[p9l1885t1252r2148b1308],
2	testing	NN	O	testing	nsubj	10	SENT_143	[p9l9t1349r240b1422],
3	of	IN	O	of	_	0	SENT_143	[p9l265t1346r334b1404],
4	DNA	NN	O	dna	nn	5	SENT_143	[p9l356t1347r522b1403],
5	samples	NNS	O	sample	prep_of	2	SENT_143	[p9l548t1346r814b1422],
6	would	MD	O	would	aux	10	SENT_143	[p9l839t1346r1054b1404],
7	not	RB	O	not	neg	10	SENT_143	[p9l1078t1353r1196b1404],
8	have	VB	O	have	aux	10	SENT_143	[p9l1221t1346r1382b1404],
9	been	VBN	O	be	cop	10	SENT_143	[p9l1405t1346r1570b1404],
10	necessary	JJ	O	necessary	_	0	SENT_143	[p9l1596t1363r1921b1422],
11	in	IN	O	in	_	0	SENT_143	[p9l1942t1349r2011b1403],
12	the	DT	O	the	det	13	SENT_143	[p9l2036t1346r2146b1404],
13	management	NN	O	management	prep_in	10	SENT_143	[p9l10t1448r462b1516],
14	of	IN	O	of	_	0	SENT_143	[p9l490t1440r560b1498],
15	this	DT	O	this	det	18	SENT_143	[p9l583t1440r708b1498],
16	mild	JJ	O	mild	amod	18	SENT_143	[p9l737t1440r895b1498],
17	adverse	JJ	O	adverse	amod	18	SENT_143	[p9l923t1441r1173b1498],
18	effect	NN	O	effect	prep_of	13	SENT_143	[p9l1202t1440r1401b1498],
19	.	.	O	.	_	0	SENT_143	[p9l1202t1440r1401b1498],

1	In	IN	O	in	_	0	SENT_144	[p9l87t1538r157b1593],
2	summary	NN	O	summary	prep_in	7	SENT_144	[p9l205t1552r529b1611],
3	,	,	O	,	_	0	SENT_144	[p9l205t1552r529b1611],
4	our	PRP$	O	we	poss	5	SENT_144	[p9l581t1552r695b1593],
5	study	NN	O	study	nsubj	7	SENT_144	[p9l741t1536r924b1611],
6	clearly	RB	O	clearly	advmod	7	SENT_144	[p9l968t1536r1186b1611],
7	demonstrates	VBZ	O	demonstrate	_	0	SENT_144	[p9l1230t1536r1678b1593],
8	that	IN	O	that	complm	14	SENT_144	[p9l1725t1536r1861b1593],
9	genetic	JJ	O	genetic	amod	10	SENT_144	[p9l1906t1539r2147b1611],
10	variation	NN	O	variation	nsubjpass	14	SENT_144	[p9l7t1633r309b1687],
11	in	IN	O	in	_	0	SENT_144	[p9l351t1633r419b1686],
12	UGT1/l1	NN	O	ugt1/l1	prep_in	10	SENT_144	[p9l465t1632r737b1687],
13	is	VBZ	O	be	auxpass	14	SENT_144	[p9l785t1633r833b1687],
14	associated	VBN	O	associate	ccomp	7	SENT_144	[p9l876t1630r1211b1687],
15	with	IN	O	with	_	0	SENT_144	[p9l1251t1630r1405b1687],
16	an	DT	O	a	det	18	SENT_144	[p9l1448t1647r1530b1687],
17	increased	VBN	O	increase	amod	18	SENT_144	[p9l1571t1630r1883b1687],
18	risk	NN	O	risk	prep_with	14	SENT_144	[p9l1924t1630r2042b1687],
19	of	IN	O	of	_	0	SENT_144	[p9l2082t1630r2151b1687],
20	tranilast-induced	JJ	O	tranilast-induced	amod	21	SENT_144	[p9l9t1725r578b1782],
21	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	18	SENT_144	[p9l632t1725r1297b1800],
22	.	.	O	.	_	0	SENT_144	[p9l632t1725r1297b1800],

1	This	DT	O	this	det	3	SENT_145	[p9l1354t1725r1496b1782],
2	genetic	JJ	O	genetic	amod	3	SENT_145	[p9l1552t1728r1793b1800],
3	variation	NN	O	variation	nsubj	4	SENT_145	[p9l1845t1728r2147b1782],
4	predisposes	VBZ	O	predispose	_	0	SENT_145	[p9l9t1820r389b1895],
5	individuals	NNS	O	individual	dobj	4	SENT_145	[p9l431t1820r801b1877],
6	to	TO	O	to	_	0	SENT_145	[p9l843t1827r910b1877],
7	a	DT	O	a	det	9	SENT_145	[p9l953t1836r988b1877],
8	benign	JJ	O	benign	amod	9	SENT_145	[p9l1026t1820r1261b1895],
9	condition	NN	O	condition	prep_to	4	SENT_145	[p9l1302t1820r1646b1890],
10	,	,	O	,	_	0	SENT_145	[p9l1302t1820r1646b1890],
11	Gilbert	NNP	PERSON	Gilbert	poss	13	SENT_145	[p9l1693t1820r1966b1877],
12	's	POS	O	's	_	0	SENT_145	[p9l1693t1820r1966b1877],
13	syndrome	NN	O	syndrome	appos	9	SENT_145	[p9l2010t1836r2145b1895, p9l10t1915r244b1973],
14	.	.	O	.	_	0	SENT_145	[p9l2010t1836r2145b1895, p9l10t1915r244b1973],

1	The	DT	O	the	det	2	SENT_146	[p9l276t1915r403b1973],
2	administration	NN	O	administration	nsubj	5	SENT_146	[p9l434t1915r931b1973],
3	of	IN	O	of	_	0	SENT_146	[p9l961t1915r1030b1973],
4	tranilast	NN	O	tranilast	prep_of	2	SENT_146	[p9l1054t1915r1326b1973],
5	unmasked	VBD	O	unmask	_	0	SENT_146	[p9l1353t1915r1701b1973],
6	the	DT	O	the	det	8	SENT_146	[p9l1729t1915r1837b1973],
7	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	8	SENT_146	[p9l1866t1915r2146b1991, p9l10t2010r400b2068],
8	condition	NN	O	condition	dobj	5	SENT_146	[p9l420t2010r749b2068],
9	in	IN	O	in	_	0	SENT_146	[p9l769t2013r837b2067],
10	these	DT	O	these	det	11	SENT_146	[p9l857t2010r1030b2068],
11	patients	NNS	O	patient	prep_in	5	SENT_146	[p9l1050t2013r1332b2086],
12	.	.	O	.	_	0	SENT_146	[p9l1050t2013r1332b2086],

1	The	DT	O	the	det	3	SENT_147	[p9l1354t2010r1483b2068],
2	rapid	JJ	O	rapid	amod	3	SENT_147	[p9l1503t2010r1675b2086],
3	identiﬁcation	NN	O	identiﬁcation	nsubj	15	SENT_147	[p9l1695t2010r2147b2068],
4	of	IN	O	of	_	0	SENT_147	[p9l10t2105r80b2163],
5	genetic	JJ	O	genetic	amod	7	SENT_147	[p9l123t2108r364b2181],
6	risk	NN	O	risk	nn	7	SENT_147	[p9l411t2105r529b2163],
7	factors	NNS	O	factor	prep_of	3	SENT_147	[p9l575t2105r794b2163],
8	during	IN	O	during	_	0	SENT_147	[p9l844t2105r1067b2181],
9	the	DT	O	the	det	10	SENT_147	[p9l1113t2105r1221b2163],
10	course	NN	O	course	prep_during	7	SENT_147	[p9l1271t2122r1482b2163],
11	of	IN	O	of	_	0	SENT_147	[p9l1532t2105r1601b2163],
12	a	DT	O	a	det	14	SENT_147	[p9l1645t2122r1680b2163],
13	clinical	JJ	O	clinical	amod	14	SENT_147	[p9l1728t2105r1967b2163],
14	trial	NN	O	trial	prep_of	10	SENT_147	[p9l2015t2105r2146b2163],
15	demonstrated	VBD	O	demonstrate	_	0	SENT_147	[p9l10t2199r475b2257],
16	the	DT	O	the	det	17	SENT_147	[p9l550t2199r658b2257],
17	power	NN	O	power	dobj	15	SENT_147	[p9l734t2216r943b2275],
18	and	CC	O	and	_	0	SENT_147	[p9l1019t2199r1145b2257],
19	potential	JJ	O	potential	amod	20	SENT_147	[p9l1220t2200r1523b2275],
20	applications	NNS	O	application	conj_and	17	SENT_147	[p9l1600t2199r2004b2275],
21	of	IN	O	of	_	0	SENT_147	[p9l2081t2199r2150b2257],
22	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	17	SENT_147	[p9l9t2295r618b2371],
23	in	IN	O	in	_	0	SENT_147	[p9l646t2298r714b2352],
24	future	JJ	DATE	future	amod	25	SENT_147	[p9l742t2295r942b2353],
25	development	NN	O	development	prep_in	15	SENT_147	[p9l970t2295r1413b2371],
26	of	IN	O	of	_	0	SENT_147	[p9l1441t2295r1510b2353],
27	safer	JJR	O	safer	amod	28	SENT_147	[p9l1535t2295r1685b2353],
28	medicines	NNS	O	medicine	prep_of	25	SENT_147	[p9l1711t2295r2066b2353],
29	.	.	O	.	_	0	SENT_147	[p9l1711t2295r2066b2353],

1	MATERIALS	NNS	O	material	nsubjpass	10	SENT_148	[p9l12t2525r444b2580],
2	AND	CC	O	and	_	0	SENT_148	[p9l472t2525r640b2579],
3	METHODS	NNS	O	method	nn	4	SENT_148	[p9l673t2525r1049b2580],
4	Samples	NNS	O	sample	conj_and	1	SENT_148	[p9l12t2615r302b2691],
5	Appropriate	JJ	O	appropriate	amod	8	SENT_148	[p9l8t2712r430b2786],
6	ethical	JJ	O	ethical	amod	8	SENT_148	[p9l471t2711r707b2768],
7	committee/IRB	NN	O	committee/irb	nn	8	SENT_148	[p9l748t2710r1279b2776],
8	approval	NN	O	approval	dep	1	SENT_148	[p9l1322t2711r1628b2786],
9	was	VBD	O	be	auxpass	10	SENT_148	[p9l1666t2727r1794b2768],
10	obtained	VBN	O	obtain	_	0	SENT_148	[p9l1835t2711r2147b2768],
11	to	TO	O	to	aux	12	SENT_148	[p9l9t2813r79b2864],
12	collect	VB	O	collect	xcomp	10	SENT_148	[p9l122t2806r353b2864],
13	blood	NN	O	blood	nn	14	SENT_148	[p9l393t2806r596b2864],
14	samples	NNS	O	sample	dobj	12	SENT_148	[p9l640t2806r915b2882],
15	prospectively	RB	O	prospectively	advmod	12	SENT_148	[p9l958t2806r1430b2882],
16	for	IN	O	for	_	0	SENT_148	[p9l1469t2806r1568b2864],
17	genetic	JJ	O	genetic	amod	18	SENT_148	[p9l1608t2809r1863b2882],
18	studies	NNS	O	study	prep_for	12	SENT_148	[p9l1906t2806r2146b2864],

1	The	DT	O	the	det	3	SENT_149	[p9l8t3074r103b3119],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_149	[p9l130t3074r640b3133],
3	Journal	NNP	O	Journal	_	0	SENT_149	[p9l663t3074r842b3130],
4	from	IN	O	from	_	0	SENT_149	[p9l9t3286r179b3344],
5	individuals	NNS	O	individual	prep_from	3	SENT_149	[p9l241t3286r634b3344],
6	participating	VBG	O	participate	partmod	5	SENT_149	[p9l697t3289r1154b3362],
7	in	IN	O	in	_	0	SENT_149	[p9l1214t3289r1285b3343],
8	PRESTO	NNP	LOCATION	PRESTO	prep_in	6	SENT_149	[p9l1348t3288r1644b3356],
9	,	,	O	,	_	0	SENT_149	[p9l1348t3288r1644b3356],
10	a	DT	O	a	det	11	SENT_149	[p9l1712t3303r1747b3344],
11	phase	NN	O	phase	appos	8	SENT_149	[p9l1808t3286r2009b3362],
12	III	CD	NUMBER	iii	number	13	SENT_149	[p9l2073t3289r2148b3343],
13	double-blind	JJ	O	double-blind	amod	3	SENT_149	[p9l10t3379r483b3449],
14	,	,	O	,	_	0	SENT_149	[p9l10t3379r483b3449],
15	placebo	NN	O	placebo	nn	16	SENT_149	[p9l524t3379r1191b3455],
16	—	NN	O	—	nsubjpass	31	SENT_149	[p9l524t3379r1191b3455],
17	controlled	VBN	O	control	partmod	16	SENT_149	[p9l524t3379r1191b3455],
18	clinical	JJ	O	clinical	amod	19	SENT_149	[p9l1229t3379r1484b3437],
19	trial	NN	O	trial	dobj	17	SENT_149	[p9l1521t3379r1662b3437],
20	of	IN	O	of	_	0	SENT_149	[p9l1700t3379r1771b3437],
21	tranilast	NN	O	tranilast	nn	22	SENT_149	[p9l1804t3372r2148b3437],
22	.3	NN	NUMBER	.3	prep_of	19	SENT_149	[p9l1804t3372r2148b3437],
23	Written	VBN	O	write	partmod	22	SENT_149	[p9l8t3477r281b3532],
24	informed	JJ	O	informed	amod	25	SENT_149	[p9l316t3474r645b3532],
25	consent	NN	O	consent	dobj	23	SENT_149	[p9l681t3482r958b3532],
26	to	TO	O	to	aux	27	SENT_149	[p9l994t3482r1064b3532],
27	perform	VB	O	perform	xcomp	23	SENT_149	[p9l1099t3474r1384b3550],
28	genetic	JJ	O	genetic	amod	29	SENT_149	[p9l1420t3477r1674b3550],
29	analysis	NN	O	analysis	dobj	27	SENT_149	[p9l1711t3474r1986b3550],
30	was	VBD	O	be	auxpass	31	SENT_149	[p9l2021t3491r2148b3532],
31	obtained	VBN	O	obtain	dep	3	SENT_149	[p9l10t3568r323b3625],
32	from	IN	O	from	_	0	SENT_149	[p9l361t3568r531b3625],
33	1042	CD	NUMBER	1042	num	34	SENT_149	[p9l577t3570r742b3625],
34	Caucasians	NNS	MISC	caucasian	prep_from	31	SENT_149	[p9l784t3570r1172b3625],
35	in	IN	O	in	_	0	SENT_149	[p9l1212t3571r1282b3625],
36	the	DT	O	the	det	38	SENT_149	[p9l1322t3568r1434b3625],
37	United	NNP	LOCATION	United	nn	38	SENT_149	[p9l1474t3568r1718b3625],
38	States	NNPS	LOCATION	States	prep_in	34	SENT_149	[p9l1758t3570r1956b3625],
39	who	WP	O	who	nsubj	41	SENT_149	[p9l1995t3568r2148b3625],
40	had	VBD	O	have	aux	41	SENT_149	[p10l9t26r141b84],
41	undergone	VBN	O	undergo	rcmod	34	SENT_149	[p10l200t26r583b102],
42	PTCR	NN	ORGANIZATION	ptcr	dobj	41	SENT_149	[p10l646t28r839b84],
43	for	IN	O	for	_	0	SENT_149	[p10l898t26r996b84],
44	treatment	NN	O	treatment	prep_for	41	SENT_149	[p10l1056t33r1406b84],
45	of	IN	O	of	_	0	SENT_149	[p10l1468t26r1539b84],
46	ischemic	JJ	O	ischemic	amod	48	SENT_149	[p10l1595t26r1906b84],
47	heart	NN	O	heart	nn	48	SENT_149	[p10l1967t26r2149b84],
48	disease	NN	O	disease	prep_of	44	SENT_149	[p10l10t121r271b178],
49	.	.	O	.	_	0	SENT_149	[p10l10t121r271b178],

1	G1aXoSmithKline	NN	O	g1axosmithkline	nsubj	4	SENT_150	[p10l324t121r931b178],
2	Clinical	JJ	O	clinical	amod	3	SENT_150	[p10l980t121r1253b178],
3	Laboratories	NNPS	O	Laboratories	dep	1	SENT_150	[p10l1301t121r1734b178],
4	performed	VBD	O	perform	_	0	SENT_150	[p10l1780t120r2149b196],
5	all	DT	O	all	det	7	SENT_150	[p10l10t216r92b274],
6	clinical	JJ	O	clinical	amod	7	SENT_150	[p10l123t216r378b274],
7	testing	NN	O	testing	dobj	4	SENT_150	[p10l409t219r666b292],
8	.	.	O	.	_	0	SENT_150	[p10l409t219r666b292],

1	The	DT	O	the	det	4	SENT_151	[p10l699t216r831b274],
2	total	JJ	O	total	amod	4	SENT_151	[p10l863t216r1025b274],
3	bilirubin	NN	O	bilirubin	nn	4	SENT_151	[p10l1053t216r1363b274],
4	levels	NNS	O	level	nsubjpass	6	SENT_151	[p10l1393t216r1587b274],
5	were	VBD	O	be	auxpass	6	SENT_151	[p10l1616t233r1780b274],
6	measured	VBN	O	measure	conj_and	6	SENT_151	[p10l1811t216r2150b274],
7	before	IN	O	before	_	0	SENT_151	[p10l7t310r227b367],
8	and	CC	O	and	_	0	SENT_151	[p10l253t310r384b367],
9	after	IN	O	after	_	0	SENT_151	[p10l409t310r567b367],
10	tranilast	NN	O	tranilast	nn	11	SENT_151	[p10l590t310r880b367],
11	treatment	NN	O	treatment	prep_after	6	SENT_151	[p10l904t317r1255b367],
12	for	IN	O	for	_	0	SENT_151	[p10l1279t310r1377b367],
13	either	CC	O	either	preconj	14	SENT_151	[p10l1401t310r1606b367],
14	1	CD	NUMBER	1	prep_for	6	SENT_151	[p10l1635t312r1664b366],
15	or	CC	O	or	_	0	SENT_151	[p10l1694t327r1766b367],
16	3	CD	DURATION	3	num	17	SENT_151	[p10l1790t312r1825b367],
17	months	NNS	NUMBER	month	conj_or	14	SENT_151	[p10l1853t310r2145b367],
18	.	.	O	.	_	0	SENT_151	[p10l1853t310r2145b367],

1	DNA	NN	O	dna	nsubjpass	3	SENT_152	[p10l10t406r179b462],
2	was	VBD	O	be	auxpass	3	SENT_152	[p10l217t421r344b462],
3	extracted	VBN	O	extract	_	0	SENT_152	[p10l388t405r713b462],
4	using	VBG	O	use	xcomp	3	SENT_152	[p10l754t408r946b480],
5	a	DT	O	a	det	8	SENT_152	[p10l987t421r1022b462],
6	Nucleon	NN	O	nucleon	nn	8	SENT_152	[p10l1062t405r1362b462],
7	DNA	NN	O	dna	nn	8	SENT_152	[p10l1405t406r1574b462],
8	extraction	NN	O	extraction	dobj	4	SENT_152	[p10l1615t408r1976b462],
9	and	CC	O	and	_	0	SENT_152	[p10l2019t405r2149b462],
10	purification	NN	O	purification	nn	11	SENT_152	[p10l9t500r427b576],
11	kit	NN	O	kit	dobj	4	SENT_152	[p10l457t500r548b558],
12	(	CD	NUMBER	(	dep	8	SENT_152	[p10l581t500r839b576],
13	Tepnel	NNP	ORGANIZATION	Tepnel	nn	18	SENT_152	[p10l581t500r839b576],
14	Life	NNP	ORGANIZATION	Life	nn	18	SENT_152	[p10l870t500r996b558],
15	Sciences	NNPS	ORGANIZATION	Sciences	nn	18	SENT_152	[p10l1028t502r1335b571],
16	,	,	O	,	_	0	SENT_152	[p10l1028t502r1335b571],
17	UK	NNP	LOCATION	UK	dep	18	SENT_152	[p10l1370t500r1522b572],
18	)	NNP	O	)	dep	12	SENT_152	[p10l1370t500r1522b572],
19	.	.	O	.	_	0	SENT_152	[p10l1370t500r1522b572],

1	Mild	JJ	O	mild	amod	2	SENT_153	[p10l85t595r250b653],
2	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubjpass	4	SENT_153	[p10l300t595r989b671],
3	was	VBD	O	be	auxpass	4	SENT_153	[p10l1038t612r1166b653],
4	defined	VBN	O	define	_	0	SENT_153	[p10l1218t595r1483b653],
5	quantitatively	RB	O	quantitatively	advmod	4	SENT_153	[p10l1535t595r2035b671],
6	as	IN	O	as	_	0	SENT_153	[p10l2084t612r2148b653],
7	total	JJ	O	total	amod	10	SENT_153	[p10l9t690r171b748],
8	serum	NN	O	serum	nn	10	SENT_153	[p10l218t707r431b748],
9	bilirubin	NN	O	bilirubin	nn	10	SENT_153	[p10l474t690r784b748],
10	levels	NNS	O	level	prep_as	4	SENT_153	[p10l830t690r1023b748],
11	greater	JJR	O	greater	mwe	12	SENT_153	[p10l1069t697r1311b766],
12	than	IN	O	than	quantmod	13	SENT_153	[p10l1355t690r1520b748],
13	2.00	CD	NUMBER	2.00	num	14	SENT_153	[p10l1566t691r1715b748],
14	mg/dl	NN	O	mg/dl	dep	4	SENT_153	[p10l1732t690r1959b766],
15	.	.	O	.	_	0	SENT_153	[p10l1732t690r1959b766],

1	Five	CD	NUMBER	five	num	2	SENT_154	[p10l2009t692r2148b748],
2	individuals	NNS	O	individual	nsubj	3	SENT_154	[p10l9t784r402b842],
3	(	VBP	O	(	dep	21	SENT_154	[p10l450t785r672b857],
4	0.5	CD	PERCENT	0.5	number	5	SENT_154	[p10l450t785r672b857],
5	%	NN	PERCENT	%	amod	7	SENT_154	[p10l450t785r672b857],
6	)	CD	NUMBER	)	num	7	SENT_154	[p10l450t785r672b857],
7	preadministration	NN	O	preadministration	nsubj	16	SENT_154	[p10l718t784r1361b860],
8	of	IN	O	of	_	0	SENT_154	[p10l1405t784r1476b842],
9	tranilast	NN	O	tranilast	prep_of	7	SENT_154	[p10l1514t784r1805b842],
10	and	CC	O	and	_	0	SENT_154	[p10l1848t784r1980b842],
11	127	CD	PERCENT	127	number	12	SENT_154	[p10l2028t786r2148b841],
12	(	CD	PERCENT	(	conj_and	7	SENT_154	[p10l13t880r213b951],
13	12	CD	PERCENT	12	num	14	SENT_154	[p10l13t880r213b951],
14	%	NN	PERCENT	%	dep	12	SENT_154	[p10l13t880r213b951],
15	)	CD	NUMBER	)	num	16	SENT_154	[p10l13t880r213b951],
16	individuals	NNS	O	individual	xcomp	3	SENT_154	[p10l247t879r640b937],
17	following	VBG	O	follow	_	0	SENT_154	[p10l672t879r1010b955],
18	administration	NN	O	administration	prep_following	16	SENT_154	[p10l1040t879r1568b937],
19	of	IN	O	of	_	0	SENT_154	[p10l1599t879r1671b937],
20	tranilast	NN	O	tranilast	prep_of	18	SENT_154	[p10l1697t880r1988b937],
21	had	VBD	O	have	_	0	SENT_154	[p10l2018t879r2150b937],
22	bilirubin	NN	O	bilirubin	nn	23	SENT_154	[p10l7t975r317b1033],
23	levels	NNS	O	level	dobj	21	SENT_154	[p10l356t975r549b1033],
24	greater	JJR	O	greater	dep	25	SENT_154	[p10l589t982r831b1051],
25	than	IN	O	than	advmod	21	SENT_154	[p10l869t975r1034b1033],
26	2.00	CD	NUMBER	2.00	num	27	SENT_154	[p10l1074t977r1223b1033],
27	mg/dl	NN	O	mg/dl	nsubj	21	SENT_154	[p10l1239t975r1467b1051],
28	.	.	O	.	_	0	SENT_154	[p10l1239t975r1467b1051],

1	These	DT	O	these	det	3	SENT_155	[p10l1508t975r1710b1033],
2	127	CD	NUMBER	127	num	3	SENT_155	[p10l1756t977r1876b1032],
3	individuals	NNS	O	individual	nsubjpass	5	SENT_155	[p10l1917t975r2148b1033, p10l10t1070r192b1127],
4	were	VBD	O	be	auxpass	5	SENT_155	[p10l218t1086r381b1127],
5	defined	VBN	O	define	_	0	SENT_155	[p10l410t1069r675b1127],
6	as	IN	O	as	_	0	SENT_155	[p10l704t1086r768b1127],
7	cases	NNS	O	case	prep_as	5	SENT_155	[p10l797t1086r968b1127],
8	in	IN	O	in	_	0	SENT_155	[p10l997t1073r1067b1127],
9	this	DT	O	this	det	10	SENT_155	[p10l1094t1070r1223b1127],
10	study	NN	O	study	prep_in	7	SENT_155	[p10l1253t1070r1455b1145],
11	.	.	O	.	_	0	SENT_155	[p10l1253t1070r1455b1145],

1	Controls	NNP	O	Controls	nsubj	2	SENT_156	[p10l1488t1070r1793b1127],
2	consisted	VBD	O	consist	_	0	SENT_156	[p10l1822t1070r2150b1127],
3	of	IN	O	of	_	0	SENT_156	[p10l10t1165r81b1223],
4	the	DT	O	the	det	7	SENT_156	[p10l112t1165r224b1223],
5	remaining	VBG	O	remain	amod	7	SENT_156	[p10l261t1168r627b1241],
6	909	CD	NUMBER	909	num	7	SENT_156	[p10l662t1167r786b1223],
7	subjects	NNS	O	subject	prep_of	2	SENT_156	[p10l825t1165r1119b1241],
8	,	,	O	,	_	0	SENT_156	[p10l825t1165r1119b1241],
9	whose	WP$	O	whose	dep	14	SENT_156	[p10l1158t1165r1380b1223],
10	total	JJ	O	total	amod	12	SENT_156	[p10l1416t1165r1577b1223],
11	bilirubin	NN	O	bilirubin	nn	12	SENT_156	[p10l1611t1165r1921b1223],
12	levels	NNS	O	level	nsubj	14	SENT_156	[p10l1955t1165r2149b1223],
13	were	VBD	O	be	cop	14	SENT_156	[p10l8t1277r171b1318],
14	equal	JJ	O	equal	dep	7	SENT_156	[p10l203t1260r392b1336],
15	to	TO	O	to	_	0	SENT_156	[p10l423t1267r492b1318],
16	or	CC	O	or	cc	17	SENT_156	[p10l524t1277r595b1318],
17	less	JJR	O	less	prep_to	14	SENT_156	[p10l624t1260r744b1318],
18	than	IN	O	than	_	0	SENT_156	[p10l774t1260r939b1318],
19	2.00	CD	NUMBER	2.00	num	20	SENT_156	[p10l970t1262r1119b1318],
20	mg/dl	NN	O	mg/dl	prep_than	14	SENT_156	[p10l1136t1260r1346b1336],
21	following	VBG	O	follow	_	0	SENT_156	[p10l1376t1260r1715b1336],
22	administration	NN	O	administration	prep_following	20	SENT_156	[p10l1744t1260r2148b1318, p10l9t1358r154b1412],
23	of	IN	O	of	_	0	SENT_156	[p10l180t1354r252b1412],
24	tranilast	NN	O	tranilast	prep_of	22	SENT_156	[p10l273t1355r582b1412],
25	.	.	O	.	_	0	SENT_156	[p10l273t1355r582b1412],

1	A	DT	O	a	det	6	SENT_157	[p10l611t1356r662b1412],
2	‘	JJ	O	‘	amod	6	SENT_157	[p10l690t1355r899b1430],
3	super	JJ	O	super	amod	6	SENT_157	[p10l690t1355r899b1430],
4	control	NN	O	control	nn	6	SENT_157	[p10l923t1355r1198b1412],
5	’	CD	NUMBER	’	num	6	SENT_157	[p10l923t1355r1198b1412],
6	subset	NN	O	subset	nsubjpass	12	SENT_157	[p10l1225t1355r1441b1412],
7	of	IN	O	of	_	0	SENT_157	[p10l1467t1354r1538b1412],
8	541	CD	NUMBER	541	num	9	SENT_157	[p10l1562t1357r1682b1412],
9	patients	NNS	O	patient	prep_of	6	SENT_157	[p10l1713t1358r1996b1430],
10	was	VBD	O	be	auxpass	12	SENT_157	[p10l2021t1371r2148b1412],
11	also	RB	O	also	advmod	12	SENT_157	[p10l10t1450r144b1508],
12	defined	VBN	O	define	_	0	SENT_157	[p10l175t1450r457b1521],
13	,	,	O	,	_	0	SENT_157	[p10l175t1450r457b1521],
14	whose	WP$	O	whose	poss	15	SENT_157	[p10l490t1450r713b1508],
15	bilirubin	NN	O	bilirubin	nsubj	23	SENT_157	[p10l741t1450r1051b1508],
16	level	NN	O	level	dep	15	SENT_157	[p10l1080t1450r1243b1508],
17	was	VBD	O	be	cop	23	SENT_157	[p10l1271t1467r1399b1508],
18	less	JJR	O	less	mwe	19	SENT_157	[p10l1429t1450r1549b1508],
19	than	IN	O	than	quantmod	20	SENT_157	[p10l1579t1450r1743b1508],
20	1.00	CD	NUMBER	1.00	num	21	SENT_157	[p10l1779t1452r1923b1508],
21	mg/dl	NN	O	mg/dl	npadvmod	22	SENT_157	[p10l1940t1450r2149b1526],
22	post-tranilast	JJ	O	post-tranilast	amod	23	SENT_157	[p10l9t1545r477b1621],
23	administration	NN	O	administration	ccomp	12	SENT_157	[p10l507t1545r1053b1603],
24	.	.	O	.	_	0	SENT_157	[p10l507t1545r1053b1603],

1	Single-Nucleotide	NNP	O	Single-Nucleotide	nn	3	SENT_158	[p10l12t1758r642b1834],
2	Polymorphism	NN	O	polymorphism	nn	3	SENT_158	[p10l775t1758r1282b1834],
3	Identification	NN	O	identification	nsubjpass	38	SENT_158	[p10l1417t1758r1886b1816],
4	and	CC	O	and	_	0	SENT_158	[p10l2018t1758r2147b1816],
5	Genotyping	NN	O	genotyping	nsubjpass	38	SENT_158	[p10l11t1852r429b1927],
6	The	DT	O	the	det	12	SENT_158	[p10l7t1947r140b2005],
7	TA	NNP	O	TA	nn	12	SENT_158	[p10l192t1948r287b2004],
8	repeat	NN	O	repeat	nn	12	SENT_158	[p10l340t1954r556b2023],
9	polymorphism	NN	O	polymorphism	nn	12	SENT_158	[p10l608t1947r1134b2023],
10	(	NN	O	(	nn	12	SENT_158	[p10l1191t1947r1602b2019],
11	rs3064744	NN	O	rs3064744	nn	12	SENT_158	[p10l1191t1947r1602b2019],
12	)	NN	O	)	dep	5	SENT_158	[p10l1191t1947r1602b2019],
13	and	CC	O	and	_	0	SENT_158	[p10l1660t1947r1791b2005],
14	the	DT	O	the	det	19	SENT_158	[p10l1844t1947r1956b2005],
15	G/A	NN	O	g/a	nn	19	SENT_158	[p10l2012t1947r2150b2012],
16	substitution	NN	O	substitution	nn	19	SENT_158	[p10l11t2042r436b2100],
17	(	CD	NUMBER	(	num	19	SENT_158	[p10l488t2042r919b2114],
18	rs4148323	NN	O	rs4148323	nn	19	SENT_158	[p10l488t2042r919b2114],
19	)	NN	O	)	conj_and	3	SENT_158	[p10l488t2042r919b2114],
20	,	,	O	,	_	0	SENT_158	[p10l488t2042r919b2114],
21	which	WDT	O	which	nsubj	22	SENT_158	[p10l970t2042r1191b2100],
22	results	VBZ	O	result	rcmod	3	SENT_158	[p10l1239t2042r1464b2100],
23	in	IN	O	in	_	0	SENT_158	[p10l1513t2045r1583b2099],
24	the	DT	O	the	det	27	SENT_158	[p10l1631t2042r1743b2100],
25	GLY71Arg	NN	O	gly71arg	nn	27	SENT_158	[p10l1794t2044r2151b2118],
26	amino-acid	JJ	O	amino-acid	amod	27	SENT_158	[p10l10t2136r409b2194],
27	change	NN	O	change	prep_in	22	SENT_158	[p10l433t2137r684b2212],
28	within	IN	O	within	_	0	SENT_158	[p10l708t2136r943b2194],
29	exon	NN	O	exon	prep_within	27	SENT_158	[p10l968t2153r1141b2194],
30	1	CD	NUMBER	1	num	29	SENT_158	[p10l1170t2138r1199b2193],
31	of	IN	O	of	_	0	SENT_158	[p10l1229t2136r1301b2194],
32	UGT1/l1	NN	O	ugt1/l1	nn	35	SENT_158	[p10l1325t2138r1609b2194],
33	(	CD	NUMBER	(	num	35	SENT_158	[p10l1644t2137r2144b2209],
34	MlM191740	NN	O	mlm191740	nn	35	SENT_158	[p10l1644t2137r2144b2209],
35	)	NN	O	)	prep_of	29	SENT_158	[p10l1644t2137r2144b2209],
36	,	,	O	,	_	0	SENT_158	[p10l1644t2137r2144b2209],
37	were	VBD	O	be	auxpass	38	SENT_158	[p10l8t2250r171b2291],
38	genotyped	VBN	O	genotype	_	0	SENT_158	[p10l214t2233r605b2309],
39	.	.	O	.	_	0	SENT_158	[p10l214t2233r605b2309],

1	The	DT	O	the	det	4	SENT_159	[p10l649t2233r782b2291],
2	TA	NNP	O	TA	nn	4	SENT_159	[p10l823t2235r917b2290],
3	repeat	NN	O	repeat	nn	4	SENT_159	[p10l958t2240r1175b2309],
4	polymorphism	NN	O	polymorphism	nsubjpass	6	SENT_159	[p10l1215t2233r1742b2309],
5	was	VBD	O	be	auxpass	6	SENT_159	[p10l1782t2250r1910b2291],
6	genotyped	VBN	O	genotype	_	0	SENT_159	[p10l1952t2250r2148b2309, p10l9t2328r207b2404],
7	by	IN	O	by	_	0	SENT_159	[p10l263t2328r351b2404],
8	direct	JJ	O	direct	amod	9	SENT_159	[p10l406t2328r606b2386],
9	sequencing	NN	O	sequencing	agent	6	SENT_159	[p10l665t2331r1065b2404],
10	of	IN	O	of	_	0	SENT_159	[p10l1122t2328r1193b2386],
11	PCR	NN	O	pcr	nn	12	SENT_159	[p10l1247t2330r1393b2386],
12	products	NNS	O	product	prep_of	9	SENT_159	[p10l1449t2328r1775b2404],
13	.	.	O	.	_	0	SENT_159	[p10l1449t2328r1775b2404],

1	In	IN	O	in	_	0	SENT_160	[p10l1838t2331r1910b2385],
2	brief	NN	O	brief	prep_in	6	SENT_160	[p10l1966t2328r2144b2398],
3	,	,	O	,	_	0	SENT_160	[p10l1966t2328r2144b2398],
4	PCR	NN	O	pcr	nn	5	SENT_160	[p10l10t2423r156b2479],
5	primers	NNS	O	primer	nsubj	6	SENT_160	[p10l243t2425r509b2497],
6	(	VBP	O	(	_	0	SENT_160	[p10l603t2420r1927b2494],
7	5	CD	NUMBER	5	dobj	6	SENT_160	[p10l603t2420r1927b2494],
8	’	SYM	O	’	dep	11	SENT_160	[p10l603t2420r1927b2494],
9	-	:	O	-	_	0	SENT_160	[p10l603t2420r1927b2494],
10	GAGGTTCTGGAAGTACTITGC-3	NN	O	gaggttctggaagtactitgc-3	nn	11	SENT_160	[p10l603t2420r1927b2494],
11	’	NN	O	’	dep	6	SENT_160	[p10l603t2420r1927b2494],
12	and	CC	O	and	prep	11	SENT_160	[p10l2019t2422r2150b2479],
13	5	CD	NUMBER	5	dep	12	SENT_160	[p10l11t2514r1144b2588],
14	’	SYM	O	’	dep	16	SENT_160	[p10l11t2514r1144b2588],
15	-	:	O	-	_	0	SENT_160	[p10l11t2514r1144b2588],
16	CCAAGCATGCACACCAG-3	NN	O	ccaagcatgcacaccag-3	dep	13	SENT_160	[p10l11t2514r1144b2588],
17	’	CD	NUMBER	’	num	18	SENT_160	[p10l11t2514r1144b2588],
18	)	NN	O	)	nsubjpass	20	SENT_160	[p10l11t2514r1144b2588],
19	were	VBD	O	be	auxpass	20	SENT_160	[p10l1202t2533r1365b2574],
20	designed	VBN	O	design	rcmod	16	SENT_160	[p10l1423t2516r1734b2592],
21	using	VBG	O	use	xcomp	20	SENT_160	[p10l1789t2519r1981b2592],
22	the	DT	O	the	det	23	SENT_160	[p10l2036t2516r2148b2574],
23	sequence	NN	O	sequence	dobj	21	SENT_160	[p10l11t2627r331b2686],
24	of	IN	O	of	_	0	SENT_160	[p10l375t2610r446b2668],
25	UGT1A1	NN	O	ugt1a1	prep_of	23	SENT_160	[p10l489t2612r772b2668],
26	to	TO	O	to	aux	27	SENT_160	[p10l821t2618r890b2668],
27	amplify	VB	O	amplify	xcomp	21	SENT_160	[p10l933t2610r1205b2686],
28	a	DT	O	a	det	32	SENT_160	[p10l1245t2627r1280b2668],
29	423	CD	NUMBER	423	num	32	SENT_160	[p10l1322t2612r1446b2668],
30	bp	NN	O	bp	nn	32	SENT_160	[p10l1463t2610r1552b2686],
31	DNA	NN	MISC	dna	nn	32	SENT_160	[p10l1595t2612r1764b2667],
32	fragment	NN	O	fragment	dobj	27	SENT_160	[p10l1805t2610r2145b2686],
33	.	.	O	.	_	0	SENT_160	[p10l1805t2610r2145b2686],

1	PCR	NN	O	pcr	nn	2	SENT_161	[p10l10t2707r156b2764],
2	products	NNS	O	product	nsubjpass	22	SENT_161	[p10l189t2706r497b2782],
3	were	VBD	O	be	auxpass	4	SENT_161	[p10l531t2723r695b2764],
4	sequenced	VBN	O	sequence	_	0	SENT_161	[p10l733t2706r1101b2782],
5	using	VBG	O	use	xcomp	4	SENT_161	[p10l1134t2709r1327b2782],
6	the	DT	O	the	det	13	SENT_161	[p10l1361t2706r1474b2764],
7	ABI	NNP	MISC	ABI	nn	13	SENT_161	[p10l1508t2707r1632b2763],
8	Prism	NNP	MISC	Prism	nn	13	SENT_161	[p10l1669t2708r1865b2764],
9	BigDye	NNP	MISC	BigDye	nn	13	SENT_161	[p10l1901t2708r2148b2782],
10	Terminator	NNP	MISC	Terminator	nn	13	SENT_161	[p10l8t2803r406b2858],
11	cycle	NN	O	cycle	nn	13	SENT_161	[p10l453t2800r627b2876],
12	sequencing	NN	O	sequencing	nn	13	SENT_161	[p10l677t2803r1077b2876],
13	chemistry	NN	O	chemistry	dobj	5	SENT_161	[p10l1124t2801r1478b2876],
14	according	VBG	O	accord	_	0	SENT_161	[p10l1524t2800r1871b2876],
15	to	TO	O	to	prepc_according_to	5	SENT_161	[p10l1918t2808r1987b2858],
16	the	DT	O	the	det	17	SENT_161	[p10l2036t2800r2148b2858],
17	manufacturer	NN	O	manufacturer	poss	19	SENT_161	[p10l9t2896r538b2954],
18	's	POS	O	's	_	0	SENT_161	[p10l9t2896r538b2954],
19	instructions	NNS	O	instruction	pobj	5	SENT_161	[p10l575t2899r1016b2966],
20	,	,	O	,	_	0	SENT_161	[p10l575t2899r1016b2966],
21	and	CC	O	and	_	0	SENT_161	[p10l1057t2896r1188b2954],
22	analyzed	VBN	O	analyze	conj_and	4	SENT_161	[p10l1224t2896r1535b2972],
23	on	IN	O	on	_	0	SENT_161	[p10l1571t2913r1662b2954],
24	an	DT	O	a	det	28	SENT_161	[p10l1699t2913r1783b2954],
25	ABI	NNP	O	ABI	nn	28	SENT_161	[p10l1818t2898r1941b2953],
26	3700	CD	NUMBER	3700	num	28	SENT_161	[p10l1979t2898r2149b2954],
27	capillary	JJ	O	capillary	amod	28	SENT_161	[p10l10t2991r314b3067],
28	sequencer	NN	O	sequencer	prep_on	22	SENT_161	[p10l376t3008r739b3067],
29	.	.	O	.	_	0	SENT_161	[p10l376t3008r739b3067],

1	The	DT	O	the	det	3	SENT_162	[p10l804t2991r937b3049],
2	resultant	JJ	O	resultant	amod	3	SENT_162	[p10l1000t2991r1313b3049],
3	forward	RB	O	forward	nsubjpass	18	SENT_162	[p10l1376t2991r1650b3049],
4	and	CC	O	and	_	0	SENT_162	[p10l1712t2991r1844b3049],
5	reverse	VB	O	reverse	conj_and	3	SENT_162	[p10l1906t3008r2149b3049],
6	sequence	NN	O	sequence	nn	8	SENT_162	[p10l11t3102r331b3161],
7	trace	NN	O	trace	nn	8	SENT_162	[p10l375t3093r543b3143],
8	files	NNS	O	file	nsubjpass	11	SENT_162	[p10l587t3085r726b3143],
9	were	VBD	O	be	auxpass	11	SENT_162	[p10l768t3102r932b3143],
10	independently	RB	O	independently	advmod	11	SENT_162	[p10l976t3086r1498b3161],
11	analyzed	VBN	O	analyze	ccomp	5	SENT_162	[p10l1539t3086r1850b3161],
12	by	IN	O	by	_	0	SENT_162	[p10l1890t3086r1978b3161],
13	two	CD	NUMBER	two	num	14	SENT_162	[p10l2018t3093r2149b3143],
14	individuals	NNS	O	individual	agent	11	SENT_162	[p10l9t3182r402b3240],
15	and	CC	O	and	_	0	SENT_162	[p10l446t3182r577b3240],
16	genotypes	NNS	O	genotype	conj_and	3	SENT_162	[p10l620t3189r977b3258],
17	were	VBD	O	be	auxpass	18	SENT_162	[p10l1018t3199r1182b3240],
18	assigned	VBN	O	assign	_	0	SENT_162	[p10l1225t3182r1522b3258],
19	to	TO	O	to	_	0	SENT_162	[p10l1564t3189r1634b3240],
20	each	DT	O	each	det	21	SENT_162	[p10l1677t3182r1838b3240],
21	sample	NN	O	sample	prep_to	18	SENT_162	[p10l1881t3182r2145b3258],
22	.	.	O	.	_	0	SENT_162	[p10l1881t3182r2145b3258],

1	The	DT	O	the	det	6	SENT_163	[p10l8t3277r140b3335],
2	G/A	NN	O	g/a	nn	6	SENT_163	[p10l184t3277r323b3342],
3	substitution	NN	O	substitution	nn	6	SENT_163	[p10l365t3277r790b3335],
4	(	CD	NUMBER	(	num	6	SENT_163	[p10l835t3278r1246b3349],
5	rs4148323	NN	O	rs4148323	nn	6	SENT_163	[p10l835t3278r1246b3349],
6	)	NN	O	)	nsubjpass	8	SENT_163	[p10l835t3278r1246b3349],
7	was	VBD	O	be	auxpass	8	SENT_163	[p10l1290t3294r1418b3335],
8	genotyped	VBN	O	genotype	_	0	SENT_163	[p10l1460t3277r1834b3353],
9	by	IN	O	by	_	0	SENT_163	[p10l1873t3277r1961b3353],
10	TaqMan	NNP	PERSON	TaqMan	nn	11	SENT_163	[p10l1998t3280r2148b3353, p10l8t3366r224b3428],
11	®	NN	O	®	agent	8	SENT_163	[p10l1998t3280r2148b3353, p10l8t3366r224b3428],
12	assay	NN	O	assay	nn	14	SENT_163	[p10l263t3388r444b3447],
13	(	CD	NUMBER	(	num	14	SENT_163	[p10l482t3371r978b3443],
14	Perkin-Elmer	NNP	O	Perkin-Elmer	tmod	8	SENT_163	[p10l482t3371r978b3443],
15	,	,	O	,	_	0	SENT_163	[p10l482t3371r978b3443],
16	USA	NNP	LOCATION	USA	appos	14	SENT_163	[p10l1019t3371r1212b3443],
17	)	CD	NUMBER	)	num	16	SENT_163	[p10l1019t3371r1212b3443],
18	.	.	O	.	_	0	SENT_163	[p10l1019t3371r1212b3443],

1	Primers	NNS	O	primer	nsubj	2	SENT_164	[p10l1254t3373r1518b3429],
2	(	VBP	O	(	_	0	SENT_164	[p10l1559t3370r2151b3443],
3	5	CD	NUMBER	5	number	4	SENT_164	[p10l1559t3370r2151b3443],
4	’	CD	NUMBER	’	dobj	2	SENT_164	[p10l1559t3370r2151b3443],
5	.	.	O	.	_	0	SENT_164	[p10l1559t3370r2151b3443],

1	—	NN	O	—	_	0	SENT_165	[p10l1559t3370r2151b3443],
2	.	.	O	.	_	0	SENT_165	[p10l1559t3370r2151b3443],

1	CTAGCACCT	NNP	O	CTAGCACCT	nn	3	SENT_166	[p10l1559t3370r2151b3443],
2	GACGCCTCGTT-3	NN	O	gacgcctcgtt-3	nn	3	SENT_166	[p10l11t3464r688b3522],
3	’	NN	O	’	_	0	SENT_166	[p10l11t3464r688b3522],
4	and	CC	O	and	prep	3	SENT_166	[p10l742t3465r873b3522],
5	5	CD	NUMBER	5	dep	4	SENT_166	[p10l926t3464r2151b3522],
6	’	SYM	O	’	dep	3	SENT_166	[p10l926t3464r2151b3522],
7	-	:	O	-	_	0	SENT_166	[p10l926t3464r2151b3522],
8	CACAGGGTACGTCTTCAAGGT	NN	O	cacagggtacgtcttcaaggt	dep	3	SENT_166	[p10l926t3464r2151b3522],

1	GTA-3	NN	O	gta-3	nn	3	SENT_167	[p11l11t24r274b98],
2	’	CD	NUMBER	’	num	3	SENT_167	[p11l11t24r274b98],
3	)	NN	O	)	nsubj	6	SENT_167	[p11l11t24r274b98],
4	and	CC	O	and	_	0	SENT_167	[p11l301t25r432b83],
5	probes	NNS	O	probe	nsubj	6	SENT_167	[p11l455t25r686b101],
6	(	VBP	O	(	_	0	SENT_167	[p11l713t24r1779b97],
7	5	CD	NUMBER	5	dobj	6	SENT_167	[p11l713t24r1779b97],
8	’	SYM	O	’	dep	10	SENT_167	[p11l713t24r1779b97],
9	-	:	O	-	_	0	SENT_167	[p11l713t24r1779b97],
10	ATCAGAGACGGAGCAT-3	NN	O	atcagagacggagcat-3	dep	7	SENT_167	[p11l713t24r1779b97],
11	’	CD	NUMBER	’	num	10	SENT_167	[p11l713t24r1779b97],
12	(	CD	NUMBER	(	num	14	SENT_167	[p11l1809t26r1991b98],
13	VIC	NNP	O	VIC	nn	14	SENT_167	[p11l1809t26r1991b98],
14	)	NN	O	)	nsubjpass	26	SENT_167	[p11l1809t26r1991b98],
15	and	CC	O	and	prep	14	SENT_167	[p11l2019t25r2150b83],
16	5	CD	NUMBER	5	dep	15	SENT_167	[p11l11t119r1044b178],
17	’	SYM	O	’	dep	14	SENT_167	[p11l11t119r1044b178],
18	-	:	O	-	_	0	SENT_167	[p11l11t119r1044b178],
19	ATCAGAGACAGAGCAT3	NN	O	atcagagacagagcat3	dep	14	SENT_167	[p11l11t119r1044b178],
20	’	CD	NUMBER	’	number	21	SENT_167	[p11l11t119r1044b178],
21	(	CD	NUMBER	(	num	22	SENT_167	[p11l1129t120r1364b192],
22	FAM	NN	O	fam	dep	19	SENT_167	[p11l1129t120r1364b192],
23	)	CD	NUMBER	)	num	24	SENT_167	[p11l1129t120r1364b192],
24	)	NN	O	)	dep	14	SENT_167	[p11l1129t120r1364b192],
25	were	VBD	O	be	auxpass	26	SENT_167	[p11l1445t137r1608b178],
26	supplied	VBN	O	supply	rcmod	10	SENT_167	[p11l1690t120r1988b196],
27	by	IN	O	by	_	0	SENT_167	[p11l2065t120r2152b196],
28	Invitrogen	NNP	ORGANIZATION	Invitrogen	nn	30	SENT_167	[p11l10t217r382b290],
29	Life	NNP	ORGANIZATION	Life	nn	30	SENT_167	[p11l420t214r547b272],
30	Technologies	NNP	ORGANIZATION	Technologies	agent	26	SENT_167	[p11l583t214r1047b290],
31	(	CD	NUMBER	(	num	33	SENT_167	[p11l1088t215r1242b286],
32	UK	NNP	LOCATION	UK	nn	33	SENT_167	[p11l1088t215r1242b286],
33	)	NN	O	)	dep	30	SENT_167	[p11l1088t215r1242b286],
34	and	CC	O	and	_	0	SENT_167	[p11l1284t214r1415b272],
35	Applied	NNP	ORGANIZATION	Applied	nn	36	SENT_167	[p11l1450t214r1726b290],
36	Biosystems	NNP	ORGANIZATION	Biosystems	conj_and	30	SENT_167	[p11l1763t217r2149b290],
37	(	CD	NUMBER	(	num	38	SENT_167	[p11l13t310r228b382],
38	USA	NNP	LOCATION	USA	dep	36	SENT_167	[p11l13t310r228b382],
39	)	CD	NUMBER	)	num	38	SENT_167	[p11l13t310r228b382],
40	,	,	O	,	_	0	SENT_167	[p11l13t310r228b382],
41	respectively	RB	O	respectively	advmod	36	SENT_167	[p11l293t310r722b386],
42	.	.	O	.	_	0	SENT_167	[p11l293t310r722b386],

1	An	DT	O	a	det	3	SENT_168	[p11l784t312r884b367],
2	ABI	NN	O	abus	nn	3	SENT_168	[p11l943t312r1066b367],
3	79OOHT	NN	O	79ooht	nsubjpass	5	SENT_168	[p11l1133t312r1409b368],
4	was	VBD	O	be	auxpass	5	SENT_168	[p11l1463t327r1591b368],
5	used	VBN	O	use	_	0	SENT_168	[p11l1650t310r1811b368],
6	to	TO	O	to	aux	7	SENT_168	[p11l1870t317r1939b368],
7	read	VB	O	read	xcomp	5	SENT_168	[p11l2000t310r2150b368],
8	ﬂuorescence	NN	O	ﬂuorescence	nn	9	SENT_168	[p11l9t405r448b463],
9	signals	NNS	O	signal	dobj	7	SENT_168	[p11l479t405r714b481],
10	for	IN	O	for	_	0	SENT_168	[p11l745t405r843b463],
11	each	DT	O	each	det	12	SENT_168	[p11l872t405r1033b463],
12	sample	NN	O	sample	prep_for	7	SENT_168	[p11l1063t405r1327b481],
13	.	.	O	.	_	0	SENT_168	[p11l1063t405r1327b481],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_169	[p11l12t609r347b667],
2	Analysis	NN	MISC	analysis	nsubjpass	10	SENT_169	[p11l378t609r662b685],
3	The	DT	MISC	the	det	4	SENT_169	[p11l7t706r140b764],
4	association	NN	O	association	dep	2	SENT_169	[p11l195t709r586b764],
5	between	IN	O	between	_	0	SENT_169	[p11l638t706r936b764],
6	genotypes	NNS	O	genotype	prep_between	2	SENT_169	[p11l990t713r1347b782],
7	and	CC	O	and	_	0	SENT_169	[p11l1402t706r1533b764],
8	phenotype	NN	O	phenotype	prep_between	2	SENT_169	[p11l1586t706r1968b782],
9	was	VBD	O	be	auxpass	10	SENT_169	[p11l2021t723r2148b764],
10	determined	VBN	O	determine	_	0	SENT_169	[p11l10t801r418b859],
11	using	VBG	O	use	xcomp	10	SENT_169	[p11l460t804r652b877],
12	Fisher	NNP	PERSON	Fisher	poss	15	SENT_169	[p11l695t801r951b859],
13	's	POS	O	's	_	0	SENT_169	[p11l695t801r951b859],
14	exact	JJ	O	exact	amod	15	SENT_169	[p11l996t808r1179b859],
15	test	NN	O	test	dobj	11	SENT_169	[p11l1221t808r1363b859],
16	.	.	O	.	_	0	SENT_169	[p11l1221t808r1363b859],

1	P-values	NNS	O	p-value	nsubjpass	3	SENT_170	[p11l1407t801r1696b859],
2	were	VBD	O	be	auxpass	3	SENT_170	[p11l1739t818r1902b859],
3	determined	VBN	O	determine	_	0	SENT_170	[p11l1948t801r2149b859, p11l9t896r237b953],
4	using	VBG	O	use	xcomp	3	SENT_170	[p11l282t899r474b971],
5	the	DT	O	the	det	10	SENT_170	[p11l518t896r631b953],
6	PROC	NNP	O	PROC	nn	10	SENT_170	[p11l679t897r885b953],
7	FREQ	NNP	O	FREQ	nn	10	SENT_170	[p11l932t897r1129b965],
8	procedure	NN	O	procedure	nn	10	SENT_170	[p11l1168t896r1521b971],
9	(	CD	NUMBER	(	num	10	SENT_170	[p11l1572t895r2145b971],
10	http://www.sas	NNS	O	http://www.sas	dobj	4	SENT_170	[p11l1572t895r2145b971],
11	.	.	O	.	_	0	SENT_170	[p11l1572t895r2145b971],

1	com	NN	O	com	_	0	SENT_171	[p11l10t991r206b1063],
2	)	NN	O	)	dep	1	SENT_171	[p11l10t991r206b1063],
3	.	.	O	.	_	0	SENT_171	[p11l10t991r206b1063],

1	PROC	NNP	O	PROC	nn	2	SENT_172	[p11l249t993r456b1049],
2	FREQ	NNP	O	FREQ	nsubj	3	SENT_172	[p11l495t993r692b1061],
3	computes	VBZ	O	compute	_	0	SENT_172	[p11l723t998r1065b1067],
4	exact	JJ	O	exact	amod	5	SENT_172	[p11l1104t998r1288b1049],
5	P-values	NNS	O	p-value	dobj	3	SENT_172	[p11l1322t991r1612b1049],
6	by	IN	O	by	_	0	SENT_172	[p11l1649t991r1737b1067],
7	generating	VBG	O	generate	prepc_by	3	SENT_172	[p11l1772t994r2151b1067],
8	R	NN	O	r	nn	11	SENT_172	[p11l10t1088r56b1141],
9	x	NN	O	x	nn	11	SENT_172	[p11l80t1103r117b1141],
10	C	NN	O	c	nn	11	SENT_172	[p11l144t1087r195b1142],
11	tables	NNS	O	table	dobj	7	SENT_172	[p11l225t1085r445b1142],
12	.	.	O	.	_	0	SENT_172	[p11l225t1085r445b1142],

1	ACKNOWLEDGEMENTS	NNS	O	acknowledgement	nsubj	3	SENT_173	[p11l8t1274r873b1329],
2	We	PRP	O	we	nsubj	3	SENT_173	[p11l8t1365r105b1415],
3	thank	VBP	O	thank	_	0	SENT_173	[p11l130t1363r315b1415],
4	the	DT	O	the	det	6	SENT_173	[p11l336t1363r436b1415],
5	significant	JJ	O	significant	amod	6	SENT_173	[p11l462t1363r791b1431],
6	contribution	NN	O	contribution	dobj	3	SENT_173	[p11l815t1363r1214b1415],
7	of	IN	O	of	_	0	SENT_173	[p11l1239t1363r1302b1415],
8	our	PRP$	O	we	poss	9	SENT_173	[p11l1322t1378r1428b1415],
9	colleagues	NNS	O	colleague	prep_of	6	SENT_173	[p11l1450t1363r1770b1431],
10	in	IN	O	in	_	0	SENT_173	[p11l1793t1366r1856b1414],
11	Genetics	NNP	ORGANIZATION	Genetics	nn	12	SENT_173	[p11l1881t1365r2150b1415],
12	Research	NNP	ORGANIZATION	Research	prep_in	3	SENT_173	[p11l10t1448r297b1511],
13	,	,	O	,	_	0	SENT_173	[p11l10t1448r297b1511],
14	Clinical	JJ	O	clinical	amod	15	SENT_173	[p11l335t1448r578b1500],
15	Pharmacology	NN	O	pharmacology	conj_and	12	SENT_173	[p11l610t1448r1062b1516],
16	and	CC	O	and	_	0	SENT_173	[p11l1092t1448r1208b1500],
17	Discovery	NNP	O	Discovery	nn	18	SENT_173	[p11l1241t1451r1550b1516],
18	Medicine	NNP	O	Medicine	conj_and	12	SENT_173	[p11l1579t1448r1887b1500],
19	.	.	O	.	_	0	SENT_173	[p11l1579t1448r1887b1500],

1	Thanks	NNS	O	thanks	nsubj	4	SENT_174	[p11l1921t1448r2149b1500],
2	are	VBP	O	be	cop	4	SENT_174	[p11l10t1548r100b1585],
3	also	RB	O	also	advmod	4	SENT_174	[p11l123t1533r242b1585],
4	due	JJ	O	due	_	0	SENT_174	[p11l264t1533r376b1585],
5	to	TO	O	to	_	0	SENT_174	[p11l397t1540r460b1585],
6	the	DT	O	the	det	9	SENT_174	[p11l481t1533r581b1585],
7	tranilast	NN	O	tranilast	nn	9	SENT_174	[p11l603t1533r862b1585],
8	clinical	JJ	O	clinical	amod	9	SENT_174	[p11l883t1533r1110b1585],
9	team	NN	O	team	prep_to	4	SENT_174	[p11l1131t1540r1302b1596],
10	,	,	O	,	_	0	SENT_174	[p11l1131t1540r1302b1596],
11	the	DT	O	the	det	13	SENT_174	[p11l1327t1533r1427b1585],
12	principal	JJ	O	principal	amod	13	SENT_174	[p11l1448t1533r1730b1601],
13	investigators	NNS	O	investigator	appos	9	SENT_174	[p11l1751t1536r2149b1601],
14	and	CC	O	and	_	0	SENT_174	[p11l9t1616r126b1667],
15	patients	NNS	O	patient	appos	9	SENT_174	[p11l151t1619r401b1683],
16	who	WP	O	who	nsubj	17	SENT_174	[p11l427t1616r563b1667],
17	participated	VBD	O	participate	rcmod	13	SENT_174	[p11l589t1616r966b1683],
18	in	IN	O	in	_	0	SENT_174	[p11l992t1619r1054b1666],
19	this	DT	O	this	det	20	SENT_174	[p11l1081t1616r1196b1667],
20	study	NN	O	study	prep_in	17	SENT_174	[p11l1224t1616r1403b1683],
21	.	.	O	.	_	0	SENT_174	[p11l1224t1616r1403b1683],

1	This	DT	O	this	det	2	SENT_175	[p11l1433t1616r1565b1667],
2	study	NN	O	study	nsubjpass	5	SENT_175	[p11l1594t1616r1765b1683],
3	was	VBD	O	be	auxpass	5	SENT_175	[p11l1787t1631r1901b1667],
4	wholly	RB	O	wholly	advmod	5	SENT_175	[p11l1927t1616r2145b1683],
5	funded	VBN	O	fund	_	0	SENT_175	[p11l8t1699r231b1750],
6	by	IN	O	by	_	0	SENT_175	[p11l254t1699r331b1766],
7	GSK	NNP	ORGANIZATION	GSK	nn	8	SENT_175	[p11l356t1701r486b1750],
8	Research	NNP	ORGANIZATION	Research	agent	5	SENT_175	[p11l511t1699r783b1750],
9	and	CC	ORGANIZATION	and	_	0	SENT_175	[p11l810t1699r926b1750],
10	Development	NNP	ORGANIZATION	Development	agent	5	SENT_175	[p11l952t1699r1392b1766],
11	.	.	O	.	_	0	SENT_175	[p11l952t1699r1392b1766],

1	DUALITY	NNP	O	DUALITY	nsubj	5	SENT_176	[p11l11t1919r342b1974],
2	OF	IN	O	of	_	0	SENT_176	[p11l373t1919r467b1974],
3	INTEREST	NN	O	interest	nn	4	SENT_176	[p11l499t1919r850b1974],
4	None	NN	O	none	prep_of	1	SENT_176	[p11l7t2014r197b2069],
5	declared	VBD	O	declare	_	0	SENT_176	[p11l229t2012r522b2069],

1	ABBREVIATIONS	NNS	O	abbreviation	_	0	SENT_177	[p11l36t2264r654b2320],

1	PRESTO	NNP	O	PRESTO	nn	2	SENT_178	[p11l129t2373r341b2421],
2	Prevention	NNP	O	Prevention	dep	16	SENT_178	[p11l397t2372r682b2421],
3	of	IN	O	of	_	0	SENT_178	[p11l709t2371r766b2421],
4	REStenosi	NNP	O	REStenosi	prep_of	2	SENT_178	[p11l784t2372r1068b2421],
5	$	$	O	$	dep	4	SENT_178	[p11l784t2372r1068b2421],
6	with	IN	O	with	_	0	SENT_178	[p11l1094t2371r1209b2421],
7	Tranilast	NN	O	tranilast	prep_with	4	SENT_178	[p11l1240t2371r1476b2421],
8	and	CC	O	and	_	0	SENT_178	[p11l1500t2371r1607b2421],
9	its	PRP$	O	its	poss	10	SENT_178	[p11l1629t2372r1688b2421],
10	Outcomes	NNS	O	outcome	prep_with	4	SENT_178	[p11l1716t2373r1988b2421],
11	PTCR	NN	O	ptcr	dep	16	SENT_178	[p11l107t2449r247b2498],
12	percutaneous	JJ	O	percutaneous	amod	16	SENT_178	[p11l393t2453r764b2513],
13	transluminal	JJ	O	transluminal	amod	16	SENT_178	[p11l791t2448r1136b2498],
14	coronary	JJ	O	coronary	amod	16	SENT_178	[p11l1159t2462r1402b2513],
15	revascularization	NN	O	revascularization	nn	16	SENT_178	[p11l1423t2448r1889b2498],
16	SNP	NN	O	snp	dep	23	SENT_178	[p11l106t2526r220b2574],
17	sing/e-nucleotide	JJ	O	sing/e-nucleotide	amod	19	SENT_178	[p11l395t2524r856b2590],
18	polymorphism	NN	O	polymorphism	nn	19	SENT_178	[p11l877t2524r1267b2590],
19	UGTlA1	NN	O	ugtla1	dep	16	SENT_178	[p11l109t2602r332b2650],
20	uridine	NN	O	uridine	nn	23	SENT_178	[p11l397t2601r584b2650],
21	diphosphate	NN	O	diphosphate	nn	23	SENT_178	[p11l609t2601r948b2666],
22	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	23	SENT_178	[p11l968t2601r1621b2666],
23	1A1	NN	O	1a1	_	0	SENT_178	[p11l1653t2602r1745b2650],

1	REFERENCES	NNS	O	reference	_	0	SENT_179	[p11l11t2858r464b2913],
2	1	CD	NUMBER	1	num	4	SENT_179	[p11l44t2941r60b2987],
3	Nobuyoshi	NNP	PERSON	Nobuyoshi	nn	4	SENT_179	[p11l144t2940r440b3003],
4	M	NN	PERSON	m	dep	1	SENT_179	[p11l477t2942r544b2998],
5	,	,	O	,	_	0	SENT_179	[p11l477t2942r544b2998],
6	Kimura	NNP	ORGANIZATION	Kimura	nn	7	SENT_179	[p11l581t2941r773b2988],
7	T	NN	ORGANIZATION	t	appos	4	SENT_179	[p11l804t2942r852b2998],
8	,	,	O	,	_	0	SENT_179	[p11l804t2942r852b2998],
9	Nosaka	FW	PERSON	nosaka	appos	7	SENT_179	[p11l890t2940r1086b2988],
10	H	NN	PERSON	h	dep	9	SENT_179	[p11l1122t2942r1175b2998],
11	,	,	O	,	_	0	SENT_179	[p11l1122t2942r1175b2998],
12	Mioka	FW	LOCATION	mioka	dep	7	SENT_179	[p11l1212t2940r1377b2988],
13	S	NN	LOCATION	s	dep	1	SENT_179	[p11l1411t2941r1454b2998],
14	,	,	O	,	_	0	SENT_179	[p11l1411t2941r1454b2998],
15	Ueno	NNP	LOCATION	Ueno	nn	16	SENT_179	[p11l1491t2942r1634b2988],
16	K	NNP	LOCATION	K	appos	13	SENT_179	[p11l1669t2942r1714b2998],
17	,	,	O	,	_	0	SENT_179	[p11l1669t2942r1714b2998],
18	Yokoi	NNP	PERSON	Yokoi	nn	19	SENT_179	[p11l1747t2940r1896b2988],
19	H	NNP	O	H	appos	1	SENT_179	[p11l1933t2942r1967b2987],
20	et	FW	O	et	nn	21	SENT_179	[p11l2004t2945r2053b2988],
21	al.	FW	O	al.	dep	19	SENT_179	[p11l2081t2940r2139b2988],
22	.	.	O	.	_	0	SENT_179	[p11l2081t2940r2139b2988],

1	Restenosis	NNP	O	Restenosis	_	0	SENT_180	[p11l144t3016r421b3062],
2	after	IN	O	after	_	0	SENT_180	[p11l453t3014r578b3062],
3	successful	JJ	O	successful	amod	4	SENT_180	[p11l607t3014r875b3062],
4	percutaneous	JJ	O	percutaneous	amod	7	SENT_180	[p11l911t3020r1285b3077],
5	transluminal	JJ	O	transluminal	amod	7	SENT_180	[p11l1317t3014r1656b3062],
6	coronary	JJ	O	coronary	amod	7	SENT_180	[p11l1691t3028r1936b3077],
7	angioplasty	NN	O	angioplasty	prep_after	1	SENT_180	[p11l1967t3016r2142b3077, p11l143t3090r315b3153],
8	:	:	O	:	_	0	SENT_180	[p11l1967t3016r2142b3077, p11l143t3090r315b3153],
9	serial	NN	O	serial	nn	11	SENT_180	[p11l346t3090r481b3138],
10	angiographic	JJ	O	angiographic	amod	11	SENT_180	[p11l512t3090r879b3153],
11	follow-up	NN	O	follow-up	dep	1	SENT_180	[p11l904t3090r1169b3153],
12	of	IN	O	of	_	0	SENT_180	[p11l1198t3090r1252b3138],
13	229	CD	NUMBER	229	num	14	SENT_180	[p11l1277t3091r1381b3138],
14	patients	NNS	O	patient	prep_of	11	SENT_180	[p11l1412t3091r1643b3153],
15	.	.	O	.	_	0	SENT_180	[p11l1412t3091r1643b3153],

1	/	:	O	/	punct	4	SENT_181	[p11l1672t3092r1692b3149],
2	Am	VBP	O	be	cop	4	SENT_181	[p11l1715t3092r1803b3137],
3	Coll	NNP	O	Coll	nn	4	SENT_181	[p11l1833t3090r1932b3138],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_181	[p11l1959t3090r2148b3138],
5	1988	CD	DATE	1988	dep	4	SENT_181	[p11l144t3167r297b3223],
6	;	:	O	;	_	0	SENT_181	[p11l144t3167r297b3223],
7	12	CD	NUMBER	12	num	9	SENT_181	[p11l330t3167r411b3213],
8	:	:	O	:	_	0	SENT_181	[p11l330t3167r411b3213],
9	616-623	CD	NUMBER	616-623	dep	4	SENT_181	[p11l440t3167r701b3213],
10	.	.	O	.	_	0	SENT_181	[p11l440t3167r701b3213],

1	2	CD	NUMBER	2	num	3	SENT_182	[p11l41t3241r72b3287],
2	Tamai	NNP	ORGANIZATION	Tamai	nn	3	SENT_182	[p11l139t3241r306b3288],
3	H	NNP	ORGANIZATION	H	_	0	SENT_182	[p11l335t3242r388b3298],
4	,	,	O	,	_	0	SENT_182	[p11l335t3242r388b3298],
5	Katoh	NNP	PERSON	Katoh	nn	6	SENT_182	[p11l418t3240r574b3288],
6	o	NN	O	o	appos	3	SENT_182	[p11l601t3241r661b3298],
7	,	,	O	,	_	0	SENT_182	[p11l601t3241r661b3298],
8	Suzuki	NNP	PERSON	Suzuki	nn	9	SENT_182	[p11l690t3240r863b3288],
9	S	NNP	O	S	appos	3	SENT_182	[p11l891t3241r933b3298],
10	,	,	O	,	_	0	SENT_182	[p11l891t3241r933b3298],
11	Fujii	NNP	PERSON	Fujii	nn	12	SENT_182	[p11l963t3241r1067b3302],
12	K	NNP	PERSON	K	appos	3	SENT_182	[p11l1096t3242r1142b3298],
13	,	,	O	,	_	0	SENT_182	[p11l1096t3242r1142b3298],
14	Aizawa	NNP	ORGANIZATION	Aizawa	nn	15	SENT_182	[p11l1168t3241r1361b3288],
15	T	NN	ORGANIZATION	t	appos	3	SENT_182	[p11l1384t3242r1432b3298],
16	,	,	O	,	_	0	SENT_182	[p11l1384t3242r1432b3298],
17	Takase	NNP	ORGANIZATION	Takase	nn	18	SENT_182	[p11l1457t3240r1641b3288],
18	S	NNP	O	S	appos	3	SENT_182	[p11l1667t3241r1693b3288],
19	et	FW	O	et	nn	20	SENT_182	[p11l1721t3245r1770b3288],
20	al.	FW	O	al.	dep	18	SENT_182	[p11l1791t3240r1849b3288],
21	.	.	O	.	_	0	SENT_182	[p11l1791t3240r1849b3288],

1	Impact	NN	O	impact	nsubj	16	SENT_183	[p11l1879t3242r2069b3303],
2	of	IN	O	of	_	0	SENT_183	[p11l2092t3240r2145b3288],
3	tranilast	NN	O	tranilast	prep_of	1	SENT_183	[p11l140t3314r360b3362],
4	on	IN	O	on	_	0	SENT_183	[p11l395t3328r463b3362],
5	restenosis	NN	O	restenosis	prep_on	3	SENT_183	[p11l504t3316r769b3362],
6	after	IN	O	after	_	0	SENT_183	[p11l806t3314r931b3362],
7	coronary	JJ	O	coronary	amod	8	SENT_183	[p11l966t3328r1211b3377],
8	angioplasty	NN	O	angioplasty	prep_after	5	SENT_183	[p11l1247t3314r1580b3377],
9	:	:	O	:	_	0	SENT_183	[p11l1247t3314r1580b3377],
10	tranilast	NN	O	tranilast	nn	11	SENT_183	[p11l1620t3314r1840b3362],
11	restenosis	NN	O	restenosis	dep	3	SENT_183	[p11l1877t3316r2142b3362],
12	following	VBG	O	follow	_	0	SENT_183	[p11l138t3390r396b3453],
13	angioplasty	JJ	O	angioplasty	amod	14	SENT_183	[p11l424t3390r742b3453],
14	trial	NN	O	trial	prep_following	11	SENT_183	[p11l766t3390r866b3438],
15	(	RB	O	(	advmod	16	SENT_183	[p11l895t3390r1127b3450],
16	TREAT	VBP	O	treat	_	0	SENT_183	[p11l895t3390r1127b3450],
17	)	CD	NUMBER	)	dobj	16	SENT_183	[p11l895t3390r1127b3450],
18	.	.	O	.	_	0	SENT_183	[p11l895t3390r1127b3450],

1	Am	VBP	O	be	dep	2	SENT_184	[p11l1154t3392r1242b3437],
2	Heart	NNP	O	Heart	_	0	SENT_184	[p11l1269t3392r1452b3449],
3	]	CD	NUMBER	]	num	2	SENT_184	[p11l1269t3392r1452b3449],
4	1999	CD	DATE	1999	dep	2	SENT_184	[p11l1477t3391r1631b3448],
5	;	:	O	;	_	0	SENT_184	[p11l1477t3391r1631b3448],
6	138	CD	NUMBER	138	dep	4	SENT_184	[p11l1663t3391r1781b3438],
7	:	:	O	:	_	0	SENT_184	[p11l1663t3391r1781b3438],
8	968-975	CD	NUMBER	968-975	dep	6	SENT_184	[p11l1810t3391r2070b3438],
9	.	.	O	.	_	0	SENT_184	[p11l1810t3391r2070b3438],

1	3	CD	NUMBER	3	num	3	SENT_185	[p11l44t3466r71b3513],
2	Holmes	NNP	ORGANIZATION	Holmes	nn	3	SENT_185	[p11l144t3465r347b3513],
3	D	NNP	ORGANIZATION	D	_	0	SENT_185	[p11l374t3467r428b3523],
4	,	,	O	,	_	0	SENT_185	[p11l374t3467r428b3523],
5	Fitzgerald	NNP	PERSON	Fitzgerald	nn	6	SENT_185	[p11l457t3465r721b3527],
6	P	NN	PERSON	p	appos	3	SENT_185	[p11l750t3467r792b3523],
7	,	,	O	,	_	0	SENT_185	[p11l750t3467r792b3523],
8	Goldberg	NNP	PERSON	Goldberg	nn	9	SENT_185	[p11l818t3465r1078b3527],
9	S	NNP	O	S	appos	3	SENT_185	[p11l1104t3466r1147b3523],
10	,	,	O	,	_	0	SENT_185	[p11l1104t3466r1147b3523],
11	LaB	NN	O	lab	nn	14	SENT_185	[p11l1176t3465r1452b3513],
12	|	NN	O	|	nn	14	SENT_185	[p11l1176t3465r1452b3513],
13	anche	NN	O	anche	nn	14	SENT_185	[p11l1176t3465r1452b3513],
14	J	NN	O	j	appos	3	SENT_185	[p11l1474t3467r1503b3524],
15	,	,	O	,	_	0	SENT_185	[p11l1474t3467r1503b3524],
16	Lincoff	NNP	PERSON	Lincoff	nn	17	SENT_185	[p11l1532t3465r1715b3513],
17	AM	NNP	O	AM	appos	3	SENT_185	[p11l1733t3467r1844b3523],
18	,	,	O	,	_	0	SENT_185	[p11l1733t3467r1844b3523],
19	Savage	NNP	O	Savage	nn	20	SENT_185	[p11l1872t3466r2064b3527],
20	M	NNP	O	M	appos	3	SENT_185	[p11l2090t3467r2139b3512],
21	et	FW	O	et	nn	22	SENT_185	[p11l142t3545r191b3587],
22	al.	FW	O	al.	dep	20	SENT_185	[p11l233t3539r290b3587],
23	.	.	O	.	_	0	SENT_185	[p11l233t3539r290b3587],

1	The	DT	O	the	det	4	SENT_186	[p11l336t3539r438b3587],
2	PRESTO	NNP	O	PRESTO	nn	4	SENT_186	[p11l486t3541r698b3587],
3	(	CD	NUMBER	(	num	4	SENT_186	[p11l744t3540r1059b3599],
4	Prevention	NNP	O	Prevention	nsubj	12	SENT_186	[p11l744t3540r1059b3599],
5	of	IN	O	of	_	0	SENT_186	[p11l1106t3539r1160b3587],
6	restenosis	NN	O	restenosis	prep_of	4	SENT_186	[p11l1203t3541r1468b3587],
7	with	IN	O	with	_	0	SENT_186	[p11l1511t3539r1630b3587],
8	tranilast	NN	O	tranilast	prep_with	6	SENT_186	[p11l1675t3539r1896b3587],
9	and	CC	O	and	_	0	SENT_186	[p11l1938t3539r2038b3587],
10	its	PRP$	O	its	poss	11	SENT_186	[p11l2086t3541r2142b3587],
11	outcomes	NNS	O	outcome	conj_and	8	SENT_186	[p11l141t3615r433b3674],
12	)	VBP	O	)	_	0	SENT_186	[p11l141t3615r433b3674],
13	protocol	NN	O	protocol	dobj	12	SENT_186	[p11l458t3614r703b3677],
14	:	:	O	:	_	0	SENT_186	[p11l458t3614r703b3677],
15	a	DT	O	a	det	19	SENT_186	[p11l728t3628r754b3662],
16	double-blind	JJ	O	double-blind	amod	19	SENT_186	[p11l776t3614r1148b3672],
17	,	,	O	,	_	0	SENT_186	[p11l776t3614r1148b3672],
18	placebo-controlled	JJ	O	placebo-controlled	amod	19	SENT_186	[p11l1175t3614r1694b3677],
19	trial	NN	O	trial	dobj	12	SENT_186	[p11l1716t3614r1834b3662],
20	.	.	O	.	_	0	SENT_186	[p11l1716t3614r1834b3662],

1	Am	VBP	O	be	dep	2	SENT_187	[p11l1857t3617r1945b3662],
2	Heart	NNP	O	Heart	_	0	SENT_187	[p11l1967t3617r2146b3673],
3	]	CD	NUMBER	]	num	2	SENT_187	[p11l1967t3617r2146b3673],
4	2000	CD	DATE	2000	dep	2	SENT_187	[p11l141t3692r297b3748],
5	;	:	O	;	_	0	SENT_187	[p11l141t3692r297b3748],
6	139	CD	NUMBER	139	dep	4	SENT_187	[p11l330t3692r448b3738],
7	:	:	O	:	_	0	SENT_187	[p11l330t3692r448b3738],
8	23-31	CD	NUMBER	23-31	dep	6	SENT_187	[p11l476t3692r664b3738],
9	.	.	O	.	_	0	SENT_187	[p11l476t3692r664b3738],

1	4	LS	NUMBER	4	dep	2	SENT_188	[p11l40t3767r72b3812],
2	Bosma	NN	PERSON	bosma	_	0	SENT_188	[p11l144t3767r322b3813],
3	P	NN	O	p	prep	2	SENT_188	[p11l375t3767r434b3824],
4	]	CD	NUMBER	]	dep	3	SENT_188	[p11l375t3767r434b3824],
5	,	,	O	,	_	0	SENT_188	[p11l375t3767r434b3824],
6	Seppen	NNP	PERSON	Seppen	nn	7	SENT_188	[p11l488t3766r691b3828],
7	J	NNP	PERSON	J	appos	2	SENT_188	[p11l741t3767r771b3824],
8	,	,	O	,	_	0	SENT_188	[p11l741t3767r771b3824],
9	Goldhoorn	NNP	O	Goldhoorn	nn	10	SENT_188	[p11l823t3765r1122b3813],
10	B	NNP	O	B	appos	7	SENT_188	[p11l1176t3767r1220b3823],
11	,	,	O	,	_	0	SENT_188	[p11l1176t3767r1220b3823],
12	Bakker	NNP	PERSON	Bakker	nn	13	SENT_188	[p11l1276t3765r1455b3813],
13	C	NNP	O	C	appos	10	SENT_188	[p11l1502t3766r1556b3823],
14	,	,	O	,	_	0	SENT_188	[p11l1502t3766r1556b3823],
15	Oude	NNP	O	Oude	nn	16	SENT_188	[p11l1609t3765r1761b3813],
16	Elferink	NNP	O	Elferink	appos	10	SENT_188	[p11l1813t3765r2011b3813],
17	RP	NN	O	rp	dep	16	SENT_188	[p11l2061t3767r2139b3823],
18	,	,	O	,	_	0	SENT_188	[p11l2061t3767r2139b3823],

1	Genetic	JJ	O	genetic	amod	2	SENT_189	[p12l9t1892r190b1937],
2	susceptibility	NN	O	susceptibility	_	0	SENT_189	[p12l208t1892r529b1951],
3	to	TO	O	to	_	0	SENT_189	[p12l545t1897r595b1937],
4	tranilast-induced	JJ	O	tranilast-induced	amod	7	SENT_189	[p12l613t1892r1025b1937],
5	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	7	SENT_189	[p12l1048t1892r1508b1951],
6	TM	NNP	O	TM	nn	7	SENT_189	[p12l7t1965r73b2004],
7	Danoff	NNP	PERSON	Danoff	prep_to	2	SENT_189	[p12l96t1963r233b2005],
8	et	FW	O	et	nn	9	SENT_189	[p12l250t1968r287b2005],
9	al	FW	O	al	dep	2	SENT_189	[p12l303t1963r339b2005],

1	Chowdhury	NNP	PERSON	Chowdhury	nn	2	SENT_190	[p12l141t15r470b78],
2	JR	NNP	O	JR	_	0	SENT_190	[p12l492t18r543b74],
3	et	FW	O	et	nn	4	SENT_190	[p12l567t21r615b63],
4	al.	FW	O	al.	dep	2	SENT_190	[p12l637t15r695b63],
5	.	.	O	.	_	0	SENT_190	[p12l637t15r695b63],

1	Bilirubin	NNP	O	Bilirubin	nn	2	SENT_191	[p12l725t15r947b63],
2	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nsubj	10	SENT_191	[p12l975t15r1774b78],
3	1	CD	NUMBER	1	num	2	SENT_191	[p12l1801t17r1818b63],
4	is	VBZ	O	be	cop	10	SENT_191	[p12l1856t17r1891b63],
5	the	DT	O	the	det	10	SENT_191	[p12l1913t15r2001b63],
6	only	RB	O	only	advmod	7	SENT_191	[p12l2026t15r2144b78],
7	relevant	JJ	O	relevant	amod	10	SENT_191	[p12l143t91r362b139],
8	bilirubin	NN	O	bilirubin	nn	10	SENT_191	[p12l396t91r619b139],
9	glucuronidating	VBG	O	glucuronidate	amod	10	SENT_191	[p12l655t91r1097b154],
10	isoform	NN	O	isoform	_	0	SENT_191	[p12l1134t91r1336b139],
11	in	IN	O	in	_	0	SENT_191	[p12l1374t92r1418b138],
12	man	NN	O	man	prep_in	10	SENT_191	[p12l1456t105r1590b139],
13	.	.	O	.	_	0	SENT_191	[p12l1456t105r1590b139],

1	/	:	O	/	punct	3	SENT_192	[p12l1623t93r1643b150],
2	Biol	NNP	ORGANIZATION	Biol	nn	3	SENT_192	[p12l1676t91r1770b139],
3	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_192	[p12l1801t91r1951b139],
4	1994	CD	DATE	1994	dep	3	SENT_192	[p12l1985t92r2139b149],
5	;	:	O	;	_	0	SENT_192	[p12l1985t92r2139b149],
6	269	CD	NUMBER	269	dep	3	SENT_192	[p12l141t168r262b214],
7	:	:	O	:	_	0	SENT_192	[p12l141t168r262b214],
8	17960-17964	CD	NUMBER	17960-17964	dep	6	SENT_192	[p12l293t168r698b214],
9	.	.	O	.	_	0	SENT_192	[p12l293t168r698b214],

1	Crigler	NNP	PERSON	Crigler	nn	2	SENT_193	[p12l141t241r327b304],
2	JF	NNP	O	JF	_	0	SENT_193	[p12l354t244r414b300],
3	,	,	O	,	_	0	SENT_193	[p12l354t244r414b300],
4	Najjar	NNP	PERSON	Najjar	nn	5	SENT_193	[p12l450t243r612b304],
5	VA.	NNP	O	VA.	appos	2	SENT_193	[p12l637t243r728b289],
6	.	.	O	.	_	0	SENT_193	[p12l637t243r728b289],

1	Congenital	JJ	O	congenital	amod	4	SENT_194	[p12l762t241r1064b304],
2	familial	JJ	O	familial	amod	4	SENT_194	[p12l1094t241r1290b289],
3	non-hemolytic	JJ	O	non-hemolytic	amod	4	SENT_194	[p12l1325t241r1729b304],
4	jaundice	NN	O	jaundice	_	0	SENT_194	[p12l1757t241r1992b304],
5	with	IN	O	with	_	0	SENT_194	[p12l2020t241r2140b289],
6	kernicterus	NN	O	kernicterus	prep_with	4	SENT_194	[p12l143t316r457b364],
7	.	.	O	.	_	0	SENT_194	[p12l143t316r457b364],

1	Pediatrics	NNS	O	pediatrics	_	0	SENT_195	[p12l488t316r739b364],
2	1952	CD	DATE	1952	num	1	SENT_195	[p12l765t318r918b374],
3	;	:	O	;	_	0	SENT_195	[p12l765t318r918b374],
4	10	CD	NUMBER	10	num	6	SENT_195	[p12l951t318r1031b364],
5	:	:	O	:	_	0	SENT_195	[p12l951t318r1031b364],
6	169-180	CD	NUMBER	169-180	dep	1	SENT_195	[p12l1063t318r1322b364],
7	.	.	O	.	_	0	SENT_195	[p12l1063t318r1322b364],

1	Seppen	JJ	O	seppen	amod	2	SENT_196	[p12l142t393r345b455],
2	J	NN	O	j	_	0	SENT_196	[p12l396t394r425b451],
3	,	,	O	,	_	0	SENT_196	[p12l396t394r425b451],
4	Bosma	NNP	PERSON	Bosma	nn	5	SENT_196	[p12l481t394r659b440],
5	PJ	NNP	O	PJ	appos	2	SENT_196	[p12l713t394r773b451],
6	,	,	O	,	_	0	SENT_196	[p12l713t394r773b451],
7	Goldhoorn	NNP	ORGANIZATION	Goldhoorn	nn	8	SENT_196	[p12l827t392r1126b440],
8	BG	NNP	ORGANIZATION	BG	appos	2	SENT_196	[p12l1180t393r1272b450],
9	,	,	O	,	_	0	SENT_196	[p12l1180t393r1272b450],
10	Bakker	NNP	PERSON	Bakker	nn	11	SENT_196	[p12l1328t392r1507b440],
11	CT	NNP	O	CT	appos	2	SENT_196	[p12l1555t393r1644b450],
12	,	,	O	,	_	0	SENT_196	[p12l1555t393r1644b450],
13	Chowdhury	NNP	PERSON	Chowdhury	nn	14	SENT_196	[p12l1698t392r2027b455],
14	JR	NNP	O	JR	appos	2	SENT_196	[p12l2074t394r2139b451],
15	,	,	O	,	_	0	SENT_196	[p12l2074t394r2139b451],
16	Chowdhury	NNP	PERSON	Chowdhury	nn	17	SENT_196	[p12l141t467r470b530],
17	NR	NNP	O	NR	appos	2	SENT_196	[p12l513t469r592b514],
18	et	FW	O	et	nn	19	SENT_196	[p12l633t472r682b515],
19	al.	FW	O	al.	dep	17	SENT_196	[p12l720t467r778b515],
20	.	.	O	.	_	0	SENT_196	[p12l720t467r778b515],

1	Discrimination	NN	O	discrimination	_	0	SENT_197	[p12l825t468r1222b515],
2	between	IN	O	between	_	0	SENT_197	[p12l1268t467r1503b515],
3	Crig	NNP	O	Crig	nn	5	SENT_197	[p12l1547t467r1930b529],
4	|	CD	NUMBER	|	num	5	SENT_197	[p12l1547t467r1930b529],
5	er	NN	O	er	prep_between	1	SENT_197	[p12l1547t467r1930b529],
6	.	.	O	.	_	0	SENT_197	[p12l1547t467r1930b529],

1	—	NN	O	—	_	0	SENT_198	[p12l1547t467r1930b529],
2	.	.	O	.	_	0	SENT_198	[p12l1547t467r1930b529],

1	Najjar	NNP	PERSON	Najjar	nn	2	SENT_199	[p12l1547t467r1930b529],
2	type	NN	O	type	_	0	SENT_199	[p12l1969t472r2089b530],
3	I	CD	NUMBER	i	dep	2	SENT_199	[p12l2133t469r2140b514],
4	and	CC	O	and	_	0	SENT_199	[p12l141t541r241b589],
5	II	CD	NUMBER	ii	dep	2	SENT_199	[p12l280t544r304b589],
6	by	IN	O	by	_	0	SENT_199	[p12l343t541r407b604],
7	expression	NN	O	expression	prep_by	3	SENT_199	[p12l440t543r730b604],
8	of	IN	O	of	_	0	SENT_199	[p12l766t541r820b589],
9	mutant	JJ	O	mutant	amod	14	SENT_199	[p12l853t547r1055b589],
10	bilirubin	NN	O	bilirubin	nn	14	SENT_199	[p12l1089t541r1312b589],
11	uridine	NN	O	uridine	nn	14	SENT_199	[p12l1351t541r1540b589],
12	diphosphateg	NN	O	diphosphateg	nn	14	SENT_199	[p12l1575t541r2142b604, p12l141t617r633b680],
13	|	NN	O	|	nn	14	SENT_199	[p12l1575t541r2142b604, p12l141t617r633b680],
14	ucuronosyltransferase	NN	O	ucuronosyltransferase	prep_of	7	SENT_199	[p12l1575t541r2142b604, p12l141t617r633b680],
15	.	.	O	.	_	0	SENT_199	[p12l1575t541r2142b604, p12l141t617r633b680],

1	/	:	O	/	punct	3	SENT_200	[p12l658t619r678b676],
2	Clin	NNP	O	Clin	nn	3	SENT_200	[p12l704t617r801b665],
3	Invest	NNP	O	Invest	_	0	SENT_200	[p12l827t619r981b665],
4	1994	CD	DATE	1994	dep	3	SENT_200	[p12l1005t618r1159b675],
5	;	:	O	;	_	0	SENT_200	[p12l1005t618r1159b675],
6	94	CD	NUMBER	94	dep	3	SENT_200	[p12l1187t619r1272b665],
7	:	:	O	:	_	0	SENT_200	[p12l1187t619r1272b665],
8	2385-2391	CD	DATE	2385-2391	dep	6	SENT_200	[p12l1301t618r1636b665],
9	.	.	O	.	_	0	SENT_200	[p12l1301t618r1636b665],

1	Tukey	NNP	PERSON	Tukey	nn	2	SENT_201	[p12l139t692r304b754],
2	RH	NNP	O	RH	_	0	SENT_201	[p12l332t694r420b749],
3	,	,	O	,	_	0	SENT_201	[p12l332t694r420b749],
4	Strassburg	NNP	LOCATION	Strassburg	nn	5	SENT_201	[p12l451t692r735b754],
5	CP	NNP	O	CP	appos	2	SENT_201	[p12l763t693r853b739],
6	.	.	O	.	_	0	SENT_201	[p12l763t693r853b739],

1	Human	JJ	O	human	amod	2	SENT_202	[p12l885t694r1082b739],
2	UDP-glucuronosyltransferasesz	NN	O	udp-glucuronosyltransferasesz	_	0	SENT_202	[p12l1113t692r1953b754],
3	metabolism	NN	O	metabolism	dep	2	SENT_202	[p12l1984t697r2142b739, p12l143t767r337b825],
4	,	,	O	,	_	0	SENT_202	[p12l1984t697r2142b739, p12l143t767r337b825],
5	expression	NN	O	expression	dep	2	SENT_202	[p12l372t768r678b830],
6	,	,	O	,	_	0	SENT_202	[p12l372t768r678b830],
7	and	CC	O	and	_	0	SENT_202	[p12l712t767r813b815],
8	disease	NN	O	disease	dep	2	SENT_202	[p12l845t767r1055b815],
9	.	.	O	.	_	0	SENT_202	[p12l845t767r1055b815],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_203	[p12l1087t769r1193b814],
2	Rev	NN	PERSON	rev	nn	4	SENT_203	[p12l1224t769r1316b815],
3	Pharmacol	NNP	PERSON	Pharmacol	nn	4	SENT_203	[p12l1343t767r1627b815],
4	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_203	[p12l1658t767r1840b815],
5	2000	CD	DATE	2000	num	4	SENT_203	[p12l1865t768r2021b825],
6	;	:	O	;	_	0	SENT_203	[p12l1865t768r2021b825],
7	40	CD	NUMBER	40	num	9	SENT_203	[p12l2054t768r2139b815],
8	:	:	O	:	_	0	SENT_203	[p12l2054t768r2139b815],
9	581-616	CD	NUMBER	581-616	dep	4	SENT_203	[p12l141t844r403b890],
10	.	.	O	.	_	0	SENT_203	[p12l141t844r403b890],

1	Kadakol	NNP	MISC	Kadakol	nn	2	SENT_204	[p12l144t918r356b966],
2	A	NNP	MISC	A	_	0	SENT_204	[p12l377t920r429b976],
3	,	,	O	,	_	0	SENT_204	[p12l377t920r429b976],
4	Ghosh	NNP	PERSON	Ghosh	nn	5	SENT_204	[p12l454t918r630b966],
5	SS	NNP	O	SS	appos	2	SENT_204	[p12l655t919r731b976],
6	,	,	O	,	_	0	SENT_204	[p12l655t919r731b976],
7	Sappal	NNP	O	Sappal	nn	8	SENT_204	[p12l756t918r936b981],
8	BS	NNP	O	BS	appos	5	SENT_204	[p12l962t920r1040b976],
9	,	,	O	,	_	0	SENT_204	[p12l962t920r1040b976],
10	Sharma	NNP	PERSON	Sharma	nn	11	SENT_204	[p12l1066t918r1272b966],
11	G	NNP	PERSON	G	appos	5	SENT_204	[p12l1295t919r1352b976],
12	,	,	O	,	_	0	SENT_204	[p12l1295t919r1352b976],
13	Chowdhury	NNP	PERSON	Chowdhury	nn	14	SENT_204	[p12l1378t918r1707b981],
14	JR	NNP	O	JR	appos	5	SENT_204	[p12l1725t920r1790b977],
15	,	,	O	,	_	0	SENT_204	[p12l1725t920r1790b977],
16	Chowdhury	NNP	O	Chowdhury	nn	17	SENT_204	[p12l1815t918r2143b981],
17	NR	NNP	O	NR	appos	5	SENT_204	[p12l144t995r237b1041],
18	.	.	O	.	_	0	SENT_204	[p12l144t995r237b1041],

1	Genetic	JJ	O	genetic	amod	2	SENT_205	[p12l271t994r484b1041],
2	lesions	NNS	O	lesion	_	0	SENT_205	[p12l516t993r695b1041],
3	of	IN	O	of	_	0	SENT_205	[p12l725t993r779b1041],
4	bilirubin	NN	O	bilirubin	nn	6	SENT_205	[p12l808t993r1032b1041],
5	uridine-diphosphoglucuronate	JJ	O	uridine-diphosphoglucuronate	amod	6	SENT_205	[p12l1066t993r1915b1056],
6	glucuronosyltransferase	NN	O	glucuronosyltransferase	prep_of	2	SENT_205	[p12l1947t993r2142b1055, p12l141t1067r617b1130],
7	(	NN	O	(	nn	8	SENT_205	[p12l660t1068r937b1127],
8	UGT1A1	NN	O	ugt1a1	dep	6	SENT_205	[p12l660t1068r937b1127],
9	)	CD	NUMBER	)	num	8	SENT_205	[p12l660t1068r937b1127],
10	causing	VBG	O	cause	xcomp	8	SENT_205	[p12l981t1069r1188b1130],
11	Crigler-Najjar	NNP	O	Crigler-Najjar	nn	14	SENT_205	[p12l1233t1067r1618b1130],
12	and	CC	O	and	_	0	SENT_205	[p12l1657t1067r1758b1115],
13	Gilbert	NNP	PERSON	Gilbert	conj_and	11	SENT_205	[p12l1802t1067r1991b1115],
14	syndromes	NNS	O	syndrome	dobj	10	SENT_205	[p12l2031t1081r2142b1130, p12l141t1143r362b1191],
15	:	:	O	:	_	0	SENT_205	[p12l2031t1081r2142b1130, p12l141t1143r362b1191],
16	correlation	NN	O	correlation	dep	2	SENT_205	[p12l394t1143r688b1191],
17	of	IN	O	of	_	0	SENT_205	[p12l719t1143r773b1191],
18	genotype	NN	O	genotype	prep_of	16	SENT_205	[p12l799t1149r1062b1206],
19	to	TO	O	to	_	0	SENT_205	[p12l1090t1149r1145b1191],
20	phenotype	NN	O	phenotype	prep_to	18	SENT_205	[p12l1176t1143r1490b1206],
21	.	.	O	.	_	0	SENT_205	[p12l1176t1143r1490b1206],

1	Hum	NNP	O	Hum	nn	2	SENT_206	[p12l1524t1145r1648b1191],
2	Mutat	NNP	O	Mutat	_	0	SENT_206	[p12l1677t1145r1842b1191],
3	2000	CD	DATE	2000	num	2	SENT_206	[p12l1867t1144r2023b1201],
4	;	:	O	;	_	0	SENT_206	[p12l1867t1144r2023b1201],
5	16	CD	NUMBER	16	num	7	SENT_206	[p12l2059t1144r2140b1191],
6	:	:	O	:	_	0	SENT_206	[p12l2059t1144r2140b1191],
7	297-306	CD	NUMBER	297-306	dep	2	SENT_206	[p12l141t1220r403b1266],
8	.	.	O	.	_	0	SENT_206	[p12l141t1220r403b1266],

1	Gilbert	NNP	PERSON	Gilbert	nn	2	SENT_207	[p12l141t1294r330b1342],
2	NA	NNP	PERSON	NA	_	0	SENT_207	[p12l354t1296r451b1352],
3	,	,	O	,	_	0	SENT_207	[p12l354t1296r451b1352],
4	Lereboullet	NNP	PERSON	Lereboullet	nn	6	SENT_207	[p12l481t1294r789b1342],
5	P.	NNP	PERSON	P.	nn	6	SENT_207	[p12l814t1296r856b1342],
6	La	NNP	PERSON	La	appos	2	SENT_207	[p12l886t1296r940b1342],
7	cholémie	JJ	O	cholémie	amod	9	SENT_207	[p12l965t1290r1217b1342],
8	simple	JJ	O	simple	amod	9	SENT_207	[p12l1240t1294r1419b1357],
9	familiale	NN	O	familiale	dep	6	SENT_207	[p12l1440t1294r1686b1342],
10	.	.	O	.	_	0	SENT_207	[p12l1440t1294r1686b1342],

1	Sein	NNP	O	Sein	nn	2	SENT_208	[p12l1715t1295r1822b1342],
2	Méd	NNP	O	Méd	_	0	SENT_208	[p12l1845t1290r1964b1342],
3	1901	CD	DATE	1901	num	2	SENT_208	[p12l1985t1295r2139b1351],
4	;	:	O	;	_	0	SENT_208	[p12l1985t1295r2139b1351],
5	21	CD	NUMBER	21	num	7	SENT_208	[p12l141t1371r225b1417],
6	:	:	O	:	_	0	SENT_208	[p12l141t1371r225b1417],
7	241-243	CD	NUMBER	241-243	dep	2	SENT_208	[p12l254t1371r515b1417],
8	.	.	O	.	_	0	SENT_208	[p12l254t1371r515b1417],

1	Owens	NNP	PERSON	Owens	nn	2	SENT_209	[p12l146t1447r335b1493],
2	D	NNP	O	D	_	0	SENT_209	[p12l374t1447r429b1503],
3	,	,	O	,	_	0	SENT_209	[p12l374t1447r429b1503],
4	Evans	NNP	PERSON	Evans	nn	7	SENT_209	[p12l470t1447r620b1493],
5	J.	NNP	O	J.	nn	7	SENT_209	[p12l654t1447r683b1504],
6	Population	NNP	O	Population	nn	7	SENT_209	[p12l725t1445r1018b1508],
7	studies	NNS	O	study	appos	2	SENT_209	[p12l1055t1445r1245b1493],
8	on	IN	O	on	_	0	SENT_209	[p12l1280t1459r1347b1493],
9	Gilbert	NNP	PERSON	Gilbert	poss	11	SENT_209	[p12l1385t1445r1614b1493],
10	's	POS	O	's	_	0	SENT_209	[p12l1385t1445r1614b1493],
11	syndrome	NN	O	syndrome	prep_on	7	SENT_209	[p12l1649t1445r1940b1508],
12	.	.	O	.	_	0	SENT_209	[p12l1649t1445r1940b1508],

1	/	:	O	/	punct	3	SENT_210	[p12l1975t1447r1996b1504],
2	Med	NNP	O	Med	nn	3	SENT_210	[p12l2029t1445r2148b1493],
3	Genet	NNP	O	Genet	_	0	SENT_210	[p12l149t1521r305b1567],
4	1975	CD	DATE	1975	dep	3	SENT_210	[p12l330t1521r483b1577],
5	;	:	O	;	_	0	SENT_210	[p12l330t1521r483b1577],
6	12	CD	NUMBER	12	dep	3	SENT_210	[p12l516t1521r597b1567],
7	:	:	O	:	_	0	SENT_210	[p12l516t1521r597b1567],
8	152-156	CD	NUMBER	152-156	dep	6	SENT_210	[p12l628t1521r887b1567],
9	.	.	O	.	_	0	SENT_210	[p12l628t1521r887b1567],

1	Bailey	NNP	PERSON	Bailey	nn	2	SENT_211	[p12l148t1594r306b1657],
2	A	NNP	O	A	_	0	SENT_211	[p12l327t1597r379b1652],
3	,	,	O	,	_	0	SENT_211	[p12l327t1597r379b1652],
4	Robinson	NNP	PERSON	Robinson	nn	5	SENT_211	[p12l410t1594r660b1642],
5	D	NNP	O	D	appos	2	SENT_211	[p12l690t1597r745b1652],
6	,	,	O	,	_	0	SENT_211	[p12l690t1597r745b1652],
7	Dawson	NNP	PERSON	Dawson	nn	8	SENT_211	[p12l777t1597r994b1642],
8	AM	NNP	O	AM	appos	5	SENT_211	[p12l1019t1597r1130b1642],
9	.	.	O	.	_	0	SENT_211	[p12l1019t1597r1130b1642],

1	Does	VBZ	O	do	_	0	SENT_212	[p12l1161t1597r1295b1642],
2	Gilbert	NNP	PERSON	Gilbert	poss	4	SENT_212	[p12l1320t1594r1549b1642],
3	's	POS	O	's	_	0	SENT_212	[p12l1320t1594r1549b1642],
4	disease	NN	O	disease	nsubj	5	SENT_212	[p12l1574t1594r1769b1642],
5	exist	VB	O	exist	ccomp	1	SENT_212	[p12l1794t1594r1946b1642],
6	?	.	O	?	_	0	SENT_212	[p12l1794t1594r1946b1642],

1	Lancet	NNP	O	Lancet	_	0	SENT_213	[p12l1973t1597r2147b1642],
2	1977	CD	DATE	1977	num	1	SENT_213	[p12l149t1671r302b1727],
3	;	:	O	;	_	0	SENT_213	[p12l149t1671r302b1727],
4	1	CD	NUMBER	1	num	6	SENT_213	[p12l335t1671r379b1718],
5	:	:	O	:	_	0	SENT_213	[p12l335t1671r379b1718],
6	931-933	CD	NUMBER	931-933	dep	1	SENT_213	[p12l408t1671r669b1718],
7	.	.	O	.	_	0	SENT_213	[p12l408t1671r669b1718],

1	Black	JJ	O	black	amod	2	SENT_214	[p12l149t2251r288b2299],
2	M	NN	O	m	_	0	SENT_214	[p12l339t2254r406b2309],
3	,	,	O	,	_	0	SENT_214	[p12l339t2254r406b2309],
4	Billing	NN	O	billing	nn	5	SENT_214	[p12l461t2251r624b2314],
5	BH	NN	O	bh	appos	2	SENT_214	[p12l679t2254r769b2299],
6	.	.	O	.	_	0	SENT_214	[p12l679t2254r769b2299],

1	Hepatic	JJ	O	hepatic	amod	5	SENT_215	[p12l825t2253r1033b2314],
2	bilirubin	NN	O	bilirubin	nn	5	SENT_215	[p12l1084t2251r1307b2299],
3	UDP-glucuronyl	NN	MISC	udp-glucuronyl	nn	5	SENT_215	[p12l1361t2251r1799b2314],
4	transferase	NN	O	transferase	nn	5	SENT_215	[p12l1850t2251r2146b2299],
5	activity	NN	O	activity	_	0	SENT_215	[p12l146t2328r343b2390],
6	in	IN	O	in	_	0	SENT_215	[p12l378t2328r423b2374],
7	liver	NN	O	liver	nn	8	SENT_215	[p12l462t2327r574b2375],
8	disease	NN	O	disease	prep_in	5	SENT_215	[p12l606t2327r801b2375],
9	and	CC	O	and	_	0	SENT_215	[p12l836t2327r936b2375],
10	Gilbert	NNP	PERSON	Gilbert	poss	12	SENT_215	[p12l974t2327r1203b2375],
11	's	POS	O	's	_	0	SENT_215	[p12l974t2327r1203b2375],
12	syndrome	NN	O	syndrome	prep_in	5	SENT_215	[p12l1237t2327r1529b2390],
13	.	.	O	.	_	0	SENT_215	[p12l1237t2327r1529b2390],

1	N	NN	O	n	nn	3	SENT_216	[p12l1569t2329r1613b2374],
2	Engll	NNP	O	Engll	nn	3	SENT_216	[p12l1646t2327r1805b2390],
3	Med	NNP	O	Med	_	0	SENT_216	[p12l1838t2327r1957b2375],
4	1969	CD	DATE	1969	num	3	SENT_216	[p12l1988t2328r2143b2385],
5	;	:	O	;	_	0	SENT_216	[p12l1988t2328r2143b2385],
6	280	CD	NUMBER	280	num	8	SENT_216	[p12l147t2404r267b2450],
7	:	:	O	:	_	0	SENT_216	[p12l147t2404r267b2450],
8	1266-1271	CD	DATE	1266-1271	dep	3	SENT_216	[p12l299t2404r631b2450],
9	.	.	O	.	_	0	SENT_216	[p12l299t2404r631b2450],

1	Bosma	NNP	PERSON	Bosma	nn	2	SENT_217	[p12l149t2480r327b2526],
2	PJ	NNP	PERSON	PJ	_	0	SENT_217	[p12l352t2480r411b2537],
3	,	,	O	,	_	0	SENT_217	[p12l352t2480r411b2537],
4	Chowdhury	NNP	PERSON	Chowdhury	nn	5	SENT_217	[p12l436t2478r765b2541],
5	JR	NNP	O	JR	appos	2	SENT_217	[p12l783t2480r847b2537],
6	,	,	O	,	_	0	SENT_217	[p12l783t2480r847b2537],
7	Bakker	NNP	PERSON	Bakker	nn	8	SENT_217	[p12l874t2478r1053b2526],
8	C	NNP	O	C	appos	2	SENT_217	[p12l1072t2480r1126b2536],
9	,	,	O	,	_	0	SENT_217	[p12l1072t2480r1126b2536],
10	Gantla	NNP	LOCATION	Gantla	nn	11	SENT_217	[p12l1150t2478r1329b2526],
11	S	NNP	LOCATION	S	appos	2	SENT_217	[p12l1352t2480r1395b2536],
12	,	,	O	,	_	0	SENT_217	[p12l1352t2480r1395b2536],
13	de	FW	O	de	nn	15	SENT_217	[p12l1418t2478r1484b2526],
14	Boer	FW	O	boer	nn	15	SENT_217	[p12l1507t2480r1631b2526],
15	A	NN	O	a	appos	2	SENT_217	[p12l1646t2480r1698b2536],
16	,	,	O	,	_	0	SENT_217	[p12l1646t2480r1698b2536],
17	Oostra	NNP	O	Oostra	nn	18	SENT_217	[p12l1722t2480r1904b2526],
18	BA	NN	O	ba	appos	2	SENT_217	[p12l1928t2480r1999b2525],
19	et	FW	O	et	nn	20	SENT_217	[p12l2019t2484r2067b2526],
20	al.	FW	O	al.	dep	18	SENT_217	[p12l2085t2478r2143b2526],
21	.	.	O	.	_	0	SENT_217	[p12l2085t2478r2143b2526],

1	The	DT	O	the	det	3	SENT_218	[p12l144t2552r247b2600],
2	genetic	JJ	O	genetic	amod	3	SENT_218	[p12l301t2554r506b2615],
3	basis	NN	O	basis	_	0	SENT_218	[p12l561t2552r689b2600],
4	of	IN	O	of	_	0	SENT_218	[p12l744t2552r797b2600],
5	the	DT	O	the	det	7	SENT_218	[p12l847t2552r935b2600],
6	reduced	VBN	O	reduce	amod	7	SENT_218	[p12l992t2552r1213b2600],
7	expression	NN	O	expression	prep_of	3	SENT_218	[p12l1270t2554r1559b2615],
8	of	IN	O	of	_	0	SENT_218	[p12l1616t2552r1670b2600],
9	bilirubin	NN	O	bilirubin	nn	10	SENT_218	[p12l1723t2552r1946b2600],
10	UDPglucuronosyltransferase	NN	O	udpglucuronosyltransferase	prep_of	3	SENT_218	[p12l2005t2555r2145b2600, p12l146t2628r802b2691],
11	1	CD	NUMBER	1	num	10	SENT_218	[p12l839t2629r856b2675],
12	in	IN	O	in	_	0	SENT_218	[p12l902t2629r947b2675],
13	Gilbert	NNP	PERSON	Gilbert	poss	15	SENT_218	[p12l983t2628r1212b2676],
14	's	POS	O	's	_	0	SENT_218	[p12l983t2628r1212b2676],
15	syndrome	NN	O	syndrome	prep_in	3	SENT_218	[p12l1245t2628r1536b2691],
16	.	.	O	.	_	0	SENT_218	[p12l1245t2628r1536b2691],

1	N	NN	O	n	nn	3	SENT_219	[p12l1575t2630r1619b2675],
2	Englj	NNP	O	Englj	nn	3	SENT_219	[p12l1651t2628r1808b2691],
3	Med	NNP	O	Med	_	0	SENT_219	[p12l1840t2628r1958b2676],
4	1995	CD	DATE	1995	num	3	SENT_219	[p12l1989t2629r2143b2686],
5	;	:	O	;	_	0	SENT_219	[p12l1989t2629r2143b2686],
6	333	CD	NUMBER	333	num	8	SENT_219	[p12l147t2706r267b2752],
7	:	:	O	:	_	0	SENT_219	[p12l147t2706r267b2752],
8	1171-1175	CD	DATE	1171-1175	dep	3	SENT_219	[p12l299t2706r631b2752],
9	.	.	O	.	_	0	SENT_219	[p12l299t2706r631b2752],

1	Aono	NNP	O	Aono	nn	2	SENT_220	[p12l144t2781r291b2826],
2	S	NNP	O	S	_	0	SENT_220	[p12l314t2780r357b2836],
3	,	,	O	,	_	0	SENT_220	[p12l314t2780r357b2836],
4	Adachi	NNP	PERSON	Adachi	nn	5	SENT_220	[p12l380t2778r568b2826],
5	Y	NN	PERSON	y	appos	2	SENT_220	[p12l590t2780r638b2836],
6	,	,	O	,	_	0	SENT_220	[p12l590t2780r638b2836],
7	Uyama	NN	O	uyama	nn	8	SENT_220	[p12l665t2781r853b2841],
8	E	NN	O	e	appos	2	SENT_220	[p12l879t2781r919b2836],
9	,	,	O	,	_	0	SENT_220	[p12l879t2781r919b2836],
10	Yamada	NNP	PERSON	Yamada	nn	11	SENT_220	[p12l942t2778r1164b2826],
11	Y	NN	PERSON	y	appos	2	SENT_220	[p12l1185t2780r1232b2836],
12	,	,	O	,	_	0	SENT_220	[p12l1185t2780r1232b2836],
13	Keino	NN	PERSON	keino	nn	14	SENT_220	[p12l1260t2780r1413b2826],
14	H	NN	O	h	appos	2	SENT_220	[p12l1437t2781r1490b2836],
15	,	,	O	,	_	0	SENT_220	[p12l1437t2781r1490b2836],
16	Nanno	NNP	ORGANIZATION	Nanno	nn	17	SENT_220	[p12l1518t2781r1704b2826],
17	T	NN	ORGANIZATION	t	appos	2	SENT_220	[p12l1724t2781r1759b2826],
18	et	FW	O	et	nn	19	SENT_220	[p12l1780t2784r1829b2826],
19	al.	FW	O	al.	dep	17	SENT_220	[p12l1848t2778r1905b2826],
20	.	.	O	.	_	0	SENT_220	[p12l1848t2778r1905b2826],

1	Analysis	NN	O	analysis	_	0	SENT_221	[p12l1928t2778r2146b2841],
2	of	IN	O	of	_	0	SENT_221	[p12l146t2854r200b2902],
3	genes	NNS	O	gene	prep_of	1	SENT_221	[p12l265t2868r426b2917],
4	for	IN	O	for	_	0	SENT_221	[p12l491t2854r568b2902],
5	bilirubin	NN	O	bilirubin	nn	6	SENT_221	[p12l635t2854r860b2902],
6	UDP-gIucuronosyltransferase	NN	O	udp-giucuronosyltransferase	prep_for	3	SENT_221	[p12l932t2854r1732b2917],
7	in	IN	O	in	_	0	SENT_221	[p12l1801t2855r1846b2901],
8	Gilbert	NNP	PERSON	Gilbert	poss	10	SENT_221	[p12l1916t2854r2146b2902],
9	's	POS	O	's	_	0	SENT_221	[p12l1916t2854r2146b2902],
10	syndrome	NN	O	syndrome	prep_in	1	SENT_221	[p12l146t2929r438b2991],
11	.	.	O	.	_	0	SENT_221	[p12l146t2929r438b2991],

1	Lancet	NNP	O	Lancet	_	0	SENT_222	[p12l468t2931r642b2976],
2	1995	CD	DATE	1995	num	1	SENT_222	[p12l666t2930r820b2986],
3	;	:	O	;	_	0	SENT_222	[p12l666t2930r820b2986],
4	345	CD	NUMBER	345	num	6	SENT_222	[p12l850t2930r970b2976],
5	:	:	O	:	_	0	SENT_222	[p12l850t2930r970b2976],
6	958-959	CD	NUMBER	958-959	dep	1	SENT_222	[p12l999t2930r1261b2976],
7	.	.	O	.	_	0	SENT_222	[p12l999t2930r1261b2976],

1	Monaghan	NNP	PERSON	Monaghan	nn	2	SENT_223	[p12l149t3004r448b3066],
2	G	NNP	PERSON	G	_	0	SENT_223	[p12l472t3005r530b3062],
3	,	,	O	,	_	0	SENT_223	[p12l472t3005r530b3062],
4	Ryan	NNP	PERSON	Ryan	nn	5	SENT_223	[p12l557t3006r684b3067],
5	M	NNP	PERSON	M	appos	2	SENT_223	[p12l709t3006r776b3062],
6	,	,	O	,	_	0	SENT_223	[p12l709t3006r776b3062],
7	Seddon	NNP	PERSON	Seddon	nn	8	SENT_223	[p12l802t3004r1009b3052],
8	R	NNP	PERSON	R	appos	2	SENT_223	[p12l1035t3006r1078b3062],
9	,	,	O	,	_	0	SENT_223	[p12l1035t3006r1078b3062],
10	Hume	NNP	PERSON	Hume	nn	11	SENT_223	[p12l1105t3006r1269b3052],
11	R	NNP	PERSON	R	conj_and	5	SENT_223	[p12l1293t3006r1336b3062],
12	,	,	O	,	_	0	SENT_223	[p12l1293t3006r1336b3062],
13	Burchell	NNP	PERSON	Burchell	nn	16	SENT_223	[p12l1363t3004r1579b3052],
14	B.	NNP	O	B.	nn	16	SENT_223	[p12l1605t3006r1650b3052],
15	Genetic	NNP	O	Genetic	nn	16	SENT_223	[p12l1674t3005r1887b3052],
16	variation	NN	O	variation	conj_and	5	SENT_223	[p12l1905t3005r2144b3052],
17	in	IN	O	in	_	0	SENT_223	[p12l148t3080r192b3126],
18	bilirubin	NN	O	bilirubin	nn	21	SENT_223	[p12l228t3078r452b3126],
19	UPD-gIucuronosyltransferase	NN	O	upd-giucuronosyltransferase	nn	21	SENT_223	[p12l488t3078r1289b3141],
20	gene	NN	O	gene	nn	21	SENT_223	[p12l1321t3092r1456b3141],
21	promoter	NN	O	promoter	prep_in	16	SENT_223	[p12l1490t3084r1752b3141],
22	and	CC	O	and	_	0	SENT_223	[p12l1782t3078r1882b3126],
23	Gilbert	NNP	PERSON	Gilbert	poss	25	SENT_223	[p12l1916t3078r2146b3126],
24	's	POS	O	's	_	0	SENT_223	[p12l1916t3078r2146b3126],
25	syndrome	NN	O	syndrome	appos	2	SENT_223	[p12l146t3154r438b3217],
26	.	.	O	.	_	0	SENT_223	[p12l146t3154r438b3217],

1	Lancet	NNP	O	Lancet	_	0	SENT_224	[p12l468t3156r642b3202],
2	1996	CD	DATE	1996	num	1	SENT_224	[p12l666t3155r820b3212],
3	;	:	O	;	_	0	SENT_224	[p12l666t3155r820b3212],
4	347	CD	NUMBER	347	num	6	SENT_224	[p12l851t3156r970b3202],
5	:	:	O	:	_	0	SENT_224	[p12l851t3156r970b3202],
6	578-581	CD	NUMBER	578-581	dep	1	SENT_224	[p12l999t3155r1261b3202],
7	.	.	O	.	_	0	SENT_224	[p12l999t3155r1261b3202],

1	Borlak	NNP	PERSON	Borlak	nn	2	SENT_225	[p12l149t3229r316b3276],
2	J	NNP	PERSON	J	_	0	SENT_225	[p12l337t3231r367b3287],
3	,	,	O	,	_	0	SENT_225	[p12l337t3231r367b3287],
4	Thum	NNP	O	Thum	nn	5	SENT_225	[p12l392t3229r553b3276],
5	T	NN	O	t	appos	2	SENT_225	[p12l577t3231r625b3287],
6	,	,	O	,	_	0	SENT_225	[p12l577t3231r625b3287],
7	Landt	NN	PERSON	landt	nn	8	SENT_225	[p12l656t3229r810b3276],
8	O	NN	PERSON	o	appos	2	SENT_225	[p12l833t3230r893b3287],
9	,	,	O	,	_	0	SENT_225	[p12l833t3230r893b3287],
10	Erb	NN	PERSON	erb	nn	11	SENT_225	[p12l924t3229r1008b3276],
11	K	NN	O	k	appos	2	SENT_225	[p12l1035t3230r1081b3286],
12	,	,	O	,	_	0	SENT_225	[p12l1035t3230r1081b3286],
13	Hermann	NNP	PERSON	Hermann	nn	16	SENT_225	[p12l1111t3231r1364b3276],
14	R.	NNP	PERSON	R.	nn	16	SENT_225	[p12l1393t3231r1437b3276],
15	Molecular	JJ	PERSON	molecular	amod	16	SENT_225	[p12l1466t3229r1742b3276],
16	diagnosis	NN	O	diagnosis	appos	2	SENT_225	[p12l1763t3229r2020b3291],
17	of	IN	O	of	_	0	SENT_225	[p12l2044t3229r2098b3276],
18	a	DT	O	a	det	21	SENT_225	[p12l2118t3243r2145b3276],
19	familial	JJ	O	familial	amod	21	SENT_225	[p12l144t3304r340b3352],
20	nonhemolytic	JJ	O	nonhemolytic	amod	21	SENT_225	[p12l403t3304r787b3367],
21	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	16	SENT_225	[p12l847t3304r1369b3367],
22	(	CD	NUMBER	(	dep	2	SENT_225	[p12l1430t3304r1682b3364],
23	Gilbert	NNP	PERSON	Gilbert	poss	26	SENT_225	[p12l1430t3304r1682b3364],
24	's	POS	O	's	_	0	SENT_225	[p12l1430t3304r1682b3364],
25	syndrome	NN	O	syndrome	nn	26	SENT_225	[p12l1741t3304r2039b3367],
26	)	NN	O	)	npadvmod	27	SENT_225	[p12l1741t3304r2039b3367],
27	in	IN	O	in	dep	2	SENT_225	[p12l2100t3305r2144b3351],
28	healthy	JJ	O	healthy	amod	29	SENT_225	[p12l148t3379r351b3442],
29	subjects	NNS	O	subject	pobj	27	SENT_225	[p12l375t3379r610b3442],
30	.	.	O	.	_	0	SENT_225	[p12l375t3379r610b3442],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_226	[p12l642t3379r949b3442],
2	2000	CD	DATE	2000	num	1	SENT_226	[p12l968t3380r1125b3437],
3	;	:	O	;	_	0	SENT_226	[p12l968t3380r1125b3437],
4	32	CD	NUMBER	32	num	6	SENT_226	[p12l1155t3380r1237b3427],
5	:	:	O	:	_	0	SENT_226	[p12l1155t3380r1237b3427],
6	792-795	CD	NUMBER	792-795	dep	1	SENT_226	[p12l1270t3380r1529b3427],
7	.	.	O	.	_	0	SENT_226	[p12l1270t3380r1529b3427],

1	Rauchschwalbe	NNP	PERSON	Rauchschwalbe	nn	2	SENT_227	[p12l149t3454r573b3501],
2	SK	NNP	O	SK	_	0	SENT_227	[p12l605t3455r685b3511],
3	,	,	O	,	_	0	SENT_227	[p12l605t3455r685b3511],
4	Zuhlsdorf	NNP	O	Zuhlsdorf	nn	5	SENT_227	[p12l718t3454r985b3501],
5	MT	NNP	O	MT	appos	2	SENT_227	[p12l1016t3456r1118b3511],
6	,	,	O	,	_	0	SENT_227	[p12l1016t3456r1118b3511],
7	Schuhly	NNP	O	Schuhly	nn	8	SENT_227	[p12l1153t3454r1370b3516],
8	U	NNP	O	U	appos	2	SENT_227	[p12l1401t3456r1454b3511],
9	,	,	O	,	_	0	SENT_227	[p12l1401t3456r1454b3511],
10	Kuhlmann	NNP	PERSON	Kuhlmann	nn	11	SENT_227	[p12l1490t3454r1771b3501],
11	J.	NNP	O	J.	nsubj	12	SENT_227	[p12l1802t3456r1832b3513],
12	Predicting	VBG	O	predict	dep	2	SENT_227	[p12l1868t3454r2144b3516],
13	the	DT	O	the	det	14	SENT_227	[p12l145t3529r233b3577],
14	risk	NN	O	risk	dobj	12	SENT_227	[p12l269t3529r356b3577],
15	of	IN	O	of	_	0	SENT_227	[p12l387t3529r441b3577],
16	sporadic	JJ	O	sporadic	amod	19	SENT_227	[p12l470t3529r703b3592],
17	elevated	JJ	O	elevated	amod	19	SENT_227	[p12l736t3529r965b3577],
18	bilirubin	NN	O	bilirubin	nn	19	SENT_227	[p12l1002t3529r1225b3577],
19	levels	NNS	O	level	prep_of	14	SENT_227	[p12l1263t3529r1408b3577],
20	and	CC	O	and	_	0	SENT_227	[p12l1441t3529r1541b3577],
21	diagnosing	VBG	O	diagnose	conj_and	12	SENT_227	[p12l1576t3529r1881b3591],
22	Gilbert	NNP	PERSON	Gilbert	poss	24	SENT_227	[p12l1916t3529r2146b3577],
23	's	POS	O	's	_	0	SENT_227	[p12l1916t3529r2146b3577],
24	syndrome	NN	O	syndrome	dobj	21	SENT_227	[p12l146t3603r421b3666],
25	by	IN	O	by	_	0	SENT_227	[p12l457t3603r522b3666],
26	genotyping	VBG	O	genotype	prepc_by	21	SENT_227	[p12l554t3605r874b3666],
27	UGT1A1	NN	O	ugt1a1	dobj	26	SENT_227	[p12l912t3605r1243b3651],
28	*	CD	NUMBER	*	number	29	SENT_227	[p12l912t3605r1243b3651],
29	28	CD	NUMBER	28	num	31	SENT_227	[p12l912t3605r1243b3651],
30	promoter	NN	O	promoter	nn	31	SENT_227	[p12l1280t3609r1542b3666],
31	polymorphism	NN	O	polymorphism	dobj	12	SENT_227	[p12l1576t3603r1994b3666],
32	.	.	O	.	_	0	SENT_227	[p12l1576t3603r1994b3666],

1	Int	NN	O	int	nn	5	SENT_228	[p12l2033t3606r2150b3662],
2	]	CD	NUMBER	]	num	5	SENT_228	[p12l2033t3606r2150b3662],
3	Clin	NNP	O	Clin	nn	5	SENT_228	[p12l150t3679r248b3727],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_228	[p12l274t3679r559b3727],
5	Ther	NNP	O	Ther	_	0	SENT_228	[p12l585t3679r702b3727],
6	2002	CD	DATE	2002	dep	5	SENT_228	[p12l720t3680r877b3737],
7	;	:	O	;	_	0	SENT_228	[p12l720t3680r877b3737],
8	40	CD	NUMBER	40	num	10	SENT_228	[p12l905t3680r991b3727],
9	:	:	O	:	_	0	SENT_228	[p12l905t3680r991b3727],
10	233-240	CD	NUMBER	233-240	dep	5	SENT_228	[p12l1020t3680r1281b3727],
11	.	.	O	.	_	0	SENT_228	[p12l1020t3680r1281b3727],

1	Raijmakers	NNPS	O	Raijmakers	nn	2	SENT_229	[p12l149t3754r438b3816],
2	MT	NNP	O	MT	_	0	SENT_229	[p12l484t3756r586b3811],
3	,	,	O	,	_	0	SENT_229	[p12l484t3756r586b3811],
4	Jansen	NNP	PERSON	Jansen	nn	5	SENT_229	[p12l631t3756r806b3813],
5	PL	NNP	O	PL	appos	2	SENT_229	[p12l853t3756r926b3811],
6	,	,	O	,	_	0	SENT_229	[p12l853t3756r926b3811],
7	Steegers	NNP	ORGANIZATION	Steegers	nn	8	SENT_229	[p12l974t3755r1206b3816],
8	EA	NN	ORGANIZATION	ea	appos	2	SENT_229	[p12l1251t3756r1330b3811],
9	,	,	O	,	_	0	SENT_229	[p12l1251t3756r1330b3811],
10	Peters	NNP	PERSON	Peters	nn	11	SENT_229	[p12l1379t3756r1540b3801],
11	WH	NNP	PERSON	WH	appos	2	SENT_229	[p12l1580t3755r1698b3801],
12	.	.	O	.	_	0	SENT_229	[p12l1580t3755r1698b3801],

1	Association	NNP	O	Association	_	0	SENT_230	[p12l1741t3755r2050b3801],
2	of	IN	O	of	_	0	SENT_230	[p12l2095t3754r2149b3801],
3	human	JJ	O	human	amod	7	SENT_230	[p13l148t13r340b61],
4	liver	NN	O	liver	nn	7	SENT_230	[p13l379t13r491b61],
5	bilirubin	NN	O	bilirubin	nn	7	SENT_230	[p13l525t13r749b61],
6	UDP-glucuronyltransferase	NN	MISC	udp-glucuronyltransferase	nn	7	SENT_230	[p13l788t13r1527b76],
7	activity	NN	O	activity	prep_of	1	SENT_230	[p13l1561t14r1758b76],
8	with	IN	O	with	_	0	SENT_230	[p13l1790t13r1909b61],
9	a	DT	O	a	det	10	SENT_230	[p13l1946t27r1972b61],
10	polymorphism	NN	O	polymorphism	prep_with	7	SENT_230	[p13l2010t13r2146b76, p13l148t88r427b151],
11	in	IN	O	in	_	0	SENT_230	[p13l461t89r506b135],
12	the	DT	O	the	det	14	SENT_230	[p13l537t88r625b136],
13	promoter	NN	O	promoter	nn	14	SENT_230	[p13l657t94r920b151],
14	region	NN	O	region	prep_in	10	SENT_230	[p13l949t89r1122b151],
15	of	IN	O	of	_	0	SENT_230	[p13l1154t88r1208b136],
16	the	DT	O	the	det	19	SENT_230	[p13l1234t88r1322b136],
17	UGT1	NN	O	ugt1	nn	19	SENT_230	[p13l1355t89r1498b136],
18	A1	NN	O	a1	nn	19	SENT_230	[p13l1512t89r1574b135],
19	gene	NN	O	gene	prep_of	1	SENT_230	[p13l1616t102r1767b151],
20	.	.	O	.	_	0	SENT_230	[p13l1616t102r1767b151],

1	/	:	O	/	punct	2	SENT_231	[p13l1797t90r1818b147],
2	Hepatology	NNP	O	Hepatology	_	0	SENT_231	[p13l1846t88r2153b151],
3	2000	CD	DATE	2000	dep	2	SENT_231	[p13l147t164r304b221],
4	;	:	O	;	_	0	SENT_231	[p13l147t164r304b221],
5	33	CD	NUMBER	33	dep	2	SENT_231	[p13l334t164r417b211],
6	:	:	O	:	_	0	SENT_231	[p13l334t164r417b211],
7	348-351	CD	NUMBER	348-351	dep	5	SENT_231	[p13l448t164r708b211],
8	.	.	O	.	_	0	SENT_231	[p13l448t164r708b211],

1	Beutler	NNP	PERSON	Beutler	nn	2	SENT_232	[p13l149t238r342b285],
2	E	NNP	O	E	_	0	SENT_232	[p13l396t240r436b295],
3	,	,	O	,	_	0	SENT_232	[p13l396t240r436b295],
4	Gelbart	NNP	PERSON	Gelbart	nn	5	SENT_232	[p13l494t238r699b285],
5	T	NN	O	t	appos	2	SENT_232	[p13l749t240r797b296],
6	,	,	O	,	_	0	SENT_232	[p13l749t240r797b296],
7	Demina	NNP	PERSON	Demina	nn	10	SENT_232	[p13l857t239r1070b285],
8	A.	NNP	O	A.	nn	10	SENT_232	[p13l1122t240r1175b285],
9	Racial	JJ	O	racial	amod	10	SENT_232	[p13l1235t238r1386b285],
10	variability	NN	O	variability	appos	2	SENT_232	[p13l1440t238r1708b300],
11	in	IN	O	in	_	0	SENT_232	[p13l1762t239r1806b285],
12	the	DT	O	the	det	13	SENT_232	[p13l1862t238r1950b285],
13	UDPglucuronosyltransferase	NN	O	udpglucuronosyltransferase	prep_in	10	SENT_232	[p13l2006t240r2146b285, p13l146t312r802b375],
14	1	CD	NUMBER	1	number	15	SENT_232	[p13l830t314r846b360],
15	(	CD	NUMBER	(	num	19	SENT_232	[p13l883t313r1051b372],
16	UGT1	NN	O	ugt1	nn	19	SENT_232	[p13l883t313r1051b372],
17	A1	NN	O	a1	nn	19	SENT_232	[p13l1065t313r1161b372],
18	)	NN	O	)	nn	19	SENT_232	[p13l1065t313r1161b372],
19	promoter	NN	O	promoter	dep	10	SENT_232	[p13l1188t318r1464b375],
20	:	:	O	:	_	0	SENT_232	[p13l1188t318r1464b375],
21	a	DT	O	a	det	23	SENT_232	[p13l1491t326r1518b360],
22	balanced	JJ	O	balanced	amod	23	SENT_232	[p13l1544t312r1791b360],
23	polymorphism	NN	O	polymorphism	dep	2	SENT_232	[p13l1819t312r2146b375, p13l148t389r236b436],
24	for	IN	O	for	_	0	SENT_232	[p13l257t388r336b436],
25	regulation	NN	O	regulation	prep_for	23	SENT_232	[p13l356t388r633b451],
26	of	IN	O	of	_	0	SENT_232	[p13l657t388r711b436],
27	bilirubin	NN	O	bilirubin	nn	28	SENT_232	[p13l730t388r954b436],
28	metabolism	NN	O	metabolism	prep_of	23	SENT_232	[p13l980t388r1332b436],
29	?	.	O	?	_	0	SENT_232	[p13l980t388r1332b436],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_233	[p13l1356t390r1469b436],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_233	[p13l1487t388r1603b436],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_233	[p13l1617t388r1753b436],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_233	[p13l1770t389r1843b436],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_233	[p13l1863t390r1966b436],
6	1998	CD	DATE	1998	num	5	SENT_233	[p13l1989t389r2143b446],
7	;	:	O	;	_	0	SENT_233	[p13l1989t389r2143b446],
8	95	CD	NUMBER	95	num	10	SENT_233	[p13l146t466r230b512],
9	:	:	O	:	_	0	SENT_233	[p13l146t466r230b512],
10	8170-8174	CD	DURATION	8170-8174	dep	5	SENT_233	[p13l260t466r594b512],
11	.	.	O	.	_	0	SENT_233	[p13l260t466r594b512],

1	Ando	NNP	PERSON	Ando	nn	2	SENT_234	[p13l144t539r293b587],
2	Y	NN	PERSON	y	nsubj	22	SENT_234	[p13l318t541r366b597],
3	,	,	O	,	_	0	SENT_234	[p13l318t541r366b597],
4	Chida	NNP	PERSON	Chida	nn	5	SENT_234	[p13l398t539r557b587],
5	M	NNP	O	M	appos	2	SENT_234	[p13l589t541r656b597],
6	,	,	O	,	_	0	SENT_234	[p13l589t541r656b597],
7	Nakayama	NNP	PERSON	Nakayama	nn	8	SENT_234	[p13l690t539r979b602],
8	K	NNP	PERSON	K	appos	2	SENT_234	[p13l1010t541r1056b597],
9	,	,	O	,	_	0	SENT_234	[p13l1010t541r1056b597],
10	Saka	NNP	PERSON	Saka	nn	11	SENT_234	[p13l1089t539r1209b587],
11	H	NNP	PERSON	H	appos	2	SENT_234	[p13l1240t541r1294b597],
12	,	,	O	,	_	0	SENT_234	[p13l1240t541r1294b597],
13	Kamataki	NNP	PERSON	Kamataki	nn	16	SENT_234	[p13l1327t539r1577b587],
14	T.	NNP	O	T.	nn	16	SENT_234	[p13l1604t541r1653b587],
15	The	NNP	O	The	nn	16	SENT_234	[p13l1681t539r1784b587],
16	UGT1A1	NN	O	ugt1a1	appos	2	SENT_234	[p13l1814t541r2145b587],
17	*	CD	NUMBER	*	number	18	SENT_234	[p13l1814t541r2145b587],
18	28	CD	NUMBER	28	num	19	SENT_234	[p13l1814t541r2145b587],
19	allele	NN	O	allele	dep	16	SENT_234	[p13l146t613r285b661],
20	is	VBZ	O	be	cop	22	SENT_234	[p13l308t615r342b661],
21	relatively	RB	O	relatively	advmod	22	SENT_234	[p13l366t613r610b676],
22	rare	JJ	O	rare	_	0	SENT_234	[p13l633t627r735b661],
23	in	IN	O	in	_	0	SENT_234	[p13l758t615r802b661],
24	a	DT	O	a	det	26	SENT_234	[p13l826t627r852b661],
25	Japanese	JJ	MISC	japanese	amod	26	SENT_234	[p13l874t616r1116b676],
26	population	NN	O	population	prep_in	22	SENT_234	[p13l1140t613r1456b676],
27	.	.	O	.	_	0	SENT_234	[p13l1140t613r1456b676],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_235	[p13l1483t613r1967b676],
2	1998	CD	DATE	1998	num	1	SENT_235	[p13l1989t615r2143b671],
3	;	:	O	;	_	0	SENT_235	[p13l1989t615r2143b671],
4	8	CD	NUMBER	8	num	6	SENT_235	[p13l145t691r194b738],
5	:	:	O	:	_	0	SENT_235	[p13l145t691r194b738],
6	357-360	CD	NUMBER	357-360	dep	1	SENT_235	[p13l226t691r485b738],
7	.	.	O	.	_	0	SENT_235	[p13l226t691r485b738],

1	Soeda	NNP	PERSON	Soeda	nn	2	SENT_236	[p13l147t765r313b812],
2	Y	NN	PERSON	y	_	0	SENT_236	[p13l350t766r398b822],
3	,	,	O	,	_	0	SENT_236	[p13l350t766r398b822],
4	Yamamoto	NNP	PERSON	Yamamoto	nn	5	SENT_236	[p13l437t766r743b812],
5	K	NNP	PERSON	K	appos	2	SENT_236	[p13l784t766r830b822],
6	,	,	O	,	_	0	SENT_236	[p13l784t766r830b822],
7	Adachi	NNP	PERSON	Adachi	nn	8	SENT_236	[p13l869t765r1057b812],
8	Y	NN	PERSON	y	appos	2	SENT_236	[p13l1095t766r1143b822],
9	,	,	O	,	_	0	SENT_236	[p13l1095t766r1143b822],
10	Hori	NNP	PERSON	Hori	nn	11	SENT_236	[p13l1187t766r1297b812],
11	T	NN	O	t	appos	2	SENT_236	[p13l1335t767r1383b822],
12	,	,	O	,	_	0	SENT_236	[p13l1335t767r1383b822],
13	Aono	NNP	LOCATION	Aono	nn	14	SENT_236	[p13l1422t767r1570b812],
14	S	NNP	LOCATION	S	appos	2	SENT_236	[p13l1610t766r1653b822],
15	,	,	O	,	_	0	SENT_236	[p13l1610t766r1653b822],
16	Koiwai	NNP	PERSON	Koiwai	nn	17	SENT_236	[p13l1697t766r1875b812],
17	O	NNP	O	O	appos	2	SENT_236	[p13l1915t766r1960b812],
18	et	FW	O	et	nn	19	SENT_236	[p13l2001t770r2050b812],
19	al.	FW	O	al.	dep	17	SENT_236	[p13l2085t765r2143b812],
20	.	.	O	.	_	0	SENT_236	[p13l2085t765r2143b812],

1	Predicted	VBN	O	predict	_	0	SENT_237	[p13l149t840r404b888],
2	homozygous	JJ	O	homozygous	amod	4	SENT_237	[p13l457t840r814b903],
3	mis-sense	NN	O	mis-sense	nn	4	SENT_237	[p13l864t841r1127b888],
4	mutation	NN	O	mutation	dobj	1	SENT_237	[p13l1178t841r1427b888],
5	in	IN	O	in	_	0	SENT_237	[p13l1479t841r1524b887],
6	Gilbert	NNP	PERSON	Gilbert	poss	8	SENT_237	[p13l1575t840r1804b888],
7	's	POS	O	's	_	0	SENT_237	[p13l1575t840r1804b888],
8	syndrome	NN	O	syndrome	prep_in	4	SENT_237	[p13l1851t840r2143b903],
9	.	.	O	.	_	0	SENT_237	[p13l1851t840r2143b903],

1	Lancet	NNP	O	Lancet	_	0	SENT_238	[p13l149t917r322b963],
2	1995	CD	DATE	1995	num	1	SENT_238	[p13l347t916r500b973],
3	;	:	O	;	_	0	SENT_238	[p13l347t916r500b973],
4	346	CD	NUMBER	346	num	6	SENT_238	[p13l531t916r651b963],
5	:	:	O	:	_	0	SENT_238	[p13l531t916r651b963],
6	1494	CD	DATE	1494	dep	1	SENT_238	[p13l682t916r836b963],
7	.	.	O	.	_	0	SENT_238	[p13l682t916r836b963],

1	Sato	NNP	PERSON	Sato	nn	2	SENT_239	[p13l147t991r265b1037],
2	H	NNP	O	H	_	0	SENT_239	[p13l298t992r351b1047],
3	,	,	O	,	_	0	SENT_239	[p13l298t992r351b1047],
4	Adachi	NNP	PERSON	Adachi	nn	5	SENT_239	[p13l382t990r570b1037],
5	Y	NN	PERSON	y	appos	2	SENT_239	[p13l600t991r648b1047],
6	,	,	O	,	_	0	SENT_239	[p13l600t991r648b1047],
7	Koiwai	NNP	PERSON	Koiwai	nn	11	SENT_239	[p13l684t991r861b1037],
8	O.	NNP	O	O.	nn	11	SENT_239	[p13l894t991r955b1037],
9	The	NNP	O	The	nn	11	SENT_239	[p13l985t990r1088b1037],
10	genetic	JJ	O	genetic	amod	11	SENT_239	[p13l1118t991r1323b1052],
11	basis	NN	O	basis	appos	2	SENT_239	[p13l1354t990r1482b1037],
12	of	IN	O	of	_	0	SENT_239	[p13l1512t990r1566b1037],
13	Gilbert	NNP	PERSON	Gilbert	poss	15	SENT_239	[p13l1592t990r1823b1037],
14	's	POS	O	's	_	0	SENT_239	[p13l1592t990r1823b1037],
15	syndrome	NN	O	syndrome	prep_of	11	SENT_239	[p13l1851t990r2143b1052],
16	.	.	O	.	_	0	SENT_239	[p13l1851t990r2143b1052],

1	Lancet	NNP	O	Lancet	_	0	SENT_240	[p13l149t1067r322b1113],
2	1996	CD	DATE	1996	num	1	SENT_240	[p13l347t1067r500b1123],
3	;	:	O	;	_	0	SENT_240	[p13l347t1067r500b1123],
4	347	CD	NUMBER	347	num	6	SENT_240	[p13l531t1067r651b1113],
5	:	:	O	:	_	0	SENT_240	[p13l531t1067r651b1113],
6	557-558	CD	NUMBER	557-558	dep	1	SENT_240	[p13l679t1067r942b1113],
7	.	.	O	.	_	0	SENT_240	[p13l679t1067r942b1113],

1	Koiwai	NNP	PERSON	Koiwai	nn	2	SENT_241	[p13l149t1141r327b1187],
2	O	NNP	PERSON	O	_	0	SENT_241	[p13l356t1141r416b1197],
3	,	,	O	,	_	0	SENT_241	[p13l356t1141r416b1197],
4	Nishizawa	NNP	PERSON	Nishizawa	nn	5	SENT_241	[p13l449t1139r725b1187],
5	M	NNP	O	M	appos	2	SENT_241	[p13l755t1142r822b1197],
6	,	,	O	,	_	0	SENT_241	[p13l755t1142r822b1197],
7	Hasada	NNP	PERSON	Hasada	nn	8	SENT_241	[p13l855t1139r1050b1187],
8	K	NNP	PERSON	K	appos	2	SENT_241	[p13l1080t1141r1126b1197],
9	,	,	O	,	_	0	SENT_241	[p13l1080t1141r1126b1197],
10	Aono	NNP	O	Aono	nn	11	SENT_241	[p13l1154t1142r1301b1187],
11	S	NNP	O	S	appos	2	SENT_241	[p13l1328t1141r1371b1197],
12	,	,	O	,	_	0	SENT_241	[p13l1328t1141r1371b1197],
13	Adachi	NNP	PERSON	Adachi	nn	14	SENT_241	[p13l1399t1139r1587b1187],
14	Y	NN	PERSON	y	appos	2	SENT_241	[p13l1613t1141r1661b1197],
15	,	,	O	,	_	0	SENT_241	[p13l1613t1141r1661b1197],
16	Mamiya	NNP	PERSON	Mamiya	nn	17	SENT_241	[p13l1693t1141r1912b1202],
17	N	NNP	O	N	appos	2	SENT_241	[p13l1942t1142r1982b1187],
18	et	FW	O	et	nn	19	SENT_241	[p13l2013t1145r2062b1187],
19	al.	FW	O	al.	dep	17	SENT_241	[p13l2085t1139r2143b1187],
20	.	.	O	.	_	0	SENT_241	[p13l2085t1139r2143b1187],

1	Gilbert	NNP	PERSON	Gilbert	poss	3	SENT_242	[p13l147t1215r377b1263],
2	's	POS	O	's	_	0	SENT_242	[p13l147t1215r377b1263],
3	syndrome	NN	O	syndrome	nsubjpass	5	SENT_242	[p13l404t1215r680b1278],
4	is	VBZ	O	be	auxpass	5	SENT_242	[p13l710t1216r744b1263],
5	caused	VBN	O	cause	_	0	SENT_242	[p13l772t1215r960b1263],
6	by	IN	O	by	_	0	SENT_242	[p13l992t1215r1057b1278],
7	a	DT	O	a	det	10	SENT_242	[p13l1084t1229r1111b1263],
8	heterozygous	JJ	O	heterozygous	amod	10	SENT_242	[p13l1143t1215r1514b1278],
9	missense	NN	O	missense	nn	10	SENT_242	[p13l1545t1216r1787b1263],
10	mutation	NN	O	mutation	agent	5	SENT_242	[p13l1817t1216r2067b1263],
11	in	IN	O	in	_	0	SENT_242	[p13l2100t1216r2144b1262],
12	the	DT	O	the	det	13	SENT_242	[p13l145t1290r233b1337],
13	gene	NN	O	gene	prep_in	10	SENT_242	[p13l273t1304r408b1352],
14	for	IN	O	for	_	0	SENT_242	[p13l446t1290r524b1337],
15	bilirubin	NN	O	bilirubin	nn	16	SENT_242	[p13l562t1290r785b1337],
16	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	prep_for	13	SENT_242	[p13l829t1290r1645b1352],
17	.	.	O	.	_	0	SENT_242	[p13l829t1290r1645b1352],

1	Hum	NNP	O	Hum	nn	3	SENT_243	[p13l1690t1292r1814b1337],
2	Mol	NNP	O	Mol	nn	3	SENT_243	[p13l1854t1290r1957b1337],
3	Genet	NNP	O	Genet	_	0	SENT_243	[p13l1994t1291r2150b1337],
4	1995	CD	DATE	1995	num	3	SENT_243	[p13l149t1367r304b1423],
5	;	:	O	;	_	0	SENT_243	[p13l149t1367r304b1423],
6	4	CD	NUMBER	4	num	8	SENT_243	[p13l331t1367r380b1413],
7	:	:	O	:	_	0	SENT_243	[p13l331t1367r380b1413],
8	1183-1186	CD	DATE	1183-1186	dep	3	SENT_243	[p13l412t1367r744b1413],
9	.	.	O	.	_	0	SENT_243	[p13l412t1367r744b1413],

1	Schork	NNP	PERSON	Schork	nn	2	SENT_244	[p13l148t1440r334b1488],
2	NJ	NNP	O	NJ	_	0	SENT_244	[p13l375t1442r451b1499],
3	.	.	O	.	_	0	SENT_244	[p13l375t1442r451b1499],

1	Power	NNP	O	Power	nn	2	SENT_245	[p13l497t1442r668b1488],
2	calculations	NNS	O	calculation	_	0	SENT_245	[p13l706t1440r1029b1488],
3	for	IN	O	for	_	0	SENT_245	[p13l1067t1440r1145b1488],
4	genetic	JJ	O	genetic	amod	6	SENT_245	[p13l1183t1441r1387b1503],
5	association	NN	O	association	nn	6	SENT_245	[p13l1427t1441r1726b1488],
6	studies	NNS	O	study	prep_for	2	SENT_245	[p13l1769t1440r1958b1488],
7	using	VBG	O	use	partmod	2	SENT_245	[p13l2001t1441r2144b1503],
8	estimated	VBN	O	estimate	amod	10	SENT_245	[p13l146t1515r415b1562],
9	probability	NN	O	probability	nn	10	SENT_245	[p13l475t1515r773b1577],
10	distributions	NNS	O	distribution	dobj	7	SENT_245	[p13l828t1515r1185b1562],
11	.	.	O	.	_	0	SENT_245	[p13l828t1515r1185b1562],

1	Am	VBP	O	be	_	0	SENT_246	[p13l1242t1517r1330b1562],
2	/	:	O	/	punct	3	SENT_246	[p13l1379t1517r1400b1573],
3	Hum	NNP	O	Hum	nsubj	5	SENT_246	[p13l1454t1517r1578b1562],
4	Genet	NNP	O	Genet	dep	5	SENT_246	[p13l1636t1516r1792b1562],
5	2002	CD	DATE	2002	ccomp	1	SENT_246	[p13l1844t1516r2001b1572],
6	;	:	O	;	_	0	SENT_246	[p13l1844t1516r2001b1572],
7	70	CD	NUMBER	70	dobj	1	SENT_246	[p13l2062t1516r2143b1562],
8	:	:	O	:	_	0	SENT_246	[p13l2062t1516r2143b1562],
9	1480-1489	CD	DATE	1480-1489	dep	7	SENT_246	[p13l149t1593r482b1639],
10	.	.	O	.	_	0	SENT_246	[p13l149t1593r482b1639],

1	Zucker	NNP	O	Zucker	nn	2	SENT_247	[p13l146t1665r336b1713],
2	SD	NN	O	sd	_	0	SENT_247	[p13l371t1667r461b1723],
3	,	,	O	,	_	0	SENT_247	[p13l371t1667r461b1723],
4	Qin	NN	O	qin	nn	5	SENT_247	[p13l502t1667r598b1723],
5	X	NN	O	x	appos	2	SENT_247	[p13l637t1667r689b1723],
6	,	,	O	,	_	0	SENT_247	[p13l637t1667r689b1723],
7	Rouster	NNP	O	Rouster	nn	8	SENT_247	[p13l732t1668r937b1713],
8	SD	NN	O	sd	appos	2	SENT_247	[p13l972t1667r1061b1723],
9	,	,	O	,	_	0	SENT_247	[p13l972t1667r1061b1723],
10	Yu	NN	O	yu	nn	11	SENT_247	[p13l1100t1667r1166b1713],
11	F	NN	O	f	appos	2	SENT_247	[p13l1208t1668r1247b1723],
12	,	,	O	,	_	0	SENT_247	[p13l1208t1668r1247b1723],
13	Green	NNP	O	Green	nn	14	SENT_247	[p13l1288t1667r1452b1713],
14	RM	NN	O	rm	appos	2	SENT_247	[p13l1494t1668r1596b1723],
15	,	,	O	,	_	0	SENT_247	[p13l1494t1668r1596b1723],
16	Keshavan	NNP	O	Keshavan	nn	17	SENT_247	[p13l1639t1665r1894b1713],
17	P	NN	O	p	appos	2	SENT_247	[p13l1936t1668r1963b1713],
18	et	FW	O	et	nn	19	SENT_247	[p13l2002t1671r2051b1713],
19	al.	FW	O	al.	dep	17	SENT_247	[p13l2085t1665r2142b1713],
20	.	.	O	.	_	0	SENT_247	[p13l2085t1665r2142b1713],

1	Mechanism	NN	O	mechanism	_	0	SENT_248	[p13l149t1741r465b1789],
2	of	IN	O	of	_	0	SENT_248	[p13l493t1741r546b1789],
3	indinavir-induced	JJ	O	indinavir-induced	amod	4	SENT_248	[p13l570t1741r1053b1789],
4	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	1	SENT_248	[p13l1083t1741r1622b1804],
5	.	.	O	.	_	0	SENT_248	[p13l1083t1741r1622b1804],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_249	[p13l1653t1743r1766b1789],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_249	[p13l1788t1741r1905b1789],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_249	[p13l1922t1741r2058b1789],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_249	[p13l2079t1742r2152b1789],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_249	[p13l151t1817r254b1863],
6	2001	CD	DATE	2001	num	5	SENT_249	[p13l279t1817r436b1873],
7	;	:	O	;	_	0	SENT_249	[p13l279t1817r436b1873],
8	98	CD	NUMBER	98	num	10	SENT_249	[p13l464t1817r549b1863],
9	:	:	O	:	_	0	SENT_249	[p13l464t1817r549b1863],
10	12671-12676	CD	NUMBER	12671-12676	dep	5	SENT_249	[p13l581t1817r986b1863],
11	.	.	O	.	_	0	SENT_249	[p13l581t1817r986b1863],

1	Ando	NNP	PERSON	Ando	_	0	SENT_250	[p13l144t1891r293b1939],
2	Y	NN	PERSON	y	nn	1	SENT_250	[p13l343t1893r391b1949],
3	,	,	O	,	_	0	SENT_250	[p13l343t1893r391b1949],
4	Saka	FW	PERSON	saka	dep	1	SENT_250	[p13l449t1891r570b1939],
5	H	NN	PERSON	h	dep	1	SENT_250	[p13l626t1893r680b1949],
6	,	,	O	,	_	0	SENT_250	[p13l626t1893r680b1949],
7	Ando	NNP	PERSON	Ando	nn	8	SENT_250	[p13l733t1891r882b1939],
8	M	NNP	O	M	appos	5	SENT_250	[p13l938t1893r1005b1949],
9	,	,	O	,	_	0	SENT_250	[p13l938t1893r1005b1949],
10	Sawa	NNP	ORGANIZATION	Sawa	nn	11	SENT_250	[p13l1063t1893r1203b1939],
11	T	NN	ORGANIZATION	t	appos	5	SENT_250	[p13l1254t1893r1303b1949],
12	,	,	O	,	_	0	SENT_250	[p13l1254t1893r1303b1949],
13	Muro	NNP	PERSON	Muro	nn	14	SENT_250	[p13l1362t1893r1509b1939],
14	K	NNP	PERSON	K	appos	5	SENT_250	[p13l1564t1893r1610b1949],
15	,	,	O	,	_	0	SENT_250	[p13l1564t1893r1610b1949],
16	Ueoka	NNP	LOCATION	Ueoka	nn	17	SENT_250	[p13l1669t1891r1837b1939],
17	H	NNP	O	H	appos	5	SENT_250	[p13l1894t1893r1928b1938],
18	et	FW	O	et	nn	19	SENT_250	[p13l1986t1897r2035b1939],
19	al.	FW	O	al.	dep	17	SENT_250	[p13l2085t1891r2142b1939],
20	.	.	O	.	_	0	SENT_250	[p13l2085t1891r2142b1939],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_251	[p13l149t1966r573b2029],
2	of	IN	O	of	_	0	SENT_251	[p13l614t1966r667b2014],
3	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nn	4	SENT_251	[p13l708t1966r1508b2029],
4	gene	NN	O	gene	prep_of	1	SENT_251	[p13l1549t1980r1685b2028],
5	and	CC	O	and	_	0	SENT_251	[p13l1726t1966r1827b2014],
6	irinotecan	NN	O	irinotecan	nn	7	SENT_251	[p13l1871t1967r2144b2014],
7	toxicity	NN	O	toxicity	prep_of	1	SENT_251	[p13l145t2042r364b2103],
8	:	:	O	:	_	0	SENT_251	[p13l145t2042r364b2103],
9	a	DT	O	a	det	11	SENT_251	[p13l390t2055r417b2088],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_251	[p13l443t2041r930b2103],
11	analysis	NN	O	analysis	dep	1	SENT_251	[p13l952t2041r1176b2103],
12	.	.	O	.	_	0	SENT_251	[p13l952t2041r1176b2103],

1	Cancer	NNP	O	Cancer	nn	2	SENT_252	[p13l1205t2042r1392b2088],
2	Res	NNP	O	Res	_	0	SENT_252	[p13l1410t2043r1494b2088],
3	2000	CD	DATE	2000	num	2	SENT_252	[p13l1514t2042r1671b2098],
4	;	:	O	;	_	0	SENT_252	[p13l1514t2042r1671b2098],
5	60	CD	NUMBER	60	num	7	SENT_252	[p13l1696t2042r1782b2088],
6	:	:	O	:	_	0	SENT_252	[p13l1696t2042r1782b2088],
7	6921-6926	CD	DURATION	6921-6926	dep	2	SENT_252	[p13l1809t2042r2143b2088],
8	.	.	O	.	_	0	SENT_252	[p13l1809t2042r2143b2088],

1	lyer	NN	O	lyer	nn	2	SENT_253	[p13l149t2118r248b2178],
2	L	NN	O	l	_	0	SENT_253	[p13l272t2118r310b2173],
3	,	,	O	,	_	0	SENT_253	[p13l272t2118r310b2173],
4	Das	NN	O	da	nn	5	SENT_253	[p13l339t2118r436b2163],
5	S	NN	O	s	appos	2	SENT_253	[p13l461t2117r504b2173],
6	,	,	O	,	_	0	SENT_253	[p13l461t2117r504b2173],
7	Janisch	NNP	PERSON	Janisch	nn	8	SENT_253	[p13l530t2116r718b2175],
8	L	NNP	PERSON	L	appos	2	SENT_253	[p13l747t2118r786b2173],
9	,	,	O	,	_	0	SENT_253	[p13l747t2118r786b2173],
10	Wen	NNP	O	Wen	nn	11	SENT_253	[p13l810t2117r935b2163],
11	M	NNP	O	M	appos	2	SENT_253	[p13l963t2118r1031b2174],
12	,	,	O	,	_	0	SENT_253	[p13l963t2118r1031b2174],
13	Ramirez	NNP	PERSON	Ramirez	nn	14	SENT_253	[p13l1061t2117r1277b2163],
14	J	NNP	PERSON	J	appos	2	SENT_253	[p13l1298t2118r1327b2175],
15	,	,	O	,	_	0	SENT_253	[p13l1298t2118r1327b2175],
16	Karrison	NNP	PERSON	Karrison	nn	17	SENT_253	[p13l1357t2117r1575b2163],
17	T	NN	O	t	appos	2	SENT_253	[p13l1599t2118r1634b2163],
18	et	FW	O	et	nn	19	SENT_253	[p13l1658t2121r1707b2163],
19	al.	FW	O	al.	dep	17	SENT_253	[p13l1727t2116r1785b2163],
20	.	.	O	.	_	0	SENT_253	[p13l1727t2116r1785b2163],

1	UGT1	NN	O	ugt1	nn	2	SENT_254	[p13l1814t2117r1958b2163],
2	A1	NN	O	a1	_	0	SENT_254	[p13l1972t2117r2033b2163],
3	*	CD	NUMBER	*	number	4	SENT_254	[p13l2050t2117r2145b2163],
4	28	CD	NUMBER	28	num	5	SENT_254	[p13l2050t2117r2145b2163],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_254	[p13l148t2191r549b2254],
6	as	IN	O	as	_	0	SENT_254	[p13l579t2205r631b2239],
7	a	DT	O	a	det	8	SENT_254	[p13l659t2205r686b2239],
8	determinant	NN	O	determinant	prep_as	5	SENT_254	[p13l715t2191r1060b2239],
9	of	IN	O	of	_	0	SENT_254	[p13l1086t2191r1139b2239],
10	irinotecan	NN	O	irinotecan	nn	11	SENT_254	[p13l1166t2192r1438b2239],
11	disposition	NN	O	disposition	prep_of	8	SENT_254	[p13l1468t2191r1764b2254],
12	and	CC	O	and	_	0	SENT_254	[p13l1795t2191r1895b2239],
13	toxicity	NN	O	toxicity	prep_of	8	SENT_254	[p13l1924t2192r2143b2254],
14	.	.	O	.	_	0	SENT_254	[p13l1924t2192r2143b2254],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_255	[p13l149t2266r667b2329],
2	/	:	O	/	punct	3	SENT_255	[p13l687t2268r707b2325],
3	2002	CD	DATE	2002	dep	1	SENT_255	[p13l729t2267r886b2324],
4	;	:	O	;	_	0	SENT_255	[p13l729t2267r886b2324],
5	2	CD	NUMBER	2	num	7	SENT_255	[p13l915t2267r963b2314],
6	:	:	O	:	_	0	SENT_255	[p13l915t2267r963b2314],
7	43-47	CD	NUMBER	43-47	dep	3	SENT_255	[p13l990t2268r1180b2314],
8	.	.	O	.	_	0	SENT_255	[p13l990t2268r1180b2314],

1	Holmes	NNP	PERSON	Holmes	nn	3	SENT_256	[p13l149t2341r353b2388],
2	Jr	NNP	PERSON	Jr	nn	3	SENT_256	[p13l373t2343r412b2399],
3	DR	NN	PERSON	dr	_	0	SENT_256	[p13l433t2343r524b2398],
4	,	,	O	,	_	0	SENT_256	[p13l433t2343r524b2398],
5	Savage	NN	O	savage	nn	6	SENT_256	[p13l550t2342r742b2403],
6	M	NN	O	m	appos	3	SENT_256	[p13l767t2343r834b2398],
7	,	,	O	,	_	0	SENT_256	[p13l767t2343r834b2398],
8	LaB	NN	O	lab	nn	10	SENT_256	[p13l862t2341r1138b2388],
9	|	NN	O	|	nn	10	SENT_256	[p13l862t2341r1138b2388],
10	anche	NN	O	anche	appos	3	SENT_256	[p13l862t2341r1138b2388],
11	]	CD	NUMBER	]	num	12	SENT_256	[p13l1158t2343r1246b2399],
12	M	NN	O	m	dep	10	SENT_256	[p13l1158t2343r1246b2399],
13	,	,	O	,	_	0	SENT_256	[p13l1158t2343r1246b2399],
14	Grip	NN	ORGANIZATION	grip	nn	15	SENT_256	[p13l1272t2342r1389b2403],
15	L	NN	ORGANIZATION	l	appos	3	SENT_256	[p13l1413t2343r1452b2398],
16	,	,	O	,	_	0	SENT_256	[p13l1413t2343r1452b2398],
17	Serruys	NNP	PERSON	Serruys	nn	18	SENT_256	[p13l1477t2342r1675b2403],
18	PW	NNP	O	PW	appos	3	SENT_256	[p13l1699t2342r1800b2398],
19	,	,	O	,	_	0	SENT_256	[p13l1699t2342r1800b2398],
20	Fitzgerald	NNP	PERSON	Fitzgerald	nn	21	SENT_256	[p13l1828t2341r2092b2403],
21	P	NN	O	p	appos	3	SENT_256	[p13l2119t2343r2146b2388],
22	et	FW	O	et	nn	23	SENT_256	[p13l148t2423r197b2465],
23	al.	FW	O	al.	dep	21	SENT_256	[p13l214t2417r272b2465],
24	.	.	O	.	_	0	SENT_256	[p13l214t2417r272b2465],

1	Results	NNS	O	result	nsubj	11	SENT_257	[p13l298t2417r482b2465],
2	of	IN	O	of	_	0	SENT_257	[p13l502t2417r556b2465],
3	Prevention	NNP	O	Prevention	prep_of	1	SENT_257	[p13l576t2418r867b2465],
4	of	IN	O	of	_	0	SENT_257	[p13l890t2417r943b2465],
5	REStenosis	NN	O	restenosis	prep_of	3	SENT_257	[p13l963t2418r1249b2465],
6	with	IN	O	with	_	0	SENT_257	[p13l1267t2417r1387b2465],
7	Tranilast	NN	O	tranilast	prep_with	5	SENT_257	[p13l1407t2417r1642b2465],
8	and	CC	O	and	_	0	SENT_257	[p13l1660t2417r1760b2465],
9	its	PRP$	O	its	poss	10	SENT_257	[p13l1784t2418r1840b2465],
10	Outcomes	NNS	O	outcome	prep_with	5	SENT_257	[p13l1861t2419r2146b2465],
11	(	VBP	O	(	_	0	SENT_257	[p13l147t2492r406b2551],
12	PRESTO	NNP	O	PRESTO	nsubj	14	SENT_257	[p13l147t2492r406b2551],
13	)	CD	NUMBER	)	num	14	SENT_257	[p13l147t2492r406b2551],
14	trial	NN	O	trial	xcomp	11	SENT_257	[p13l433t2492r551b2540],
15	.	.	O	.	_	0	SENT_257	[p13l433t2492r551b2540],

1	Circulation	NN	O	circulation	_	0	SENT_258	[p13l583t2492r867b2540],
2	2002	CD	DATE	2002	num	1	SENT_258	[p13l891t2493r1048b2550],
3	;	:	O	;	_	0	SENT_258	[p13l891t2493r1048b2550],
4	106	CD	NUMBER	106	num	6	SENT_258	[p13l1080t2493r1198b2540],
5	:	:	O	:	_	0	SENT_258	[p13l1080t2493r1198b2540],
6	1243-1250	CD	DATE	1243-1250	dep	1	SENT_258	[p13l1229t2493r1562b2540],
7	.	.	O	.	_	0	SENT_258	[p13l1229t2493r1562b2540],

1	www.nature.com/tpj	NN	O	www.nature.com/tpj	_	0	SENT_259	[p13l1595t2744r2145b2803],

